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Abstract
Dilated cardiomyopathy (DCM) is common in pedigree dog breeds including
Newfoundlands. The breed predisposition and the familial prevalence within breeds support
a genetic basis to the disease. Familial occurrence of DCM has only recently been
recognised in man, and echocardiography abnormalities are common in relatives of DCM
patients.
Echocardiography is the method of choice for confirming the diagnosis of DCM.
Echocardiographic/Doppler data are presented from 223 scans from 165 individual
Newfoundland dogs. The scans were categorised into six groups based on the clinical
presentation, M-mode echocardiography results and the Doppler derived aortic velocity.
The Normal group showed no abnormalities (n=86). The DCM (overt or occult) group had
a rounded left ventricle and fractional shortening (FS) <22% (n=35). There were two
depressed fractional shortening groups, without other abnormalities; one with FS less than
18% (dFS<18%) (n=29) and the other with FS 18-20% (dFS18-20%) (n=24). The left
ventricular enlargement (LVE) group was defined as a LV diastolic dimension greater than
55mm (males) or >50 mm (females), without any M-mode evidence of systolic dysfunction
(n=8). Dogs with an aortic velocity exceeding 1.7 m/s were defined as showing evidence of
subaortic stenosis (SAS group) (n=40).
Data from complete echocardiographic/Doppler analysis of the Normal group were assessed
for dependence on the gender, age and size of dog (weight or body surface area (BSA)) and
the heart rate (mean R-R interval) by linear regression analyses. LV volumes and M-mode
measurements were positively correlated with size. Gender was not an important predictor
of most echo measurements once data was normalised for BSA. Advancing age was a
significant negative predictor of LV volumes and dimensions although influence on wall
thickness was not significant. Age also showed a significant influence on diastolic function,
assessed by mitral inflow and pulmonary venous flow, similar to changes described in man.
The Newfoundland groups were compared. The DCM group had significantly increased LV
volume and dimensions and decreased systolic function than other groups. There were few
significant differences between the groups for diastolic function parameters. There was
considerable overlap between groups for all dimensions and the parameters of systolic
function, although the pre-ejection period: ejection time (PEP:ET) ratio appeared to be most
sensitive for distinguishing normal from DCM dogs. In both dFS groups and the LVE group,
this ratio was intermediate between the Normal and DCM groups, in contrast to other
parameters of systolic function. Left atrial dysfunction was also identified in the DCM
group, but was less marked in both dFS and the LVE groups. Some dogs in the LVE and
dFS groups progressed to develop DCM but a longer duration of study would be required
before firm conclusions can be drawn about progression.
Most of the dogs in this study were related. Pedigree and segregation analyses were
supportive but not conclusive for an autosomal dominant mode of inheritance for DCM. A
simulated linkage analysis indicated that this family was sufficiently informative for a
genetic linkage analysis study. A pilot study assessing a number of anonymous canine
microsatellites confirmed that there was sufficient heterozygosity and polymorphism,
despite significant inbreeding, to permit a genetic linkage analysis study. No significant
LOD score was achieved for the twelve microsatellites assessed. However, the available
data indicate that a genome-wide linkage analysis is likely to be successful, with
phenotyping based on the echocardiography data.
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Aims of this study
(i) A major aim of this study was to produce echocardiography / Doppler criteria of
normality for the specific breeds susceptible to dilated cardiomyopathy and to
identify factors affecting the various parameters.
(ii) To examine the use of echocardiography in screening dogs for evidence of occult
dilated cardiomyopathy in breeds susceptible to dilated cardiomyopathy.
(iii) To carry out serial evaluation of individuals with echocardiographic parameters
which were abnormal to determine the significance of such abnormalities and
whether they allow prediction of occult dilated cardiomyopathy.
(iv) To determine the mode of inheritance of familial dilated cardiomyopathy in
susceptible breeds and to ascertain whether the family under investigation would be
suitable for a genetic linkage analysis study.








Cardiomyopathies are defined as diseases of the myocardium associated with cardiac
dysfunction (Richardson et al 1996). The original World Health Organisation
classification included three major morphological types of cardiomyopathy; dilated,
hypertrophic and restrictive. The new classification is by dominant pathophysiology
or, where possible, by aetiological / pathogenetic factors (Richardson et al 1996). The
1995 World Health Organisation / International Society and Federation of Cardiology
Task Force on the definition and classification of cardiomyopathies defined dilated
cardiomyopathy as being characterised by dilatation and impaired contraction of the
left ventricle or both ventricles (Richardson et al 1996). A number of different
definitions of dilated cardiomyopathy are present in the literature, but it is striking
that rather than an actual definition, most authors, as in the WHO classification,
describe the condition as being characterised by left ventricular dilatation and
dysfunction (Thomas 1987; Calvert 1995b; Monnet et al 1995; Sisson & Thomas
1995; Freeman et al 1996). One of the best working definitions of the canine disease
was given by Cobb (1992) who defined idiopathic dilated cardiomyopathy as a
"condition of unknown aetiology characterised by a progressive dilatation of one or
both ventricles with severe impairment of systolic function and a high end-diastolic
pressure, excluding congenital, coronary arterial, hypertensive, vascular, pulmonary
parenchymal, valvular or other cardiovascular disorders". This was based on the
definition by Wynne and Braunwald (1992). Some authors include the presence of
arrhythmias and the poor prognosis in the definition (Freeman et al 1996), some note
that left atrial dilatation is usually present (Ware & Bonagura 1986) and others
include in the definition the presence of some myocardial hypertrophy (Keene 1989;
ISACHC 1995).
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Idiopathic dilated cardiomyopathy is probably not a single disease but the result of a
variety of different pathological processes or defects in myocardial metabolism
leading to chronic end-stage organ failure (Keene 1989). Primary idiopathic dilated
cardiomyopathy is a diagnosis of exclusion (Thomas 1987) and greater
understanding of this condition will result in expansion of some of the secondary
cardiomyopathy categories.
Secondary cardiomyopathies may be categorised by aetiology and have been listed
(Church 1980; Wood 1983; Ware & Bonagura 1986; Thomas 1987; Fox 1988; Fox
1989; Cobb 1992; Calvert 1995a; Sisson & Thomas 1995). Secondary
cardiomyopathies will expand with increased understanding of the aetiopathogeneisis
of idiopathic dilated cardiomyopathy.
A.2. Canine idiopathic dilated cardiomyopathy
A.2.1. A historical perspective
Idiopathic dilated cardiomyopathy (DCM) was first reported in the veterinary
literature in 1970 (Ettinger et al 1970; Ettinger & Suter 1970) having been
recognised in the US in the late 1960s (Thomas 1987). Atrial fibrillation was said to
be a constant feature of DCM in the earliest literature (Ettinger & Suter 1970). Initial
veterinary reports stated that right sided heart failure signs preceding left sided failure
(Ettinger et al 1970; Ettinger & Suter 1970). This discrepancy with what is generally
appreciated about the disease today, with a predominance of left sided heart failure
(Sisson & Thomas 1995) may reflect improved clinical recognition of the disease and
earlier diagnosis.
Even shortly prior to 1970, the veterinary literature did not recognise any syndromes
typical of DCM (Detweiler & Patterson 1965; Luginbtihl & Detweiler 1965; Bishop
1971). Atrial fibrillation was treated as a "primary diagnosis" in the early literature.
, Ettinger (1971) described atrial fibrillation occurring secondary to left ventricular
dilatation in middle aged giant breed dogs but did not specify any underlying
myocardial disease or cardiomyopathy. In a series of cases with atrial fibrillation
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cases reported by Bohn and colleagues (1971), a high breed specific prevalence rate
of atrial fibrillation in giant breeds such as Newfoundlands, great Danes, St.
Bernards, Irish Wolfhounds and also the Dobermann was recorded, and it is
reasonable to speculate with the benefit of hindsight that many of these dogs had
DCM. The poor prognosis associated with congestive failure and atrial fibrillation
was noted by Bohn and colleagues (1971) although these authors also comment on
the improved prognosis associated with atrial fibrillation in giant breeds of dogs. A
trend to increased survival in dogs with atrial fibrillation was noted to be weakly
correlated to body weight by Boeve and others (1984).
In the early literature, there appears to have been some confusion about the diagnosis
of DCM and distinguishing it from congenital heart disease, especially conditions
resulting in mitral insufficiency (Hamlin et al 1965; Hamlin & Harris; 1969; Dear
1971; Lord 1974).
Other early case reports detailing the findings in DCM are sparse. Church et al
(1976) published a case report in an Irish Setter and Wilkes (1980) detailed the
findings in giant breeds of dogs. The condition is covered by book chapters (Dear
1974; Ettinger 1975; Ogburn 1977; Bond & Tilley 1980; Harpster 1983; Wood 1983;
Tilley et al 1983) and Lord (1974; 1976) published results of some impressive
observations about assessment of systolic and diastolic function in DCM.
The literature variously refers to the condition as cardiomyopathy (Darke & Else
1984) (unclassified), idiopathic cardiomyopathy (Ettinger & Suter 1970; Ettinger et
al 1970), myocardiopathy (Dear 1971; Otter 1991); congestive cardiomyopathy
(Ogburn 1977; van Fleet et al 1981), idiopathic congestive cardiomyopathy (Ettinger
1975; Church et al 1976; Wilkes 1980; McCarthy 1984; Thomas 1987b), congestive
(dilated) cardiomyopathy (Wood 1983), dilated cardiomyopathy (Lombard 1984a)
and idiopathic dilated cardiomyopathy (Cobb 1992). The latter term is now generally
accepted in the human and veterinary literature, although with increasing knowledge
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about aetiological factors, fewer cases are likely to be defined as idiopathic in the
future.
A.2.2. Prevalence of canine dilated cardiomyopathy
Few estimates of the incidence or prevalence of DCM have been published although
Keene (1989) felt that the incidence was increasing. Sisson & Thomas (1995)
published details about the prevalence of this condition in the United States, deriving
information from the Veterinary Medical Database at Purdue University for 1986 -
1991.
The overall prevalence was about 0.5% although if this was analysed further,
prevalence rates were much higher in pedigree dogs (0.65%) than mixed breed dogs
(0.16%). They confirmed that it was predominantly a disease of large and giant
breeds and dogs under 12 kg were rarely affected. Overall, males were predisposed
(0.66%) compared with bitches (0.34%) although it was noted that where the
inclusion was dependent on identification of the presence of congestive heart failure,
this may underestimate the prevalence in females (Sisson & Thomas 1995).
Breed specific prevalences were recorded. DCM appeared to be most prevalent in
Deerhounds (6.0%) although numbers were low compared with the other predisposed
breeds. In order of frequency, breed prevalence was 5.8% Dobermanns, 5.6% Irish
wolfhounds, 3.9% great Danes, 3.4% boxers, 2.6% St. Bernards, 1.7% Afghan
hounds, 1.3% Newfoundlands, 0.9% old English sheepdogs, 0.69% English cocker
spaniels and 0.34% American cocker spaniels. The prevalence increased with age.
Boxers, Dobermanns and great Danes were analysed in different age groups, which
showed a trend to increasing prevalence in older dogs.
A.2.3. Prevalence in Man
In man, a prevalence of DCM has been quoted as 36.5/100 000 with an annual
incidence of 8 per 100 000 in the US literature (Wynne & Braunwald 1997). In
Sweden, an autopsy survey gave an incidence of 5 per 100 000. These figures are felt
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to be an underestimate because DCM has a long preclinical phase during which the
patient is asymptomatic and remains undiagnosed (Keeling & McKenna 1994). In an
Italian study, with relative screening of new cases, the autopsy incidence
(4.5 / 100 000 / year) and the new cases diagnosed (2.45 / 100 000 / year) were added
to give an annual incidence rate of 6.95 cases per 100 000 population per year (Rakar
et al 1997), although this addition was criticised as potentially over-estimating cases
by Tavazzi (1997). There is increased risk of disease in males and the black
population (Mestroni et al 1994b). DCM is the leading reason for cardiac
transplantation in the world (Mestroni et al 1994b).
A.3. Aetiology of DCM
By definition, idiopathic DCM is of unknown aetiology, although this may merely
reflect the current lack of understanding of aetiopathogenesis (Cobb 1992). Indeed,
with increasing understanding of the aetiology and pathogenesis, the difference
between cardiomyopathy and specific heart muscle disease has become indistinct
(Richardson et al 1996). It is probable that the condition does not reflect a single
clinical entity but represents end-stage myocardial failure resulting from a wide
variety of disorders (Thomas 1987; Keene 1989). Indeed, the original myocardial
insult may not have been recognised and the offending cause is no longer apparent at
the time of presentation (Cobb 1992) and end-stage human DCM often cannot be
linked to a specific aetiology (McMinn & Ross 1995). Some potential aetiological
factors have been reviewed (Cobb 1992). One or more subcellular metabolic
abnormalities are suspected as being responsible for the myocardial failure (Thomas
1987; Sisson & Thomas 1995; ISACHC 1995). Dear (1974) showed foresight in
describing that the idiopathic cardiomyopathies probably had an underlying
metabolic (biochemical) or an ultrastructual defect. The fact that the disease occurred
predominantly in large, fast growing breeds of dog led Bond and Tilley (1980) to
postulate hereditary and nutritional factors. An inherited or genetic basis to canine
DCM has received increasing support, as reviewed in Section C of this thesis.
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In man, many factors, alone or in combination, can contribute to the development of
DCM, including excessive alcohol consumption (McKenna et al 1998), hypertension,
myocarditis, pregnancy, diabetes mellitus, doxorubicin therapy and secondary to a
generalised disorder (Abelmann & Lorrell 1989; McMinn & Ross 1995).
Currently, three major aetiopathogenetic mechanisms are hypothesised in human
DCM (Mestroni et al 1994a;b):
(i) Enteroviral infection with viral persistence leading to chronic myocardial
damage
(ii) Autoimmune heart disease, with humoral and cellular immune
dysfunction
(iii) The presence of a primary genetic defect which could act separately or in
association with one of the categories above.
These three pathogenetic factors may all be closely linked (Keeling & McKenna
1994). Detailed discussion of the possible aetiology is beyond the scope of this
thesis. The evidence for a genetic basis to DCM is reviewed and discussed in
Section C of this thesis.
A.4. Biochemical defects associated with canine DCM
Biochemical abnormalities have been reported in association with DCM (Bishop
1987). More specific biochemical abnormalities have been found in some dogs with
DCM which include a variety of abnormalities in Dobermann DCM. Although
biochemical abnormalities may offer evidence for a genetic basis for DCM, they may
merely be a consequence of heart failure.
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A.4.1. Biochemical defects in energy production within the myocardium of
cardiomyopathic Dobermanns
McCutcheon and colleagues (1992) investigated the hypothesis that a myocardial
metabolic defect was associated with naturally occurring Dobermann DCM. In DCM,
the myocardium had greatly reduced mitochondrial electron transport activity (50%
reduced) and myoglobin concentration (90% reduced). The myoglobin deficiency
was investigated in further detail. O'Grady and others (1992) reported that
myocardial myoglobin deficiency may be an aetiological factor for Dobermann DCM
and that normal Dobermanns had lower myoglobin concentration than mongrels,
associated with subclinical systolic dysfunction in this breed. Myoglobin levels
decrease in all models of heart failure, and were correlated with mitochondrial and
sarcoplasmic reticular ATPase activities and parameters of cardiac performance
(O'Brien et cil 1992). Myoglobin is known to protect the heart from hypoxia by
functioning as a sarcoplasmic oxygen reservoir and shuttle. Myoglobin deficiency
was implicated in the pathogenesis of congestive heart failure and possibly the
predisposition of Dobermanns to DCM (O'Brien et cil 1992).
DCM is known to be associated with derangement of myocardial sarcoplasmic
calcium (Ca) homeostasis and energy production. O'Brien and co-workers (1995)
investigated calcium cycling of the sarcoplasmic reticulum, by assessing both
mRNA and expression of the Ca release channel and Ca ATPase of the sarcoplasmic
reticulum. An asymmetric down-regulation of the Ca cycle was identified, with the
Ca channel more depressed than the Ca ATPase. The mRNA and enzyme contents
of the markers of the glycolytic and oxidative phosphorylation pathways were down-
regulated in DCM, but the markers of the TCA (tricarboxylic acid) cycle and
ribosomal RNA were up-regulated. Another interesting observation was that mRNA
was more degraded in cardiomyopathic than normal hearts. These authors concluded
that transcriptional and translational responses to the pathophysiology of
cardiomyopathy are responsible for the major determinants of the metabolic
responses seen in heart failure. Changes specific to the entity of Dobermann DCM
were not recognised.
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The cardiomyoctye cellular energy deficiency associated with Dobermann DCM,
evidenced by these various biochemical abnormalities, was postulated to be due to
an abnormality of the creatinine kinase (CK) system, which plays a dominant role in
energy cycling (O'Brien 1997). In this system, the mitochondrial isoenzyme of CK
uses ATP to produce creatine phosphate, which is utilised by the myofibrillar
isoenzyme of CK (CK-MM) and the cytosolic isoenzyme of CK (CK-MB) to
replenish ATP that has been hydrolysed during contractile and ion-transport
activities. In Dobermann DCM, cytosolic CK-MB was significantly reduced, by 50%
compared with controls. This relative deficiency of CK-MB may have a central role
in the energy deficiency associated with this condition. It is in marked contrast to the
relative increase in CK-MB associated with a decrease in total CK in human and
Syrian hamster DCM but is similar to the findings of cardiomyopathy associated with
diabetes mellitus or dietary restriction. O'Brien (1997) therefore concluded that these
changes may be related to deficiency of an energy substrate or of delivery of this
substrate within the cardiomyocyte.
Although biochemical defects as a result of a genetic abnormality are an attractive
hypothesis supporting the genetic aetiology of DCM, these results demonstrate that
caution must be urged in differentiating identified biochemical abnormalities as a
consequence of the heart disease rather than the cause of the heart disease.
Some abnormalities in energy production have also been implicated in human DCM.
Bonnet and colleagues (1998) metabolically screened consecutive childhood
cardiomyopathies. They assessed mitochondrial respiratory chain complex activity in
endomyocardial or skeletal muscle biopsies, and found respiratory chain enzyme
deficiency in seven patients, with defects confined to the myocardium in six of these
children. Antozzi and Zeviani (1997) reviewed the disorders of cardiac energy
metabolism, including defects ofmitochondrial oxidative phosphorylation.
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A.4.2. Altered [i receptor function
Hoey and colleagues (1991) reported on the findings from four dogs with DCM. Pi
receptor density was preserved in the left ventricle although P2 density was reduced.
A reduction in cyclic AMP production stimulated via adenylate cyclase was
interpreted to reflect a post receptor defect or dysfunction of a catalytic subunit of
adenylate cyclase.
Tarducci and colleagues (1998) compared the P adrenergic receptor density on
lymphocytes in six great Danes with cardiomyopathy and six normal great Danes. A
significant reduction in density of both total p receptors, and Pi and P2 receptor
subtypes was identified. This is consistent with prolonged sympathetic stimulation or
to the presence of auto-antibodies against the p receptor.
A.4.3. Myocardial L-carnitine deficiency
Myocardial L-camitine deficiency has been identified in a family of Boxers with
DCM (Keene et a/ 1991). L-carnitine (3 hydroxy 4-N-trimethylaminobutyric acid) is
synthesised in the liver and is soluble in the plasma, concentrating in skeletal and
cardiac myocytes by an ill-defined transport mechanism. Adequate myocardial
concentration of L-carnitine has been shown to be critical for fatty acid metabolism.
Long chain free fatty acids are quantitatively the most important energy producing
substrate in the myocardium (Keene 1991). Free fatty acids are esterified and L-
camitine is required to catalyse their transfer across the outer and inner mitochondrial
membranes, to release acetyl CoA for p oxidation of fats and energy production.
Normally, plasma and myocardial L-carnitine levels are closely correlated (Pion et a/
1998). As plasma levels of L-carnitine are usually normal or even high in affected
dogs while endomyocardial biopsy confirmed low myocardial L-carnitine levels, it is
thought that an abnormality of the membrane transport from plasma into myocardial
cells underlies this form ofmyocardial failure (Keene 1991; 1992), which is certainly
familial and possibly inherited in the Boxer breed (Keene et at 1991).
Supplementation of L-camitine at 220 mg/kg per day orally divided as three doses
results in clinical improvement after one to four weeks and echocardiographic
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improvement from two to three months of the start of dosing, although after six
months of treatment, they plateau with generally subnormal left ventricular function.
Some Dobermanns may have myocardial L-carnitine deficiency (Keene et al 1989).
In man, L-carnitine deficiency has been associated with familial DCM in children,
where an abnormality of renal tubular reabsorption of L-carnitine and increased
fractional excretion of carnitine was believed to be responsible for one case (Waber
et al 1982). Elimination of carnitine deficiency as a factor in familial DCM in man is
considered mandatory (McMinn & Ross 1995; Bonnet et al 1998). As well as DCM,
other systemic signs reported in some affected children include hypoketotic
hypoglyaemia and a skeletal myopathy (Antozzi & Zeviani 1997).
There is no evidence that carnitine supplementation in the absence of myocardial
deficiency has any beneficial effect (Keene 1992). L-carnitine is expensive to use
routinely in cases where documented deficiency has not been shown (Keene 1991).
However, Abelmann and Lorrell (1989) reviewed the literature suggesting that
supplementation in experimental doxorubicin-induced cardiomyopathy or Syrian
hamster cardiomyopathy may be beneficial.
A.4.4. Taurine deficiency
Since a reversible dilated cardiomyopathy associated with dietary taurine deficiency
and supplementation was reported in cats (Pion et al 1987), this condition is now of
greatly reduced incidence in this species following action by pet food manufacturers
(Pion 1998). Although the high concentration of taurine in the myocardium is
appreciated, the role played by taurine is poorly understood (Pion et al 1998). It is
believed to play a role in inotropy, antiarrhythmia, enhanced sarcolemmal calcium
binding properties, carbohydrate metabolism and osmotic regulation (Kramer et al
1995). Human patients with heart failure and some dogs with valvular heart disease
are reported to have increased myocardial taurine concentrations (Pion et al 1987;
Kramer & Fox 1989; Kramer et al 1995) and this is believed to be a compensatory
mechanism. Most dogs with DCM do not have decreased plasma levels of taurine;
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indeed levels may be significantly increased (Kramer & Fox 1989), but American
cocker spaniels and golden retrievers with DCM may have a low plasma taurine
(Kramer et al 1995). The association between low plasma taurine concentration and
American cocker spaniel DCM has been proposed although this breed did not appear
to respond to taurine supplementation as convincingly as cats (Pion et al 1998).
However, when taurine deficient (<50 nmol/ml) American cocker spaniels were
treated with both taurine and L-carnitine in a double blind, placebo controlled study,
echocardiographic and clinical improvement was recognised (Kittleson et al 1997).
There has been some controversy over whether taurine levels should be assessed in
whole blood or plasma. Sanderson and colleagues (1998) suggested that both should
be done simultaneously to accurately predict tissue (cardiac or skeletal muscle)
levels. Heparinised samples are normally obtained (Pion 1998).
A.4.5. Other nutritional factors
Nutritional factors were also implicated in a report on DCM in nine Dalmations
which were fed a prescription diet to treat or prevent urate urolithaisis, common in
the breed as a familial abnormality of urate metabolism (Freeman et al 1996). This
diet is restricted in proteins, nucleic acids, calcium, phosphate, magnesium, sodium
and copper. However, it appears that the probable aetiology of the cardiomyopathy
in these dogs is due to urinary loss of other amino-acids including taurine and
carnitine (Pion et al 1998) and these authors urged that breeds of dog with the
potential for developing urate or cysteine urolithiasis should receive taurine and
carnitine supplementation if DCM is acquired, as well as conventional medication.
Selenium and thiamine deficiencies are known to cause or contribute to the
development of DCM in various species (Abelmann & Lorrell 1989; Freeman et al
1996).
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A.5. Pathophysiology of dilated cardiomyopathy
Various aspects of the pathophysiology of DCM are discussed in the literature
(Bonagura & Ware 1986; Thomas 1987; Fox 1988; Sisson & Thomas 1995; Calvert
1995b; ISACHC 1995). DCM is associated primarily with systolic or pump failure
which initially and predominantly affects the left ventricular myocardium. Impaired
contractility results in decreased stroke volume and decreased rate of rise of left
ventricular pressure (dP/dt). Increased left ventricular end-systolic and end-diastolic
volumes result (volume overloading), causing increased wall stress with
compensatory sarcomere replication in series (eccentric hypertrophy) (La Place
relationship). Reduced stroke volume mediates a baroreceptor response, reflexly
increasing sympathetic drive (and withdrawal of vagal tone). Pi stimulation results in
increased heart rate (and contractility where there is sufficient myocardial reserve)
and stimulation of renin release from the juxtaglomerular apparatus of the kidney, cti
stimulation results in arteriolar constriction, increasing peripheral vascular resistance
to maintain blood pressure and venoconstriction, increasing preload thereby
attempting to improve stroke volume by the Frank-Starling mechanism. Renin
release is also stimulated by reduced renal perfusion pressure, and these factors
activate the renin-angiotensin-aldosterone system (RAAS). Angiotensin II has a
number of potent effects. It is a potent vasoconstrictor, augmenting the a adrenergic
effects. It increases synthesis and release of aldosterone resulting in increased sodium
and water retention, which increases preload. Angiotensin II also has effects on the
central nervous system causing increased thirst, increased synthesis and release of
vasopressin (antidiuretic hormone) and increasing sympathetic drive further.
Angiotensin II also plays a role in myocardial and vascular remodelling. The
cardiovascular system is able to compensate for the disease initially and dogs remain
asymptomatic for a considerable time as a result of various neurohormonal
compensatory mechanisms. Eventually the effects become detrimental in the chronic
setting and the patient shows overt signs of congestive heart failure.
Left ventricular dilatation eventually is out of proportion to hypertrophy and as left
ventricular end-diastolic pressure increases, filling pressures increase, resulting in
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increased left atrial pressure and gradual dilatation. From La Place's relationship, it
can be appreciated that the left ventricular dilatation with relatively thin walls
increases wall stress. The atrioventricular annulus becomes dilated and this, possibly
in association with papillary muscle dysfunction, results in mitral regurgitation,
exacerbating left atrial / left ventricular volume overload. Pulmonary venous
congestion and pulmonary oedema result from left sided heart failure. Increased
afterload and wall stress causes increased myocardial oxygen consumption and areas
of ischaemia or overt myocardial damage may result in ventricular ectopy. The
incessant tachycardia recognised in patients with high sympathetic drive due to
congestive heart failure also increases myocardial oxygen consumption as well as
compromising diastolic function. Increased left atrial size and pressure may cause the
development of atrial fibrillation especially in giant breeds. Atrial fibrillation is a
haemodynamically important arrhythmia in dilated cardiomyopathy as it may reduce
the cardiac output by up to 25% by the mechanisms of:
(i) loss of atrial contraction and atrioventricular synchronisation
(ii) increased ventricular rate with reduced diastolic filling time
(iii) the variable R-R interval resulting in erratic cardiac filling (Bonagura & Ware
1986)
(iv) In addition, the persistent tachycardia usually recognised with atrial fibrillation
may cause or exacerbate signs of congestive heart failure, as in paced canine
models of congestive heart failure (Allworth et al 1995).
A.6. Clinical signs associated with DCM
The presenting signs are well described in text books and include weakness, lethargy,
dyspnoea, exercise intolerance, cough, anorexia, weight loss, abdominal distension
and syncope (Bond & Tilley 1980; Wilkes 1980; Darke & Else 1984; Darke 1985;
Ware & Bonagura 1986; Thomas 1987; Fox 1988; 1989; Keene 1989; Calvert 1995b;
Sisson & Thomas 1995). Weight loss and skeletal muscle wasting is often dramatic
(Keene 1989). Most clinicians consider this finding to be associated with a grave
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prognosis although weight loss was not statistically found to be an prognostic
indicator of survival (Monnet et al 1995).
Clinical examination of the dog with congestive heart failure due to DCM is usually
characteristic for the condition (Darke & Else 1984; Bond, 1985; Darke 1985; Ware
& Bonagura 1986; Thomas 1987; Fox 1988; 1989; Calvert 1995b; Sisson & Thomas
1995). Clinical findings include the following: pale mucous membranes, sluggish
capillary refill, weak peripheral pulse and cold extremities, weak precordial impulse,
quiet or muffled heart sounds, irregular heart rate and pulse rate, variable pulse
volume and pulse deficit, chaotic rhythm or ectopy, soft systolic murmurs and
diastolic gallop sounds. Clinical signs of left sided congestive failure include a
shallow tachypnoea to overt dyspnoea with ausculatory evidence of pulmonary
oedema. Clinical signs of right sided heart failure include jugular venous distension,
hepatomegaly, a positive hepatojugular reflux and abdominal distension due to
ascites. A pleural effusion may be appreciated. Sometimes the clinical signs due to
low cardiac output predominate over the congestive signs (cardiogenic shock).
Muscle wasting may be clinically evident, especially over the temporal muscles and
the thoracic and lumbar spinal epaxial muscles.
The presence of cardiac disease, evidence of cardiomegaly and the severity of clinical
signs are variously used to classify heart failure in the New York Heart Association
(NYHA) (Keene & Bonagura 1995) or the newer International Small Animal Cardiac
Health Council (ISACHC) classifications (ISACHC 1995).
A.7. Diagnosis ofDCM
Lombard (1984a) wrote that the clinical diagnosis of DCM may be based on
signalment (particularly breed), the presence of congestive failure (left sided or
generalised), radiographic evidence of moderate to severe cardiomegaly and the
absence of loud heart murmurs suggesting congenital heart disease or acquired
valvular heart disease. Even today, with more sophisticated techniques available, it is
still a diagnosis of exclusion. However, standard diagnostic tests used include
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electrocardiography, radiography and echocardiography and overall patient health
and consequences of heart failure or drug treatment are assessed by clinical
pathology. In man, the diagnosis of DCM is based on physical and non-invasive
(echocardiographic) examinations with investigations to exclude other disease
(Mestroni et al 1994b). There are practical difficulties in making the diagnosis of
DCM, as recognised in humans by Keeling and McKenna (1994). In man, the
exclusion of coronary artery disease and hypertensive disease is required (both
uncommon in the dog) as well as valvular and pericardial disorders and other specific
heart diseases including myocarditis and alcohol induced cardiomyopathy. In man,
selective coronary artery angiography, indicated to exclude coronary artery disease, is
required to confirm a diagnosis of DCM and in many centres, so is endomyocardial
biopsy to exclude myocarditis (Keeling et al 1995), although this is still controversial
(Keeling & McKenna 1994). There have been occasional reports of myocardial
infarction in dogs (e.g. DeFrancesco et al 1996). Myocarditis appears to be more rare
in dogs than in man. The technique of obtaining endomyocardial biopsy samples
from dogs has been described (Keene et al 1990) and is not without risk. The
importance of strict diagnostic criteria for DCM has been emphasised (Keeling &
McKenna 1994; Keeling et al 1995).
In dogs, the signalment, history and clinical signs will usually result in a high index
of suspicion about the diagnosis of DCM. Most cardiologists will perform ancillary
examinations to confirm the diagnosis and to guide therapeutic options. These
techniques have been reviewed in an number of texts (Thomas 1987; Fox 1988; Fox
1989; Calvert 1995b; Sisson & Thomas 1995). They include electrocardiography,
signal averaged electrocardiography (Calvert 1992; 1995a;b; Calvert et al 1998a;b;
Jacobs & Calvert 1998), Holter monitoring (Calvert 1992; 1995a;b; Moise &
Defrancesco 1995; Goodwin 1998), radiography and echocardiography. These
techniques will not be reviewed in detail in this thesis, with the exception of
echocardiography (see Section B of this thesis). Echocardiography is considered to be
the gold standard in the diagnosis ofDCM (ISACHC 1995).
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A.8. Pathology of DCM
In their series of fifty cases of presumed DCM in dogs, Darke and Else (1984)
reported on the post mortem findings from eleven cases. Marked cardiac enlargement
was reported associated with a flaccid heart. Left ventricular dilatation was
sometimes associated with concurrent right ventricular dilatation giving a bifid apex.
The ventricular walls are relatively thin although myocardial hypertrophy is present
with increased heart weight: body weight ratio (Thomas 1987). Papillary muscles and
trabeculae in the ventricles can appear flattened and atrophic (Bond & Tilley 1980;
Sisson & Thomas 1995). The atrioventricular annulus is often proportionately more
dilated than the chambers (Fox 1988; Sisson & Thomas 1995).
In human DCM, histopathological changes are reported to be common but non¬
specific. The 1995 WHO definition of DCM included non-specific histological
findings as a criterion of diagnosis (Richardson et al 1996). They include myocyte
hypertrophy, nuclear changes, myofibrillar loss, mitochondrial changes and variable
degrees of fibrosis (Mestroni et al 1994b). The myocyte hypertrophy is determined
by the increased nuclear DNA content, although myocyte width may be normal or
even reduced (attenuation). It is uncertain whether this is a consequence of increased
cell length or cell slippage (Davies & McKenna 1994) although a recent abstract
suggested that increased length was responsible (Kaprielian et al 1998). Myocyte
myofibrillary loss is reported as well as varying degrees of interstitial fibrosis (Davies
& McKenna 1994). In the human disease, increased numbers of T lymphocytes are
reported, although this finding varies considerably from case to case (Davies &
McKenna 1994).
In dogs, it is remarkable how much relatively normal myocardium is present in a
patient dying of myocardial failure (ISACHC 1995). Myocardial cells may be longer
than normal, characteristic of eccentric hypertrophy (ISACHC 1995).
Histopathological changes are most pronounced in the subendocardial region of the
left ventricle and at the base of papillary muscles (Sisson & Thomas 1995). Darke
and Else (1984) found canine myocardium grossly often appeared normal but there
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were irregular patchy areas or occasional focal pale areas like distinct infarcts. Over
25% of dogs in atrial fibrillation had no obvious atrial lesions even on histopathology
but in some cases fibrosis was present. These authors supported the findings of van
Fleet and colleagues (1981) that disseminated foci myocardial necrosis, scattered
areas of myocardial fibrosis and medial hyperplasia of intramyocardial arteries all
were apparent in most cases. Darke & Else (1984) additionally reported fragmented
muscle bundles together with lipoid droplets, myocytolysis and diffuse infiltration of
collagen. Giant and irregular mitochondria with some bizarre mitochondrial figures
were also recognised. Currently, however, the increased numbers of mitochondria
and ultrastructural changes affecting mitochondria are generally regarded as
nonspecific markers of cell damage (Sisson & Thomas 1995). Attenuated wavy fibres
and interstitial fibrosis have been reported (Tidholm 1996; Tidholm & Jonsson
1996). These workers considered that the presence of attenuated wavy fibres,
defined as myocardial cells less than six microns in width with a wavy appearance,
were almost a pathognomic finding of canine DCM (Tidholm et al 1997; 1998a).
They used the presence of attenuated wavy fibres to define the condition of occult
DCM. prior to any clinical or echocardiographic abnormality (Tidholm et al 1998b).
Darke & Else (1984) felt that gross post mortem and light microscopy offered no
further understanding as to the aetiology of DCM in the dog, especially as the
histological and ultrastructural changes at post mortem are nonspecific and may be
seen in other forms of advanced heart failure. This limits the usefulness of other
proposed diagnostic techniques such as endomyocardial biopsy (Cobb 1992). Post¬
mortem specimens, rather than endomyocardial biopsy, were used in the attenuated
wavy fibre studies of Tidholm and colleagues (1998a;b).
A.9. Treatment of canine DCM
Treatment is directed at alleviating the patient's clinical signs of heart failure and
attempts to monitor and control arrhythmias (Keene 1989) with the goals of
improving quality of life and prolonging survival (Sisson & Thomas 1995).
Advances into the treatment have resulted primarily from research into therapy of
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congestive heart failure rather than specific treatment of the diseased myocardium
(Cobb 1992). A balanced pharmacological approach is normally used to optimise
cardiac output by manipulating the major determinants of left ventricular
performance, namely preload, afterload, contractility and controlling heart rate and
rhythm (Fox 1988). The adverse neuro-hormonal consequences of congestive heart
failure are also counteracted with therapy. Diuretics, the angiotensin-converting
enzyme inhibitors and digoxin are indicated in most cases. Antiarrhythmic drugs may
be indicated in some cases. Detailed description of the therapeutics of DCM is
beyond the scope of this thesis.
A.9.1. Angiotensin converting enzyme inhibitors
The angiotensin converting enzyme (ACE) inhibitors, particularly enalapril, have
become almost mandatory in the treatment of DCM after human trials
(CONSENSUS (The CONSENSUS trial study group 1987) and SOLVD (The
SOLVD investigators 1991)) and veterinary trials (IMPROVE (The IMPROVE study
group 1995) and COVE (The COVE study group 1995)) have documented the
efficacy of enalapril in improving quality of life and survival times in humans and
dogs with DCM. It is a logical treatment as it counteracts the adverse neurohormonal
activation seen in congestive heart failure.
As well as improvement in moderate and severe congestive failure, ACE inhibitors
have been shown in man to reduce morbidity in patients with asymptomatic left
ventricular dysfunction (The SOLVD investigators 1992). They may have the same
beneficial effect in dogs with early DCM. This has been supported by the initial
findings of O'Grady and colleagues (1997), comparing Dobermanns with occult
DCM receiving an ACE inhibitor with those not on any therapy. The ACE inhibitor
group showed increased time to onset of clinical signs.
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A.9.2. Nutritional Therapy
Keene & Bonagura (1995) advocate trial therapy of L-carnitine for three months
where owners of patients have no financial constraints at a dose of 220 rng/kg
divided three times daily.
When DCM is identified in spaniels and small breeds of dogs, it is recommended that
plasma or blood taurine levels are assayed to investigate whether taurine deficiency is
an aetiological factor (Keene & Bonagura 1995). Taurine supplementation has also
been recommended in breeds susceptible to urate or cysteine urolithiasis (Pion et al
1998), which includes the Newfoundland.
Nonspecific nutritional additives to attempt to improve myocardial function have
also been advocated. Co-enzyme Q10 or ubiquinone (2,3-dimethoxy-5-methyl-6-
decaprenyl-l,4-benzoquinone) is a lipid soluble compound located on the inner
mitochondrial membranes where it functions as an integral part of electron transport
of oxidative phosphory lation. It is essential for the aerobic production of energy as
ATP. Benefits have been reported in human idiopathic DCM but only after three to
six months of supplementation (Tangsjoen et al 1985; 1990a;b;c) and it has been
advocated for canine idiopathic DCM at doses of 30 - 90 mg/day.
Some veterinarians or cardiologists advocate non-specific L-carnitine, taurine and
co-enzyme Q10 supplementation in an attempt to improve myocardial function
(Keene, 1991, Freeman et al 1996).
A. 10. Prognosis of DCM
The prognosis for dogs with DCM is generally stated to be guarded or poor (Ettinger
& Suter 1970; Wilkes 1980, Darke & Else 1984; Darke 1985; Ware & Bonagura
1986; Cobb 1992) with mean survival time of six months (Fox 1989). It is a
relentlessly progressive disease (Calvert 1992) and after the onset of signs of
congestive failure, the survival time is short, although prior to this, the dog may show
no signs of the disease. Prognosis varies with breed. In Dobermanns, survival times
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are short while cocker spaniels may live a long time (Calvert 1992; Darke et al
1993). There is no cure and there have been no reports of spontaneous recovery
(Sisson & Thomas 1995). It is not possible to predict response to treatment or
prognosis based on initial clinical parameters (Thomas 1987). An investigation into
survival and prognostic indicators associated with this condition was undertaken by
Monnet and colleagues (1995). Pleural effusion and pulmonary oedema were
statistically significant independent prognostic indicators for survival. The median
survival was only two months after initial echocardiography confirmed the diagnosis.
However, dogs surviving in excess of seven months had a good probability of
becoming long term survivors. The biphasic nature of this suggests that there may be
disparity in the severity of disease at initial presentation, possibly due to variable
owner awareness of clinical signs or to variable aetiology of the disease (Monnet et
al 1995).
The risk of sudden death in DCM is noted in man. It can occur at any stage
(Richardson et al 1996), as has been shown in dogs, particularly Dobermanns
(Calvert 1995a).
A.11. Occult dilated cardiomyopathy
In canine cardiology, the term occult DCM was first coined and the course described
by Calvert (1992), mainly referring to Dobermanns. He recognised that dogs with
occult or early DCM have left ventricular dilatation and dysfunction beginning
insidiously and progressing gradually over a period of several years and affected dogs
exhibit no overt abnormalities prior to the development of congestive heart failure.
Clinical examination may reveal no abnormalities. During the early decompensation
stage (ejection fraction reduced by 35 - 50%), a murmur and / or S3 may be
auscultable. Clinical signs of congestive heart failure or low cardiac output are not
usually apparent until ejection fraction has reduced by 60 - 70% (Calvert 1995b).
In Dobermanns, Calvert (1992) described left ventricular dysfunction gradually
progressing for two to two and a half years, after which left ventricular dilatation and
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reduced contractility accelerates and congestive heart failure usually occurs within
another year. Ventricular arrhythmias are evident throughout the course and sudden
death may intervene at any time. Some dogs may develop DCM at older ages and
abnormalities may not be detected until they are over ten years old. They may die of
intercurrent disease and the DCM is never recognised (Calvert 1992).
Calvert (1995b) recognised that it was desirable to diagnose DCM during the occult /
preclinical stage of the disease. By the time the dog shows clinical signs, the disease
is advanced and therapeutic intervention at this stage is unlikely to significantly alter
the course of the diseases. Selective screening for DCM is difficult as there may be
no particular reason to suspect DCM other than breed predisposition but Calvert
(1995b) recommends routine annual screening of dogs at high risk of developing
DCM, particularly all Dobermanns and families within other breeds where familial
disease is prevalent.
ha the Dobermann and boxer, echocardiography and ambulatory ECG are useful in
the diagnosis of occult DCM. Ventricular ectopy may precede echocardiographic
abnormalities in the Dobermann by some months or over a year (Calvert 1995a).
Diagnosis of occult DCM in breeds not characterised by arrhythmias is difficult
(Calvert 1995b). Brownlie (1991; personal communication) indicated that
conduction disturbances or atrial fibrillation precede the development of
echocardiographic abnormalities or clinical signs in the Irish wolfhound with occult
DCM.
Even in man, the diagnosis of occult DCM is controversial. Some relatives of DCM
patients in Keeling & McKenna's (1994) series of human familial DCM were
asymptomatic yet had increased left ventricular end-diastolic dimensions after
correction for age and body size, some had audible diastolic gallops, some had
decreased exercise capacity and some had late potentials on the signal averaged ECG.
All these factors may indicate that these relatives have early DCM.
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Treatment of occult DCM remains controversial and whether early medical
intervention is able to influence the progression of left ventricular dysfunction is not
proven. The prevention arm of the SOLVD trial of enalapril in human patients with
asymptomatic DCM suggested that the onset of heart failure could be delayed (The
SOLVD investigators 1992). However, it appears unlikely that ACE inhibitors will
alter the progression of disease if they are used too early (prior to activation of the
renin-angiotensin-aldosterone system) (Calvert 1992). If ACE inhibitors are used
too early, tolerance may develop (Fox & Sisson 1995), and the initial early
compensatory ventricular remodelling associated with tissue angiotensin II is
inhibited, which may result in more rapid ventricular dilatation, as suggested by
Haggstrom and colleagues in cavalier King Charles spaniels with mitral valve disease
(personal communication; cited by Wotton 1998a). ACE inhibitors are indicated once
evidence of early decompensation is present (Calvert 1995b) and appear to slow
progression to the onset of clinical signs in Dobermanns with occult DCM (O'Grady
etal 1997).
A.12. Breed specific forms of idiopathic DCM
DCM has been reported in a variety of breeds and breed predispositions lend support
to a genetic basis to this condition. Bulldogs were reported in the early literature
(Ettinger & Suter 1970; Ettinger 1975; Ogburn 1977) and immunological basis to
myocarditis present in Bulldogs has been postulated (Ware & Bonagura 1986)
although a non-inflammatory "myocardiopathy" in a Bulldog was reported by Otter
(1991). German Shepherd dogs have been included in the earlier literature as being
commonly affected (Ettinger & Suter 1970, Ettinger 1975; Ogbum 1977) although
the breed is currently under-represented as having the condition (Tidholm, 1996).
Dalmations have recently been reported in a series by Freeman and colleagues
(1996), but in association with urate urolithiasis (Pion et al 1998). Weimaraners have
not been reported in the literature, although were recognised during the course of this
study (data not shown). A juvenile onset malignant dilated cardiomyopathy has
recently been reported in Portuguese water dogs (Dambach et al 1999).
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DCM has been reported in a variety of breeds but the best characterised phenotypic
forms of the condition reported appear to be distinct for the giant breeds
(Newfoundlands, great Danes and Irish wolfhounds), Dobermanns, boxers and
cocker spaniels.
A.12.1. Newfoundlands
Newfoundlands were included in the list of breeds said to be predisposed to DCM in
the earliest reports of the canine condition (Ettinger & Suter 1970). Sisson and
Thomas (1995) reported the prevalence ofDCM in this breed in the U.S. as 1.3%. In
a series of dogs with atrial fibrillation (Bohn et al 1971), breed specific prevalence
rates were reported. Newfoundlands had the highest rate of 56.6/1000 (although
numbers were small; there were 53 Newfoundlands out of a population of over
30 000 dogs, of which three Newfoundlands had atrial fibrillation although the
numbers of Newfoundlands with cardiac disease was not reported). Although the
associated underlying heart disease was not reported for Newfoundlands specifically,
it is interesting to speculate that some of these cases may have been due to DCM,
although subaortic stenosis was listed as being associated with atrial fibrillation and
Newfoundlands were later reported by some of these authors as being predisposed to
this condition (Pyle et al 1976; Jones et al 1982).
The features of DCM in Newfoundlands are consistent with those reported for the
giant breeds in general. Tidholm and Jonsson (1996) reporting on 37 Newfoundlands
with DCM found no statistically significant sex predisposition (more bitches were
included in their series). The age range of dogs affected with DCM and congestive
failure was 3.5 months to 11.7 years with a mean and median of five years. These
authors noted that many of these dogs were hyperthermic. Murmurs associated with
DCM were reported as being infrequent, although the authors were aware that they
may have missed murmurs as they are generally low grade, the dogs panted and
adventitious respiratory sounds may have masked the murmurs. No mention was




Great Danes were reported as being a breed predisposed to DCM in the earliest
veterinary literature describing the canine condition (Ettinger & Suter 1970; Ettinger
1975; Ogburn 1977) and are commonly included in series of cases (Monnet et al
1995). Prevalence rates in Great Danes in the U.S. are reported to be 3.9% with age
dependant prevalence reported (Sisson & Thomas 1995). An affected dog as young
as 0.33 years has been reported (Fleet et al 1981), and there has been confusion in
the literature between mitral insufficiency, mitral incompetence, DCM and what has
since been recognised as mitral dysplasia in the breed (Hamlin et al 1965; Hamlin &
Harris 1969; Dear 1971). In 1971, Great Danes were recognised as being predisposed
to atrial fibrillation (Bohn et al 1971; Boeve et al 1984) and also show ventricular
arrhythmias (Hamlin & Harris 1969, Dear 1971), associated with sudden death. Great
Danes were over-represented in a pathological study of DCM (van Fleet et al 1981).
A.12.3. Dobermanns
Dobermanns were not listed in the original report of canine DCM affected breeds
(Ettinger & Suter 1970), but this breed features prominently in subsequent reports
(van Fleet et al 1981; Calvert et al 1982; Hazlett et al 1983; Calvert 1984; Lombard
1984a; McCarthy 1984; Darke & Else 1984; Calvert 1986; Monnet et al 1995).
Congestive heart failure and sudden death has been recognised in Dobermanns in the
USA since the early 1950s (Calvert 1995a). Pedigrees of Dobermanns demonstrate
that cardiac disease can be traced back to the original members of this breed in North
America (Meurs et al 1996b). Sisson and Thomas (1995) report the prevalence of
DCM in this breed to be 5.8%. Other authors report much higher rates, with 63.2% of
Dobermanns in a longitudinal study of 192 initially normal dogs affected by 4.5 years
follow up (O'Grady & Home 1992; 1998). The prevalence increases, ranging from
0.29% in Dobermanns less than one year old to 10.6% in Dobermanns older than ten
years (Sisson & Thomas 1995). The age of onset of congestive heart failure due to
DCM is on average 7V2 years old in males and 8V2 - 9 years old in females (Calvert
1995a).
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Dobermann DCM is strongly suspected to be a familial disease. Since Wood (1983)
first proposed this, increasing evidence has supported this view, with reports of
family clusters with DCM affecting four consecutive generations (Calvert 1992;
1995a). In some kindreds, an autosomal dominant mode of inheritance is suspected
(Meurs 1998).
Most veterinary cardiologists consider that Dobermanns have a more severe and
rapidly progressive form of DCM than other breeds (Wood 1983; Ware & Bonagura
1986; Keene 1989; Calvert et al 1997b), although Monnet and colleagues (1995)
failed to demonstrate statistically that this breed was less likely to survive. Many
Dobermanns present with apparently acute onset disease, with fulminant pulmonary
oedema. However, serial evaluation in longitudinal studies indicate that DCM is in
fact a chronic, slowly progressive disease (Calvert 1992; 1995a; Calvert et al 1997a).
Adverse prognostic indicators for survival in symptomatic Dobermanns include the
presence of biventricular failure and atrial fibrillation in this breed (Calvert et al
1997a). Sudden death may occur at any stage of the development of DCM, although
dogs with periods of sustained ventricular tachycardia were at increased risk (Calvert
et al 1997b).
A number of myocardial biochemical abnormalities have been associated with
Dobermann DCM (McCutcheon et al 1992; O'Brien et al 1992; 1995; O'Grady et al
1992; O'Brien 1997), as summarised previously (Section A.4.1.), consistent with
impaired oxidative phosphorylation. Dobermanns with proven myocardial carnitine
deficiency survive longer with supplementation and conventional treatment than non-
deficient dogs (Keene et al 1989; Keene 1991).
A.12.3.1.
Dobermann occult DCM
Smucker and others (1990) noted that even apparently normal Dobermanns had
occult left ventricular dysfunction. Calvert (1992; 1995a) published observations of
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great value about the preclinical (occult) stages of DCM in this breed. In general, the
disease begins in dogs between three to six years of age, with death due to congestive
heart failure occurring three to four years later, although sudden death can occur at
any time. Survival times are short once congestive heart failure develops (Calvert
1995a). After onset of clinical signs of congestive heart failure, mean survival time
is reported as 9.5 weeks with a median of five weeks (Calvert 1992).
Calvert (1995a) reported that 25 - 30% of asymptomatic Dobermanns between the
ages of two and 14 years old show echocardiographic or Holter evidence of DCM. It
is important that dogs are identified prior to anaesthesia for surgical procedures as
exacerbation of arrhythmias or systolic dysfunction may be life threatening (Calvert
et al 1996).
When Dobermanns developing DCM are followed sequentially, progressive left
ventricular dilatation and dysfunction occurs over a period of 2 - 2V2 years and then
accelerates resulting in congestive heart failure in another year, although some
Dobermanns may show more slowly progressive disease (Calvert 1992; 1995a). If
abnormalities are evident in Dobermanns as pups or at less than two years of age,
they tend to show an accelerated course. If Holter or echocardiographic abnormalities
are not detected until dogs are greater than six years old, the course is much more
prolonged (Calvert 1995a). When left atrial enlargement is radiographically evident,
Dobermanns with occult DCM will generally develop left sided heart failure within
nine months (Calvert 1992).
Calvert (1995a) gave some criteria for the Holter diagnosis of occult DCM based on
the frequency of ventricular ectopy in Dobermanns. Dobutamine stress
echocardiography has also been utilised in the identification of very early systolic and
diastolic dysfunction which herald the development of occult DCM (Minors &
O'Grady 1998).
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Ventricular arrhythmias are believed to be responsible for sudden death in most
Dobermanns with DCM, which can occur at any stage. Up to 25% of Dobermanns
with occult DCM die suddenly while the remaining 75% develop congestive heart
failure (Calvert 1995a). The mean age for sudden death associated with DCM is
reported as 6V2 - 7 years old with a male predisposition and 20% of Dobermanns
with DCM (all stages) die suddenly (Calvert 1992). Not all syncopal Dobermanns
with DCM collapse due to ventricular arrhythmias. Calvert (1995a) reported that
cardiomyopathy Dobermanns were prone to neurocardiogenic syncope associated
with bradycardia on excitement or exertion.
A.12.3.2.
Echocardiographic screening
In order to identify echocardiographic abnormalities indicative of occult DCM,
reference ranges of normality are required. This is discussed in more detail in
Section B of this thesis. Briefly, however, normal Dobermanns up to 45kg body
weight recognised by Calvert (1995a) have fractional shortening of 30 - 36%, left
ventricular end-diastolic dimensions less than 50 mm, interventricular septal and left
ventricular free wall systolic dimensions exceeding 10 mm and diastolic dimensions
greater than 7 mm. Calvert (1995a) reported that a fractional shortening < 25% was
abnormal. In Dobermanns identified with occult DCM, dogs with fractional
shortening less than 20% develop congestive heart failure within one year.
The older a Dobermann is with unremarkable echocardiographic and Holter findings,
the more likely it is to be truly normal, although Calvert (1995a) urged extreme
caution in declaring any Dobermann to be normal and felt that the only conclusion
may be that it would not die prematurely due to DCM. It is likely that a great number
of Dobermanns are affected but the disease may be sufficiently mild in some dogs to
allow them to achieve advanced age before developing overt disease and may die of
intercurrent disease before any cardiac signs are appreciated (Calvert 1995a).
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A.12.4. Cocker spaniels
Cocker spaniels (probably the American cocker spaniel) affected with congestive
heart failure and particularly males were recognised to be over-represented during
screening dogs to assess the prevalence and types of cardiovascular disease between
1948 and 1965 (Detweiler & Patterson 1965). Sisson & Thomas (1995) recorded the
U.S. prevalence of DCM in English cocker spaniels as 0.69% and in American
cocker spaniels as 0.34%. Wotton (1996b) estimated a UK prevalence of DCM in
cocker spaniels as 3.4%. Wotton (1996b) presented the data from 27 cocker spaniels
of ages 3.5 months to 11 years (mean 4.6 + 2.6 years) with males slightly over-
represented (59%). Two spaniels (unspecified) were reported in the series of 50 cases
by Darke and Else (1984). Cocker spaniels (presumably American) were included in
the series by Monnet et cd (1995).
The first report of English cocker spaniels with myocardial disease was from an
isolated Australian kennel (Staaden 1981). A familial basis to this condition was
recognised. Another Australian paper presenting material from the same kennel
(Gooding et til 1982) reported findings from 49 dogs, 26 of which were normal, and
proposed that concentric hypertrophy progressed to eccentric hypertrophy (i.e.
hypertrophic cardiomyopathy progressed to dilated cardiomyopathy). In a later
publication, however, Gooding and colleagues (1986b) did not mention concentric
hypertrophy further but they presented an echocardiographic characterisation of
DCM in cocker spaniels from this kennel. However, the control group was selected
from the same kennel and five dogs were shown to have reduced fractional
shortening. These findings may suggest that this subgroup had occult DCM and that
the echocardiographic abnormalities precede electrocardiographic, radiographic and
clinical abnormalities. The first report in the UK of this condition was by Thomas
(1987a) who documented presumed congestive cardiomyopathy in eight cocker
spaniels in the UK, six ofwhom were related.
These initial reports suggesting that some cockers have concentric hypertrophy and
possibly hypertrophic cardiomyopathy is confusing. In the absence of definitive data
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documenting progression, it seems unlikely that these cases represent the same
condition. A case of presumed hypertrophic cardiomyopathy in a cocker spaniel
documented by echocardiography was reported by Wotton (1996b; 1998d).
Cocker spaniel DCM has a more benign course than other breeds, with some dogs
surviving several episodes of severe congestive heart failure (Gooding et al 1986;
Wotton 1992; 1996b;1998c;d). Arrhythmias are uncommon, although pulsus
alternans is recognised in some cases (Staaden 1981; Wotton 1996b).
Keene and Bonagura (1995) recommend that spaniels with DCM should have blood
or plasma taurine levels assayed to determine whether taurine deficiency is an
aetiological factor. American cocker spaniels are known to respond incompletely to
taurine and L-carnitine supplementation (Kittleson et al 1997). Wotton (1996b;
1998d) felt that there was no evidence that taurine or carnitine deficiency was a
significant cause of heart disease in the UK.
A.12.5. Boxers
Boxers first reported in 1970 as being susceptible to DCM (Ettinger & Suter 1970).
By 1983, the fact that Boxers had a breed-specific form of DCM was recognised
(Wood 1983) and Harpster (1983) gave an excellent clinical description of the
condition, which is still utilised today (Wotton 1996a; 1998b). The prevalence of
DCM in Boxers in the US has been reported as 3.4% with increased prevalence
associated with age (Sisson & Thomas 1995). DCM in UK Boxers is not identical to
that occurring in the USA, as the arrhythmic forms are less prevalent (Wotton
1996a). Even in the USA, there may be geographical differences in the distribution
and clinical characteristics (Keene 1989).
Harpster (1983) recognised that there was less marked ventricular dilatation in the
Boxer compared with other breeds with DCM and atrial fibrillation was infrequent.
Harpster (1983) reported on 64 Boxers which were closely related and an inherited
basis to the disease was suspected; some family lines had greater prevalence of
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disease. The survey of heart disease in Boxers was updated to a total of 112 dogs
(Harpster 1991). Males were slightly over-represented (56.3%) and Boxers of one to
fifteen years of age years were affected, although most Boxers were over six years
old with a mean age of 6.9 years (Harpster 1991). Arrhythmias (usually ventricular)
are common and murmurs of mitral regurgitation secondary to dilatation of the
atrioventricular annulus occur later in the course of the disease. Diastolic gallops are
frequent once congestive failure has developed. An electrocardiogram is said to be
almost pathognomic with ventricular premature complexes or runs of right
ventricular origin (left bundle branch block pattern) (Harpster 1983; 1991).
Harpster (1983; 1991) recognised three categories to DCM resulting in different
presentations of the boxer breed. In category 1, dogs are asymptomatic but an
arrhythmia may be detected. Holter monitoring is used to identify dogs (Meurs &
Brown 1998). In category 2, affected dogs have a history of episodic weakness or
collapse. Some degree of cardiomegaly may be identified. Category 3 is
characterised by the presence of congestive heart failure.
Pathological findings are distinct in this breed. Histologically, there is usually
evidence of active or chronic changes. The right ventricle is the earliest and the most
severely affected (Harpster 1991). Active changes described included focal areas of
myocytolysis, myofibrillar necrosis, haemorrhage, a mild cellular infiltrate
(predominantly mononuclear cells) and the chronic changes included myofibrillar
atrophy, marked variation in size and shape of individual fibres, fibrosis and
extensive fatty infiltration and fatty change (Harpster 1983; 1991). The characteristic
pathology associated with Boxer cardiomyopathy, in contrast to the non-specific
changes recognised in other breeds (Sisson & Thomas 1995) and man with DCM has
led some authors to refer to the condition as Boxer myocarditis (Tidholm et al
1998a). However, the histological findings are very similar to those in human
arrhythmogenic right ventricular cardiomyopathy (also called arrhythmogenic right
ventricular dysplasia, ARVD), particularly with respect to the fatty infiltration.
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Wotton (1998b) has proposed that boxer cardiomyopathy bears marked resemblances
to the human condition.
Keene and colleagues (1991) recognised that myocardial L-camitine deficiency was
associated with DCM in a family of Boxers, with improvement demonstrated after L-
carnitine supplementation in many but not all dogs (Keene 1991). Even when
effective, L-camitine supplementation does not influence ventricular ectopy and
antiarrhythmic medication is indicated (Harpster 1991; Keene 1991; Meurs &
Brown 1998).
A familial basis to the disease was suspected by Harpster (1983) in his original
report. The familial dysrhythmia is reported to be transmitted as an autosomal
dominant trait is some families (Meurs et al 1998), although Wotton (1998b) felt
that an autosomal recessive mode of inheritance was more consistent with pedigree
data from his study.
A. 12.6. Irish Wolfhounds
Irish wolfhounds were first reported in 1970 as being susceptible to DCM (Ettinger
& Suter 1970; McCarthy, 1984; Thomas 1987a). Irish Wolfhounds were reported as
having a high prevalence rate of atrial fibrillation (41.6/1000) (Bohn et al 1971) and
it is likely that many of these cases were due to DCM although this disease was not
mentioned in the text. Atrial fibrillation and other electrocardiographic abnormalities
were reported to precede the development of occult DCM in this breed (Brownlie
1991). Similar electrocardiographic abnormalities were reported in European dogs
(Vollmar 1996). The prevalence rate from a group of 440 dogs was given as 16.4%,
with abnormal electrocardiographic findings in 34.1% of dogs (Vollmar 1998).
Brownlie and Nott (1991) demonstrated that males with larger girth measurements
and females with increased girth and height measurements had a higher incidence of
heart disease. In one line of Irish Wolfhounds, an inherited basis of the disease has




ECHOCARDIOGRAPHY / DOPPLER DIAGNOSIS OF
DILATED CARDIOMYOPATHY
A REVIEW OF THE LITERATURE
B.1. Assessment of Chamber size
B.1.1. Introduction
Dilated cardiomyopathy (DCM) is characterised by dilatation and impaired
contraction of the left ventricle (Richardson et al 1996). Diastolic abnormalities are
increasingly recognised with this condition (Werner et al 1994; Fruhwald et al
1997b). It therefore follows that echocardiographic criteria which identify left
ventricular dilatation and impaired systolic and / or diastolic function of the left
ventricle may be used to diagnose this condition. Echocardiography / Doppler is also
an excellent modality to exclude most primary cardiac causes of secondary
myocardial failure. A knowledge of normal chamber size and reference parameters
for criteria of systolic and diastolic function determined by echocardiography /
Doppler is required to identify early abnormalities associated with the development
of DCM. Breed specific reference ranges are required. Although there are some
reference ranges for echocardiographic parameters published in man, measurements
outside these reference ranges are difficult to evaluate and Vasan and colleagues
(1997) proposed partitioning abnormal echocardiographic measurements, normalised
to height and gender, by their deviation from the reference using 95 - 99% percentile
values. A large number of echocardiographic parameters are available in the
assessment of specific chamber size and systolic and diastolic function and these will
be reviewed
B.1.2. Assessment of left ventricular size
There are a number of methods for estimating left ventricular size or volume. M-
mode echocardiography has conventionally been used to measure the diameter of the
left ventricular lumen as well as the interventricular septum and left ventricular free
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wall thickness. In veterinary echocardiography, the only method of quantifying left
ventricular function has tended to be by M-mode echocardiography until recently. In
veterinary echocardiography, most cardiologists follow the American Society for
Echocardiography recommendations (Sahn et al 1978). However, these M-mode
echocardiographic recommendations are the result of a questionnaire to
echocardiographers cardiologists with a poor response rate (19%) (Sahn et al 1978;
Luis Fuentes & Bonagura 1998). They were, however, largely based on measurement
techniques with the least coefficient of variation (standard deviation divided by
mean) between observers measuring the same brief M-mode echocardiogram. End-
diastole is defined as the start of the QRS complex and systole as the nadir of the
septal systolic posterior motion where septal motion is normal (Sahn et al 1978).
Since most M-modes obtained today are guided using a cursor on an optimised two-
dimensional image, it is now advised that a short axis two-dimensional view from a
right parasternal window should be used to place the M-mode cursor at the level of
the chordae tendinae (Feigenbaum 1994a). The leading edge-leading edge technique
should be used as the M-mode endocardial echos may be affected by gain settings
(Sahn et al 1978; Feigenbaum 1994a) although this is not always done. O'Grady et al
(1986) and Allworth et al (1995) used intraluminal left ventricular measurements i.e.
trailing edge to leading edge. Positioning of the M-mode cursor within the left
ventricular cavity is critical, and prior orientation with both the long axis and short
axis cross sectional images is essential for successful placement (De Madron 1995;
1996). The long axis image is used to ensure that the left ventricular axis is
perpendicular to the M-mode cursor, and that both the inter-ventricular septum and
left ventricular free walls are transected at similar levels, at the level of the chordae
tendinae. The short axis view is then selected to ensure that the M-mode cursor
bisects the centre of the left ventricular cavity.
In man, the left ventricular length and diameter show a strong linear relationship
with height, weight and body surface area (BSA). However, if data are corrected for
height, body weight and BSA have no additional effect on parameters of left
ventricular size (Weyman 1994b). The parameters of left ventricular internal
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diameter in diastole (LVIDd) and systole (LVIDs) are affected by heart rate (Jacobs
& Mahjoob 1988a;b) and are also highly preload, afterload and contractility
dependent (Borow 1 989).
Calculations of left ventricular volume from the minor axes have been described, the
simplest ofwhich is the cubed formula for a prolate ellipse:
Volume = (7t/3)x(LVID)3
Although this formula is reasonably accurate in normal ventricles, it becomes
increasingly inaccurate in dilated ventricles as they assume a more spherical rather
than an elliptical shape (and the major axis becomes less than twice the minor axis)
(Movsowitz et al 1996). The Teicholz correction for the decrease in the major:
minor axes ratio associated with left ventricular dilatation is more accurate. The
Teicholz formula is shown (Borow 1989) (Movsowitz et al 1996):
Volume = [7/(2.4 + LVID)jx(LVID)3
It should be noted that M-mode derived left ventricular volumes are based on
geometrical assumptions which become invalid in the presence of regional wall
motion abnormalities or altered left ventricular morphology.
These techniques have been largely superseded by two dimensional calculations of
left ventricular volume in human cardiology although veterinary texts including
ventricular volume and ejection fraction usually refer to M-mode derived parameters
(Freeman et al 1996). However, left ventricular diameters have a wide range of error
for the assessment of left ventricular size, especially tor enlarged ventricles and left
ventricular volumes calculated by two dimensional echocardiography is the preferred
method to assess left ventricular remodelling (Dujardin et al 1997). In addition, M-
mode echocardiography only measures a small point of the left ventricle at a single
level of the interventricular septum and left ventricular freewall. Various two-
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dimensional methods of assessing left ventricular volume, and so global left
ventricular function, have been devised (Feigenbaum 1994a; Vuille & Weyman
1994).
The geometrical assumption that the left ventricular lumen approximates the shape of
a prolate ellipse has led to a variety of calculations of left ventricular volume based
on this mathematical model (Movsowitz et al 1996). The length-area method
calculates left ventricular volume from a single plane, conventionally done from the
apical four chamber view (Borow 1989; Schiller et al 1989; Feigenbaum 1994a;
Vuilie & Weyman 1994).
Vol = 8 x (area2) = 0.85 x area2
3 xttx length length
The single plane ellipse method may also be determined from a two chamber view or
apical long axis view of the left ventricle. The left ventricular length and volumes are
larger from the four chamber view (St. John Sutton et al 1998). The formula may be
modified for use with two orthogonal planes (i.e. from left apical two-chamber and
four chamber views).
One of the problems in serial evaluation of changes in load are the potential
consequences on geometrical assumptions. Gaynor and colleagues (1994) found that
a cylindrical model was most accurate at estimating changes in volume associated
with differing loads, although this model did not estimate true left ventricular volume
accurately. Eaton and colleagues (1979) showed that serial cross sectional views of
the left ventricle every three millimetres could be used to accurately assess volume.
These authors had the foresight to predict that with advances in computer technology
and echocardiography that this would become a viable technique and, indeed, this has
become the basis of Simpson's method to estimate left ventricular volumes.
One of the most accurate methods of assessing left ventricular volumes is Simpson's
rule, which has now evolved to the modified Simpson's rule (the biplane method of
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discs) (Borow 1989; Schiller et al 1989; Feigenbaum 1994a; Schiller & Foster 1996).
This is based on the mathematical principle that the sum of volumes of multiple
slices of known thickness through an object equal the total volume of the object. This
formula is consequently independent of any geometrical assumptions and it correlates
well with angiographically derived left ventricular volumes (Movsowitz et al 1996;
Schiller & Foster 1996). In echocardiographic software, twenty slices are used.
Volumes and ejection fraction can be reliably determined even in the presence of
regional wall motion abnormalities (Albin & Rahko 1990). The disadvantage of
Simpson's rule is that at least two image planes are required (a two chamber and four
chamber left apical view) and it is a time consuming technique even with
echocardiographic software. Nosir and others (1997) reported that an apical long
axis view rather than the two chamber view should be used with the four chamber
view, as it was more truly orthogonal and it was easier to standardise the view as the
valve leaflets of the mitral and aortic valves provided landmarks for good central
alignment.
Obtaining the area measurements is fraught with problems as the lateral resolution
may not be good and endocardial images parallel with the imaging ultrasound beam
suffer from echo dropout making accurate tracing of endocardial surfaces prone to
error. In addition, as the area measurement is squared, any measurement error in this
parameter is multiplied four-fold. It is because of this problem that the American
Society of Echocardiography suggest that two-dimensional echocardiographic
measurements should be made from "black-white" interfaces, i.e. a trailing edge to
leading edge (Schiller et al 1989). In people, two-dimensional imaging may be too
poor to allow determination of volumes in ten to twenty percent of individuals, and
there is substantial inter- and intra-observer variability in the measurements
(Movsowitz et al 1996). Echocardiography consistently underestimates left
ventricular volume (Vuille & Weyman 1994). Increasingly, on sophisticated
machines, software to improve endocardial boundary detection is being used
(Movsowitz et al 1996). This technique, known as acoustic quantification, is based
on ultrasonic backscatter analysis and it allows on-line continuous display of
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endocardial borders which allow beat to beat calculation of cavity areas, volume and
ejection fraction (Gorscan et al 1993b; Yvorchuk et al 1994) and stroke volume
(Gorscan et al 1993a). It has been validated in canine open chest models (Morrissey
et al 1994). The technique has also been used to estimate left ventricular compliance
from end-diastolic pressure / volume curves (Gorscan et al 1994). There is a report of
acoustic quantification being assessed in dogs and cats (Rosenthal & Saunders
1996).
Although it is tempting to assess left ventricular area from a right parasternal long
axis four chamber view, because of improved endocardial delineation as the images
are perpendicular to the ultrasound beam, this plane fails to include the left
ventricular apex (Vuille & Weyman 1994) and there have been no reports or
validation of using this view in human echocardiography. However, attempts at
obtaining a left apical view in dogs have not been successful (Thomas 1984; Thomas
et al 1993). O'Grady and colleagues (1986) found that the longest left ventricular
length was obtainable from the right parasternal view and proposed that the right
parasternal view may be more accurate for assessing left ventricular volumes in dogs.
The left ventricular volumes (calculated by length / diameter calculations) reported
by these authors were obtained from an RPS view (O'Grady et al 1986). It was felt
that left apical views could not be adequately obtained in dogs because the cardiac
window (between lung lobes) was smaller than on the right hemithorax (O'Grady et
al 1986).
The use of left ventricular volumes indexed to body weight or BSA has allowed
comparison between individuals of differing sizes. The end-systolic volume index
(ESVI) is recommended as a method of assessing systolic function in man, which is
more reliably predictive of prognosis than the ejection fraction (Schiller & Foster
1996). The end-diastolic volume index (EDVI) is a valuable but less powerful
predictor of cardiac events in man. Reference values are given for people for these
indices by Schiller and Foster (1996). In humans, there is a gender difference in the
normal EDVI and ESVI. In dogs, Amberger and Lombard (1998) gave figures for a
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normal left ventricular end-systolic volume index (ESVI) as <30 mls/m and
indicated that ESVI >80 mls/m2 was consistent with cardiac insufficiency, using the
cubed or Teicholz formula from M-mode parameters. Dogs with DCM had a
significantly decreased survival time if they had an end-diastolic volume index of
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>210 mls/m or with end-systolic volume indices > 138 mls/m (Borgarelli et al
1998) which implies that the more dilated the ventricle, the worse the prognosis.
Cardiomyopathy without significant or only mild left ventricular dilatation has been
described in the human literature (Keren et al 1988a; D'Cruz et al 1992). These
patients had improved course and survival compared with classical DCM patients
(Keren et al 1988a). Despite failing to meet the classically accepted criteria for the
diagnosis of DCM, left ventricular shape, assessed by various methods comparing
short axis with long axis dimensions was significantly more spherical than normal,
age matched individuals, despite being slightly less spherical than the LV of patients
with classical DCM (D'Cruz et al 1992). Douglas and colleagues (1989) also
showed that LV shape was important. In human patients with DCM, survival was
adversely affected by having a more spherical LV, with increased minor axis
dimension, and more evenly distributed wall stress (assessed by the ratio of
meridional to circumferential wall stress).
There are formulas for determining left ventricular mass, which have been validated
anatomically (Devereux & Reichek 1977), although repeatability is poor (Kuecherer
et al 1991). Stollberger and others (1996) used a mathematical formula to show that
even small measurement inaccuracies, in the order of 5%, a magnitude error inherent
in echocardiographic measurements, result in changes in estimation of left ventricular
mass by the Devereux formula of 8 - 15%. The measurement of left ventricular mass
is described by Levy and Lauer (1996), with formulae derived from M-mode
parameters.
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B.1.3. Assessment of left atrial size
Left atrial size can be calculated by a number of techniques. From the right
parasternal long axis four chamber view, the width of the left atrium just above and
parallel to the mitral annulus and its length may be measured. The maximal left atrial
dimensions and area are at the end of ventricular systole (Weyman 1994a) Similar
measurements are usually obtained from an apical four chamber view, although the
posterior wall is prone to echo dropout, but this is the standard view in human
echocardiography (Weyman 1994a). Area measurements have also been described
and may be improved by automatic boundary detection (Clarkson et al 1995). In
dogs, O'Grady and colleagues (1986) assessed left atrial area by planimetry from the
right parasternal views and an apical views and have found them to be highly
correlated. Left atrial area and anterior-posterior and apico-basilar distances were
correlated with body weight and BSA (O'Grady et al 1986). In man, area and
diameters of the left atrium show a strong relationship for height. If corrected for
height, the other variables, weight and BSA, have no other significant effect on left
atrial parameters (Weyman 1994b).
A diastolic emptying index has been proposed by Clarkson and colleagues (1995) as:
maximum atrial area - minimal atrial area
maximum atrial area
Maximal left atrial area is at the end of ventricular systole. Atrial systole gives the
smallest left atrial area (corresponding to the end of ventricular diastole - start of
QRS complex on ECG). This measurement may also be considered as a derivative of
a left atrial ejection fraction and intrinsic left atrial dysfunction has been shown in
DCM in human patients (Ito et at 1996). The actual timing of maximal and minimal
left atrial areas is controversial (Ito et al 1996). Volume calculations for the left
atrium are not well validated (Vuille & Weyman 1994).
The left atrium has often been compared with the aortic root diameter at the level of
the aortic valves in man and dogs. This may be done from a five chamber long axis
view, which visualises the left auricular appendage more than the left atrial body or,
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more conventionally, from an M-mode of the aortic root and left auricular appendage
(Bonagura et al 1985). The aortic root is measured in diastole and the LA from
ventricular systole and expressed as a ratio (LA:Ao).
In dogs, because of various chest conformations, by placing an M-mode cursor
through the centre of the aortic root, the more distal intersection of the cursor can be
variable and inconsistent; it may be different areas within the left auricular
appendage or the left atrium or even the pulmonary trunk (De Madron 1995). To
avoid this variability, it has been suggested obtaining the left atrial length from a
short axis view, to its maximum length, in a plane which also intersects the aortic
root (Haggstrom et al 1994). Both parameters are measured from two dimensional
diastolic images and a ratio can be expressed .
Assessment of left atrial function is important to explain some of the features of
pulmonary venous flow and it may be impaired in DCM (Ito et al 1996). In human
essential hypertension, in patients with normal left ventricular systolic function, the
left atrial size, particularly in systole, correlates well with LV wall thickness, better
than the indices of diastolic function and Simek and others (1995) proposed that left
atrial systolic size, in the absence of atrial fibrillation or mitral valve disease,
indicated the severity and chronicity of left atrial hypertension. Left atrial size
assessment was postulated by these authors to provide a single, non-invasive estimate
of the degree of diastolic dysfunction. A left atrial area in man exceeding 18 cm2 is
an independent predictor of an adverse prognosis in patients with systolic failure
(Giannuzzi et al 1996). Increased left atrial size and reduced function are strong
negative predictors of exercise capacity (Triposkiadis et al 1992).
Left atrial size affects mitral annulus size independent of left ventricular dimensions.
Consequently, isolated left atrial enlargement may result in mitral regurgitation
despite normal left ventricular size and function and intrinsically normal mitral valve
leaflets (Tanimoto & Pai 1996).
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B.2. Echocardiographic / Doppler assessment of left ventricular
systolic function
Left ventricular systolic function is determined by the extent of left ventricular fibre
shortening during systole and is a result of the interaction between preload, afterload,
heart rate and myocardial contractility (Movsowitz et al 1996). Contractility as an
isolated parameter cannot be easily measured because of the inter-dependence on
preload, afterload and heart rate.
B.2.1. Fractional shortening (FS%)
Fractional shortening, usually expressed as a percentage, is obtained from the LV M-
mode measurements described above:
FS% = LVIDd - LVIDs x 100
LVIDd (Allworth et al 1995).
This measurement relies on the minor axis of the left ventricle representing overall
LV function (Vuille & Weyman 1994). It is predominantly preload, afterload and
contractility dependent (Borow 1989). Lonsdale and colleagues (1998) showed that
fractional shortening was influenced by training in greyhounds; it was increased in
trained dogs.
There is considerable controversy in the veterinary literature about the lower
reference limit for fractional shortening in normal dogs. Reference values have been
generated in populations where DCM is prevalent, probably including a mixture of
normal and cardiomyopathic individuals, and where follow up has been limited to
two to three years at the most (Kienle 1998). Sarcomeres normally contract 30%
(from diastolic length of 2.2 pm to systolic length of about 1.5 pm), which Kienle
(1998) argued should result in a 30% change in left ventricular circumference and
consequently a 30% change in left ventricular diameter.
42
B.2.2. Percentage thickening of the interventricular septum (%thlVS) &
left ventricular posterior wall (%thLVpw)
These parameters are also obtained from the LV M-mode parameters and are
calculated by the software of the echocardiograph machine (O'Grady et a! 1986;
Borow 1989; Allworth et aI 1995):
IVSs - IVSd x 100% LVpws - LVpwd x 100%
IVSs LVpws
Although usually systole is defined as the nadir of septal motion, sometimes the
posterior wall (also called the free wall) lags behind this so a true "systolic" free wall
measurement is not obtained, although most echocardiograph software prompts the
measurement to be made in a line defined by systole. Allworth and colleagues (1995)
used the LVpw systole as the peak anterior systolic motion of the free wall to obtain
this measurement.
Wall thickening is almost linear throughout systole, although wall thinning is
biphasic, with an initial rapid phase during the first 40% of diastole and a slower
phase in late diastole. In DCM, the systolic wall thickening is similar but of lower
magnitude, although the biphasic diastolic phase is lost and thinning is slowed
(Goldberg 1984).
B.2.3. Ejection fraction (EF)
Calculation of the ejection fraction, usually expressed as a percentage, is based on
determination of the left ventricular volumetric measurements.
EF = LVdv - LVsv x 100%
LVdv
The ejection fraction will give a better estimate of global left ventricular function, as
during the fractional shortening method, only two small segments of myocardium are
used. However, the ejection fraction reflects a complex interaction between preload,
afterload and heart rate as well as contractility (Borow 1989). In man, the reference
ejection fraction is 61 + 10 % (Schiller & Foster 1996). Two dimensional
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echocardiographic determination of ejection fraction has been appreciated to have
high sensitivity and specificity for impaired left ventricular function since 1984
(Erbcl et al 1984).
Errors in this measurement will be the same as are incurred during the volumetric
measurements, although presuming the errors affect diastole and systole to the same
degree, they are cancelled out (Borow 1989).
Many human cardiologists will visually estimate the ejection fraction fairly
accurately ("eye-balling") (Movsowitz et al 1996; Schiller & Foster 1996). In
additon, Silcocks and colleagues (1997) showed that a qualitative echocardiographic
assessment of left ventricular dysfunction was of prognostic value, whereas no single
quantitative echocardiographic index was of independent prognostic significance.
Determination of left ventricular diastolic (LVdv) and systolic volumes (LVsv)
enables the stroke volume (SV) to be calculated, and therefore the cardiac output
(CO), if the heart rate (HR) is known.
SV = LVdv - LVsv
CO = SVx HR
It should be noted that this is the total left ventricular stroke volume; if there is
significant mitral or aortic regurgitation, these parameters do not correspond to
forward stroke volume or cardiac output.
B.2.4. Mitral valve E point to septal separation (EPSS)
This is a relatively simple parameter to measure taken from M-mode of the mitral
valve. It gives an indication of global left ventricular function and left ventricular
dilatation independent of ventricular geometry, size or abnormal motion (Vuille &
Weyman 1994). It can be used to confirm the measured ejection fraction, and in adult
humans an EPSS in excess of seven millimetres corresponds to an ejection fraction
44
of less than 45% (Schiller & Foster 1996). Pollick and colleagues (1982) found that
EPSS was primarily a function of left ventricular size rather than fractional
shortening or ejection fraction. As mitral stenosis is rare in the dog, there are few
limitations to this measure in this species, although significant aortic regurgitation
will affect it. Increased EPSS has high specificity but low sensitivity for DCM
(Borow 1989). Kirberger (1991a) reported EPSS values ranging from 1.0 - 6.0 mm,
using Beagles and German Shepherd dogs and found no significant effects of breed,
weight, sex or heart rate. In children, when EPSS was normalised to the left
ventricular end-diastolic diameter, there was no correlation with age, height, BSA or
weight in normal subjects or patients with congenital volume overloading defects,
but the EPSS: LVIDd did increase in the presence of DCM (Engle et al 1983). A B
bump on the anterior mitral valve leaflet is indicative of impaired left ventricular
systolic performance (Movsowitz et al 1996).
Mitral M-mode may also be used to measure early leaflet separation, between the
anterior and posterior leaflets of the mitral valve, in early diastole. In DCM, both
early and late (subsequent to atrial contraction) leaflet separation are reduced
compared with normal individuals (Douglas et al 1987a). The mitral orifice area,
relative to the short axis left ventricular area at mitral valve level, is reduced in DCM
(Pollick et al 1982). This is related both to left ventricular dilatation and to reduced
stroke volume, as these authors also showed that aortic orifice area, relative to aortic
root diameter, was also reduced in DCM patients compared with healthy humans.
B.2.5. Mitral annulus motion (Atrioventricular plane displacement)
Mitral annulus motion, also known as atrioventricular plane displacement or mitral
valve annulus displacement, gives an indicator of contractility in an apico-basilar
direction. Circumferential fibre shortening has formed the basis for the dominant
methods for ascertaining left ventricular function, such as chamber dimensions,
fractional shortening and ejection fraction (Simpson 1997). However, left ventricular
myocardial architecture also includes longitudinally arranged myocardial fibres,
particularly in the subendocardium, within the trabeculae and the papillary muscles
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(Simpson 1997). Because of a constant relation between the heart and the chest wall,
atrioventricular plane displacement is a consequence of this longitudinal fibre
shortening (Simpson 1997).
The events associated with and the description of mitral annulus motion have been
detailed by Keren and colleagues (1988c). After about 90 milliseconds after the onset
of the QRS complex, the mitral annulus is displaced towards the left ventricular apex
due to contraction of the longitudinal fibres. This contraction usually occurs prior to
short-axis fibre shortening, resulting in a transiently more spherical ventricle during
the isovolumic contraction period (Simpson 1997). During diastole, the annulus
recoils towards the atrium, corresponding to the onset of rapid ventricular filling and
the onset of the D phase of pulmonary venous flow. The final displacement towards
the atrium (corresponding to about 2.4 mm in normal humans) occurs after atrial
systole (Keren et al 1988c).
The magnitude of systolic excursion in the apico-basilar dimension is measured from
a four chamber and two chamber view, and the mean recorded (Alam et al 1990;
Alam 1991; Pai et al 1991). Although normally measured from M-mode, it has been
described from 2D techniques (Reynolds 1997). Provided four areas are assessed, the
mean is a good indicator of global LV performance even in the presence of regional
wall motion abnormalities (Simpson 1997). The normal mitral annulus motion in
man is fifteen millimetres and measurement abnormalities are said to provide an
early indication of myocardial dysfunction (Schiller & Foster 1996), particularly
associated with myocardial hypoxia or ischaemia since the subendocardial
longitudinal fibres are particularly susceptible to these environments (Simpson
1997). In man, mitral annulus excursion in excess of ten millimetres is likely to be
associated with a normal left ventricular ejection fraction of 0.5 or 50% (Alam 1991).
A mean mitral annulus motion of less than seven millimetres predicts an ejection
fraction below 30%, with a sensitivity of 92% and specificity of 67% (Alam et al
1990).
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Mitral annulus motion influences pulmonary venous flow (Keren et al 1988c).
Magnitude of the mitral annulus motion is reduced in DCM (Keren et al 1988c;
Alam et al 1990). The technique may be used to assess septal contractility even
when left bundle branch block results in paradoxical septal motion (Silva et al 1996).
The magnitude of the atrioventricular plane displacement has also been suggested to
have prognostic significance (Willenheimer et al 1997), and has been suggested as an
alternative to determination of ejection fraction, as the technique is less dependent on
image quality or operator experience (Willenheimer et al 1997).
Schober and colleagues (1997) presented the results of mitral annulus motion in
dogs, and reported a normal mean motion of 1.2 + 0.18 centimetres for the septal
annulus and showed it was decreased in dogs with mitral valve disease and was
markedly low in dogs with DCM. No mention was made of the influence of body
weight in this mixed breed group, although most dogs were small or medium size
breeds.
B.2.6. Systolic time intervals
Systolic time intervals (STIs) provide a quantitative description of overall left
ventricular performance reflecting the combined influences of heart disease,
compensatory responses and pharmacological intervention (Henik 1995). Findings
expected with diminished left ventricular performance are increased pre-ejection
period (showing reduced rate of LV systolic pressure rise), reduced left ventricular
ejection time (due to reduced fibre shortening), increased pre-ejection period to
ejection time ratio (PEP:ET) and reduced velocity of circumferential fibre shortening
(Vcf). The time for electromechanical systole (start of Q to aortic valve closure
(QAVC) is normally unaltered (Henik 1995). The systolic time intervals normally
fall between narrow physiologic limits and thus are highly sensitive measures of
overall ventricular function (Allworth et al 1995). It can be argued that this is a
preferable method of assessing left ventricular global function, whereas fractional
shortening only assesses a small, possibly unrepresentative portion of the
myocardium (Allworth et al 1995) and ejection fractions detemiined volumetrically
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are prone to error. STIs are non-specific indicators of left ventricular performance
because they are affected by myocardial contractility, heart rate and loading
conditions, but they do correlate with invasively derived measurements of ejection
fraction, cardiac output and stroke volume (Henik 1995). They can be measured
from M-mode of the aortic valve from a short axis view. Although, M-mode has
better temporal resolution than pulsed wave Doppler, this is not clinically significant
and using Doppler aortic flow spectra has been justified (Borow 1989). Amberger
and Lombard (1998) commented that precision of measurement was improved by
using spectral Doppler aortic flow traces.
The pre-ejection period, PEP, is influenced by heart rate, aortic diastolic pressure,
duration of intraventricular conduction, LV end-diastolic pressure and contractility
(Borow 1989). In dogs, however, Pipers and others (1978) showed, using linear
regression, that there was no significant relationship between PEP and heart rate,
which was supported by Atkins and Snyder (1992). PEP tends to increase with left
ventricular systolic failure due to decreased rate of pressure rise during isovolumic
systole (dP/dt) (Borow 1989).
The ejection time (ET) is influenced by heart rate, stroke volume, preload, afterload
and contractility. ET tends to shorten with systolic failure and mitral regurgitation
(Borow 1989). There is a significant inverse relationship with heart rate (Pipers et al
1978) and it may be corrected for heart rate in various ways to give an ejection time
index (LVETI). From the linear regression between HR and STI, Atkins and Snyder
(1992) used the following formula in dogs:
LVETI = ET + (0.55xHR)
The ratio of PEP:ET is less heart rate dependant and can be used as a sensitive
indicator of contractility although it does also depend on preload and afterload
(Borow 1989). In dogs, there has been some controversy in the veterinary literature
in the dependency of this ratio on heart rate. A clear relationship was shown by
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Pipers and colleagues (1978), although the study by Atkins and Snyder (1992) and
Amberger and Lombard (1998) showed no significant association. Normal values
given for canine PEP:ET ratio range from 0.24 (Pipers et al 1978) and 0.34 (Atkins
& Snyder 1992), and Amberger and Lombard (1998) suggested using a median value
of 0.3 as a cut off between normal and abnormal.
The velocity of circumferential fibre shortening (Vcf) is a derivative of the systolic
time interval, ET. Vcf is an indicator of the rate of contraction between systole and
diastole expressed in circumferences / second although it is really a measure of the
rate of change of LV size in diameters per second (Borow 1989). It is calculated from
the fractional shortening (expressed as a fraction rather than a percentage) and the
ejection time (Feigenbaum 1994a):
Vcf = FS/ET.
Vcf is relatively preload independent but is highly dependent on heart rate and
afterload as well contractility (Borow 1989). The effect of heart rate can be
minimised by correcting the value by multiplying it by the square root of the
preceding R-R interval (Borow 1989). Atkins and Snyder (1992) normalised for
heart rate by dividing the value of Vcf by the heart rate and multiplying by 100.
STIs have been validated in the dog using M-mode (Pipers et al 1978; Atkins &
Snyder 1992). Amberger and Lombard (1998) showed that there should be no
difference between values obtained by M-mode of the aortic valve motion and values
determined from spectral Doppler of aortic flow. There are probably breed related
differences in the normal values in dogs as has been demonstrated for the greyhound
(Snyder et al 1995).
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B.2.7. Doppler indices
B.2.7.1. Doppler indices of aortic flow
Doppler may be used to assess global left ventricular systolic performance by
measuring parameters of aortic blood flow and results are not subject to any
assumptions based on chamber size or shape (Movsowitz et al 1996). Peak aortic
flow and the peak acceleration rate of aortic flow correlate well with global left
ventricular systolic performance, although the indices are load dependent (Goldberg
et al 1988a; Movsowitz et al 1996). Obviously, this can only be true in the absence
of any aortic stenosis. As the best alignment with flow is usually from the subcostal
view in dogs with aortic stenosis (Lehmkuhl & Bonagura 1994), it is evident that this
would be the optimal view to use in determining left ventricular systolic function in
the absence of aortic stenosis.
Doppler of the aortic outflow allows calculation of the forward stroke volume and the
cardiac output (Goldberg et al 1988a;c; Borow 1989), although this requires an
accurate measure of aortic diameter (any error in the radius is magnified four fold)
(Feigenbaum 1994b; Movsowitz et al 1996). The aortic spectrum velocity time
integral is a good indicator of left ventricular performance and can be used without
introducing errors due to inaccuracies in measurement of vessel diameters
(Feigenbaum 1994a). Aortic flow peak velocity and velocity time integral are
significantly reduced in patients with DCM, with minimal overlap with data from
normal healthy individuals (Gardin et al 1983). Similar findings are reported in dogs
(Darke 1990; 1992; 1994; Darke et al 1993).
The rate of acceleration at which blood is ejected from the left ventricle (dv/dt), or
the ejection force, can be used to indicate contractility, with calculation of aortic
dv/dt (maximum or mean) and acceleration time (Feigenbaum 1994a). There is
significant overlap between normal acceleration time and prolonged acceleration
time in patients with DCM (Gardin et al 1983).
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One confounding factor about the use of Doppler evaluation of aortic flow in DCM is
the difficulty in sample volume positioning, since the velocity distribution in the
aortic annulus in patients with DCM is skewed, with higher velocities obtained from
the anterior and septal parts of the annulus (Zhou et al 1996).
B.2.7.2. Doppler indices ofmitral regurgitation
With patients with mitral regurgitation, then a calculation which gives the gold
standard indicator of contractility, dP/dt, can be used. From the acceleration slope of
the spectrum, two points of known velocity are selected, allowing calculation of the
pressure gradient between them (dP) from the modified Bernouille equation. The
time between the two points (dt) is determined and dP/dt is calculated (Bargiggia et
al 1989; Chen et al 1991; Feigenbaum 1994a; Vuille & Weyman 1994; Movoswitz et
al 1996).
Borgarelli and others (1998) found that the velocity of mitral regurgitant jets in
canine DCM was related to survival times; dogs with jet velocity less than four
metres per second (m/s) had a worse prognosis than those dogs with mitral
regurgitation with peak velocity exceeding four m/s.
The severity of mitral regurgitation may be subjectively or semi-quantitatively
assessed by the jet area in the left atrium, assessed by pulsed wave spectral or colour
flow mapping Doppler echocardiography (Flelmcke et al 1987; Goldberg et al
1988b; Kisslo et al 1988; Perry 1989). More accurate methods of quantifying the
mitral regurgitant fraction are reported, by determining the total left ventricular
stroke volume (from two-dimensional echocardiographic computation, or possibly
from mitral inflow pulsed wave Doppler echocardiography) and the forward stroke
volume, from aortic flow velocity time integral and cross sectional area and then
calculating the mitral regurgitant fraction (Blumlein et al 1986; Rokey et al 1986;
Goldberg et al 1988c; Keren & LeJemtel 1989).
B.2.7.3. Left ventricular meridional systolic wall stress
This is a useful parameter to measure as it is less dependent on loading conditions
compared with the other parameters of systolic function (Feigenbaum 1994a; Vuille
& Weyman 1994). It is valid in the absence of aortic stenosis and is derived from M-
mode indices and systolic arterial pressure (SAP), with wall stress units in dynes/cm .
Stress = 0.334 x SAP x LVIDs
LVpws [1 + (LVpws/LVIDs)]
Systolic arterial pressure may be measured in dogs using the DynamapR oscillometric
method (Allworth et at 1995), although this significantly underestimates systolic
pressure (Meurs et al 1996a). The Doppler technique may be more accurate (Binns,
S.H. etal 1995).
A number of techniques have been described for calculating meridional or
circumferential wall stress, relating altered geometry in cardiac disease to increasing
wall stress (Marsh et al 1979; Quinones et al 1980; Douglas et al 1987c; Binkley et
al 1988; Morgan et al 1989; Grandi et al 1993; Vuille & Weyman 1994; Municino et
al 1996).
B.3. Echocardiography / Doppler assessment of left ventricular
diastolic function
B.3.1. Introduction to the assessment of diastolic function
Diastolic function is a complex sequence of many inter-related events (Nishimura &
Tajik 1997) and it is therefore difficult to assess (Yamamoto et al 1996). For
simplification, diastolic function is usually subdivided into the following different
haemodynamic phases which are fundamentally different in their properties. These
include isovolumic relaxation, rapid filling phase, diastasis and the late filling phase
corresponding to atrial contraction (Little & Downes 1990; Taylor & Waggoner
1992; Modersohn et al 1993; Choong 1994). The two major determinants of
ventricular filling are ventricular relaxation and effective chamber compliance
(Nishimura & Tajik 1997).
52
Diastolic dysfunction occurs when left ventricular filling required to produce an
adequate cardiac output requires an elevated pulmonary venous pressure. Systolic
dysfunction is the major cause of diastolic dysfunction (Little & Cheng 1998), since
an elevated end-diastolic pressure is required to maintain cardiac output, and an
elevated pulmonary venous pressure may therefore be required to achieve ventricular
filling. Consequently, it is not surprising that diastolic dysfunction is recognised in
association with DCM. However, diastolic dysfunction is an integral part of the
pathophysiology of DCM (Takenaka et al 1986). Failure of complete relaxation and
increased myocardial stiffness may play a part in explaining the elevated filling
pressures and reduced cardiac performance ofDCM patients (Keren et al 1992). Left
ventricular filling parameters are reported to correlate better with NYHA class of
congestive failure than indices of systolic function in patients with DCM
(Vanoverschelde et al 1990).
B.3.2.1. Mitral inflow parameters in the assessment of diastolic function
For over a decade, it has been appreciated that study of mitral inflow patterns provide
information about left ventricular diastolic function (Labovitz & Pearson 1987;
Harizi et al 1988; Little & Downes 1990; Taylor & Waggoner 1992). Doppler
echocardiography is reported to compare favourably with radionuclide angiographic
techniques (Spirito et al 1986; Pearson et al 1988) and gated blood pool scintigraphy
(Friedman et al 1986) in the evaluation of left ventricular diastolic function.
Although various cardiac diseases are associated with abnormal mitral inflow
patterns, it should be noted that these patterns are related more to myocardial
function and haemodynamics than the specific type of disease process (Appleton et al
1988).
During early diastole, and the isovolumic relaxation period, myocardial relaxation
results in a steep exponential fall in intraventricular pressure as the elastic
components of the left ventricle, compressed and twisted during ejection, are allowed
to recoil. These processes allow rapid filling after opening of the mitral valve. The
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left ventricular pressure in the normal heart should continue to decline despite the
increase in volume associated with filling (it is the left atrial to left ventricular
pressure gradient which is responsible for the rapid filling phase) (Little & Cheng
1998). This represents the E peak of mitral inflow. Left atrial pressure is the most
important determinant of the velocity and shape of the E wave (Lewis 1996) although
left ventricular function influences it (Nakatani et al 1992). Factors listed by
Yamamoto and colleagues (1996) as influencing the mitral E wave are the atrial
factors (left atrial pressure and compliance) and the ventricular factors (left
ventricular relaxation, elastic recoil, compliance and interventricular interaction).
During diastasis, small late (L) waves may be evident. The other major phase of left
ventricular filling is the A wave subsequent to atrial contraction. The A wave reflects
the contractile state of the left atrium, the left atrial: left ventricular instantaneous
pressure gradient and the state of left ventricular compliance (Lewis 1996).
Normally, most flow is early in diastole so E peaks are higher velocity and have
larger velocity time integral than A peaks (Labovitz & Pearson 1987; Harizi et al
1988; Spirito & Maron 1988b; Smith 1990). In patients with fast heart rates
(especially cats) E and A peaks may be poorly separated or even summated (Frey &
Douglas 1990; Santilli & Bussadori 1998). In man, increasing age reduces the E:A
ratio, but the parameters of mitral inflow are not influenced by body size (Spirito &
Maron 1988b). Other parameters assessed in diastolic function is the E wave
deceleration time (Klein & Cohen 1996) or the E wave deceleration half-time
(Takenaka et al 1986). In normal individuals, left atrial diameter, left ventricular
wall thickness or chamber diameter, left ventricular mass and patient body mass
index are reported to have little or no association with Doppler indices (Benjamin et
al 1992). However, in the presence of left ventricular hypertrophy or left ventricular
dilatation, the E to A ratio and the A velocity time integral as a fraction of total
inflow does correlate with the left ventricular radius: wall thickness ratio, over-riding
the effects of age (Sartori et al 1987). Mitral A wave and A:E ratio is related to an
interaction of left ventricular chamber volume and mass and not just chamber size or
hypertrophy alone (Kenny et al 1991).
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Sample volume position also influences mitral inflow pattern (Feigenbaum 1994a;
Choong 1994) and positioning between mitral valve leaflet tips is normally
advocated (Klein & Cohen 1996; Appleton et al 1997), which optimises E:A ratio
(Choong 1994; Mantero et al 1998). Other authors, however, suggest positioning at
the mitral annulus (Frey & Douglas 1990). The image plane is also important. Mitral
inflow velocities are approximately four percent higher if obtained from the apical
four chamber view compared with the apical two chamber view (Gardin et al 1986).
Abnormal LV diastolic function due to impaired relaxation may be recognised by:
• E:A < 1 (i.e. A>E)
• prolonged isovolumic relaxation time (IVRT)
• Prolonged deceleration time
These features characterise impaired relaxation. The fall in diastolic left ventricular
pressure is reduced, compromising the early filling phase, so LV filling is more
dependent on atrial contraction (Klein & Cohen 1996; Masuyama & Popp 1997).
If the underlying condition evolves to result in more severe impairment of diastolic
function, and left atrial pressure increases, this compensates for the impaired
relaxation pattern, since there is a more rapid rate of early diastolic transmitral flow
and a faster deceleration time (Little & Cheng 1998). Consequently, superficial
scrutiny of the mitral inflow pattern may not detect the presence of diastolic
dysfunction in the patient under examination; the transmitral pattern is described as
"pseudonormalised" (Nishimura & Tajik 1997). In man, Valsalva manoeuvres may
unmask a pseudonormal pattern (Masuyama & Popp 1997). Mitral regurgitation may
also play a role in pseudonormalisation (Werner et al 1994).
In the presence of even more severe diastolic function with a markedly elevated left
ventricular pressure, this more than offsets the impaired relaxation pattern, and a
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restrictive transmittal flow pattern may be recognised (Masuyama & Popp 1997;
Little & Cheng 1998):
• E:A > 2
• decreased IVRT
• decreased deceleration time
The increase in left ventricular stiffness results in brief early flow duration,
decreased E wave deceleration time and increased deceleration rate. These features
characterise a restrictive left ventricle (Klein & Cohen 1996). During the rapid filling
phase, the stiff left ventricle abruptly restricts further filling, and atrial contraction
offers minimal additional filling. These changes can also be seen with elevated filling
pressures associated with congestive heart failure, significant mitral regurgitation and
left atrial and left ventricular volume overload, reduced compliance of the left
ventricle or restrictive myocardial disease (Klein & Cohen 1996). With increased
left ventricular volumes, pericardial restraint becomes significant and shifts the
diastolic pressure-volume curve upwards and leftwards, which explains the increased
E wave velocity and decreased deceleration time identified with increasing preload
(Nishimura & Tajik 1997). The fact that these different mitral inflow patterns evolve
with disease progression is not actually proven, but is a hypothesis supported by most
authors (Cohen et al 1996; Appleton et al 1988; Nishimura & Tajik 1997; Oh et al
1997) and has been demonstrated in cardiac amyloidosis (Abdulla et al 1998).
Mitral inflow patterns are also affected by changes in LV volume (Fragata & Areias
1996). Decreased preload (Castini et al 1992), nitroglycerine administration (Choong
et al 1987) or ACE inhibitor therapy (Keren et al 1992) may mimic diastolic
dysfunction. In contrast, increased preload may result in mitral inflow patterns
masking diastolic dysfunction (Stoddard et al 1989), as may the presence of mitral
regurgitation (Takenaka et al 1986), although this effect depends on the presence of
elevated filling pressures (Lavine & Arends 1989). Changes in posture and exertion
may also influence transmittal flow (Kmetzo et al 1991). Caution was urged in
interpreting diastolic abnormalities from trans-mitral filling patterns, as the
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conclusions may be diametrically opposed to actual haemodynamic changes, as
shown in a study where catheterisation data indicated improved diastolic function
with an amrinone infusion, whereas mitral inflow patterns suggested reduced LV
compliance (David et al 1989). Other determinants of Doppler indices of diastolic
function are the P-R interval, left ventricular systolic function and systolic blood
pressure (Benjamin et al 1992) and gender (Kangro et al 1996).
The fact that normal mitral flow patterns will vary with loading conditions, age and
heart rate confounds the interpretation of patterns identified in various cardiac
diseases (Nishimura et al 1989; Nishimura & Tajik 1997). Despite these confounding
factors, a grading system for the severity of diastolic dysfunction has been proposed
by Nishimura and Tajik (1997). A grade I pattern corresponds to abnormal
relaxation, grade II to pseudonormalisation, grade III to a restrictive filling pattern
which improves with treatment and grade IV represents a restrictive filling pattern
which is maintained despite therapy, indicating severe abnormalities of left
ventricular compliance and end-stage heart disease. Peak E velocity and short E
deceleration time were the strongest negative predictors of survival in patients with
DCM, from a Cox proportional hazards analysis (Werner et al 1994). A number of
authors support the fact that unresolving mitral inflow restrictive patterns are
associated with poor prognosis (Giannuzzi et al 1996; Nishimura & Appleton 1996;
Traversi et al 1996; Xie et al 1996; Lee et al 1997; Pinamonti et al 1997).
Tenenbaum and colleagues (1996) showed that measurement of the A wave
deceleration time was also informative; if shortened, it indicated elevated left
ventricular filling pressure. Castini and others (1992) reported that the peak A
velocity and A velocity time integral were independent of preload reduction (unlike
the E wave) and could provide an index of diastolic function. A positive relationship
between the A wave velocity and the body mass index suggests that left ventricular
compliance is reduced in obese individuals (Lewis 1996). Other factors influencing
the A wave have been listed (Yamamoto et al 1996).
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The ratio of velocity time integrals less than one (Evti:Avti < 1) is insensitive but
specific at detecting abnormal left ventricular compliance. Calculation of the atrial
contribution to total left ventricular filling (Avti/(Evti+Avti) may also indicate
impaired relaxation when increased as long as left atrial function is normal (Choong
1994).
Scalia and colleagues (1997) reported on a noninvasive technique for estimating the
ventricular relaxation time constant, tau (x), from Doppler derived IVRT, peak
systolic blood pressure and left atrial pressure (determined from the pulmonary
capillary wedge pressure on right sided catheterisation or presumed at 10 mmHg). x
was underestimated but correlated well with the invasively determined method.
It has only been recently that diastolic dysfunction has been appreciated to be a factor
in DCM. Ng and Gibson (1991) described "E fillers" and "A fillers" depending on
the mitral inflow pattern shown. DCM patients commonly show altered diastolic
filling parameters (Fruhwald et al 1997b) which are of prognostic significance
(Werner et al 1994). Left ventricular diastolic function is an integral component of
end-stage DCM (St.Goar et al 1991). It is interesting to note that in doxorubicin-
induced cardiomyopathy, left ventricular diastolic abnormalities precede systolic
dysfunction (Marchandise et al 1989). Normally in DCM, E and A velocities are
reduced and E:A ratio is increased (Sadaniantz et al 1997), but mitral regurgitation
has the effect of increasing E masking these findings. Peak E velocity and E:A ratio
correlate with the severity of mitral regurgitation, although the E deceleration time is
not affected by mitral regurgitation (Thomas et al 1998).
The deceleration time of the early mitral inflow wave is determined by the effective
stiffness of the left ventricle. In man, if it is less than 125 - 150 milliseconds, this is
associated with a poor prognosis and if less than 115 - 130 milliseconds, this is
associated with a grave prognosis (Pinamonti et al 1993; Little & Cheng 1998)
regardless of rhythm (Hurrell et al 1998). In man, short deceleration time is more
sensitive than low ejection fraction in the prediction of adverse prognosis (Pinamonti
58
et al 1993; Rihal et al 1994). The peak E velocity and E:A ratio also offers
independent prognostic information (Werner et al 1994; Lapu-Bula et al 1998).
Borgarelli and colleagues (1998) also showed a trend to decreased survival time in
dogs with a restrictive mitral inflow pattern, although this was not statistically
significant.
The informativeness of Doppler indices of diastolic function have been hampered by
difficulties in obtaining accurate and reproducible measurements. Appleton and
colleagues (1997) indicated some of the technical pitfalls which may be responsible
for poor reproducibility. One factor was proper alignment with mitral inflow, which
must take into account the size and geometry of the left ventricle. In the normal
human heart, mitral inflow direction is approximately 20° to the apex. In a dilated
heart, mitral inflow is orientated more laterally and may be 30 - 40° to the apex, and
so transducer position must be modified from the standard apical view. The mitral E
wave deceleration time is most affected by technical errors of alignment and sample
volume placement (Appleton et al 1997), which is unfortunate as this parameter is of
critical importance in obtaining prognostic information in DCM (Giannuzzi et al
1996).
The peak filling rate of the left ventricle has been demonstrated to be a useful index
for evaluating diastolic function and to monitor the effect of therapeutic
interventions. It has conventionally been normalised to end-diastolic volume, during
radionuclide studies. Bowman and colleagues (1988) proposed that if the peak filling
rate was instead normalised to the mitral stroke volume, this provided an index
relatively free from geometrical assumptions, diameter measurements and errors in
sample volume positioning. The peak filling rate (PFR) (expressed as stroke volumes
per second; (SV/s)) is given by:
PFR = E wave velocity / total mitral velocity time integral
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Excellent correlation was shown with radionuclide methods. Bowman and colleagues
(1988) postulated that this index would provide a more reliable and reproducible
method for assessing left ventricular filling. Santilli and Bussadori (1998) described
its use in the cat as a method of correcting for errors of transducer orientation or
sample volume positioning, to allow comparisons between individuals to be made.
B.3.2.2. Intraventricular transmission of mitral flow
Colour flow M-mode of mitral inflow from a left apical view has also been used to
assess diastolic function. The propagation velocity is defined as the slope of the wave
front during early filling, and it correlates well with spectral Doppler indices of mitral
inflow (Brun et at 1992; Cohen et al 1996). The velocity is related to peak E velocity
and varies inversely with IVRT. In patients with diastolic dysfunction, the velocity of
flow propagation is reduced and Brun and colleagues (1992) proposed that this would
be an important tool in investigating diastolic function. It is an ideal technique
because of the high sampling rate offering the ability to measure flow velocities in
temporal and spatial domains (Nishimura & Appleton 1996). Mego and colleagues
(1998) described this technique in the assessment of left ventricular filling
characteristics and showed that age resulted in decreased propagation velocity and
the technique compared favourably with other mitral inflow Doppler indices in
healthy individuals. In a pacing model of DCM dogs, colour M-mode of mitral
inflow was found to be more sensitive than the conventional Doppler indices in the
detection of early diastolic function during evolution of the disease (Crabbe et at
1997). Propagation velocity is slowed in human patients with acute myocardial
infarction (Steine et al 1998). Flow propagation is slow in myocardial disease
associated with a restrictive physiology, but is increased with constriction (e.g.
pericardial disease). This slope is decreased as tan (x), -dP/dt and minimal early
diastolic pressure increase (Cohen et al 1996). Takatsuji and co-workers (1996)
described a modification of this technique.
Spectral Doppler studies of mitral inflow mapped from mitral valve leaflets towards
the left ventricular apex have also been assessed in various ways (Jacobs et al 1990;
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Sniderman et al 1997; Kozan et al 1998). Velocity declines and propagation is
slowed with diastolic dysfunction. The best estimate of the pulmonary capillary
wedge pressure was reported to be the ratio of the mitral E wave and the flow
propagation velocity (Garcia et al 1997).
In the normal left ventricle, there is normally rapid reversal of mitral inflow towards
the left ventricular outflow tract. Pennestri and others (1992) showed that abnormal
persistence of systolic flow towards the left ventricular apex on colour flow M-mode
ofmitral inflow was evident in both regional and global left ventricular dysfunction,
which could be measured by a flow persistence index.
Fujimoto and others (1995) noted that in DCM, there is narrowed effective mitral
orifice area. This, as well as the increased left atrial to left ventricular pressure
gradient, may explain the increased inflow accelerations. In normal individuals, the
mitral inflow signal disappears by three or four centimetres within the left ventricle
but may persist up to seven or eight centimetres in DCM patients (Fujimoto et al
1995), suggesting that mitral inflow may be regarded as a column of blood, longer
and thinner in DCM patients. Similar findings were reported by Yamamoto and
colleagues (1995), who demonstrated that these changes could unmask
pseudonormalised mitral inflow and were also present in patients with atrial
fibrillation.
Pai and Stoletniy (1997; 1998) further examined the fate of the mitral inflow wave
within the left ventricle and postulated that study of the intra-ventricular transmission
of the mitral inflow E wave would provide information about the global left
ventricular diastolic performance. The early mitral E wave is transmitted along the
postero-lateral wall towards the left ventricular apex, where it is reflected towards the
left ventricular outflow tract, and may be identified as an Er wave. The E-Er interval
was prolonged in patients with abnormal relaxation (Pai & Stoletniy 1998). The
mitral A wave is also reflected in a similar manner as an Ar wave (Pai & Stoletniy
1997). Brennan and colleagues (1997) reported that the A-Ar interval was an index of
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left ventricular diastolic function reflecting its intrinsic elasticity and end diastolic
pressure.
B.3.2.3. Effect of age
Age related changes result in a decreased rate of early filling, due to a reduced left
atrial to left ventricular pressure gradient as a consequence of slowed left ventricular
relaxation (Little & Cheng 1998). This results in a lower E to A wave ratio associated
with age. Age related changes affecting mitral inflow are decreased E, increased A,
increased A velocity time integral, decreased E to A velocity and velocity time
integral ratios and increased E deceleration time (Stork et al 1990/91; Mantero et al
1995). Mitral E wave duration also increases in healthy elderly people, associated
with decreased left ventricular compliance (Manyari et al 1985). In healthy humans
over seventy years of age, an inverted E to A ratio is normal (Benjamin et al 1992;
Mantero et al 1995). Age is the major independent variable influencing diastolic
function parameters, with a greater influence than heart rate (Mantero et al 1998).
These changes probably reflect changing collagen content, cardiomyocyte atrophy
and the effect of disease (Lewis 1996). Benjamin and others (1992) reported that the
mechanisms of change in diastolic function associated with age remained
unexplained. They postulated that concurrent age-related disease such as myocardial
ischaemia, hypertension or diabetes mellitus may be associated with these changes.
An intricate combination of cellular hyperplasia, cell death, fibrosis, reduced calcium
sequestration and increased passive stiffness may underlie the changes in diastolic
function with ageing (Benjamin et al 1992). Manyari and others (1985) considered
that age related changes could be considered as intracellullar (increase myofibre
vacuolisation) or extracellular (increased collagen, fibrous and adipose tissue and
calcium and amyloid deposition). The incidence of diastolic dysfunction is age
related and heart failure due to diastolic dysfunction is markedly increased in elderly
humans (Nishimura & Tajik 1997). Yu and Sanderson (1997) showed that age and
heart rate exerted similar although weaker effects on mitral inflow parameters of
diastolic function in patients with congestive heart failure. A weak relationship
between age and the atrial filling fraction is maintained in the presence of left
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ventricular hypertrophy. In DCM, the relationship between the Doppler flow indices
and age is lost (Kuo et al 1987). In general, mitral inflow patterns are significantly
affected by age and comparison should be made with published reference ranges
based on gender, age and heart rate (Benjamin et al 1992; Mantero et al 1995;
Nishimura & Tajik 1997). Such information is lacking in the veterinary literature.
B.3.3. Isovolumic relaxation time
Ventricular relaxation begins in mid-systole and continues through the first third of
diastole (Nishimura & Tajik 1997). If this relaxation is slow or incomplete, left
ventricular distensibility is reduced (Little & Cheng 1998). IVRT depends on this
myocardial relaxation as well as the pressure gradients between the left atrium and
left ventricle and the left ventricle and the aorta (Little & Cheng 1998). IVRT is
significantly correlated with the acceleration of the E wave of mitral inflow and the
IVRT and the A:E ratio show a linear relationship (Brecker et al 1992). IVRT
increases with age (Spirito & Maron 1988a).
IVRT may be measured using pulsed wave Doppler with the sample volume
positioned in the left ventricular outflow tract so detecting left ventricular outflow
and mitral inflow (Borow 1989). Lee and others (1990) found that the IVRT was 25
+ 10 milliseconds longer if measured by Doppler compared with the mitral M-mode
technique, unless phonocardiography to identify S2 was used, showing that the two
measurement techniques are not interchangeable. The IVRT increased with volume
loading (Fragata & Areias 1996).
B.3.4. Pulmonary venous flow
Although the right ventricle generates the energy driving pulmonary venous flow
(PVF), the actual pattern of PVF is determined by haemodynamic events in the left
atrium which in turn are influenced by left ventricular events (Choong 1994). The
pulmonary veins are thin walled, very compliant structures which may accommodate
a potential reservoir ofmore than one stroke volume of blood (Klein & Tajik 1991).
PVF has been suggested as a noninvasive semiquantitative method of assessing left
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ventricular filling pressure (Steen et al 1994). There are three major phases to PVF
(Klein & Tajik 1991; Feigenbaum 1994a; Weyman 1994a; Choong 1994). After the
P wave on the ECG, a small wave passes retrogradely into the pulmonary veins
associated with atrial systole (Ar or R). During subsequent atrial relaxation, forward
flow in the pulmonary veins may be seen, called the early systolic flow (Se)
associated with resulting fall in left atrial pressure. Associated with ventricular
systole, and the movement of the mitral annulus apically, the major forward systolic
flow is identified in the pulmonary veins (Sl) resulting from the increased left atrial
volume and fall in left atrial pressure. It has been proposed that there is a direct linear
relationship between the velocity of peak S and cardiac output (Weyman 1994a). The
Sl waves is also influenced by right ventricular stroke volume (Appleton et al 1997).
t hese two phases may not be distinctly separate and may be represented as a single
systolic phase (S). During ventricular diastole, the left atrium functions as a conduit
between the pulmonary veins and the left ventricle and during this time, in normal
animals, the major forward flow (D) can be recognised in the pulmonary veins. D
corresponds to the L (diastasis) phase of mitral inflow (Choong 1994) and peak D is
about 50 milliseconds behind peak E (Weyman 1994a). Normally, the D wave is of
higher peak velocity than the S wave. There is a small reversal wave (R2) recognised
in dogs and other species by Schober and colleagues (1995; 1996; 1998) demarcating
the S and D phases, which probably represents recoil of the mitral annulus. Although
this feature was evident in figures included in publications about human PVF, it was
not noted until Klein and Cohen (1996) called it a late systolic reversal wave (Vr),
who commented it resembled an equivalent but more pronounced and better
recognised late systolic reversal wave in systemic venous flow.
Study of PVF gives further insights into diastolic function in an individual (Oh et al
1997). Klein and Tajik (1991) and Yamamoto and others (1996) listed the factors
which were important in determining the various PVF wave forms.
Spontaneous respiration has little effect on the PVF pattern (Klein et al 1998). The
S:D ratio tends to increase with faster heart rates, because of reduced diastolic filling
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time (Klein & Tajik 1991; Steen et al 1994). With advancing age, the S wave has
higher and the D wave lower velocities, so increasing the Sv:Dv ratio (Klein & Tajik
1991). Age is said to be principle determinant of PVF parameters (Gentile et al
1997).
Although it is not possible to determine left atrial pressure from the PVF, there is
strong negative correlation between LA pressure and the systolic forward velocity as
a percentage of overall forward velocity i.e. Sv/(Sv+Dv) x 100% (Klein et al 1997;
Choong 1994) and the systolic fraction of total forward flow (Svti/total forward vti)
(Klein & Tajik 1991). A systolic fraction less than 40% is predictive of increased
mean left atrial pressure (Klein et al 1998). The ratio of PVF Ar and PVF Se waves
are also reported to correlate positively with mean pulmonary capillary wedge
pressure (PCWP) (Tabata et al 1997). Multiple linear regression equations have been
reported as significantly predicting a relationship between PCWP, validated by right
heart catheterisation. These involve a positive association between mitral E
deceleration rate (peak velocity divided by deceleration time) with a negative
association of the systolic fraction of forward PVF (Pozzoli et al 1996). The
equations are predictive even in the presence of mitral regurgitation.
If there is impaired left ventricular relaxation, the D wave is reduced and the Ar
wave increases (Feigenbaum 1994a), as the abnormal left ventricle receives reduced
amounts of blood from the left atrium and atrial pressures prior to atrial contraction
are higher than normal, so atrial systole is associated with increased back flow into
the pulmonary veins as well as into the left ventricle. Increased left ventricular end-
diastolic stiffness is associated with an increased Ar wave. With elevated LV filling
pressures, mitral A velocity is diminished as Ar increases (Ito et al 1998). In man, the
velocity exceeds 35 centimetres per second in the presence of a restrictive or a
pseudonormalised mitral inflow pattern, unless there is atrial systolic dysfunction or
atrial fibrillation (Little & Cheng 1998). In the presence of mitral inflow
pseudonormalisation, PVF D wave velocity greater than 60 cm/s or an Sv:Dv ratio
of less than 0.75 will unmask this finding, although will only identify about sixty
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percent of patients with the pseudonormal transmitral filling pattern (Masuyama &
Popp 1997). The ratio of PVF Ar to mitral A wave velocities (Arv:Av) is strongly
correlated with the mean PCWP. A ratio exceeding 0.5 predicts a PCWP greater
than 15 mmHg with 88% sensitivity and 80% specificity (Ito et al 1998) and
consequently is a useful marker for elevated PCWP in patients with systolic
dysfunction.
The difference in durations between the mitral A wave and the PVF Ar wave is also
informative. PVF Ar duration exceeds A duration in patients with a left ventricular
end-diastolic pressure (LVEDP) of greater than 15 mmHg (Yamamoto et al 1997;
Abdalla et al 1998; Klein et al 1998). The differences in durations are relatively
independent of age in normal human subjects (Klein et al 1998). The magnitude in
the difference between the two durations reflects the severity of the diastolic
dysfunction. Differences increase in diastolic dysfunction both by prolongation of Ar
and shortening of mitral A duration (Abdalla et al 1998).
PVF corresponding to the restrictive pattern of mitral inflow may be recognised as a
small S and a large D, with large atrial wave (Klein & Tajik 1991; Feigenbaum
1994a). During early passive filling, rapid ventricular filling is mirrored by rapid
pulmonary venous diastolic forward flow. As left atrial pressures are increased,
mitral annulus motion does not significantly increase left atrial volume so less
systolic forward flow is recognised. Atrial contraction into a stiff left ventricle means
that more blood follows the favourable pressure gradient retrogradely into pulmonary
veins giving large Ar.
In patients with atrial fibrillation, 34% were reported to only have a D wave although
the remainder showed an Sl and a D wave (Chirillo et al 1997). In this study, if the D
wave duration and D wave deceleration time was normalised to the heart rate (by
dividing by the square root of the R-R interval), a D wave deceleration time of more
than 220 milliseconds predicted a mean PCWP exceeding 12 mmHg with 100%
sensitivity and 100% specificity (Chirillo et al 1997).
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Mitral regurgitation, by influencing pressure changes within the left atrium, also
exerts an effect on PVF patterns. The S wave may be blunted or even reversed in
patients with severe MR (Weyman 1994a; Pieper et al 1996; Seiler et al 1998). The
S:D velocity time integral ratio may be used to semi-quantitatively classify the
severity ofmitral regurgitation (Klein et al 1997; Seiler et al 1998).
In human patients with DCM, the S wave may be reduced or even absent due to poor
mitral annulus motion, mitral regurgitation or the presence of atrial fibrillation (Klein
& Tajik 1991; Klein et al 1997; Kranidis et al 1994) and associated diastolic
dysfunction may fail to augment the Ar wave; this is probably due to intrinsic left
atrial dysfunction (Ito et al 1996). A PVF S:D velocity ratio <0.7 in man indicates
severely compromised LV function with elevated left atrial pressure (Kranidis et al
1994).
Canine reference values for PVF including data from fourteen normal dogs have been
reported (Schober et al 1998). Some abnormalities in dogs with various heart
diseases have also been illustrated (Schober et al 1995; 1996).
Technical problems may confound the use of PVF wave forms in the assessment of
diastolic function, and Appleton and colleagues (1997) gave a useful technical guide
in optimising PVF signals and reproducibility. In man, it is recommended that the
right upper pulmonary vein is interrogated, and it is this, or the right middle
pulmonary vein, recommended in dogs (Schober et al 1998).
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B.4. Combinedmyocardial performance (systolic and diastolic function)
Tei and colleagues (1995; 1996; 1997) proposed a global index of myocardial
performance (IMP) combining systolic and diastolic function. This is equivalent to
the sum of isovolumic contraction time and isovolumic relaxation time, divided by
the left ventricular ejection time. The sum of the isovolumic indices are determined
by measuring the duration between cessation of mitral inflow during one cardiac
cycle and onset of mitral inflow in the subsequent cardiac cycle. The ejection time is
subtracted from this duration to give the sum of the isovolumic contraction and
relaxation times. In patients with severe DCM, this index was much greater than in
normal individuals, with much less inter-group overlap compared with other
parameters (Tei et cil 1995). In the assessment of biopsy-proven amyloidosis, the
isovolumic times increased and the ejection time decreased, resulting in a marked
increase in the index (Tei et al 1996). In normal humans, the index is 0.39 ± 0.04,
compared with amyloidosis patients, with a mean index result of 0.81 + 0.21. The
index, ejection time and mitral E deceleration time were all significant predictors of
outcome (Tei et al 1996). The index is reported to correlate well with invasive
measurements of systolic and diastolic function (Tei et al 1997). It has been well
received by human cardiologists (Burgess 1998).
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B.5. Echocardiography /Doppler: Canine reference values
Reference values for normality are required prior to detecting abnormalities
indicative of chamber dilatation or systolic or diastolic dysfunction. Although
echocardiography has become the gold standard in the diagnosis of DCM (Keene
1989; ISACHC 1995), it is important to understand the limitations of
echocardiography (Sisson & Thomas 1995).
Since the advent of M-mode echocardiography in veterinary cardiology (Mashiro et
al 1976; Dennis et al 1978; Bonagura 1983), knowledge and application of
ultrasound techniques has exploded, although until recently, publications giving
reference values for M-mode parameters have been based almost solely on weight
(Mashiro et al 1976; Boon et al 1983; Lombard 1984b; Bonagura et al 1985; Jacobs
& Mahjoob 1988b; Miller et al 1989; Lusk & Ettinger 1990) and many of these
publications cite the work of previous authors for their reference values. These
reference ranges were generated for various breeds or mongrels of different weights,
up to only about 35 kilograms. The failure to take into account the possible effects of
breed may explain in part the wide confidence intervals for the regression lines
published (Boon et al 1983; Lombard 1984b; Bonagura et al 1985; Jacobs &
Mahjoob 1988b; Miller et al 1989, Lusk & Ettinger 1990; DeMadron 1996). Another
confusing factor in the literature is the fact that most authors publish the regression
lines for each parameter, with 95% confidence intervals for the line (e.g. Bonagura et
al 1985), but do not show 95% prediction intervals or the actual data points, although
Lombard (1984b) does show both confidence intervals and prediction intervals and
Jacobs and Mahjoob (1988a;b) use prediction intervals although confusingly called
them confidence intervals of predicted values.
Expected echocardiographic values based on body weight alone are most likely
simplistic and presumptive because of the wide variation in canine size and
somatotypic conformation (Morrison et al 1992). Echocardiographic and M-mode
parameters will vary with breed. As more data becomes available for dogs, breed
must be considered in establishing echocardiographic measurement reference ranges
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(Henik 1995) and some breed-specific M-mode values have been published for
Dobermanns (Calvert et al 1982; Calvert & Brown 1986), cocker spaniels (Gooding
et al 1986a), beagles (Crippa et al 1992), Pembroke corgis, miniature poodles,
Afghan hounds and golden retrievers (Morrison et al 1992), Boxers (Herrtage 1994),
English setters (Pietra et al 1998), Irish wolfhounds (Vollmar 1996), great Danes
(Borgarelli et al 1996) and non-racing greyhounds (Snyder et al 1995) and
greyhounds undertaking training (Lonsdale et al 1998). Most authors use only three
measurements of each parameter.
To minimise the effect of body weight or BSA, a number of authors have presented
regression lines to take into account this variable when it affects parameters (Boon et
al 1983; Lombard 1984b; Morrison et al 1992; freeman et al 1996). Jacobs and
Mahjoob (1988b) used multiple regression analysis with a derivative of heart rate, the
square root of the preceding R-R interval as well as body weight to attempt to reduce
confidence intervals further. The fact that specific breeds also differ in specific ways
from published regression equations has only recently been appreciated. Borgarelli
and colleagues (1996) reported that great Danes had much smaller left ventricular
dimensions than would be predicted by published regression equations. Snyder and
co-workers (1995) superimposed greyhound echocardiographic parameters on
published regression lines to demonstrate the differences for this breed. The fact that
regression lines with different slopes and different intercepts for specific breeds
suggest that lines generated from a mixture of breeds should not be used to elucidate
reference ranges ofM-mode parameters for specific breeds (Morrison et al 1992).
It is apparent that reference echocardiographic values depend not just on body weight
or BSA, but breed, gender (even after correcting for mass or BSA) and work
(Lonsdale et al 1998). Echocardiographic parameters are also affected by growth.
Sequential echocardiographic examinations of growing pups show that cardiac
measurements increase in a curvilinear fashion relative to body weight (Henik 1995).
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Some echocardiographic reference values cited in the literature, largely derived from
M-mode, are displayed in Table B.l. References are given. Despite the advances in
other areas of echocardiography, M-mode measurements still remain the method of
choice in determining chamber size and wall dimensions (Luis Fuentes & Bonagura
1998).
Normal values for systolic time intervals based on the aortic M-mode have been
published (Pipers et al 1978; Atkins & Snyder 1992; Amberger & Lombard 1998)
but these may vary with breed (Snyder et al 1995). O'Grady and colleagues (1986)
used two-dimensional echocardiography to generate some reference values of a
number of parameters by this method for eighteen dogs of various breeds. They
included regression equations for data significantly correlated to body weight. They
also reported on repeatability studies and intra-observer variability studies.
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Table B.1.
M-mode echocardiography reference values
for dogs from the veterinary literature
Author Breed RVd (mm) IVSd(mm) IVSs (mm) LVpwd (mm) LVpws (mm) LVIDd (mm) LVIDs (mm)
Gooding et al
1986a
Cocker spaniel X 0.82 (0.13) X 0.79 (0.11) X 3.38 (0.33) 2.22 (0.28)
Calvert et al
1982
Dobermann X 10.5 (3.77) 16.5 (1.18) 10.8 (0.987) 16.2 (0.753) 49.7 (5.61) 33.8 (3.601)
Calvert &
Brown 1986
Dobermann X 9.61 (1.19) 14.3 (0.65) 9.59 (0.6) 14.1 (0.84) 46.8 (4.16) 30.8 (3.31)
Calvert
1995a
Dobermann X >7 >10 >7 >10 <50 X
Crippa et al
1992
Beagle X 6.7(1.1) 9.6 (1.5) 8.2(1.9) 11.4 (1.9) 26.3 (3.4) 15.7 (3.4)
Morrison et al
1992





4* 5* 8* 5* 8* 20* 10*
Morrison et al
1992
Afghan hound 10* 10* 13* 9* 12* 42* 28*
Morrison et al
1992
Golden retriever 13* 10* 14* 10* 15* 45* 27*
Herrtage
1994
Boxers X 9(2) 13(2) 10(2) 15(2) 40(5) X
Snyder et al
1995
Greyhound X 13.4(1.72) X 11.6(1.67) X 46.9(3.05) 33.3(2.61)
Pietra et al
1998
English Setter X 8.1(1.5) 13.2(1.5) 7.1(1.7) 11.8(2.7) 39.7(6.1) 24.3(5.7)












X 10.14(2.2) 12.29(2.21) 9.75(1.56) 14.08(2.03) 49.00(6.79) 35.75(5.64)
Bodey1998 Scottish
Deerhounds
X 10.2 12.4 10.4 13.3 47.9 36.5
Borgarelli et
al 1996
Great Dane X X X X X X X
Tidholm &
Jonsson 1996





























Mongrels X y X ✓ X V y
Boon et al
1983
Various X y V ✓ y V y
Lombard
1984b
Various y y X y X y y
Bonagura et
al 1985




Mongrels X y y V y y y
Lusk &
Ettinqer 1990
Unspecified V y y V y y y
DeMadron
1996
Various V ✓ X y X y y
Pipers et al
1978
Various X X X X X X X
Atkins &
Snyder 1992
Various X X X X X X X
Abbreviations As in text. y= reference value given x = reference value not given Specific values, where reported, are
shown as mean (standard deviation) * = median given instead.
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Table B.1.
M-mode echocardiography reference values
for dogs from the veterinary literature continued /1
Author Breed FS <%) EF(%) LA (mm) Ao (mm) PEP (sees) ET (sees) PEP.ETratio Vcf (circs/s)
Gooding et al
1986a
Cocker spaniel 34.26 (4.54) X X X X X X X
Calvert et al
1982
Dobermann 31.8 (3.81) X X X X X X X
Calvert &
Brown 1986
Dobermann 34.2(1.81) X 26.63(1.5) 29.9(2.31) 0.07(0.01) 0.17(0.01) 0.44(0.07) 2.07(0.16)
Calvert
1995a
Dobermann 30 - 36% X X X X X X X
Crippa et al
1992










47* X 12* 10* X X X X
Morrison et al
1992





39* X 27* 24* X X X X
Herrtage
1994
Boxers 33(8) X 23(2) 22(2) 0.07(0.01) 0.18(0.02) X X
Snyder et al
1995
Greyhound 29(4.2) X X X 0.0685(0.008) 0.183(0.016) 0.38(0.05) 1.6(0.29)
Pietra et al
1998
English Setter 39(10) X 27(3.9) 20.7(2.4) X X X X
Vollmar 1996 Irish
Wolfhound














27.33(3.78) X 44.55(5.46) 32.66 (2.07) X X X X
Bodey (1998). Scottish
Deerhounds
27 X X X X X X X
Borgarelli et
al 1996
Great Dane 31.4 (4) 57(7) X X X X X X
Tidholm &
Jonsson 1996



























Mongrels X 53.8 X X X X X X
Boon et al
1983
Various 36.26 X ✓ y X 0.179(0.018) X 2.07(0.37)
Lombard
1984b
Various 39(6) X ✓ V X X X X
Bonagura et
al 1985




Mongrels y X X X X X X X
Lusk &
Ettinqer 1990
Unspecified 39(6) X y y X X X X
DeMadron
1996
Various 30.7(7.6) 60.8(7.0) V y X X X 2.0(0.4)
Pipers et al
1978
Various X X X X 0.069(0.008) 0.255(0.01) 0.27(0.04) X
Atkins &
Snyder 1992
Various X X X X 0.054 (0.007) 0.159(0.015) 0.34(0.05) 2.48(0.5)
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Table B.1.
M-mode echocardiography. Veterinary literature
continued / 2
Author Breed Comment on study or limitations with study
Gooding et al
1986a
Cocker spaniel Regression line to show effect of BSA also. Dogs from a DCM
kennel - subqroup had low FS%. No repeats.
Calvert et al
1982
Dobermann Minimal data about normal Dobermanns given.
Calvert &
Brown 1986
Dobermann Clinically normal, repeat echo after 1 year.
Calvert
1995a
Dobermann Criteria for normality in this breed.
Crippa et al
1992






"median shown. Regression lines to show influence of weight.





"median shown. Regression lines to show influence of weight.
Doqs 2- 7 years old.
Morrison et al
1992
Afghan hound •median shown. Regression lines to show influence of weight.





'median shown. Regression lines to show influence of weight.
Doqs 2- 7 years old.
Herrtage
1994




Greyhound Regression lines to show influence of body weight and BSA,
compared with breeds of similar weiqht (Morrison et al 1992).
Pietra et al
1998


















LA & Ao from 2D. Personal communication.
Bodey (1998). Scottish
Deerhounds
No standard deviations. No attempts to separate individuals




Great Dane EF from Teicholz. Published references with regression lines
over-estimated LV parameters. FS lower than published
values. No follow up. No fiqures qiven.
Tidholm &
Jonsson 1996
Newfoundland Included dogs of 3.5 mths and sig no. < 2 yo. 10% normal






Results given as Median (5-95 percentiles).
Newfs, n=27, IWH, n=20, g.Danes, n=15).








Various Regression line to show influence of body surface area. Dogs
from 6 mths - 6 yrs old (mean aqe only 16.4 mths).
Lombard
1984b




Unspecified Regression lines to show influence of body weight. Data




Mongrels Regression line to show influence of body surface area and
derivative of heart rate (square root of R-R interval)
Lusk &
Ettinqer 1990
Unspecified Data obtained from review of literature.
DeMadron
1996
Various From review of literature and based on weight tables derived
from regression equations. EF from Teicholz.
Pipers et al
1978
Various Anaesthetised animals. No correction for heart rate.
Atkins &
Snyder 1992
Various from Atkins, unpublished data.
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Although Doppler echocardiography has been available to many veterinary
cardiologists for a considerable time, it is surprising that little has been published on
Doppler reference values for dogs. Some general articles review the technique and
views required to perform an echocardiographic examination (Kirberger 1991b;
Darke 1992). Yuill and O'Grady (1990; 1991) published Doppler derived peak
velocity measurements across each cardiac valve in normal dogs of unspecified
breeds, using duplex continuous wave (CW) Doppler and showed that
"physiological" pulmonic and tricuspid insufficiency in 70% and 50% of dogs
respectively. A similar study was done by Kirberger and colleagues (1992a) who
published flow patterns and velocities from normal valves in Beagles and German
shepherd dogs using pulsed wave Doppler echocardiography. This latter study can be
heavily criticised as suboptimal angles for Doppler were obtained, judging from
illustrations provided, and they advocated the use of the angle correction facility to
compromise for this technical limitation. However, these latter authors suggested
measuring canine aortic flow through the suprasternal notch to attempt to improve
the angle, although a stand-alone probe was used and so angle could not be estimated
and peak velocity was in fact obtained from an apical view. Results obtained from
these two studies are shown in Table B.2.
Table B.2. Reference values ofDoppler derived blood flow velocities across
normal canine heart valves
PA(R) PA(L) Ao (L.Ap) MV (E/A) TV (E/A)
(m/s) (m/s) (m/s) (m/s) (m/s)
Yuill & O'Grady 0.98 0.955 1.18 0.86/- (peak) 0.69/- (peak)
1991 (0.094) (0.103) (0.11) (0.1) (0.08)
Kirberger et al 1.2 nr 1.57 0.91/0.63 0.86/0.58
1992a (0.2) (0.33) (0.15)/(0.13) (0.15)/(0.16)
Ahhreviations: PA(R) = pulmonary artery from right parasternal view; PA(L) = pulmonary artery
from left parasternal window; Ao (L.Ap)= aorta from left apical view; MV(E/A) = mitral valve, E and
A peaks; TV(E/A)= tricuspid valves E and A peaks; nr = not recorded. Results shown as mean
(standard deviation).
Kirberger and colleagues (1992b) reported on the influence of age, heart rate and
weight on these variables, showing that increasing heart rate and decreasing mass
was associated with increased peak velocities.
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B.6. Current criteria for the echocardiographic diagnosis of canine
dilated cardiomyopathy
The diagnosis of DCM is based on the demonstration of left ventricular enlargement
and impaired contractility, and these criteria have remained unchanged since first
reported (Bonagura & Herring 1985). However, it is now appreciated that reference
values, preferably breed specific, are required, and there are problems in the
diagnosis of equivocal disease (Bond 1991). Some criteria used for the diagnosis of
DCM in certain breeds are given below in Table B.3.
Table B.3. Criteria used in the diagnosis of canine idiopathic dilated cardiomyopathy
by various authors
Breed FS% LV dilation IVS/LVpw
parameters
Other criteria























Newfoundland < 22% X X presence of
CHF
Tidholm 1996 Various <25?/o X X presence of
CHF
Abbreviations: as in text, x = not given. CHF = congestive heartfailure.
The diagnosis of DCM is not a problem in most symptomatic dogs. There is a major
problem in identifying dogs with occult DCM. Equivocal echocardiographic results
are common both in normal dogs and in dogs with occult DCM because of inherent
limitations in the technique (Calvert 1995a).
Calvert (1995a) found that serial assessment of progressive left ventricular
dysfunction was best measured by sequential monitoring of the left ventricular
systolic dimension from M-mode rather than fractional shortening percentage.
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Different breeds affected by DCM appear to have variable echocardiographic
findings specific to their breed. There appears to be a difference in end-systolic
volume index or end-diastolic volume index between Dalmations with DCM and
Dobermanns with DCM, as well as Dalmations with DCM and other breeds (various)
with DCM (Freeman et al 1996).
It seems obvious that more sensitive methods of detecting echocardiographic
abnormalities are required in dogs with occult DCM. The generation of breed
specific reference ranges and the identification of sensitive and specific indicators of
impaired systolic or diastolic function will improve the sensitivity of this technique
as a screening aid. The Doppler indices, particularly of the aortic ejection phase,
accurate methods of assessing ejection fraction and possibly sensitive parameters of
diastolic function may prove to be more useful than fractional shortening and
chamber size.
B.7.1. Human echocardiographic criteria for the diagnosis of DCM
Exclusion of other cardiac disease is important prior to making a diagnosis of
idiopathic DCM in man, especially coronary artery disease, myocarditis,
hypertension, isolated right ventricular cardiomyopathy etc. (Mestroni et al 1994b).
Normally, the demonstration of low ejection fraction is required to make the
diagnosis although the actual cut-off value is controversial and ranges from less than
40% (Zimmerman et al 1992; Durand et al 1995) to less than 55% (Mestroni et al
1994b). Left ventricular enlargement is also required with various criteria used to
define this, including M-mode parameters of LVIDd exceeding two standard
deviations above the mean for weight, age and sex (Zachara et al 1993), or LVIDd >
2.7cm/m2 (based on BSA) (Mestroni et al 1994b), or LVIDd exceeding 112%
predicted values from multiple linear regression equations (Keeling et al 1995; Baig
et al 1998). Fractional shortening is only rarely used, but values less than 26%
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(Zachara et al 1993) or less than 25% (Keeling et al 1995) are judged to reflect
hypokinesis. Lestuzzi and colleagues (1991) corrected LV and LA dimensions for
age and BSA. In diagnosis of DCM, Lestuzzi et al (1991) arbitrarily set a number of
major criteria and minor criteria.
B.7.2. The problem of recognition and interpretation of mild
echocardiographic abnormalities
Keeling and McKenna (1994) asked whether human individuals with mild
echocardiographic abnormalities have early DCM. There is diagnostic difficulty in
identification of patients with early DCM; even in man, there are no well defined
criteria for diagnosis of early DCM where there is less marked ventricular dilatation
or dysfunction. In screening families with DCM. in determining mode of inheritance
or utilising molecular genetic techniques, an accurate diagnosis is crucial (Marian &
Roberts 1993) and it will be vital in human and canine echocardiography to
determine criteria for normality and to interpret the significance of slight
abnormalities. In the literature, echocardiography has been suggested as both under¬
estimating and over-estimating the frequency of DCM during family screening. In the
UK families with DCM described by Keeling and colleagues (1995), they reported a
rather low frequency of familial DCM (11%) compared with other series (e.g. Goerss
et al 1995). However, not included in this figure were relatives showing left
ventricular enlargement (16%) and relatives with a low fractional shortening < 25%
(4%). The high prevalence of left ventricular enlargement in members of families
with familial DCM compared with relatives of non-familial DCM patients certainly
supports the possibility that mild left ventricular enlargement may represent early
DCM (Keeling et a! 1995). Baig and colleagues (1998) from this group (St.
George's Hospital, London) detailed the cardiac abnormalities in symptom-free
relatives of familial DCM patients with serial evaluation over approximately three
years. They concluded that over a quarter of these relatives developed more overt
evidence of DCM in this time period. Patients with left ventricular enlargement
(defined as a left ventricular end-diastolic dimension >112% over the predicted
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value, using the formula dependent on BSA and age of individual patient) had a
statistically significant predictive association with the development of DCM. Patients
with depressed fractional shortening over the time period of this study did not show
the same progression and Baig and colleagues (1998) postulated that these patients
may have a limited manifestation of disease. Symptom free relatives may be
described as having a latent form of cardiomyopathy involvement or they are at a
different stage of DCM (Zachara et al 1993), but these authors also postulated that
the cut-offs in the definition of normality may be too sensitive and these mild
echocardiography abnormalities do not represent disease; they appreciated the
importance of follow up studies on such patients to assess whether they had
progressive disease and also in interpreting these "carriers" in pedigrees of affected
families in determining the mode of inheritance (Zachara et al 1993). The problem of
assessing relatives at a single point in time, as is usual in the human family series in
the literature (Michels et al 1992, Zachara et al 1993; Mestroni et al 1994b, Goerss et
al 1995) can lead to underestimation of the frequency of disease (Goerss et al 1995;
Keeling et al 1995). Follow up of relatives with mild left ventricular enlargement
will show whether a significant proportion of these will develop progressive left
ventricular dilatation and dysfunction, supporting the fact that left ventricular
enlargement does represent early DCM (Keeling et al 1995) although where this has
been done, there does not appear to be an answer to date. Lestuzzi and colleagues
(1991) reported on one borderline patient developing the disease but another to
normalise. The significance of left ventricular enlargement or a low fractional
shortening in a relative of a DCM patient remains to be established (Keeling et al
1995).
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AN ECHOCARDIOGRAPHIC / DOPPLER EVALUATION
OF A POPULATION OF NEWFOUNDLAND DOGS
MATERIALS AND METHODS
B.8. Aims of this study
There were three major aims for this part of the study.
(i) To generate breed-specific echocardiographic criteria of Normality in
Newfoundland dogs, and to identify which independent variables affect these.
(ii) To investigate various parameters of left sided chamber sizes and systolic and
diastolic function, and to compare these in normal Newfoundlands,
Newfoundlands with DCM or occult DCM and dogs with other echocardiographic
abnormalities. From this information, to define more sensitive or specific criteria
for the diagnosis of occult DCM or to identify echocardiographic / Doppler
predictors of disease development.
(iii) To investigate the use of serial echocardiographic evaluation of dogs, including a
repeatability study and the monitoring of progression of echocardiographic
abnormalities.
B.9. Newfoundlands
B.9.1. Criteria for dog selection
Newfoundlands were chosen because they are known to have increased prevalence of
both DCM and subaortic stenosis.
Dogs selected to generate breed specific reference ranges were over eighteen months
old (so were judged to be adult size). There was no upper age limit. The date of birth
and sex and colour of each dog was recorded. An accurate body weight was
determined and recorded for each dog when feasible, otherwise an approximate
estimate of the weight based on sex and body condition was noted. A copy of the
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pedigree was retained for each dog included for pedigree analysis where indicated.
Information about numbers, gender and status of siblings was recorded.
Dogs from lines in which there had been a family history of DCM prompted
recording a detailed family history. Details about the cardiac illness of affected
members was obtained from the owner or breeder and the veterinary surgeon where
this was possible. Where the affected family member was alive and available, it was
examined by echocardiography / Doppler to confirm the diagnosis if owner consent
was given. As many relatives from such a family were screened as possible, across as
many generations as possible.
B.9.2. Examination of each individual dog
A brief general history was recorded for each dog.
A detailed clinical examination referable to the cardiorespiratory system was made.
Each dog was carefully auscultated at rest in a quiet environment, using a Littman
Cardiology II stethoscope (3M). Note was made of heart rate and the degree of
excitement or stress the dog showed. Any heart murmur was localised and graded
(out of VI), with note made of its character, radiation, duration and location in the
cardiac cycle. The presence of abnormal heart sounds (e.g. diastolic gallops) was
recorded. The presence of any arrhythmia was noted, and documented with a six lead
electrocardiogram according to standard practice (Tilley 1992a;b) using a single
channel portable electrocardiography machine (CardiofaxR; Nihon Kohden).
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B.10. Echocardiographic / Doppler examination
B.10.1. Patient preparation
The hair coat was clipped over the site of precordial impulse on the left and right
hemithoraces and an area of ventral midline immediately caudal to the xiphisternum.
Dogs were placed on a purpose designed table in lateral recumbency on a
comfortable bedding material. The owner was involved in restraining the dog, so
most dogs were very relaxed and in some cases fell asleep during the procedure. The
area was prepared by spraying with surgical spirit and applying ultrasound gel
(Henley's Medical Ultrasound Gel; Brownfields, Welwyn Garden City,
Hertfordshire, UK). A simultaneously recorded electrocardiogram was obtained after
application of adhesive electrodes (Blue Sensor, Medicotest, Rugmarken, Denmark)
to the metacarpophalangeal pads on three feet and secured with tape. Lead II was
normally recorded if ECG quality on the screen was adequate (right fore and left
hind) with the third electrode acting as the earth lead.
B.10.2. Echocardiograph machine and set up
The echocardiography machine was the Esaote SIM 7000 Challenge (Esoate
Biomedica, Firenze, Italy) which had annular array probes with dynamic focusing.
Normally a 2.5 - 3.5 MHz transducer was used for Newfoundlands, imaging at 2.25
or 3.5 MHz with Doppler at 2.0 or 2.25 MHz. Appropriate sections of the scans were
recorded by videocasette recorder (SVO-9500MDP; Sony Corporation, Japan) on
Super VHS video tapes (Panasonic SVHS; Matsushita Electric Industrial Co. Ltd.,
Japan).
The depth of field was set to include the entire heart on the screen and so was
individualised for each dog. The imaging angle was normally 75° although where
recordings for left ventricular and left atrial areas were required, this was increased
to 90°. Overall gain and time gain compensation settings were set for each dog to
give good image quality, where endocardial surfaces could be delineated, but gain
was minimised to allow for optimal colour flow Doppler echocardiography (CFDE).
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Once set, every attempt was made not to alter the settings. During CFDE, the angle
of colour flow was 20° and the velocity variance map 1 was used, which gave an
indication of velocity of blood towards or away from the transducer with varying
intensity or red or blue respectively, and areas of turbulent flow were encoded green.
The variable focus indicator was positioned at the level of the area to be interrogated.
Colour gain was set to just below that where artefactual speckling appeared due to
over-gain. Once set, every attempt was made not to alter it during a scan. When M-
mode recordings were made, the M-mode cursor was positioned guided by the two-
dimensional images. During pulsed wave spectral Doppler recordings, sample
volume size was normally four millimetres and low pulse repetition frequency was
used and every attempt made to align blood flow in the area to be interrogated to be
parallel to the Doppler cursor. A spectral signal was displayed at maximal sweep
speed (1 sweep every 2 seconds = 100 mm/s) and the baseline position and velocity
scale was altered to display maximal envelopes. The Doppler gain and filtration was
set to be the minimal required for good well defined envelopes. Weak signals
occasionally required to be improved by reducing the Doppler frequency or
increasing sample volume size (to six millimetres). Occasionally, the power and
reject facilities were altered. If the Nyquist limit was exceeded, either high pulse rate
repetition frequency was used or the blood flow velocity spectrum was recorded by
continuous wave Doppler.
B.10.3. Images obtained and recorded
The following images were obtained and recorded.
From a caudal right parasternal four chamber view, the left ventricular length and
area was maximised and recorded for a number of cardiac cycles. Slightly more
cranially, the four chamber view was repeated with maximised left atrial area which
was recorded. CFDE was used with a velocity variance map to investigate and record
blood flow through the mitral valve and the aortic valve. The interatrial and
interventricular septae were also scrutinised. A four chamber long axis view was
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obtained, ensuring that the left ventricular axis was as perpendicular to the ultrasound
beam as possible, giving a horizontal image.
This was changed to a caudal parasternal short axis view of the left ventricle by 90°
transducer rotation, and the M-mode cursor was positioned through the centre of the
chamber at the level of the chordae tendinae, ensuring that the left ventricular cavity
was symmetrical and rounded for optimal M-mode positioning. A left ventricular M-
mode was recorded. At the level of the mitral valve, a mitral valve M-mode was
recorded, ensuring that both anterior and posterior mitral valve leaflets were
included.
A cranial long axis view allowed 2D and CFDF assessment of the left ventricular
outflow tract, aortic valves and proximal aorta. A cranial short axis view was
obtained at the level of the aortic valves including the left atrium in short axis, with
the left auricular appendage. The left atrium was maximised in this view without
losing the aortic symmetric cross sectional image. This two dimensional view was
recorded, to enable two dimensional measurements of the aorta and left atrium to be
made, according to the technique described by Haggstrom et al (1994). The M-mode
cursor was then positioned to allow an M-mode recording of the aortic root with
aortic valves and the left auricular appendage. The cranial short axis view of the aorta
was repositioned to maximise the pulmonary trunk, and angled to allow the trunk to
be as parallel as possible to the colour flow and spectral Doppler angle. CFDE of
blood flow in the right ventricular outflow tract and pulmonary trunk was assessed,
following which the sample volume (set at four millimetres) was positioned just
beyond the pulmonic valves. Pulsed wave Doppler recording at fastest sweep speed
was made and attempt made to obtain clean spectral envelopes with minimal spectral
dispersion.
With the dog still in right lateral recumbency, a subcostal view of the heart was
obtained, with the left ventricular outflow tract and the aorta visible and positioned to
be as parallel as possible to the Doppler cursor. In large dogs, pulsed wave Doppler
84
resulted in the Nyquist limit usually being exceeded due to the depth of the sample
volume, requiring the use of continuous wave Doppler spectra to display aortic
outflow. Fastest sweep speed was used and normally, machine settings had to be
altered to obtain a signal of adequate diagnostic quality, which was recorded.
In left lateral recumbency, an apical four chamber view was obtained. The image was
optimised by attempting to make it as vertical as possible, with maximal left
ventricular length and area. The transducer was slid as near the sternum and the apex
of the heart as possible to achieve this without sacrificing image quality. Transducer
rotation of 90° allowed a two chamber view to be displayed. The aorta could be
imaged from either a two or four chamber view, giving the so-called three or five
chamber views. Optimal alignment with aortic outflow was determined from the two
dimensional images. From the four chamber view, CFDE of the mitral valve was
recorded. The sample volume was positioned just between the tips of the leaflets of
the mitral valve and mitral inflow recorded. If mitral regurgitation had been
identified on CFDE, continuous wave Doppler was used to attempt to record the
mitral regurgitation spectrum. From an apical five chamber view, colour flow
mapping indicated the region where both mitral inflow (red) and left ventricular
outflow (blue) was present. The sample volume was positioned in this area to obtain
a spectral recording of simultaneous mitral inflow and left ventricular outflow, with
as clear a definition as possible of the end of the outflow trace and the start of the
inflow trace, which indicated the isovolumic relaxation time. The left ventricular
outflow tract and aorta were then aligned from a three chamber or a five chamber
apical view to allow CFDE and spectral Doppler recording of aortic outflow. The
sample volume was positioned just beyond the aortic valve leaflets. From the four
chamber view with the atrioventricular annulus as perpendicular as possible to the
M-mode cursor, mitral annulus motion of the septal and the lateral annulus was
recorded. From the four chamber view, the entry of pulmonary veins into the left
atrium were maximised, by altering the focus and using colour flow guidance if
effective at this depth. A pulmonary vein was selected which was parallel to the
Doppler cursor (usually the right middle lobe pulmonary vein). The sample volume
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(as small as possible, usually 4 mm) was positioned about 0.5 cm within a pulmonary
vein and a low pulsed repetition frequency recording of pulmonary venous inflow
was made at high sweep speed. Normally, the gain had to be increased and the
filtration minimised to obtain an adequate signal. Settings were altered to allow a
recording which was of good quality as possible, preferably showing laminar flow
(although this was not always possible). An attempt was made during the recording
to recognise the three distinct waves of pulmonary venous inflow. Repositioning
within the same pulmonary vein or another vein was made until an adequate signal
was obtained.
From a left parasternal four chamber view, CFDE and spectral Doppler recording of
tricuspid inflow was obtained. Any tricuspid regurgitation was recorded. From the
cranial left parasternal view with the short axis aorta, the pulmonary artery was
displayed by CFDE and spectral Doppler recording.
B.10.4. Analysis of the echocardiography / Doppler recording
B.10.4.1. General methods
Full echocardiographic analysis was done off-line from the video cassette recordings.
Diastolic events were timed from the ECG as the start of the QRS complex. Systolic
events were timed from the ECG as the end of the T wave or were determined from
the mechanical phase of the scan itself. For each parameter, at least five
measurements were obtained for patients in sinus rhythm without accentuated sinus
arrhythmia. Events associated with ventricular or supraventricular ectopy were
ignored. Where there was marked sinus arrhythmia or atrial fibrillation, up to ten
measurements were obtained. As far as possible, five to ten consecutive beats were
assessed. During the analyses, the approximately average heart rate during each
batch of measurements simultaneously calculated from the ECG and recorded on the
images. Occasionally, the heart rate mean was calculated from a group of R-R
interval measurements from the ECG, dividing the mean result by 60. This was
necessary in certain instances, such as dogs with tall T waves with low voltage QRS
complexes. All data were stored on an Excel (v7; Microsoft Inc.) spreadsheet). Two-
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dimensional echocardiography parameters were measured using trailing-edge to
leading-edge of endocardial borders (O'Grady et al 1986), using the black-white
interface to guide measurements (Schiller et al 1989; Feigenbaum 1994c). M-mode
parameters were normally measured using the leading-edge to leading-edge method
advocated by the American Society for Echocardiography (Sahn et al 1978), although
for the aortic diameter (diastole) and left atrium (systole), internal diameters were
selected instead. Since Newfoundlands tended to image poorly and usually had an
appreciable amount of periaortic fat, it was considered that internal dimensions were
more likely to be reproducible, and they allowed comparison with the two-
dimensional measurements of these parameters. For Doppler parameters, peak
velocities were measured, although velocity time integrals were traced around the
modal velocities, according to Feigenbaum (1994c). If there was not a clear
definition between two waves that were to be measured (e.g. close E and A waves on
mitral inflow), a perpendicular line was dropped to the baseline on the spectral
Doppler tracing to allow time durations or flow integrals to be measured.
B.10.4.2. Right parasternal view measurements
B.10.4.2.1. Left ventricular volumes and ejection fractionfrom a right
parasternal view
From the right parasternal four chamber long axis view maximising the length and
area of the left ventricle, a diastolic frame was frozen and the left ventricular area
was traced, within the endocardial border using the tracker ball. Papillary muscles
were ignored. At the base of the left ventricle, the area was closed at the level of the
mitral annulus. From the centre of the annulus at the level of this closure line, the
length of the left ventricle was determined to the apex. The software calculated the
left ventricular diastolic volume by the length-area method. For each diastolic frame,
the subsequent systolic frame was selected (end of T wave) and the left ventricular
area and length in systole was determined and the volume calculated by the machine.
Record was made of LV areas and lengths, as well as the left ventricular volume
derivatives. From each pair of diastolic and systolic measurements, as well as the end
diastolic volume (LVdv) and the end systolic volume (LVsv) calculations, the stroke
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volume (SV) and the ejection fraction (EF) were automatically calculated and
displayed by the software following the volumetric computations.
B. 10.4.2.2. Determination ofleft atrial parameters from a right parasternal view
The slightly more cranial long axis four chamber view with a decreased image angle
to increase the frame rate was used to assess the left atrium. A technique to assess
change in left atrial area was sought to attempt to correlate this with pulmonary
venous inflow. Measurements were obtained during ventricular diastole and systole
guided by the ECG. In systole, the area of the entire left atrium up to the closed
mitral valves, and tracing straight across the pulmonary veins was used. In diastole,
as the left atrium functions as a conduit to the left ventricle and the mitral valves are
open, it was decided to close the area in a line drawn straight across the mitral
annulus. Left atrial width in ventricular systole and diastole was also obtained
parallel to but just above the mitral annulus, in order to attempt to document
"stretch" of the mitral annulus and any secondary mitral regurgitation associated with
dilated cardiomyopathy.
Calculation of percentage change in LA area from the 4 chamber long axis view was
done (similar to the diastolic emptying index described by Clarkson and others
(1995) to give a left atrial emptying index (LAEI).
B. 10.4.2.3. CFDE screening
CFDE was used to assess the presence of any mitral, tricupsid or aortic incompetence
from a four chamber or a five chamber RPS or left apical views, and pulmonic valves
were assessed from left and right parasternal cranial short axis views. Any valvular
incompetence was subjectively graded as a trace, 1+, 2+, 3+ or 4+ depending on jet
area, relative to receiving area and jet width at its origin, simplifying the methods
described by a number of authors, attempting to mimic the Seller's angiographic
classification (Helmcke et al 1987; Perry et al 1987; Perry 1989; Keren & LeJemtel
1989).
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B.10.4.2.4. Left ventricular M-mode
The left ventricular M-mode study was measured using the leading edge - leading
edge technique (Sahn et al 1978). Diastole was determined at the start of the QRS
complex. Systole was defined as the nadir of the septal posterior motion. The right
ventricle in diastole was measured, although in many cases was unreliable as the
artefacts in the near field made endocardial surface of the right ventricle difficult to
determine. The interventricular septum was calculated in diastole (IVSd) and systole
(IVSs). The left ventricular internal dimension was measured in diastole (LVIDd)
and systole (LVIDs). The left ventricular posterior wall was measured in diastole
(LVpwd) and systole (LVpws). Because systole was defined as the nadir of septal
motion, and the free wall sometimes lagged behind the septum, the systolic
dimension of the left ventricle and the systolic thickness of the left ventricular free
wall was underestimated. The software computed the fractional shortening (FS%),
and the percentage thickening of the septum (%thIVS) and the left ventricular
posterior wall (%thLVpw). The ejection fraction was also calculated by the machine
software, using Teicholz method, and was recorded.
B. 10.4.2.5. Mitral M-mode
From the mitral M-mode, the E point to septal separation was measured.
B.10.4.2.6. Left atrium to aortic root ratio (two-dimensional measurement)
From a cranial short axis view of the left atrium showing the left auricular
appendage and the aortic valves, diastolic dimensions of the aortic root and the
maximal left atrium in the same plane was measured (Haggstrom et al 1994). The
maximal plane of the left atrium often corresponded to entry of pulmonary veins -
these were ignored and the border extrapolated to measure the posterior limit to the




From the aortic M-mode, a subjective impression of the anterior systolic excursions
of the aortic root was assessed. The aortic root was measured in diastole (start of
QRS complex) and the left auricular appendage in systole (maximum), measuring
internal diameters rather than leading-edge to leading-edge techniques. The M-mode
ratio of left atrium to aorta was calculated.
B.10.4.2.8. Pulmonary artery
A spectral Doppler trace of pulmonary outflow was measured if the envelopes were
of good diagnostic quality. The peak pulmonary artery velocity obtained.
B.10.4.3. Subcostal view measurements: aortic flow
The aortic outflow velocity was almost always maximal from the subcostal position.
Because of the depth of field, normally a continuous wave spectral signal was
obtained. Parameters measured were:
(i) Peak velocity (Aov).
(ii) The velocity time integral (Aovti) was measured by tracing around the spectrum,
to allow calculation of area under the curve by the machine.
(iii) Acceleration was assessed according to the steepest slope of the acceleration
phase of the signal (dv/dtmax) and the slope from start on outflow to peak flow, to
give mean acceleration (dv/dtmean)- Acceleration time was measured as the interval
between the two points used to calculate dv/dtmean-
(iv) Systolic time intervals were measured from the Doppler aortic signal. Pre-
ejection period (PEP) was measured from the start of the QRS complex to the
onset of aortic flow at the baseline, ignoring any low velocity, poorly defined
initial signal. The left ventricular ejection time (ET) was measured as the duration
of the aortic spectrum at the baseline, again ignoring any low velocity signals.
From these measurements, mean values were calculated and used to calculate a
pre-ejection period: ejection time ratio (PEP:ET). The velocity of circumferential
fibre shortening (Vcf) was calculated by dividing the fractional notation of the
mean fractional shortening obtained by M-mode by the mean ejection time.
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(v) Parameters which were likely to be influenced by heart rate were normalised for
the R-R interval by dividing by the square root of the R-R interval. These included
PEP, ET, acceleration time, PEP:ET ratio and Vcf.
A normal peak aortic velocity was defined as <1.7 m/s (Lehmkuhl & Bonagura
1995). Dogs with aortic velocity in excess of this were defined as having mild sub¬
aortic stenosis, particularly if there was other evidence of left ventricular outflow
tract abnormalities such as two-dimensional lesions, turbulent blood flow or step up
of velocity in the outflow tract, or aortic regurgitation (Lehmkuhl & Bonagura 1995).
B.10.4.4. Left parasternal view measurements
B.10.4.4.1. Mitral inflow
The presence of any mitral regurgitation was again assessed by CFDE as previously
described.
Mitral inflow was assessed and the following measurements made:
(i) Maximal velocity of E (Ev) and A (Av) waves, by measuring peak velocity. The
mitral E:A velocity ratio was calculated.
(ii) Velocity time integral (vti) of E (Evti) and A (Avti) waves. The envelopes were
traced along the modal (brightest) velocity spectrum (Mantero et al 1995). With
slow heart rates, if there were late diastasis phases to mitral inflow, these were
ignored. The E:A velocity time integral ratio was determined. Evti and Avti were
added to determine the total forward mitral inflow (ignoring any contribution in
diastasis).
(iii) The proportions of early (and late) left ventricular filling of total mitral inflow
was calculated by dividing Evti (or Avti) by the total mitral vti.
(iv) Mitral E and A wave velocities were normalised by dividing by the total mitral
vti (Bowman et al 1988; Santilli & Bussadori 1998).
(v) The duration of E (Edur) was measured as the duration of the E envelope. The
duration of the A wave (Adur) was measured in a similar way. With fast heart
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rates, if E and A peaks were summated, a line perpendicular to the baseline was
dropped between the two peaks at their intersection.
(vi) The deceleration time of E was assessed (E decel), by measuring the time
interval from the peak of the E to the intersection of the E with the baseline.
(vii) Time intervals which are influenced by heart rate were normalised by indexing
to the square root of the R-R interval. These included E duration, E deceleration
time and A duration.
B.10.4.4.2. Mitral regurgitation
If mitral regurgitation was identified and a good quality spectral continuous wave
(CW) Doppler signal could be achieved, this was recorded to allow calculation of
dP/dt, based on the techniques described (Bargiggia et al 1989; Chen et al 1991).
From the spectrum, a velocity measuring cursor was used and positioned at
approximately one metre per second on the acceleration edge of the spectrum. The
corresponding pressure was displayed by the machine soft ware, using the modified
Bernouille equation. A second velocity cursor was positioned near the peak of the
acceleration slope (usually between three and four metres per second). The
corresponding pressure was recorded and difference in pressures between the two
measurements was calculated. A time cursor was used to measure the interval
between the two velocity cursors. The difference in pressures was divided by the time
to give a rate of change of pressure (dP/dt). The negative rate of pressure change
(-dP/dt) could be calculated in a similar manner, but during this study, where no dog
had severe mitral regurgitation, it was unusual to obtain clear cut diagnostic
deceleration edges of the mitral regurgitant signal, and this was not done.
B.10.4.4.3. Jsovolumic relaxation time
If an adequate spectral signal was obtained from the left ventricle showing both
mitral inflow and left ventricular outflow, the time between closure of aortic valves
and opening of mitral valves was measured, giving the isovolumic relaxation time




The cranial left parasternal view with the aorta in long axis was scrutinised to
identify any two dimensional abnormalities of the left ventricular outflow tract or
aortic valves, and CFDE recordings were assessed for the presence of aortic
regurgitation or any variance indicating turbulent flow in the left ventricular outflow
tract or the aorta.
From the apical three or five chamber view, the angle of aortic flow was assessed
compared with the cursor. If this was parallel or within 20°, and a good quality
spectral envelope was recorded, the maximal velocity was measured. Normally, it
was less than that obtained from the subcostal view (showing that the subcostal view
is usually more successful at aligning the Doppler cursor parallel with aortic flow)
(Lehmkuhl & Bonagura 1994). If the apical aortic flow velocity was higher than that
obtained from the subcostal view or if a subcostal aortic Doppler spectra were non¬
diagnostic, the previously mentioned aortic parameters were also measured.
B.10.4.4.5. Mitral annulus motion
Septal and lateral (posterior) mitral annulus motion (MAMseptal and MAMlateral
respectively) was measured from M-modes using the maximal excursion between
end diastole and systole. This gives an indication of apico-basilar contractility. The
mean of these two values gave the mean mitral annulus motion (MAMmean) from
the two measurements derived from the left apical four chamber view.
B.10.4.4.6. Pulmonary Venous Flow
From the recording of PVF, the following parameters were measured:
(i) Velocity of systolic (S), diastolic (D) and atrial reversal (Ar) waves and R.2
waves. The S:D velocity ratio was calculated.
(ii) The velocity time integral of S (Svti) and D (Dvti) was measured by planimetry
after tracing with a tracker ball around the corresponding envelopes. If there was
overlap between S and D, a perpendicular line was dropped to baseline between
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these and used the differentiate between the two forward waves. The presence of
R2 helped to distinguish between the two waves. The S:D velocity time integral
ratio was determined. Calculation of the systolic fraction of total forward flow
(Svti/(Svti+Dvti)) was made.
(iii) Durations of S, D and Ar and R2 waves were measured at the baseline where
each envelope intersected. Where S and D waves overlapped, a vertical line was
dropped at their intersection to the baseline and this was the point used for
measurement of durations. At this point, a small reversal wave (R2) was present
normally which could be used to confirm timing. The D deceleration time was
measured from the peak velocity of the D wave until the point at which the flow
declined to baseline.
(iv) Durations of the pulmonary venous flow parameters are influenced by heart rate
and so were indexed to VR-R interval.
B.10.4.4.7. Tricuspid inflow
The velocity of the E and A waves was measured (TEv and TAv). The tricuspid E:A
velocity ratio was calculated. CFDE was used to assess any tricuspid regurgitation.
B.10.4.4.8. Pulmonary artery (left cranial parasternal view)
If the pulmonary artery signal was of good quality, the maximal velocity of the
pulmonary flow spectra were measured.
B.10.5. Statistical analyses
Means and standard deviations were calculated for each parameter using the Excel
(v.7) spreadsheet functions.
B.11. Identification and correction of a software problem
During the course of this study, a software problem was identified resulting in a time
delay in displaying spectral Doppler signals after the ECG, which resulted in
prolonged PEP and abnormal PEP:ET ratio. The investigations into this problem are
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detailed in the Supplement (available from the author). Echocardiographic data for
PEP was corrected by subtracting 38 milliseconds from the time measured.
B.12. The Newfoundland Study: Body weight and surface area
B.12.1. Weight
Where the body weight was assessed or reported by the owner or estimated with
some degree of confidence, these were recorded in the spreadsheet. From the weights
of the male and female dogs, means and standard deviations were recorded.
B.12.2. Body Surface Area
The body surface area (BSA) was derived from the body weights by the formula:
BSA = 10.1 x [Wt (grams)]0 667 x 10"4
where BSA = body surface area in nf, Wt = body weight in grams. (Appendix in
Kirk's Current Veterinary Therapy XII. Small Animal Practice. Ed. J.D. Bongura.
W.B. Saunders. Philadelphia p. 1416).
B.13. Categorising Newfoundland dogs into groups
Summary data (means and derived calculations) for each scan were transferred into a
new Excel spreadsheet into sub-divisions based largely on the M-mode data. Dogs
with DCM (overt or occult) showed altered left ventricular geometry (increased
sphericity of the chamber), may have had arrhythmias, may have had left or biatrial
enlargement and usually had left ventricular enlargement with hypokinesis (FS
usually < 22%) (DCM group). Dogs with depressed fractional shortening (<18%)
were selected by this criterion alone, if they had no additional evidence of DCM
prompting their inclusion into this former category (dFS<18% group). Dogs in an
equivocal category, with fractional shortening between 18 and 20% were included in
a separate division (dFS 18-20% group). Left ventricular enlargement was defined as
LV M-mode diastolic dimension of >55 mm (males) or >50 mm (females) (LVE
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group). Dogs with a subcostal or peak aortic velocity of >1.7 m/s were included in
another division, with the overt aortic stenosis cases (SAS group). Each scan was
not included into more than one category, although dogs with serial scans may have
appeared in different categories depending on the results of the analysis of each scan.
Once echocardiographic reference data had been obtained from the Newfoundlands
defined as Normal, limits exceeding and less than mean plus or minus two standard
deviations were recorded, and values out with these limits were indicated in bold for
each of the Newfoundland categories.
B.14. Regression analyses and derived calculations in Normal
Newfoundlands
Only nine Newfoundlands over eight years old could be defined as
echocardiographically normal. Consequently, data were compared between this
normal group and normal Newfoundlands less than eight years old. The two groups
were then combined. Descriptive statistics from the entire group were determined,
including means, standard deviations, maximum and minimum data points, the 95%
confidence interval of the mean and the lower and upper confidence limits. These
analyses were performed using SigmaStat (v.2.03; SPSS Inc.).
Variables which were considered to potentially affect the prediction of an
echocardiographic parameter were body weight, BSA, age, gender and mean R-R
interval recorded at the time of acquisition of the particular parameter. Since mean
heart rates, rather than R-R intervals, had been recorded during the echocardiographic
quantification, the mean R-R interval was calculated by dividing 60 by the heart rate
in beats per minute. Gender was indicated numerically, with 1 = male and 2 = female.
Derived parameters included in the analysis were end-diastolic and end-systolic
volume indices (EDVI and ESVI respectively), obtained from indexing the volumes
calculated by the single plane ellipse method to BSA. The stroke volume index (SVI)
was calculated in a similar manner. All M-mode parameters were also indexed to
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BSA. The M-mode left ventricular posterior wall was divided by the chamber
diameter diastolic measurements (LVpwd/LVIDd). To attempt to define an "index of
sphericity", the left ventricular diastolic length from the right parasternal long axis
view (LVld) was divided by the M-mode left ventricular internal diameter in diastole
(LVIDd). The ratio of the left atrium to aortic diameter was calculated for both the
2D short axis view measurements and the M-mode measurements. A left atrial
emptying index (LAEI) was calculated by dividing the difference between left atrial
area in systole and diastole by the left atrial systolic area ((RPSLAas -
RPSLAad)/RPSLAas).
Derived parameters from mitral inflow measurements were also included in the
analysis. The mitral E:A velocity and velocity time integral ratios were calculated.
The peak filling rate indexed to mitral stroke volume was calculated as described by
Bowman and others (1988). This was calculated as the peak E velocity divided by the
total mitral velocity time inflow integral. In this case, since the total forward vti had
not been measured by planimetry, but E and A waves had been measured separately,
the sum of Evti and Avti were used, although it was appreciated that any diastasis
flow was ignored. As well as the standard parameters of pulmonary venous flow,
the ratio of the S and D wave velocities and velocity time integrals was determined.
The total forward flow was determined by adding the Svti and Dvti, and the
fractional systolic flow was calculated by dividing Svti by this total.
Initial screening linear regressions were carried out to ensure there was a linear
relationship between the echocardiographic parameter and each independent variable,
and a scatter plot of the residuals (Y axis) was made to ensure that they were evenly
distributed around the X axis values.
Forward stepwise regression was then carried out for each echocardiographic
parameter (dependent variable) using the independent variables to identify which of
these significantly contributed to the dependent variable. If just one independent
variable significantly contributing to the dependent variable, linear regression was
97
run. Ifmore than one independent variable was significantly important, then multiple
linear regression was run. The least squares method of linear regression was used.
Statistical analyses were all carried out in SigmaStat (v.2.03; SPSS Inc.). The
regression equations, the R value (correlation coefficient), which indicates the
strength of the relationship between the variables, the R2 value, the coefficient of
determination, a measure of goodness-of fit of data to the regression line, the
adjusted R2 value (corrected for degrees of freedom) and the significance level (p
value) were all recorded.
Where body weight and BSA significantly affected the echocardiographic parameter,
regression equations were determined for both, for use in generation of reference
values for this breed.
Graphs of the dependent variable (echocardiographic parameter) against one of its
independent variables show the regression line, 95% confidence intervals for this line
and 95% prediction intervals (i.e. 95% of future subjects should be within these
lines). These were drawn using the facility in SigmaStat (v.2.03; SPSS Inc.).
BA5 Comparison between the Newfoundland categories
The Newfoundland categories were:
(i) the Normal group (dogs of all ages)
(ii) the dilated cardiomyopathy (DCM) group
(iii) two depressed fractional shortening (dFS) groups
(a) one with FS less than 18% (dFS<18%)
(b) the other with FS between 18 and 20% (dFS 18-20%)
(iv) the left ventricular enlargement (LVE) group




Statistical analysis was performed using SigmaStat (v.2.03 SPSS Inc.) software. A p
value of <0.05 was accepted as being statistically significant. Descriptive statistics
for each Newfoundland category were applied. The y2 test was used to compare the
gender ratios in each category with the total Newfoundland population. ANOVA or
ANOVA on ranks (if data not normally distributed or variance was unequal) was
used to identify any differences in age, weight, BSA or heart rate between the
groups. If differences were identified, the Tukey test or Dunn's method (non-normal
data or unequal variance) for multiple pair-wise comparisons were used to identify
the significantly different groups.
ANOVA or ANOVA on ranks with the Tukey test or Dunn's method of comparisons
were used to assess for statistically significant differences between the groups for
each echocardiographic parameter. Some parameters were indexed to BSA. Where
differences in heart rate between the groups may have explained some of the
differences, the parameter was normalised by dividing by the square-root of the R-R
interval.
The "index of sphericity" (2D LVld divided by M-mode LVIDd) was calculated for
comparison between groups, in a method similar to that described by Douglas and
colleagues (1987b) or D'Cruz and others (1992). The M-mode left ventricular
posterior wall diastolic thickness (LVpwd) was indexed to the M-mode LVIDd to
allow group comparisons. The mitral EPSS was indexed to the LVIDd for further
analysis of differences between groups. The M-mode ratio of LAs: Aod was recorded
for analysis.
To display differences between groups, box and whisker plots were used. The central
line indicated the median value, the upper and lower limits of the box incorporated
data between the 25th and 75th percentiles, and the Whiskers defined the 10th and 90th
percentiles. Data points out-with these boundaries were also illustrated.
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The number of dogs with mitral regurgitation in each group were noted with the
severity, defined by colour flow echocardiography (ranging from 1+ to 4+) graded as
absent (0), a trace (0.5), very mild (1), mild (2), moderate (3) or severe (4). %
analysis was used to compare groups. Whether the grade of mitral regurgitation
correlated with any of the two-dimensional left atrial parameters was ascertained
using stepwise regression and linear regression.
In a similar way, dogs with aortic or pulmonic insufficiency or tricuspid regurgitation
were graded and y2 analysis was used to compare groups.
If good quality CW spectral Doppler signals of mitral regurgitant jets were obtained,
with clean acceleration, the left ventricular dP/dt was calculated according to the
methods previously described, and results were compared between individuals.
Newfoundlands with aortic velocities exceeding 1.7 m/s (SAS group) were further
analysed. The aortic velocity from the subcostal view was regressed to the M-mode
and the 2D left ventricular parameters in an attempt to identify any significant
relationship.
Linear regression was also used to investigate the relationship between peak
pulmonic velocity (from the left parasternal view) and aortic velocity (from the
subcostal view) in the SAS group. Data from all Newfoundland groups was
combined to investigate this relationship in the general Newfoundland population.
B. 15.2. Sensitivity and specificity of systolic time intervals in
distinguishing between Normal and DCM Newfoundlands
The systolic time intervals PEP and PEP:ET ratio were used to investigate the
sensitivity and specificity of these parameters in differentiating between Normal
Newfoundlands and Newfoundlands with DCM. The corrected PEP data was used.
The cut-off values selected were based on mean plus two standard deviations (sd)
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(mean +2sd) or mean +1 sd for each parameter, where these values had been obtained
from the combined Normal Newfoundland group. The normal mean + sd PEP was
0.072 + 0.010 seconds, with upper limits of normality defined as 0.092 seconds
(mean + 2sd) or 0.082 seconds (mean +1 sd). The normal mean + sd PEP:ET ratio
was 0.403 + 0.057, with upper limits of normality defined as 0.517 (mean +2sd) or
0.460 (mean +lsd). Dogs in the combined normal groups or the DCM group were
separated as having a positive or negative PEP or PEP:ET ratio based on these limits.
It was assumed that the diagnosis of normality and DCM was correct for the purpose
of this part of the study. The sensitivity was defined as the proportion ofDCM cases
which were positively identified by these tests and the specificity was defined as the
proportion ofNormal dogs which were correctly identified by the test.
The positive predictive value of the test was defined as the proportion of
Newfoundlands with a positive result which were correctly identified as having
DCM. The negative predictive value of the test was the proportion of dogs with a
negative result which were correctly identified as being Normal.
This investigation was undertaken to attempt to identify which of PEP or the PEP:ET
ratio was most sensitive at distinguishing between Normal and DCM dogs, and
which cut-off value resulted in optimal sensitivity and specificity. The selected
criterion for an abnormally prolonged PEP:ET ratio of >0.460 was used to identify
the numbers of dogs in all other Newfoundland categories with this result.
A similar approach could not be used for other conventionally used parameters to
differentiate between Normal and DCM patients, such as left ventricular parameters
or fractional shortening, since these parameters had been used to define the
Newfoundland categories.
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B.16. The influence of independent variables on the echocardiographic
parameters for each Newfoundland group
Forward stepwise regression was used to identify the influence of the independent
variables weight, BSA, age, gender or R-R interval on the echocardiographic
variables using similar methods to those described for the Normal Newfoundland
group, applying this to all other Newfoundland groups.
B.17. Repeatability study
Since echocardiography / Doppler is used to serially evaluate Newfoundland dogs in
this study, it was necessary to investigate the repeatability of these measurements.
The study was carried out in boxer dogs. Details of these investigations are not
shown but are available in the Supplement (available from the author).
B.18. Serial scans in the Newfoundland population
Fifty four dogs had one repeat scan, of which four dogs had a second repeat scan. The
scans were performed and the scan categorised for the individual dog as previously
described. The category of each scan was indicated; some dogs changed categories by
the time of the second scan. Normally, the "final" category was that of the last scan,
unless it was felt that there was information in previous scans of better diagnostic
quality.
The serial scans for each individual were collated in an Excel (v7; Microsoft Inc.)
spreadsheet, included by the final category. The DNA identity and P number (for the
Pedigree/Draw data; see later) and the number for each scan were recorded. The time
interval between each scan was recorded in months. Any significant event, such as
death, was also recorded as time after initial scan. The gender, weight, BSA, presence




For each echocardiographic parameter from each scan, the mean and standard
deviation (sd) were recorded, having been calculated in the previous spreadsheet
(raw data not shown).
As an indicator of the variance for each scan parameter, the standard deviation was
presented as a percentage of the mean (sd%Mean), to give a coefficient of variation
for each individual scan. The difference between the means (%diffMeans) was
calculated as:
%diffMeans = Mean 1 - Mean 2 x 100%
Mean 1
Mean 1 was the mean value for a particular echocardiographic parameter at the initial
scan, and Mean 2 was the mean value for that parameter at the second scan, or final
scan if the dog received more than one repeat scan.
If the percentage difference between the means (%diffMeans) was greater than any
of the percentage standard deviation of the means (sd%Mean) for a particular
parameter during either or any of the scans, this was indicated in bold type.
A second method of identifying significant differences between the data sets used to
generate each mean was the Student's t test (Excel (v7; Microsoft corporation)).
Using the raw data for each echocardiographic parameter, data from the initial scan
was compared with the data from the second (or final) scan under the null hypothesis
that there are no significant differences between the data sets in a dog with no cardiac
disease or no significant progression of cardiac disease between the first and second
(or final) scans. The levels of significance were p<0.001, p<0.01, p<0.05 or ns (not
significant), and the t test result was recorded with the data for each individual dog.
The data were also compared with the coefficient of variation data for each
echocardiographic parameter generated from the boxer repeatability study.
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After detailed comparisons between serial scans for the Normal category, serial scans
in the DC.M, dFS, LVE and SAS categories were screened for differences of greater
than 20% between initial and second (or final) scan.
B. 19. Comparison of right parasternal and left apical views for
determining left ventricular volumes and left atrial areas
The use of right parasternal long axis views is not a conventional method of
determining left ventricular volume in human echocardiography, as the LV apex is
not included. However, the LV is consistently longer with larger area from the right
parasternal view in dogs compared with the left apical view. A study justifying the
use of the RPS view is detailed in the Supplement (available from the author).
B.20. Comparison ofSimpson's rule and the single plane ellipse
method in determining left ventricular volumes and ejection
fraction
A software upgrade was available during the end of this study which allowed the
determination of LV volumes by Simpson's rule. A study was undertaken to attempt
to investigate whether the two techniques were interchangeable, which is detailed in
the Supplement (available from the author).
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AN ECHOCARDIOGRAPHY / DOPPLER EVALUATION
OF A POPULATION OF NEWFOUNDLAND DOGS
RESULTS
B.21. Population details
A total of 223 scans were obtained from 165 individual Newfoundland dogs (69
males and 96 females). Fifty four dogs received a second scan and four dogs had a
total of three scans.
B.21.1. Body Weight
Using data from 75 male dogs, the mean + standard deviation body weight was 62.63
+ 9.2 kg, with a minimum weight of 43 kg and a maximum weight of 93 kg and a
median weight of 63 kg. The data from 101 bitches gave a mean + standard
deviation body weight of 55.07 + 5.6 kg, with minimum of 43 kg and maximum of
71 kg (Figure B.I.). Although the data was normally distributed, the equal variance
test failed (assessed by SigmaStat v.2.0, SPSS inc.) and so the Mann-Whitney rank
sum test was used to identify differences between the two groups. The male dogs
were significantly heavier than the female dogs (p<0.001).
B.2'1.2. Body Surface Area
The mean + standard deviation body surface area (BSA) for all Newfoundlands was
1.522 + 0.143 m2 (minimum, 1.24 m2 and maximum, 2.08 m2). The mean BSA for
2 2male Newfoundlands was 1.597 + 0.155 m (minimum, 1.24 m" and maximum, 2.08
m2). The female Newfoundlands had a mean BSA of 1.465 + 0.099 m2 (minimum,
2 21.24 m and maximum, 1.74 m ). There was a significant difference between the




Newfoundland Weights. Raw data with means and standard deviations
B.21.3. Raw data from the echocardiographic / Doppler examinations
The raw data from all the Newfoundlands included in the study are not shown.
However, the mean values for each parameter or calculated derivative are presented
for all dogs with scans of diagnostic quality in the Supplement (available from the
author). These include the reference given for each scan, numbered sequentially
based on the videotape number, the individual identity by both DNA number (if
DNA sample obtained) and P number (referring to the Pedigree/Draw data; see
Section C). Dogs are grouped according to echocardiographic category (see later).
B.22. Comparison between normal Newfoundlands and normal
Newfoundlands under eight years old
There was no significant difference for body weight, BSA or heart rate between the
two groups, although age was significantly different (p<0.001) as it had been used to
define the two groups.
Significant differences (unpaired two-tailed /-test or Mann-Whitney rank sum test)
were identified for some of the two-dimensional echocardiographic parameters
between the two groups. The left ventricular diastolic area and diastolic volumes
were significantly smaller in the older group (p<0.05 for both) and the ejection
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fraction was significantly lower in the older group (33.33% compared with 42.58%;
p<0.01), with a smaller stroke volume in the older dogs (p=0.001). The only ^
significant differences identified in the left atrial parameters was that LAls was
smaller in the older dogs (p<0.05).
There were no significant differences between the two groups for any of the M-mode
parameters. Consequently, the two groups were combined.
B.23. The Normal Newfoundland group
B.23.1. Description of the Normal Newfoundland group
The mean + standard deviation age of the group (n=86) was 4.35 + 2.57 years. It
weighed 59.01 +2.14 kg, corresponding to a BSA of 1.53 + 0.15 m . The mean heart
rate during acquisition of two-dimensional echocardiographic parameters was 106.97
+ 16.32 beats per minute (bpm), corresponding to an average R-R interval of 0.575 +
0.092 seconds, and during acquisition of right parasternal M-mode images was
104.12+14.41 bpm, with R-R interval of 0.588 + 0.081 seconds.
The results of descriptive statistical analysis of the two-dimensional and M-mode
echocardiographic parameters are shown in Table B.4. Means, standard deviations,
maximum and minimum data points, the 95% confidence interval of the mean with
the lower and upper confidence limits are detailed. To include 95% of the normal
population, the values ofmean minus and plus two standard deviations are included,
for evaluation of significant departures from the Normal group.
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Table B.4.
Descriptive Statistics of the Normal Newfoundland population:
2D and M-mode parameters
PARAMETER Mean
Standard








confidence limit Mean +2sd Mean -2sd
2D parameters
RPSLVad (sq.cm) 29 86 4.34 20.76 41.51 0.97 28.89 30.83 38.54 21.18
RPSLVId (mm) i:' 7980 6.10 63.52 92.25 1.36 78.44 81.16 92.00 67.60
RPSLVdv (mis) 95 56 22.14 56.60 159.13 4.93 90.63 100.49 139.84 51.28
RPSLVas (sq.cm) 20.73 4.90 13.62 53.87 1.09 19.64 21.82 30.53 10.93
RPSLVls (mm) 64 05 6.12 52.90 78.23 1.36 62.69 65.41 76.29 51.81
RPSLVsv (mis) 55.12 12.90 85.80 29.33 2.87 52.25 57.99 80.92 29.32
RPSEF(%) 41.77 8.26 15.17 58.50 1.84 39.93 43.61 58.29 25.25
RPSSV (mis) 40.74 13.54 11.40 77.13 3.01 37.73 43.75 67.82 13.66
EDVI (mls/sq.m) 6239 13.24 39.45 97.45 3.45 58.94 65.84 88.87 35.91
ESVI (mls/sqm) 35 96 8.13 21.01 52.32 2.12 33.84 38.08 52.22 19.70
SV1 (mls/sq.m) 2660 8.15 11.99 26.79 2.12 24.48 28.72 42.90 10.30
RPSLAad (sq.mm) 1131.78 189.71 679.40 1718.72 41.68 1090.10 1173.46 1511.20 752.36
RPSLAId (mm) 36 73 3.63 29.20 50.50 0.80 35.93 37.53 43.99 29.47
RPSLAas (sq.mm) 1634.50 281.77 2542.02 1208.22 62.31 1572.19 1696.81 2198.04 1070.96
RPSLAJs (mm) 41 29 3.98 54.28 33.25 0.88 40.41 42.17 49.25 33.33
LAEI 0 30 0.06 0.15 0.31 0.01 0.29 0.31 0.42 0.18
2DLAd (mm) 32 46 3.51 39.93 23.50 0.77 31.69 33.23 39.48 25.44
2DAod (mm) 29 56 2.42 36.08 25.10 0.53 29.03 30.09 34.40 24.72
2DLAd:Aod 1.10 0.11 0.81 1.39 0.02 1.08 1.12 1.32 0.88
M-mode parameters
RVd (mm) ' V '-v- 8 33 3.08 4.25 21.65 0.66 7.67 8.99 14.49 2.17
iVSd (mm) 10.66 1.13 8.02 13.77 0.24 10.42 10.90 12.92 8.40
LVlDd (mm) 45.35 4.03 35.78 54.85 0.86 44.49 46.21 53.41 37.29
LVpwd (mm) 10 28 1.13 8.10 13.18 0.24 10.04 10.52 12.54 8.02
IVSs (mm) 12 93 1.38 9.43 16.75 0.30 12.63 13.23 15.69 10.17
LVIDs (mm) 34.31 3.00 25.30 41.18 0.64 33.67 34.95 40.31 28.31
LVpws (mm) 13.69 1.38 11.18 16.45 0.30 13.39 13.99 16.45 10.93
%thlVS 22.97 10.25 -3.11 57.50 2.20 20.77 25.17 43.47 2.47
%thLVpw 34.45 10.00 8.83 55.33 2.14 32.31 36.59 54.45 14.45
FS(%) 24 47 3.21 20.00 34.83 0.69 23.78 25.16 30.89 18.05
EF(Teichotz)(%) 47 85 3.45 30.11 64.17 1.17 46.68 49.02 54.75 40.95
Mitral EPSS (mm) 569 1.68 2.80 10.16 0.36 5.33 6.05 9.05 2.33
LAs (mm) 24.13 4.06 14.37 35.68 0.87 23.26 25.00 32.25 16.01
Aod (mm) 29.18 2.71 23.72 37.50 0.58 28.60 29.76 34.60 23.76
LA:Ao 0.83 0.15 0.49 1.22 0.03 0.80 0.86 1.13 0.53
LVpwd/LVIDd 0.23 0.03 0.15 0.31 0.007 0.22 0.24 0.29 0.17
(LVpwd/BSA)/(LVIDd/BSA) 023 0.03 0.17 0.31 0.008 0.22 0.24 0.29 0.17
LVld/LVIDd 1.78 0.16 1.45 2.25 0.04 1.74 1.82 2.10 1.46
MAMseptal (mm) 11.29 2.08 7.55 20.64 0.45 10.84 11.74 15.45 7.13
MAMIateral (mm) 13.96 2.27 9.72 18.34 0.55 13.41 14.51 18.50 9.42
MAMmean (mm) 12.60 1.86 8.90 18.60 0.45 12.15 13.05 16.32 8.88
Indexed to BSA
RVd/BSA (mm/sq.m) 5.40 1.87 2.80 12.97 0.46 4.94 5.86 9.14 1.66
IVSd/BSA (mm/sq.m) 6.97 0.86 4.86 9.18 0.21 6.76 7.18 8.69 5.25
LVIDd/BSA (mm/sq.m) 29.78 3.40 20.80 38.09 0.84 28.94 30.62 36.58 22.98
LVpwd/BSA (mm/sq.m) 6.72 0.74 5.29 8.58 0.18 6.54 6.90 8.20 5.24
IVSs/BSA (mm/sq.m) 8.57 1.48 5.99 16.99 0.37 8.20 8.94 11.53 5.61
LVIDs/BSA (mm/sq.m) 22.51 2.53 16.01 27.38 0.63 21.88 23.14 27.57 17.45
LVpws/BSA (rrim/sqTn) 8.94 0.95 6.60 8.94 0.23 8.71 9.17 10.84 7.04
(LVld/LVIDd)/BSA 1.17 0.13 0.89 1.54 0.03 1.14 1.20 1.43 0.91
MAMseptal/BSA (mm/sq.m) 7.48 1.56 4.81 13.58 0.39 7.09 7.87 10.60 4.36
MAMIateral/BSA (mm/sq.m) 9.39 1.63 6.54 12.31 0.46 8.93 9.85 12.65 6.13
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B.23.2. Regression analyses for 2D and M-mode echocardiographic
parameters in normal Newfoundlands
The results of forward stepwise regression in identifying independent variables
significantly influencing echocardiographic parameters are shown in Tables B.5. (M-
mode parameters) and B.6. (2D parameters). The results of linear regression or
multiple linear regression analyses are also shown in these tables, with equations
given for both body weight and BSA where appropriate. The R value, R and
adjusted R2 values and the level of statistical significance (p value) are also indicated.
Linear regression graphs are shown in the Supplement (available from the author).
M-mode RVd was significantly influenced by weight or BSA. IVSd was related
significantly to BSA but the relationship to body weight did not achieve statistical
significance. IVSs was not significantly affected by any of the variables. LVpwd was
influenced by body weight or BSA and the relationship was maintained in systole
(LVpws). When indexed to BSA, no independent variable significantly affected RVd,
IVSd, IVSs, LVpwd or LVpws. LVIDd was positively correlated to body weight or
BSA but negatively to age. No parameter exerted a significant effect on LVIDs.
However, when both LVIDd and LVIDs were indexed to BSA, significant but weak
negative correlations were identified with age.
When the wall thickness was expressed as a fraction of the left ventricular internal
diameter (LVpwd/LVIDd, relative wall thickness), no significant relationship was
identified with any independent variable, although forward stepwise regression had
indicated that age may be important.
No significant relationship was confirmed by linear regression analysis for FS% or
the Teicholz derived ejection fraction (EFTeicholz). No independent variable
influenced the percentage thickening of the IVS or the LVpw.
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TableB.5.Linearregressionandmu tiplel rregre sionquat sfoind p n e tvariabl significantlyinfluenci gechocardiographicpar meter: M-modeparamet rs
Echocardragraphtc ammeter
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Mitral EPSS significantly increased with body weight or BSA. Both M-mode LAs
and Aod were significantly related to body weight and BSA. When the ratio of these
two parameters (LAs:Aod) were considered, they were not influenced by any of the
independent variables.
Mitral annulus motion, obtained from the septal annulus (MAMseptal), showed a
significant relationship to gender, with males showing the greater MAMseptal.
However, if MAMseptal was indexed to BSA, this was no longer evident, and no
independent variable was identified by forward stepwise regression to significantly
influence this parameter. Mitral annulus motion, obtained from the lateral annulus
(MAMlateral), was significantly negatively influenced by age. This relationship was
stronger and more significant after correcting for BSA. The mean mitral annulus
motion (MAMmean) determined from these two values, was predicted by R-R
interval, age and gender. A significant although weak relationship was shown
between MAMmean and FS% (R=0.247; p=0.041), but not EF (determined by 2D
techniques). MAMlateral also showed a similar relationship to FS (R=0.239;
p=0.048), but the MAMseptal showed no significant relationship to these parameters
of systolic function.
Attempts to quantify the degree of sphericity of the left ventricle, by considering the
ratio of LV diastolic length, from the RPS view (LVld), and LVIDd showed that this
ratio was significantly affected by sex. However, when this index was corrected for
BSA, this variable was eliminated as being significantly associated with the value.
The diastolic and systolic LV lengths (LVld and LVls) were significantly influenced
by BSA or weight and also gender; females had shorter left ventricles after correcting
for BSA or weight in the multiple regression model. However, if LVld and LVls
were indexed to BSA, sex was no longer a significant independent variable affecting
the value. A new significant variable was identified affecting LVls/BSA, with R-R
interval, by forward stepwise regression. This relationship was given by the linear
regression equation:
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LVIs/BSA = 33.704 + (14.681 x R-R)
(R=0.292; R2= 0.0853; adjusted R2 = 0.0687; p<0.05)
The left ventricular diastolic volume (LVdv) was positively and significantly related
to BSA or weight and negatively to age. When corrected for BSA, the left ventricular
end diastolic volume index (EDVI), still showed the significant negative effect of
age, and multiple regression indicated that the EDVI was also influenced positively
by R-R interval. The left ventricular systolic volume (LVsv) is affected similarly by
weight or BSA, and the left ventricular end-systolic volume index (ESVI) is
significantly affected by age (lower in older dogs) and also sex (females have lower
ESVI despite having corrected for BSA).
None of the independent variables showed a significant influence on EF derived by
the single plane ellipse method. However, stroke volume (SV) was significantly
affected by BSA or weight, and also significantly decreased with advancing age.
When corrected for BSA, the stroke volume index (SVI) still showed a negative
correlation for advancing age.
The left atrial parameters had also been obtained from an RPS long axis view. Left
aliial area in diastole (LAad) was positively influenced by weight or BSA and R-R
interval. The diastolic length of the left atrium, measured parallel to but slightly
above the mitral annulus (LAld) also was positively correlated to BSA or weight. The
left atrial systolic area (LAas) and length (LAls) were also significantly influenced by
BSA or weight. When the left atrial emptying index (LAEI) was calculated, it was
found that no independent variable was significantly related to this parameter.
The 2D short axis left atrial diastolic dimension (2D LAd) and the aortic diastolic
dimension (2D Aod) both were positively related to BSA or weight. The 2D
LAd:Aod ratio showed a significant positive relationship to the R-R interval.
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B.23.3. Regression analyses for Doppler echocardiography
parameters in Normal Newfoundlands
The descriptive statistics for the normal Newfoundlands (older and younger than
eight years old) are shown in Table B.7. These include the Doppler parameters for
aortic outflow, mitral inflow, pulmonary venous flow and right sided Doppler
velocities.
Tables B.8. to B.l 1. give the results of forward stepwise regression, multiple linear
2*2
regression and linear regression, with R value, R and adjusted R and the level of
significance (p value <0.05, <0.01 or <0.001). Linear regression graphs are included
in the Supplement (available from the author).
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Table B.7.
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S/C LV PEP (corrected) (s)
S/C LV ET (s)












































































































































MV E duration (s)





























MV EA velocity ratio




















(peak filling rate normalised forSV)
7.15 1.28 4.78 11.71 0.279 6.87 7.43 9.71 4.59
Isovolumic relaxation time
IVRT(s) 0.062 0.010 0.046 0.060 0.002 0.060 0.064 0.082 0.042


































































PVF Ar duration (s)
PVF S duration (s)
PVF D duration (s)
PVF D deceleration (s)














































Mitral A duration - PVF Ar duration 0.024 0.015 -0.007 0.075 0.003 0.021 0.027 0.054 -0.006
PVF S:D velocity ratio
PVF S:D vti ratio
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Edur(p<0.001)ifncl dedasnindependentvariable R-R(p<0.001);Age(p=0. 04)ifEdurexcl ded
MVEdecel=-0.00786+(0.641xE ur) MVEdecel=0.067+(0. 17xR-R)(0.002 8age
MVEdecel=0.0861+(0.05xR-R) MVEdeceJ=0.106+(0.00239xage)
0.726 0.474 0.272 0.336
0.527 0.225 0.0741 0.113
0.521 0.204 0.0621 0.101
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Table B.8. gives the details for the Doppler parameters of aortic outflow. The
subcostal view was used for the detailed analysis, although the velocity recorded
from the left apical view is noted, and systolic time intervals determined from the left
apical view were used if an inadequate subcostal signal was obtained, as there is no
significant difference between the two views for time intervals (data not shown).
Technically adequate subcostal signals were obtained in 74 out of 86 normal dogs
(86%).
Aov showed a trend to lower values with a longer R-R interval and significantly
declined with age. The aortic vti tended to decline with age. There was no association
between age and R-R interval identified. Both peak and mean aortic acceleration
(dv/dtmax and dv/dtmean) declined with R-R interval. ET showed a significant
relationship with mean R-R interval, but the influence of heart rate was less strong
and less significant on PEP. Male dogs appeared to have a significantly longer PEP
than bitches, although this relationship was not present after indexing PEP to the
square root of the R-R interval. Males also showed a trend to faster acceleration time
for aortic flow, a relationship which was still apparent although less significant after
normalisation to the VR-R. No independent variable was a significant predictor of
the PEP:ET ratio. Vcf was lower with longer R-R. No significant variables predicted
parameters normalised for heart rate (PEP/VR-R, ET/WR-R, PEP:ETNR-R or
VcfVR-R).
B.23.3.2. Mitral inflow
Table B.9 shows the details about the analysis of mitral inflow in this normal
Newfoundland population. Mitral Ev, the E:A velocity ratio, Evti and E:A vti ratio
were all inversely associated with advancing age. E duration and E deceleration time
increased with advancing age. The mitral peak filling rate, normalised to mitral
stroke volume, declined with advancing age. The mitral A wave did not appear to be
influenced by age, but increasing R-R interval was associated with lower Av. This
relationship with R-R interval was retained after normalising Av to total mitral vti.
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Forward stepwise regression had indicated that gender may influence A wave
velocity, although this was not statistically significant. However, the Avti was
influenced by both body weight and gender (female dogs tended to have higher A
wave vti). On their own, in simple linear regression models, however, neither weight
or BSA nor gender resulted in a statistically significant p value.
The proportion of early left ventricular filling (Evti/total vti) was influenced by both
age and gender in a multiple linear regression model. This proportion declined with
advancing age and was significantly lower in bitches. Similar but opposing
relationships were evident for the proportion of late ventricular filling (Avti/total vti)
and age and gender, with the larger ratio in older dogs and males.
E duration was influenced by R-R interval as well as age. The influence of age was
still significant, increasing in older dogs, after E duration was indexed to VR-R. The
major predictor of E deceleration time was mitral E duration. However, if E duration
was eliminated as an independent variable, the major effects on E deceleration time
were R-R interval as well as age. E deceleration/VR-R interval significantly increased
with advancing age. The R-R interval also influenced A duration and isovolumic
relaxation time (IVRT). Neither Adur/VR-R or IVRT/VR-R were associated with
any other independent variable.
B.23.3.3. Pulmonary venous flow
Table B.10. details the analysis of the PVF parameters. Arv, Sv, Svti, S:D velocity
ratio and S:D vti ratio all increased with advancing age. The systolic fraction of total
forward flow also increased with age. The S:D velocity ratio, S:D vti ratio and
systolic fraction of total forward flow were also influenced by R-R interval,
decreasing at slower heart rates. No independent variable influenced Dv. R2v
increased with longer R-R intervals. S and D durations were both associated with R-
R interval. The major predictor of D deceleration time was D duration, although ifD
duration was not included as an independent variable, the major effect on D
deceleration time was R-R interval. D duration also showed a weak although
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significant inverse association with age. No independent variable significantly
predicted Ar or R2 durations. No independent variable was shown to influence any
PVF wave duration indexed to VR-R interval.
The normality plot of linear regression residuals and PVF velocities was not perfectly
linear, but attempts at simple transformation of the independent variables, such as the
R-R interval under test did not improve linearity. Arv was most effected, showing
non-normal distribution when regressed to both R-R interval (Figure B.2.) and age.
It is possible that the velocities should have been transformed. The S and D velocity
residuals were relatively normally distributed; the major effects were seen with Ar
and R2 velocities.
Normal Probability Plot of residuals from
linear regression of PVF Arv and R-R interval
Figure B.2.
Plot of residuals from linear regression of PVF Arv and R-R interval is not
consistent with normal distribution
Mitral A duration was longer than the PVF Ar duration in all but three dogs, when
the difference ranged from 0.002 - 0.007 seconds, which is less than Doppler
123
temporal resolution (10 milliseconds), so is not significant. The mean difference in
durations was 0.024 seconds and no independent variable influenced this difference,
which is consistent with the data from man (Klein et al 1998).
The various parameters of PVF were assessed by forward stepwise regression for any
association with the LAEI. The left atrial emptying index proposed by Clarkson and
others (1995) was an independent negative predictor of S wave duration and S:D vti
ratio. Increase in the LAEI was associated with decreased S duration and decreased
S:D ratio.
B.23.3.4. Right heart
Table B.l 1. details the findings from the limited analysis of right sided function. PAv
was almost always higher from the LPS view (mean for group; 0.75 m/s) than the
RPS view (mean for group; 0.72 m/s). In general, the spectral signal was better from
the LPS view, although in some dogs lack of perfect alignment resulted in a bifid
tipped appearance to the envelopes. PAv was lower for longer R-R intervals and also
for increasing age. Tricuspid Ev and the E:A velocity ratio tended to decrease with
advancing age. Lengthening R-R interval was associated with lower Av and higher
E:A velocity ratio.
B.23.4. Summary of the influence of the independent variables on
echo-Doppler parameters in Normal Newfoundlands
The influence of the independent variables, body size, gender, age or mean R-R
interval on specific echo-Doppler indices are summarised in the table displayed in
Appendix B.l. (Volume II).
B.23.5. Inter-relationship of certain echo-Doppler parameters
A matrix shown in Appendix B.2. (Volume II) displays significant correlation
coefficients between certain echo-Doppler parameters assessing left ventricular
function.
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B.24. Comparison of the Newfoundland categories
B.24.1. Recorded details and summary of groups
The details for each category of Newfoundlands are not included, although are
available in the Supplement (available from the author).
There were 86 dogs in the Normal group (40 males, 46 females), 35 dogs in the DCM
group (13 males, 22 females), 29 dogs in the depressed fractional shortening < 18%
(dFS<18%) group (11 males, 18 females), 24 dogs in the dFS 18-20% group (nine
males and fifteen females), eight dogs in the left ventricular enlargement (LVE)
group (two males and six females) and a total of forty dogs in the subaortic stenosis
(SAS) group (20 males and 20 females). Compared with the total population (69
males and 96 females), there was no significant sex predisposition identified for any
group (x test; p>0.05). A significant difference in age was identified between the
groups (ANOVA on ranks, p<0.001). Dunn's method of all pair-wise multiple
comparison procedure identified that the DCM group were significantly older that the
Normal dogs, the SAS group and the dFS 18-20% group (p<0.05). Although the SAS
group showed a trend to lower weight and BSA, this was not statistically significant
(ANOVA). There was no significant difference in the heart rate recorded during
imaging of the RPS long-axis view between any of the groups, although the LVE
group tended to have a slower rate than the other groups (ANOVA). The general
comparisons between groups are illustrated in Table B.12.
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TableB.12.
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B.24.2. 2D echocardiographic parameters (Left ventricle, LV)
The mean and standard deviation for each parameter from the dogs in each
Newfoundland group are listed in Table B.12. The results from One Way analysis of
Variance (ANOVA) or the Kruskall-Waliis One Way Analysis of Variance on ranks
are also shown in this table, with multiple pair-wise comparisons performed by the
Tukey test or Dunn's method. Corresponding box and whisker plots illustrating the
differences between groups are shown in the Supplement (available from the author).
LVdv was significantly greater in the DCM group than the Normal group or the
dFS<18% group. The same significant differences were also identified for the left
ventricular diastolic area (LVad) although no significant differences were identified
from the left ventricular length (LVld), despite a trend to a longer ventricle in the
DCM group. The DCM group had a significantly larger EDVI than Normal,
dFS<18% and dFS 18-20% groups and the SAS group had a larger EDVI than the
Normal and dFS<18% groups.
LVsv was significantly larger in the DCM group than the Normal, dFS<18%, dFS18-
20% and the SAS groups. The DCM group had a larger LVas than the normal or
dFS<18% groups, and a longer LVls than the LVE, Normal and SAS groups. ESVI
was significantly larger in the DCM group was than all other groups.
The EF was significantly lower in the DCM group than the LVE, SAS, Normal and
dFS 18-20% groups. The LVE group tended to have a higher EF than the Normal
group and SAS group although this was not statistically significant. Calculation of
the total left ventricular stroke volume (SV) from the single plane ellipse method
showed a larger SV for the LVE group, although this was only significantly different
from the dFS<18% group. The SAS group also showed a higher SV than the
dFS<18% group. These differences were still evident if SV was indexed to BSA (the
stroke volume index, SVI). Although there was no significant difference between the
heart rates in the various categories, the LVE group had a slightly slower heart rate
and the SAS group a slightly higher HR than the other groups. The SVI was
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normalised to the square root of the R-R interval to allow further comparisons
between the groups. Although the LVE group still tended to have a higher value than
the other groups, this was no longer statistically significant, but the SAS group
showed a significantly larger SVLWR-R than the dFS<18%, DCM, dFS 18-20% and
the Normal groups.
B.24.3. 2D echocardiographic parameters (Left atrium, LA)
The means, standard deviations and the results of ANOVA and multiple pair-wise
comparisons are shown in Table B.12.
There was no significant difference between the R-R intervals for any of the groups.
Left atrial diastolic area (LAad) and length (LAld) were significantly greater in the
DCM group than the other five groups, although once indexed to BSA, the
differences were only significant for the Normal and the dFS<18% groups, since the
dFS 18-20%, the LVE and the SAS groups showed a trend to larger left atria. The
only significant difference in LAas was between the DCM and the dFS <18% groups.
Once normalised to BSA, the SAS group also showed a larger LAas/VR-R than the
dFS<l 8% group. The DCM LAls was significantly greater than the dFS<l 8% and the
Normal groups, which was also evident after indexing to BSA, although this figure
showed a trend to larger LAas/VR-R in the LVE and the SAS groups.
The left atrial emptying index (LAEI), showed lower values in the DCM group and
the LVE group (0.25 and 0.26 respectively) than the Normal and SAS groups (0.30
and 0.31 respectively), although this was only significant for the DCM group. The
two dFS groups were intermediate, both at 0.28.
The 2D LAd showed a significantly larger DCM measurement than dFS<18%. Once
indexed to BSA, this dimension was significantly larger for both the DCM and SAS
groups compared with the dFS<18% group. The trend to larger LAd in the LVE
group did not achieve statistical significance. 2D Aod did show a significant
ANOVA result (p<0.05), although no significant pair- wise differences were
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identified, and ANOVA showed no significant differences between Newfoundland
groups for Aod once the parameter was indexed to BSA. 2D LAd:Aod showed a
smaller ratio for dFS<l 8% than all other groups.
B.24.4.1. Presence of mitral regurgitation
A number of dogs in each group were shown to have mitral regurgitation (MR) based
on CFDE, which was scored as previously described (B. 15.1). Results are presented
in Table B.13.
Table B.13.
Newfoundlands in different categories with mitral regurgitation grades
Newfoundland
Group
0 0.5 1 2 3 4 TOTAL
Normal 45 14 26 1 0 0 86
(52.3%) (16.3%) (30.2%) (1.2%)
DCM 8 2 12 10 3 0 35
(22.9%) (5.7%) (34.3%) (28.6%) (8.5%)
dFS<18% 14 2 12 1 0 0 29
(48.3%) (6.9%) (41.4%) (3.4%)
dFS18-20% 12 3 8 1 0 0 24
(50%) (12.5%) (33.3%) (4.2%)
LVE 2 2 2 2 0 0 8
(25%) (25%) (25%) (25%)
SAS 19 4 15 2 0 0 40
(47.5%) (10%) (37.5%) (5%)
X2 analysis showed that there was significantly more MR in the DCM group than the
normal group (p<0.001). There was no significant difference between Normal
Newfoundlands or the Newfoundlands in other categories when the MR severity was
considered.
Forward stepwise regression failed to identify any relationship between the grade of
MR and the parameters LAd, LAld, LAas, LAls, LAEI, 2DLAd or 2DLAd:Aod
ratio for Newfoundlands in the Normal, dFS<18%, dFS 18-20%, LVE or SAS
categories. However, in the DCM group, a positive relationship was identified
129
between MR grade and LAld, LAas and LAls (all p<0.001) and 2DLAd:Aod
(p=0.017). The linear regression equations for LAas and LAls are shown in Table
B.24.
B.24.4.2. Calculation of left ventricular dP/dt from mitral regurgitant jet
Good quality CW spectral Doppler recordings ofmitral regurgitant jets were obtained
from only five scans from four different individual dogs which were of sufficient
diagnostic quality to allow the LV dP/dt to be calculated. Four of the scans were in
the DCM category, and one was in the dFS<18% category. LV dP/dt was determined
as previously described (B. 10.4.4.2.). The following results were obtained (Table
B.14.). Mean and standard deviations were shown for pressures (pr.) determined by
the modified Bemouille equation.
Table B.14.
Calculation ofLV dP/dt from mitral regurgitant jets
Individual Scan Category MR pr.l MR pr.2 dP dt LV dp/dt
(mmHg) (mmHg) (mmHg) (seconds) (mmHg/s)
- /P706 NF5/1 dFS<18% 4.00 + 58.76 + 54.76 ± 0.04 + 1370.16 ±
0.00 12.61 12.61 0.00 245.44
NF002/P500 NF5/6 DCM 4.00 + 64.80 + 60.80 + 0.04 + 1375.08 ±
0.01 0.80 0.80 0.00 45.23
NF017/P543 NF7/1 DCM 4.00 64.4 60.4 0.026 2323.08
NF042/P542 NF9/5 DCM 4.00 + 64.40 + 60.40 ± 0.02 + 3743.89 ±
0.00 2.77 2.77 0.01 1410.19
NF002/P500 NF12/8 DCM 4.26 + 62.82 + 58.56 + 0.04 + 1434.78 ±
0.65 2.95 2.48 0.01 335.95
The mean + standard deviation dP/dt for this limited group of individuals is 2049.40
+ 1029.57 mmHg/s, with a range from a minimum of 1370.16 to a maximum of
3743.89 mmHg/s.
B.24.5. M-mode parameters
Means and standard deviations for each M-mode parameter and the six different
Newfoundland groups are given in Table B.15. Differences between groups are
identified by ANOVA or ANOVA on ranks, with the multiple pair-wise
comparisons (Tukey test or Dunn's method). Box and whisker plots are displayed in
the Supplement (available from the author).
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TableB.15.
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There was no significant difference between the Newfoundland groups for RVd,
whether or not indexed to BSA, although the DCM group showed the largest mean
value. LVIDd was significantly larger in the DCM, LVE and SAS groups, although
the SAS group was not significantly larger than the Normal dogs. Similar results
were obtained once LVIDd was indexed to BSA, with the largest value from the LVE
group. LVfDs was significantly larger in the DCM group than the Normal, dFS 18-
20%, SAS and the dFS<18% groups. The LVE group was significantly greater than
the Normal, dFS 18-20% and the SAS groups and the dFS<18% was significantly
greater than the Normal group. Once LVIDs was indexed to BSA, DCM was greater
than Normal, dFS 18-20%, dFS<18% and SAS groups and the LVE group was
significantly larger than Normal and dFS 18-20% groups. The SAS group was larger
than the Normal group. No significant difference was identified between the groups
for IVSd, although once indexed to BSA, the SAS group showed a significantly
thicker IVSd/BSA than the Normal group or the dFS<18% group. IVSs was
significantly greater for the LVE group (compared with dFS<18%, dFS 18-20%,
DCM and Normal groups), the SAS group (compared with dFS<18% and dFS 18-
20% groups) and the Normal group IVSs was significantly thicker than for the
dFS<18% group. Once indexed to BSA, although significant differences between
groups were identified, no significant pair-wise differences were isolated, although
the trend to the greatest value was in the SAS group. LVpwd showed no significant
differences between groups, although once indexed to BSA, SAS was greater than
dFS<18% and DCM groups. LVpws was significantly greater in the LVE group
(compared with the dFS<18%, DCM and dFS 18-20% groups), the SAS group and
the Normal group (than the dFS<18% and DCM groups). Once indexed to BSA, the
LVpws/BSA was significantly greater in the SAS group compared with the
dFS<18%, DCM, dFS 18-20% and Normal groups and also the LVE and Normal
groups compared with the dFS<18% group.
The percentage thickening of the interventricular septum (%thIVS or IVS%th) was
significantly lower in the dFS<18% group than the Normal or LVE group. The
percentage thickening in the LVpw (%thLVpw or LVpw%th) was significantly lower
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in the DCM group compared with the LVE, SAS and Normal groups and the
dFS<18% group was also significantly lower than the LVE group.
The use of the parameter obtained by dividing the diastolic LV posterior wall
measurement by the LV diastolic diameter measurement (LVpwd/LVIDd) allowed
further comparison between groups. The dFS 18-20%, dFS<18% and Normal groups
had a larger index than the LVE and DCM groups.
The "index of sphericity", determined by LVld:LVIDd, was compared between
groups. The dFS<18%, dFS 18-20% and the Normal groups all had a greater index
than the LVE, the DCM and the SAS group. The mean value for the LVE group was
the lowest.
FS% was significantly greater in the LVE, Normal and SAS groups than the DCM
group and the two dFS groups. Similar differences were identified for EF when
groups were compared. The mean FS and EF were highest in the LVE group,
although these findings were not statistically significant.
Mitral M-mode parameters were compared between Newfoundland groups showed
that the DCM group had a significantly larger EPSS than the SAS, Normal and
dFS<18-20% groups. The LVE group also had a trend to larger EPSS distance
although this did not achieve statistical significance. Once the EPSS was indexed to
LVIDd, however, the only significant differences were that the DCM EPSS/LVIDd
measurement was larger than the Normal or the SAS groups.
When M-mode results obtained at aortic valve level from a short axis view,
significant differences were identified between groups (ANOVA p<0.01) for LAs,
with a trend to higher values in the DCM and the LVE groups. Flowever, multiple
pair-wise comparisons failed to identify any two different groups with a p value of
less than 0.05. Once normalised to BSA (LAs/BSA), the DCM group had a
significantly larger left atrium than the dFS<18% group although there was also a
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trend to a large normalised LAs dimension in the LVE group and the SAS group.
Aod was identified to be significantly larger in the DCM group than the SAS group,
although once normalised to BSA, there were no significant differences between
groups. The M-mode ratio of LAs:Aod was significantly larger in the LVE group
than the dFS<18% group.
Significant differences between Newfoundland groups were identified for mitral
annulus motion. MAMseptal was significantly less in the DCM group than the SAS,
Normal and dFS<18% groups. MAMlateral was significantly greater in the SAS
group than the dFS<18%, DCM and dFS 18-20% groups. In all groups, MAMlateral
was larger than MAMscptal, although MAMseptal could be more consistently
obtained. Mean mitral annulus motion (MAMmean) was significantly less in the
DCM group than SAS or Normal Newfoundlands. The SAS group also had
significantly greater MAMmean than dFS<l 8% and dFS 18-20% groups.
B.24.6. Sub-aortic stenosis group
When linear regression was used to screen for any relationship between the various
2D and M-mode echocardiographic parameters or the R-R intervals and the sub¬
costal peak aortic velocity, none was found.
B.24.7.1. Aortic flow parameters
Descriptive statistics for the various parameters of aortic flow for all Newfoundland
groups are displayed in Table B.16. Results are also shown for ANOVA or ANOVA
on ranks, with multiple pair-wise comparison procedures performed by the Tukey
test or Dunn's method respectively. Box and whisker plots are illustrated in the
Supplement (available from the author).
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Aov and Aovti were significantly greater (by definition) in the SAS group than all
other Newfoundland groups. No other significant differences were identified for Aov.
Aovti was also significantly greater in Normal Newfoundlands than the dFS<18%
and DCM groups. Peak acceleration of aortic flow (dv/dtmax) was significant greater
in the SAS and Normal groups than DCM, dFS<18% and dFS 18-20% groups. The
mean acceleration of aortic flow (dv/dtmean) was significantly greater in the SAS
group than all other Newfoundland groups and Normal Newfoundlands had greater
dv/dtmean than dogs in DCM, dFS<l 8% and dFS 18-20% groups.
There was a significant difference in heart rate determined between the groups during
recording of subcostal aortic flow spectra (p<0.01), with the SAS group having a
significantly higher heart rate than the LVE group. STIs were corrected for heart rate
by indexing by VR-R interval.
PEP was significantly greater in the DCM and LVE groups than the other
Newfoundland groups. The PEP of the dFS<18% and dFS 18-20% was significantly
longer than the SAS and Normal groups, and SAS PEP was significantly shorter than
the Normal group. PEPA/R-R was significantly greater in the DCM and dFS<18%
groups than the SAS and Normal groups, and the dFS 18-20% group had a
significantly greater value than the SAS group.
ET was significantly shorter in the DCM group than the LVE, dFS 18-20% and
Normal groups (Figure B.12.g.). After correction for heart rate, ET/VR-R was
significantly less in the DCM group than the SAS and Normal Newfoundlands.
Aortic flow acceleration time was significantly longer in the DCM group than the
SAS and normal Newfoundlands. These trends were still apparent after normalising
to VR-R.
The PEP:ET ratio was significantly longer in the DCM and dFS<18% groups than
the SAS and Normal dogs. PEP:ET/VR-R was significantly greater in the DCM
Newfoundlands than the SAS, Normal, LVE and dFS 18-20% groups. Vcf was
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significantly greater in the SAS, Normal and LVE groups than the dFS<18%, DCM
and dFS 18-20% groups. After indexing to VR-R, the SAS and Normal dogs were
shown to be significantly different from dFS<18%, DCM and dFS 18-20% groups,
although the LVE group was also significantly greater than the dFS<18% group.
B.24.7.2. Sensitivity and Specificity and Predictive value of PEP or the
PEP:ET ratio in distinguishing between Normal and DCM
Newfoundlands.
The normal PEP(corrected) (mean + sd) was 0.072 + 0.010 seconds. Two cut-off
values were assessed in order to differentiate between Normal and DCM
Newfoundlands:
(i) Mean + 2sd = values > 0.092 (positive (+ve) for DCM) and < 0.092
(negative (-ve) for DCM).
(ii) Mean + lsd = values > 0.082 (+ve for DCM) and < 0.082 (-ve for DCM).
The normal (corrected) PEP:ET ratio (mean + sd) was 0.403 + 0.057. Two cut-offs
were assessed in an attempt to differentiate between Normal and DCM
Newfoundlands:
(iii) Mean + 2sd = values >0.517 (+ve for DCM) and < (-ve for DCM).
(iv) Mean +lsd = values > 0.460 (+ve for DCM) and < (-ve for DCM).
Results for these four different criteria are displayed in Table B.17.
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Table B.17.
Data for calculating sensitivity and specificity for differentiating between
Normal and DCM Newfoundlands based on systolic time interval criteria
(i) DCM Normal Total
PEPX1.092 s
+ve 21 1 22
-ve 13 81 94
Total 34 82 116
(ii) DCM Normal Total
PEPXK082 s
+ve 27 11 38
-ve 7 71 78
Total 34 82 116
(iii) DCM Normal Total
PEP:ET > 0.517
+ve 21 1 22
-ve 13 81 94
Total 34 82 116
(iv) DCM Normal Total
PEP:ET > 0.460
+ve 29 14 43
-ve 5 68 73
Total 34 82 116
(i) PEP>0.92s.
Sensitivity = 21/34 = 61.7%
Specificity = 81/82 = 98.8%
Positive Predictive value = 21/22 = 95.5%
Negative Predictive value = 81/94 = 86.2%
(ii) PEP>0.082s
Sensitivity = 27/34 = 79.4%
Specificity = 71/82 = 86.5%
Positive Predictive value = 27/38 = 71.1%
Negative Predictive value = 71/78 = 91.0%
(iii) PEP:ET > 0.517
Sensitivity = 21/34 = 61.7%
Specificity = 81/82 = 98.8%
Positive Predictive value = 21/22 = 95.5%
Negative Predictive value = 81/94 = 86.2%
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(iv) PEP:ET > 0.460
Sensitivity = 29/34 = 85.3%
Specificity = 68/82 = 82.9%
Positive Predictive value = 29/43 = 67.4%
Negative Predictive value = 68/73 = 93.2%
If the criterion of PEP:ET ratio greater than one standard deviation above the Normal
mean (>0.460) was applied to the other Newfoundland groups, the following
"positive" results were identified. There were 14/82 positives in the Normal
Newfoundlands (17.1%), 29/34 positives in the DCM group (85.3%), 15/29 positives
in the dFS<18% group (51.7%), 11/24 positives in the dFS18-20% (45.8%), 2/8
positives in the LVE group (25%) and 1/40 positives in the SAS group (2.5%).
B.24.8. Aortic insufficiency
Aortic insufficiency was identified in a number of Newfoundlands by CFDE, scored
as previously noted (B. 15.1). Results are presented in Table B.18.
Table B.18.




0 0.5 1 2 TOTAL
Normal 64 7 14 1 86
(74.4%) (8.1%) (16.3%) (1.2%)
DCM 29 2 4 0 35
(82.9%) (5.7%) (11.4%) (0%)
dFS<18% 26 0 2 1 29
(89.7%) (0%) (6.9%) (3.4%)
dFS18-20% 17 3 4 0 24
(70.8%) (12.5%) (16.7%) (0%)
LVE 6 0 2 0 8
(75.0%) (0%) (25.0%) (0%)
SAS. 13 3 21 3 40
(32.5%) (7.5%) (52.5%) (7.5%)
X2 analysis showed that there was significantly more aortic regurgitation in the SAS
group than Normal Newfoundlands (p<0.001). There were no significant differences
identified between Normal Newfoundlands and any of the other groups.
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Linear regression was used to attempt to identify any significant relationship between
aortic velocity (CW, subcostal) and the grade of aortic insufficiency. No association
was identified in the Normal, DCM, dFS 18-20% or the LVE groups. However, a
weak but significant (p<0.05) relationship was identified for the dFS<18% group,
given by the equation:
dFS<18% S/C Aov = 1.268 + (0.169 xAol grade)
(11=0.433, R2 = 0.187, adjusted R2 = 0.147, p=0.044).
A more significant relationship was identified between aortic velocity and the
severity of aortic regurgitation for the SAS group (p<0.01). This is given by the
equation:
SAS S/C Aov = 1.767 + (0.255 x Aol grade)
(R=0.422, R2 = 0.178, adjusted R2 = 0.157, p=0.007)
When all data was grouped from all Newfoundland groups (n=193), the relationship
of S/C CW aortic velocity to grade of aortic insufficiency was investigated in a
similar manner by linear regression, and was found to be highly significant
(p<0.001). The graph and equation are shown in Figure B.3.
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Linear Regression for peak aortic velocity (subcostal view)
from all Newfoundlands and
CFDE estimated grade of aortic insufficiency
CFDE estimated grade of Aortic insufficiency
Linear regression for subcostal CW peak aortic velocity and the grade of aortic
insufficiency determined by colour flow Doppler echocardiography (CFDE). The
equation is:
S/C Aov = 1.419 + (0.278 x Aol grade)
(R=0.445, R2=0.198, adjusted R2=0.194 and p<0.001).
Figure B.3.
Linear regression for peak aortic velocity (subcostal view) from all
Newfoundlands and CFDE estimated grade of aortic insufficiency
B.24.9. Mitral inflow parameters
Descriptive statistics for the various parameters of mitral flow for all Newfoundland
groups are displayed in Table B.19. Results are also shown for ANOVA or ANOVA
on ranks, with multiple pair-wise comparison procedures performed by the Tukey
test or Dunn's method respectively. Box and whisker plots are available in the
Supplement (available from the author). There was a significant difference in heart
rate identified between the groups during the mitral flow recordings, with SAS
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Mitral Ev was significantly higher in the SAS group than the dFS<18%, dFS 18-20%
groups and in Normal Newfoundlands. It was higher in the DCM group than these
groups also, although this was only statistically significant for the depressed
fractional shortening groups. Av was significantly higher in the SAS group than the
DCM group and both depressed fractional shortening groups and was significantly
higher in Normal Newfoundlands than Newfoundlands with dFS<18%. There was no
significant difference between groups for the E:A velocity ratio, although it was
higher in the DCM and LVE groups than the other groups.
Evti was not significantly different between Newfoundland groups. Although a
significant (p<0.01) ANOVA result was recorded for Avti, no significant pair-wise
differences were identified in the multiple comparison procedure. There was no
significant differences between groups for the Evti:Avti ratio. The total mitral vti
was simply calculated by adding Evti and Avti. The SAS group showed a
significantly higher total vti than the dFS<18% group, although the DCM group also
had a similarly low value to the dFS<18% group. When Ev or Av was normalised to
the total vti, no significant differences were evident between the groups for either
parameter. If the proportions of early left ventricular filling (Evti / total vti) or late
ventricular filling (Avti / total vti) were compared between groups, no significant
differences were identified.
Mitral E duration was significantly different between the groups, although no
significant pair-wise differences were identified. Flowever, after normalising this
time to heart rate by dividing by VR-R interval, differences between the groups were
no longer evident. E deceleration time was significantly different between groups,
although no significant pair-wise differences were identified. However, after
indexing E deceleration/VR-R interval, no significant differences were identified
between the Newfoundland groups. Mitral A duration, whether or not indexed to VR-
R, was not significantly different between Newfoundland groups.
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No significant differences were identified between Newfoundland groups for IVRT
or IVRT/VR-R.
The results for mitral regurgitation were recorded previously in Section B.24.4.1 and
B.24.4.2.
B.24.10. Pulmonary venous flow
Descriptive statistics for the various parameters of pulmonary venous flow for all
Newfoundland groups are displayed in Table B.20. Results are also shown for
ANOVA or ANOVA on ranks, with multiple pair-wise comparison procedures
performed by the Tukey test or Dunn's method respectively. Box and whisker plots
available in the Supplement (available from the author). During the recordings of
PVF, a statistically significant difference between heart rates of the Newfoundland
groups was identified (p<0.01), which was due to the DCM group having a
significantly faster rate than the LVE group.
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TableB.20.
MeansandSt ndarddevi tionsforN wfou dlagroups




PVFArv PVFSv PVFDv PVFR2v
024 038 037 016
0.11 0.06 0.05 05
0.21 0.41 0.43 0.18
0.06 0.13 0.12 0.08
0.19 0.38 0.38 0.15
0.05 0.08 0.06 0.03
0.22 0.36 0.37 0.14
0.07 0.06 0.06 0.03
0.20 0.36 0.40 0.16
0.02 0.08 0.13 0.02
0.26 0.41 0.41 0.18
C .09 C11 0.07 0.05
p<0.01 ns p<0.05 p<0.05










































































































































Arv was significantly higher in the SAS group than the dFS<18% group. There were
no significant differences between groups apparent when Sv was considered.
Significant differences between Newfoundland groups were apparent for Dv velocity
(p<0.05), although no significant pair-wise differences were identified. The DCM
group appeared to have a wider range of D wave velocities, with a trend to higher
velocity than the other groups. There were no statistically significant differences
between groups for the S:D velocity ratio. R2v was significantly greater in the SAS
group than the dFS 18-20% group, although a wide range of velocities with a
tendency to higher R2 wave velocities was visually evident in the DCM group.
Svti was significantly different for the Newfoundland groups, although no pair-wise
differences were identified. However, a trend to lower Svti in the DCM group was
identified, and the higher Svtis occurred in the LVE and SAS groups. There was no
significant differences between Newfoundland groups for Dvti or the S:D vti ratio.
The total forward pulmonary venous flow was determined by summing S vti and D
vti. Although there were no statistically significant differences evident between
groups, the DCM group had the lowest PVF total vti and Normal dogs showed the
highest mean value. The systolic fraction of total forward pulmonary venous flow
was calculated as Svti/total vti. Although there were no statistically significant
differences identified in the Newfoundland groups with respect to this parameter, a
trend to a lower value was identified in the DCM and dFS<18% groups and the
maximal mean value was in Normal Newfoundlands.
PVF wave durations were compared for Newfoundland groups, uncorrected and
corrected for heart rate (by dividing by the VR-R interval). S duration was
significantly longer in the LVE group than the DCM, dFS<18%, SAS and Normal
dogs. However, this difference was largely determined by the heart rate differences
between the groups, as no statistically significant difference between the groups was
identified after indexing to VR-R, although the LVE group still tended to show the
highest values. No significant differences between Newfoundland groups were
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identified for Ar, D or R2 durations, or the D deceleration time, whether or not these
parameters were indexed to VR-R.
There was no significant difference between Newfoundland groups for the difference
between mitral A duration and PVF Ar duration (data not shown). In almost all cases,
mitral A wave duration exceeded PVF Ar duration. There were two exceptions in
each of the five abnormal groups, with differences ranging from -0.003 to -0.02
seconds. As most differences were less than ten milliseconds (the temporal resolution
of a Doppler system), these differences are not significant.
Although a significant relationship had been demonstrated between the left atrial
emptying index (LAEI) and S:D vti ratio in Normal Newfoundlands, no significant
association between these two parameters was identified for any of the other
Newfoundland groups. The LAEI showed no significant relationship to any of the
PVF parameters for any of the other Newfoundland groups.
B.24.11. Pulmonary Artery Parameters
Descriptive statistics for pulmonary artery flow velocity for all Newfoundland groups
are displayed in Table B.21. Results are also shown for ANOVA or ANOVA on
ranks, with multiple pair-wise comparison procedures performed by the Tukey test or
Dunn's method respectively. Box and Whisker plots are available in the Supplement
(available from the author). The heart rate was significantly different between
Newfoundland groups during recording of pulmonary artery signals. From the RPS
view, the heart rate of the SAS group was significantly greater than the LVE group,
and from the LPS view, the SAS group had significantly faster heart rates than the
LVE and the dFS<18% groups.
The SAS group had significantly higher PAv than all other groups, including normal
Normal Newfoundlands. Normal Newfoundlands had higher PAv than the DCM or
dFS<18% groups, from both RPS and LPS windows.
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TableB.21.
MeansandSt ndarddevi tionsfoNewfou dlandgroup































































































B.24.11.1. Relationship between pulmonary artery and aortic flow velocities
Linear regression was used to attempt to identify a relationship between LPS PAv
and subcostal Aov from the SAS group. A weak but significant relationship (p<0.05)
was identified and given by the equation:
LPS PAv = 0.613 + (0.136 x S/C Aov)
(R = 0.386, R2 = 0.149, adjusted R2 = 0.126 and p = 0.015).
The general relationship between pulmonary artery velocity and aortic velocity was
investigated by combining the data from all Newfoundland groups, and linear
regression was used to identify any association between RPS or LPS PAv and CW
Aov obtained from the subcostal view. The linear regression graphs are shown in
Figures B.4.a and B.4.b. A moderate correlation which was highly significant was
identified for both relationships (p<0.001 in both cases).
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Linear regression for RPS pulmonary artery peak velocity
and SIC CW peak Aortic velocity
for all Newfoundlands from all groups Figure B.4.a.
Subcostal CW peak Aortic velocity (nVs)
Linear regression for LPS Pulmonary artery peak velocity
and subcostal CW peak Aortic velocity
for all Newfoundlands from all groups
Subcostal CW peak Aortic velocity (m/s)
Linear regression for RPS pulmonary artery
peak velocity and subcostal CW aortic velocity
for all Newfoundlands from all groups.
Equation:
RPS PAv = 0.309 + (0.267 x S/C Aov)
(R=0.576, R2 = 0.332, adjusted R2 = 0.328, p<0.001)
Figure B.4.b.
Linear regression for LPS pulmonary artery
peak velocity and subcostal CW aortic velocity
for all Newfoundlands from all groups.
Equation:
LPS PAv = 0.356 + (0.255 x S/C Aov)
(R=0.546, R2 = 0.298, adjusted R2 = 0.294, p<0.001)
Figures B.4.
Relationship between Pulmonary artery velocity and Aortic velocity for all
Newfoundlands using combined data from all groups.
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B.24.11.2. Pulmonic insufficiency
Pulmonic insufficiency was identified by CFDE in many Newfoundlands in all
groups. This was scored as previously described. Results are given in Table B.22.
Table B.22.




0 0.5 1 2 TOTAL
Normal 60 16 8 2 86
(69.8%) (18.7%) (9.3%) (2.3%)
DCM 25 4 6 0 35
(71.4%) (11.4%) (17.1%) (0%)
dFS<18% 21 1 7 0 29
(72.4%) (3.3%) (23.3%) (0%)
dFS18-20% 12 1 7 4 24
(50%) (4.2%) (29.2%) (16.7%)
LVE 5 0 3 0 8
(62.5%) (0%) (37.5%) (0%)
SAS 23 3 12 2 40
(57.5%) (7.5%) (30%) (5%)
X2 analysis showed that there was significantly more pulmonic insufficiency in the
dFS 18-20% group (p=0.001) and the SAS group (p=0.013) than the normal
Newfoundlands. No significant differences were identified between the DCM, LVE
and dFS<18% groups and Normal Newfoundlands.
B.24.12. Tricuspid valve parameters
Descriptive statistics for the parameters of tricuspid inflow for all Newfoundland
groups are displayed in Table B.21. Results are also shown for ANOVA or ANOVA
on ranks, with multiple pair-wise comparison procedures performed by the Tukey
test or Dunn's method respectively. There was a significant difference in heart rate
between the groups, with a trend to faster rate in the SAS group and the lowest heart
rate in the LVE group.
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Tricuspid Ev was significantly higher in the SAS group than most other
Newfoundland groups. Tricuspid Av was less in the DCM group than the Normal or
SAS groups. There was no statistically significant relationship identified between
Newfoundland groups with respect to the tricuspid E:A velocity ratio.
B.24.12.1 Tricuspid regurgitation
A number of Newfoundlands had tricuspid regurgitation identified by CFDE, which
was scored as previously described (Table B.23.).
Table B.23.




0 0.5 1 2 TOTAL
Normal 65 11 9 1 86
(75.6%) (12.8%) (10.5%) (1.2%)
DCM 23 2 9 2 35
(63.9%) (5.6%) (25%) (5.6%)
dFS<18% 22 2 4 1 29
(75.8%) (6.7%) (13.3%) (3.3%)
dFS18-20% 20 1 3 0 24
(83.3%) (4.2%) (12.5%) (0%)
LVE 8 0 0 0 8
(100%) (0%) (0%) (0%)
SAS 32 4 3 1 40
(80%) (10%) (7.5%) (2.5%)
X2 analysis showed that there was significantly more tricuspid regurgitation in the
DCM group than Normal Newfoundlands (p=0.039). No significant differences were
identified between any of the other groups and Normal Newfoundlands.
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B.25. Effect of independent variables HR, BSA, Wt, Age or Gender on




The 2D echocardiographic parameters for left ventricle and left atrium are detailed in
Table B.24. (Volume II) and graphs are illustrated in the Supplement (available from
the author). LVdv and LVsv were significantly associated with BSA or body weight.
Normalisation to BSA showed that the end-systolic volume index (ESVI) was
significantly larger in male Newfoundlands with DCM than females. Most left atrial
measurements were not related to any of the independent variables, although weak
but significant (p<0.05) relationship was shown between LAls and Weight or BSA.
The 2D Aod increased significantly with body weight or BSA.
B.25.1.2. M-mode parameters
The relationship between some of the independent variables and various M-mode
echocardiographic parameters for the DCM group are shown Table B.25. (Volume
II). Graphs are illustrated in the Supplement (available from the author). Both LVIDd
and LVEDs showed weak but significant relationships with BSA or weight. No
relationships were identified for IVSd or IVSs, although IVSs normalised to BSA
showed a significant trend to thinner walls in male Newfoundlands with DCM. No
relationships were identified for the LVpwd or LVpws although the LVpwd indexed
to BSA showed a significant trend to increasing wall thickness with advancing age.
M-mode LAs, once indexed to BSA, showed a significant increasing size with
advancing age. M-mode Aod was positively associated with BSA or weight. The M-
mode ratio of LAs:Aod was shown to be influenced most significantly by gender,
with a larger ratio in male Newfoundlands with DCM. Other variables were
eliminated in the forward stepwise or multiple linear regression models, although
simple linear regression equations showed weak but significant negative association
between LAsrAod and BSA or weight and a significant positive association between
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LAs:Aod and advancing age. MAMseptal was not significantly influenced by any
parameter, although age had been initially identified in the forward stepwise
regression. MAMlateral was positively influenced by body weight or BSA No
significant variable influenced MAMmean in the DCM group.
B.25.1.3. Doppler parameters ofaortic flow
The Doppler parameters of aortic flow were not greatly affected by independent
variables in the DCM group. The significant equations are shown in Table B.26.
(Volume ft) and linear regression graphs are shown in the Supplement (available
from the author). The aortic vti tended to decrease with advancing age. There was an
age related increase in the PEP:ET ratio before and after indexing to VR-R and Vcf
and VcfA/R-R tended to increase with age.
B.25.1.4. Doppler parameters ofmitralflow
The mitral inflow spectral Doppler parameters were also assessed. Results are shown
in Table B.27. (Volume II). Graphs are available in the Supplement (available from
the author). The mitral E:A velocity ratio was positively related to body weight. Ev
indexed to total mitral velocity time integral (Ev/total vti) also tended to increase in
heavier dogs. The trend to longer E deceleration time in female dogs only became
statistically significant after indexing to VR-R. A duration and Adur/VR-R was
negatively related to body weight.
B.25.1.5. Doppler parameters ofpulmonary venous flow
A number of the Doppler parameters of PVF were influenced by the independent
variables in the DCM group. Results are shown in Table B.28. (Volume II) and
illustrated in the Supplement (available from the author). D and R2 wave velocities
were negatively influenced by the R-R interval. S and D durations showed a positive
relationship to R-R interval, and D duration was negatively influenced by advancing
age in multiple linear and linear regression models. This influence of age was still
significant after indexing to VR-R interval. D deceleration time was positively
correlated with R-R interval, although this parameter was also significantly
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influenced by gender in multiple and simple linear regression models, which was
retained after indexing to VR-R; D deceleration time showed a trend to longer values
in the female Newfoundlands. The R2 wave duration increased with advancing age,
even after indexing to VR-R.
B.25.1.6. Doppler parameters ofright sidedfunction
The limited analysis of right sided function and the effect of independent variables on
these parameters are shown in Table B.29. (Volume II). RPS PAv was negatively
influenced by age, although no independent variable influenced PAv recorded from
the LPS view in the DCM group. Tricuspid Av tended to decrease in association with




The 2D echocardiography parameters of the left ventricle showed some significant
relationships with the independent variables in the dFS<18% group (Table B.30)
(Volume II). LVdv was influenced by both BSA or weight (positively) and age
(negatively) in multiple linear regression models. This effect of age was evident after
normalising to BSA to give the EDVI, with a decline in EDVI associated with
increasing age. LVsv was influenced by body weight or BSA. EF showed a
significant association with increasing R-R interval. SV, determined by the single
plane ellipse method, was influenced by BSA or weight as well as age (negatively)
and R-R interval in a multiple linear regression model. Once indexed to BSA, the
SVI shows a significant relationship with age (negative) and R-R interval (positive)
in a multiple linear regression model.
The 2D echocardiographic left atrial parameters which are influenced in independent
variables in the dFS<18% group are shown in Table B.30. (Volume II). LAad, LAas,
LAld, LAls, 2D LAd and ratio of LAd:Aod are all positively and significantly
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associated with BSA or weight. In addition, multiple linear regression models shows
the negative influence of age on LAad and the short axis 2D LAd.
B.25.2.2. M-modeparameters
The relationships between the M-mode parameters and various independent variables
are shown in Table B.31. (Volume II). LVIDd was significantly influenced by BSA
or weight and also negatively by age, in the multiple linear regression model.
However, after normalising for BSA, no other variable was significantly related to
LVIDd. The LVIDs was positively associated with BSA and weight. IVSd was not
associated with any variable, whether or not indexed to BSA. An apparently
significant trend to lower IVSs thickness in female Newfoundlands was no longer
evident after normalising for BSA. LVpwd and LVpws, without or with
normalisation to BSA, were not significantly predicted by any of the independent
variables tested. However the LVpwd/LVJDd was negatively influenced by weight or
BSA. FS% and Teicholz derived EF were both influenced by R-R interval, tending to
increase at slower heart rates. The ratio of mitral EPSS to LVIDd declined with
increasing R-R interval. M-mode LAs was influenced by BSA or weight. Although
the M-mode Aod appeared to be significantly greater in male Newfoundlands, once
this was normalised to BSA (Aod/BSA), this gender influence was no longer
significant. Mitral annulus motion was not influenced by any significant variables
when the septal or mean parameters were considered. MAMlateral, however was
significantly negatively influenced by age and positively influenced by weight or
BSA in simple linear regression and multiple linear regression models.
B.25.2.3. Dopplerparameters ofaorticflow
The Doppler parameters of aortic flow were not greatly influenced by the
independent variables assessed in the dFS<18% group. Results are presented in Table
B.32. (Volume II). ET was influenced by age, the R-R interval and gender in a
multiple linear regression model. Simple linear regression equations are also
recorded for each of these parameters. ET declined with advancing age, increased
with R-R interval and tended to be higher in bitches than male dogs. Once indexed to
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VR-R, multiple linear regression still showed similar significant relationships of
dFS<18% ET and age and gender, although significant p values were no longer
obtained if simple linear regression models were applied to these variables. There
was an apparently significant relationship between peak aortic velocity and the grade
of aortic regurgitation as described previously in Section B.24.8.
B.25.2.4. Doppler parameters ofmitralflow
Mitral inflow Doppler parameters were assessed for any significant predictive
influence on the variables body weight or body surface area, age, gender and R-R
interval for dogs in the dFS<18% group. Results are shown in Table B.33. (Volume
II). The mitral E:A velocity ratio was apparently greater in male Newfoundlands
although this result was not statistically significant. Evti was significantly higher in
male Newfoundlands and A wave velocity normalised to total mitral vti (Av/total
vti) was significantly greater in females. A duration was positively and significantly
related to R-R interval.
B.25.2.5. Doppler parameters ofpulmonary venous flow
Doppler parameters of PVF in the dFS<18% group were assessed for dependency on
any of the independent variables. Results are shown in Table B.34. (Volume II).
Increasing R-R interval was associated with a decrease in Arv and Sv. D deceleration
time increased with lengthening R-R interval, although the other wave durations were
not significantly influenced by R-R interval or any other independent variable.
However, R2duration/VR-R tended to decrease with advancing age.
B.25.2.6. Doppler parameters ofright sidedfunction
The limited analysis of right sided function and the effect of independent variables on
these parameters are shown in Table B.35. (Volume II). LPS PAv decreased with
advancing age, although the influence of age or any other independent variable was
not apparent on the RPS recorded pulmonary artery spectrum. Tricuspid Ev tended
to decline with advancing age, although age did not significantly influence the




The relationships between the independent variables and the two-dimensional
echocardiographic parameters of the left ventricle are shown in Table B.36. (Volume
II). LVdv was apparently significantly greater in male Newfoundlands, which was
still significant after normalisation to BSA (EDVI). LVsv was influenced by BSA or
weight. The total left ventricular stroke volume was influenced by R-R interval
which was still apparent after normalisation for BSA (SVI).
The relationships between the independent variables and the two-dimensional
echocardiographic parameters of the left atrium are shown in Table B.36. (Volume
II). LAad was significantly influenced by BSA or weight and R-R interval in a
multiple linear regression model. LAld was influenced by BSA or weight. LAls and
short-axis 2D LAd were significantly greater in male Newfoundlands, although these
were not normalised to BSA to check on a genuine gender influence. LAd also
increased with size. 2D Aod increased with BSA or weight and age in a multiple
linear regression model. The 2D ratio of LAd:Aod increased with longer R-R
intervals. The LAEI significantly decreased in dogs with larger BSA or weight.
B.25.3.2. M-modeparameters
The associations between independent variables and M-mode parameters are given in
Table B.37. (Volume II) for the dFS 18-20% group of Newfoundlands. RVd was
significantly associated with BSA or weight. LVIDd was also significantly predicted
by BSA and weight but also R-R interval in a multiple linear regression model,
which was evident even after normalisation for BSA. Similar relationships were
demonstrated for LVIDs, although the predictive influence of the R-R interval was
only apparent after normalisation for BSA. The interventricular septal thicknesses, in
diastole or systole, whether or not indexed to BSA, showed no association with any
independent variable. LVpwd and LVpws were apparently significantly thicker in
male Newfoundlands, although the influence of gender was rendered insignificant
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after normalisation to BSA. %thIVS increased in association with lengthening R-R
interval. The M-mode Aod increased with body size and advancing age, although the
influence of age was no longer apparent after indexing the parameter to BSA.
MAMseptal significantly decreased with increasing R-R interval. MAMlateral was
significantly influenced by body weight (positively) and negatively by age in a
multiple linear regression model. No significant variables predicted MAMmean.
B.25.3.3. Doppler parameters ofaortic flow
The Doppler parameters of aortic flow were under the influence of various
independent variables in the dFS 18-20% group (Table B.38. Volume II). Aov tended
to decrease with lengthening R-R interval. The dv/dtmean decreased with increasing R-
R interval. ET and PEP were influenced by both R-R interval and age in a multiple
linear regression models. Simple linear regression showed that ET significantly
increased in association with R-R interval and tended to decline with advancing age,
although this influence of age was no longer apparent after indexing to VR-R. PEP
was also significantly positively related to the R-R interval and it tended to increase
with advancing age. This influence of age on PEP was still evident after indexing to
VR-R. The PEP:ET ratio and PEP:ET/VR-R also increased with age in the dFS 18-
20% group. Vcf was negatively significantly related to the R-R interval and Vcf
increased with advancing age. Even after indexing to VR-R, this relationship between
Vcf and age was retained, although gender also appeared to significantly influence
Vcf (tending to be higher in female dogs) in a multiple linear regression model
although Vcf/VR-R interval versus age or sex-code in simple linear regression
models failed to result in significant p values.
B.25.3.4. Doppler parameters ofmitralflow
Mitral inflow Doppler parameters for the influence of independent variables in the
dFS 18-20% group. Results are shown in Table B.39. (Volume II). The mitral E:A
velocity ratio was significantly influenced by weight and age in a multiple linear
regression model. Simple linear regression for dFS 18-20% Ev:Av and weight
showed an positive relationship. The trend to decreasing ratio in association with
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advancing age did not achieve statistical significance in a simple linear regression
model. Normalised A wave velocity (=Av/total vti) showed that both R-R interval
and body weight significantly predicted this parameter in a multiple linear regression
model. Simple linear regression showed that this parameter decreased with
lengthening R-R interval, although simple linear regression for this Av/total vti and
weight did not result in a statistically significant relationship, despite the trend to
lower results with increasing weight.
The proportion of LV early filling (=Evti/total vti) showed both R-R interval and
weight were significantly predictive in a multiple linear regression model. Increasing
R-R interval resulted in increased Evti/total vti. The trend to increased proportion of
early filling with heavier dogs was not statistically significant in a simple linear
regression model. Contrasting influence of R-R interval on the proportion of late LV
filling (=Avti/total vti) was apparent, with weight also negatively influencing this
ratio in a multiple linear regression model.
E duration and A duration were both significantly influenced by the R-R interval, and
no other independent variables were identified after indexing these parameters to VR-
R. No independent variable predicted mitral E deceleration.
B.25.3.5. Doppler parameters ofpulmonary venous flow
The effect of the independent variables on parameters of PVF are shown in Table
B.40. (Volume II) for the dFS 18-20% group. Arv and Sv decreased with lengthening
R-R interval. D duration and D deceleration time increased with longer R-R
intervals. In a multiple linear regression model, both body weight and gender
significantly influenced R2 duration indexed to R-R interval, although these
relationships had not been apparent for R2 wave duration prior to this. The equation
showed that R2 dur/VR-R tended to increase in heavier dogs, and was greater in
females than males. Simple linear regressions ofR2dur/VR-R and weight or sex-code
alone did not result in statistically significant p values. The S:D velocity ratio was
negatively influenced by lengthening R-R intervals.
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B.25.3.6. Doppler parameters ofright sidedfunction
The limited analysis of right sided function and the effect of independent variables on
these parameters are shown in Table B.41. (Volume II). RPS PAv was negatively
associated with age. No independent variable significantly influenced any of the
parameters of tricuspid inflow.
B.25.4. LVE group
B.25.4.1. 2D parameters
The two-dimensional echocardiographic parameters of the LV which were influenced
by independent variables are shown in Table B.42. (Volume II). No independent
variable was significantly predictive of the LV diastolic volume or the EDVI. The LV
systolic volume and ESVI were positively influenced by the R-R interval. The
ejection fraction calculated from the single plane ellipse method was negatively
associated with age.
The two-dimensional echocardiographic parameters of the LA which are influenced
by various independent variables are detailed in Table B.42. (Volume II). No
independent variable was predictive of any of the four chamber view left atrial
parameters in diastole or systole. The 2D short axis view of the diastolic left atrium
(LAd) and the 2D ratio LAd:Aod showed significant negative associations with age.
B.25.4.2. M-modeparameters
The M-mode echocardiographic parameters which were influenced by various
independent variables are shown in Table B.43. (Volume II). LVIDd was influenced
both by BSA or weight and also gender, although it should be noted that male and
female Newfoundlands included in this group were selected by gender specific
criteria. Once normalised to BSA, there was no longer any gender influence apparent
on the LVIDd/BSA parameter. LVIDs was also positively influenced by BSA or
weight. IVSd indexed to BSA showed a negative influence of R-R interval. The
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LVpwd indexed to BSA showed higher values in female than male Newfoundlands.
The LVpws indexed to BSA declined in association with advancing age and
%thLVpw also paralleled this age association. M-mode Aod declined with
increasing BSA or weight. MAMseptal was positively influenced by both R-R
interval and body weight or BSA in multiple linear regression models. However, the
relationships of MAMseptal and either of these independent variables were not
statistically significant in simple linear regression models. No independent variables
were identified which significantly predicted MAMlateral or MAMmean.
B.25.4.3. Doppler parameters ofaortic flow
The Doppler parameters of aortic flow were also assessed for dependency on
independent variables in the LVE group. Results are shown in Table B.44. (Volume
II). Aortic flow peak acceleration (dv/dtmax) was significantly predicted by both age
(tending to decline with advancing age) and gender (higher in male dogs) in a
multiple linear regression model, although simple linear regression of LVE dv/dtmax
versus age or gender alone did not result in significant p values. The aortic flow
acceleration time was also positively influenced by age, although this relationship
was no longer significant after indexing to VR-R. PEP also apparently was
significantly influenced by age, tending to increase in older dogs, although this
relationship was also no longer significant after indexing to VR-R interval. The
PEP:ET ratio appeared to increase in association with advancing age, although age
was not a significant predictor once with parameter was normalised for heart rate by
dividing by VR-R interval.
B.25.4.4. Doppler parameters ofmitralflow
The Doppler parameters of mitral inflow which were influenced by some of the
independent variables are shown in Table B.45. (Volume II). The mitral E:A velocity
ratio was positively influenced by both body weight and R-R interval in a multiple
linear regression model, although neither parameter on its own resulted in a
statistically significant simple linear regression. No other mitral inflow parameters
were significantly predicted by any other independent variable.
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B.25.4.5. Doppler parameters ofpulmonary venous flow
PVF Doppler parameters were also assessed for the predictive influences of the
independent variables. Results are shown in Table B.46. (Volume II). Dv
significantly increased in heavier dogs. D deceleration time tended to increase with
advancing age, a relationship which became even more significant after indexing to
VR-R interval. The S:D velocity ratio decreased with lengthening R-R interval.
B.25.4.6. Doppler parameters ofright sidedfunction
The limited analysis of right sided function and the effect of independent variables on
these parameters were assessed (Table B.47. Volume II). No independent variable




The two-dimensional echocardiographic LV parameters which were influenced by
independent variables are shown in Table B.48. (Volume II). LVdv was positively
related to BSA or weight. LVsv was shown to be positively influenced by BSA or
weight, but a multiple linear regression model also showed that the R-R interval was
a positive predictor and age was a negative predictor of LVsv. The ESVI retained
this association with age and R-R interval in a multiple linear regression model.
The two-dimensional echocardiographic left atrial parameters which were influenced
by independent variables are shown in Table B.48. (Volume 13). LAad was positively
influenced by BSA or weight and R-R interval in a multiple linear regression model.
LAld was also influenced by R-R interval. LAas and LAls were both influenced
solely by BSA or weight.
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B.25.5.2. M-mocleparameters
M-mode echocardiographic parameters which were influenced by independent
variables in Newfoundlands in the SAS group are shown in Table B.49. (Volume II).
RVd was negatively associated with the R-R interval. LVIDd was positively
influenced by the R-R interval although this association was no longer significant
after indexing to BSA. LVIDs was associated with BSA or weight. The
interventricular septum and left ventricular posterior wall measurements in systole or
diastole or indexed to BSA showed no evidence that they could be predicted by the
independent variables. The LVpwd:LVIDd ratio showed a significant trend to
increasing with age. FS and EF (Teicholz method) both declined with increasing
body weight. M-mode Aod indexed to BSA was greater in female Newfoundlands.
MAMseptal was significantly positively influenced by R-R interval. No significant
independent variables were identified to influence MAMlateral. MAMmean was
negatively influenced by age in a multiple linear regression model, and positively
influenced by R-R interval.
B.25.5.3. Doppler parameters ofaortic flow
The Doppler parameters of aortic flow were assessed for the predictive influence of
various independent variables on the results in dogs with aortic velocity exceeding
1.7 m/s (the SAS group). Results are shown in Table B.50. (Volume II). No
independent variable influenced aortic velocity, velocity time integral or peak or
mean flow accelerations. The acceleration time was apparently longer in male dogs,
although this relationship was no longer significant after indexing to VR-R interval.
PEP and ET increased in association with the R-R interval, although after indexing to
a/R-R, no other independent variable influenced these parameters. Vcf/VR-R was
negatively related to advancing age, although the influence of age was not
statistically significant for uncorrected Vcf.
A weak positive but significant relationship was identified by linear regression
between the grade of aortic insufficiency and the peak aortic velocity, as recorded in
Section B.24.8.
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B.25.5.4. Doppler parameters ofmitralflow
The Doppler parameters of mitral inflow were assessed for the significant influence
of any of the independent variables such as body weight or BSA, age, gender or R-R
interval on the parameters. The results are shown in Table B.51. (Volume II). Mitral
Av and Av/total vti tended to decline in association with lengthening R-R interval,
and the E:A velocity ratio was positively related to the R-R interval. Evti and the E:A
vti ratio were also positively predicted by R-R interval. In a multiple linear regression
model as well as simple linear regression, weight was identified as another positive
predictor of mitral E:A vti ratio. Body weight was significantly positively associated
with the proportion of early LV filling (=Evti/total vti) and negatively associated with
the proportion of late LV filling (=Avti/total vti). Age was a negative predictor of
E:A velocity ratio in the multiple linear regression model with R-R interval, although
this was not a statistically significant relationship in a simple linear regression model.
However, an age related decline of mitral E wave velocity normalised to total vti
(Ev/total vti). Significant trends to increasing E duration and deceleration time were
evident with advancing age, although these relationships were no longer significant
after indexing to VR-R interval. A duration was positively related to R-R interval
and also age. The predictive influence of age was still apparent after indexing A
duration to VR-R interval.
B.25.5.5. Doppler parameters ofpulmonary venous flow
The Doppler parameters of PVF were also assessed for the predictive influence of the
independent variables in the SAS group. Results are shown in Table B.52. (Volume
II). Ar duration decreased with lengthening R-R interval. Dv and Dvti were
significantly negatively influenced by body weight. Dvti was also influenced by
gender in a multiple linear regression model (higher values in male dogs), although
this relationship was not statistically significant in a simple linear regression model.
S duration and Sdur/VR-R were significantly positively associated with body weight.
D duration and D deceleration time were positively correlated with R-R interval.
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B.25.5.6. Doppler parameters ofright sidedfunction
The limited analysis of right sided function and the effect of independent variables on
these parameters in the SAS group are shown in Table B.53. (Volume II). LPS PAv
was negatively associated with age. A significant relationship was identified between
peak pulmonic velocity and peak aortic velocity in the SAS group, which was
described previously (Section B.24.11.1.).
Tricuspid Av decreased with lengthening R-R interval and the tricuspid E:A velocity
ratio was significantly influenced by both R-R interval and age in a multiple linear
regression model. The positive relationship between E:A ratio and R-R interval was
still significant in a simple linear regression model, although the trend to negative
predictive influence of advancing age on this ratio did not achieve statistical
significance in a simple linear regression model.
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B.26. Serial scans in the Newfoundland population
Details from the Newfoundland individuals concluded to be Normal after two or
more scans at the time of the second or final scan are shown in Tables B.54.a. -
B.54.h. (Volume II). Dogs with DCM are detailed in Tables B.55.a. - B.55.h.
(Volume ft). Dogs with depressed fractional shortening, both dFS<18% and dFS18-
20%, and the single individual in the LVE category, are shown in Tables B.56.a. -
B.56.h. (Volume II). Individuals with a final diagnosis with an aortic velocity
exceeding 1.7 m/s are detailed in Tables B.57.a. - B.57.h. (Volume II).
The general details regarding each individual and each scan are given in Tables
B.54.a. - B.57.a. Two-dimensional echocardiographic left ventricular parameters are
shown in Tables B.54.b. - B.57.b., left atrial parameters in Tables B.54.C. - B.57.C.
and M-mode echocardiographic parameters in Tables B.54.d. - B.57.d. Doppler
parameters of aortic flow are displayed in Tables B.54.e. - B.57.e., mitral flow in
Tables B.54.fi - B.57.fi, pulmonary venous flow in Tables B.54.g. - B.57.g. and right
sided Doppler parameters in Tables B.54.h. - B.57.h. Means and standard deviations
(sd) are recorded.
These tables include the results of the percentage difference between the means
(%diffMeans) and the standard deviation expressed as a percentage of the mean
(sd%Mean) for each echocardiographic parameter. Where %diffMeans was greater
than sd%Mean, this was indicated by displaying the %diffMean value in bold type.
If the %diffMeans was a negative value, this indicates that the later scan has a larger
value than the initial scan, and where this value is positive, the later scan is smaller.
When comparing %diffMeans with sd%Mean, the positivity or negativity was
ignored. The final set of results displayed in these tables was the significance level of
the Student t test result after this test had been applied to the raw data sets from the
initial and second (or final) scans for each echocardiographic parameter.
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B.26.1. The Normal Category
There were eleven dogs in this category.
B.26.1.1. 2D LVparameters
Results are shown in Table B.54.b. LVdv %diffMeans ranged from 1.01 to 58.08%.
From the repeatability study, the coefficient of variation (c.o.v.) for the pooled data
was 17.8% (data not shown; available in the Supplement, obtainable from the
author). Three out of the eleven dogs had %diffMeans which exceeded this figure.
LVsv %diffMeans ranged from -1.34% to 28.73%. The c.o.v. identified in the
repeatability study was 24.14%. Only two values exceeded this. EF %diffMeans
ranged from 0.42 - 52.08%, compared with c.o.v. of 16.79%. Three individuals
exceeded this value. The SV %diffMeans ranged from -1.95% to -155.33%. Three
individuals exceeded the c.o.v. of 24.83% for SV.
B.26.1.2. 2D LA parameters
Results are shown in Table B.54.C. LAad %diffMeans ranged from 4.21% to -
30.22%, with four individuals with values exceeding the c.o.v. of 15.96%. LAas
%diffMeans ranged from -1.70% to -35.10%, with six dogs with values >15.66%
(c.o.v.). LAld %diffMeans ranged from 2.78 to -24.23%, with one dog >c.o.v. of
13.47%. LAls %diffMeans ranged from -1.94 to -19.08%, with three dogs >c.o.v. of
8.16%. From the short axis view, LAd %diffMeans ranged from -0.23 to -22.06%,
with six dogs >c.o.v. value of 10.20%. Aod %diffMeans ranged from -0.27 to -
24.67%, with differences in two dogs greater than c.o.v. of 10.71%.
B.26.1.3. M-mode parameters
Results are shown in Table B.54.d. (a) and B.54.d. (b). RVd %diffMeans ranged
from 11.39 to -168.76%, with six dogs >c.o.v. of 27.37%. The %diffMeans for IVSd
and IVSs ranged from 1.08 to -19.59% and 1.82 to -35.35% respectively, with three
dogs >c.o.v. of 17.71% (IVSd) and two dogs >c.o.v. of 15.96% (IVSs). The
%diffMeans for LVpwd and LVpws ranged from 0% to -23.49% and 0.77% to -
24.36%, with six dogs >c.o.v. of 14.63 (LVpwd) and five dogs >c.o.v. of 12.77
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(LVpws); the same five dogs in the LVpws were also in the LVpwd group. LVIDd
%diffMeans ranged from 0.45% to 15.31%, with five dogs greater than c.o.v. of
7.74%. The %diffMeans for LVIDs ranged from -1.66 to 18.98%, with four dogs
exceeding the c.o.v. of 10.43%. FS% %diffMeans ranged from 0.75% to -45.99%,
with five dogs greater than c.o.v. of 17.57%. Mitral EPSS %diffMeans ranged from
6.83% to -92.49%, with five dogs with values >c.o.v. of 26.23%. M-mode Aod and
LAs ranged from -0.95% to -10.88% (one dog with differences >c.o.v. of 10.79%)
and 1.64% to 24.04% (three dogs with values >c.o.v. of 13.42%) respectively.
MAM septal and MAM lateral %diffMeans ranged from 1.3% to -49.73% and 4.57%
to -34.68% respectively, with four dogs and five dogs exceeding the coefficients of
variation of 21.57% (MAMseptal) and 18.79% (MAMlateral) respectively.
B.26.1.4. Doppler parameters ofaortic flow
Results are shown in Table B.54.e. The %diffMeans for Aov ranged from 6.25% to
27.87%, with one dog with differences greater than the c.o.v. of 19.39%, although in
a number of individuals, subcostal measurements were not obtained in both scans.
Aov (L.Ap.view) showed a range in %diffMeans of 3.82% to 27.62%, with three
dogs >c.o.v. of 20.86%. Other comparisons were generated from the subcostal view
of aortic flow. The %diffMeans for aortic vti ranged from 3.45% to 35.26% with the
same dog with a difference >c.o.v. of 21.05%. When dv/dtmax and dv/dtmean were
considered, differences ranged from 3.98% to 46.11% and 13.25% to 34.68%
respectively, with the same single dog with differences exceeding the c.o.v. values of
24.69% (dv/dtmax) and 26.08% (dv/dtmean)- The systolic time interval (STI) data were
obtained from the subcostal data, where available, but included left apical aortic flow
data also. The respective %diffMeans for PEP (uncorrected) and ET ranged from
3.74% to -14.95% (with four dogs with differences > PEP (uncorrected) c.o.v. of
7.84%) and -2.89% and 14.36% (with three dogs > ET c.o.v. of 6.70%). The
%diffMeans for the corrected PEP:ET ratio ranged from 2.30% to -43.77%, with
four dogs with values greater than the reported c.o.v. of 10.63% (although this was
generated from uncorrected data). Vcf %diffMeans ranged from 2.09% to 29.18%,
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although had not been assessed in the repeatability study. The acceleration time
%diffMeans ranged from 8.02% to -16.94%, with no dogs exceeding the c.o.v. value
of 20.00%.
B.26.1.5. Doppler parameters ofmitral flow
Results are shown in Table B.54.f. In the Normal Newfoundland group, the
%diffMeans for mitral E and A wave velocities ranged from -0.13% to 33.98% and -
1.76% to -24.29% respectively. The differences exceeded the c.o.v. for Ev (22.22%)
and Av (22.92%) in two cases. Evti and Avti %diffMeans ranged from 2.22% to
32.17% (two dogs exceeding c.o.v. of 16.67%) and -1.85% to -69.23% (with three
dogs exceeding c.o.v. of 40.91%), respectively. The %diffMeans for E duration, E
deceleration time and A duration ranged from -1.33% to -27.01%, -4.91% to 36.95%
and -0.51% to -22.75% respectively. E duration c.o.v. of 13.48% was exceeded in
five dogs, E deceleration time (24.27%) in two cases and A duration c.o.v. (16.48%)
was exceeded in four cases. IVRT %diffMeans ranged from 0.29% to 18.92% and no
dogs exceeded the c.o.v. value of 25.45%.
B.26.1.6. Doppler parameters ofpulmonary venous flow
Results are shown in Table B.54.g. The %diffMeans S and D velocities ranged from -
1.17% to 36.59% and -2.46% to 25.11% respectively. The c.o.v. values were 16.22%
and 17.65% respectively, and these were exceeded in two cases for each parameter
(only one dog being the same). PVF Ar velocity %diffMeans ranged from 2.01% to -
66.15%, with two dogs with differences >c.o.v. value of 46.43%. R2 velocity
differences ranged from 0.69% to -108.75%, with the c.o.v. value of 33.33%
exceeded in five cases. Svti and Dvti %diffMeans ranged from -2.50% and 40.43%
(>c.o.v. value of 21.67% in four dogs) and -4.26% to -48.65% (>c.o.v. of 21.78% in
four dogs) respectively. Ar duration %diffMeans ranged from -4.21% to 38.13% with
three dogs >c.o.v. value of 19.18%. S duration %diffMeans ranged from 2.46% to
16.01% with two dogs >c.o.v. value of 12.99%. D duration and D deceleration time
ranged from 0.12% to -24.04% and 3.53% to 26.03%, respectively with three dogs
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>c.o.v. of 17.92% (D duration) and no dogs exceeding c.o.v. of 26.16% (D
deceleration time).
B.26.1.7. Right sided Doppler parameters
Results are shown in Table B.54.h. The RPS PAv %diffMeans ranged between
1.76% and 48.40%, five dogs with differences >c.o.v. for RPS PAv of 13.33%. LPS
PAv %diffMeans ranged from 1.24% to -46.08%, with four cases >c.o.v. value of
17.48%. Tricuspid E and A wave velocities %diffMeans ranged from 4.62% to
23.95% (one dog >c.o.v. of 22.95%) and -5.21% to 37.91% (one dog >c.o.v. of
35.29%), respectively.
B.26.2. The Dilated Cardiomyopathy (DCM) category
Twelve dogs had a final diagnosis of DCM during serial evaluation. Results are
shown in Tables B.55.a. - B.55.h. The general details, including the category under
which each scan was collated and the time interval between scans, was recorded in
Table B.55.a. The status and any comments about the individuals were also
recorded. One dog (NF002/P500) was symptomatic in atrial fibrillation at the time of
the initial scan, while untreated. Initially, she was prescribed an ACE inhibitor, but,
with continued deterioration, she required standard medication with enalapril,
frusemide and digoxin, and subsequently improved. Dogs NF003/P505 and
NF042/P42 remained with occult disease, and both received an ACE inhibitor.
NE008/P534 suddenly developed severe congestive heart failure. He received an
ACE inhibitor after the time of his second scan, when the owner reported
breathlessness, but with continued absence of symptoms, the owner stopped
treatment and signs developed six weeks later. NF056/P262 did not receive any
medication prior to clinical signs developing at the time of the second scan. One dog
with LVE progressed to DCM, but was euthanased due to pulmonary neoplasia
(NF007/P215). There were four dogs initially included in one of the dFS categories
who progressed to DCM (NF031/P536, NF033/P531, NF010/P51 & NF070/P274).
Two dogs had initially been classified as "normal" (NF036/P40 & NF029/P723), but
later developed evidence of occult DCM.
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B.26.2.1. 2D Parameters
If an arbitrary significant difference was designated as >20% between scans, the
following 2D LV parameter results were obtained from the DCM group (Table
B.55.b.). LVdv significantly increased in four dogs. LVsv significantly increased in
two dogs, and decreased in the one dog (NF002/P500) who showed a response to
treatment. EF significantly decreased in one dog and increased in five dogs. Left
atrial parameters are shown in Table B.55.C. LAad significantly increased in three
dogs and decreased in one dog. LAas significantly increased in three dogs. LAld
significantly increased in two dogs and decreased in one dog. LAls increased in two
dogs. 2D LAd significantly increased in four dogs. No significant differences were
identified for Aod.
B.26.2.2. M-modeparameters
From the M-mode results from the DCM group (Tables B.55.d.(a) & B.55.d.(b)),
significant differences were recorded for the RVd, with decreases in RVd of>20% in
five dogs and increases in RVd of>20% in two dogs. IVSd significantly increased in
three dogs and IVSs significantly increased in one dog. LVpwd significantly
increased in three dogs and LVpws significantly increased in one dog. LVIDd and
LVIDs both significantly increased in two dogs. FS% decreased by >20% in two
dogs and increased by >20% in four dogs. Mitral EPSS increased by >20% in four
dogs and decreased by >20% in two dogs. M-mode LAs significantly decreased in
three dogs and increased in one dog. No significant differences were identified for
the Aod. MAMseptal was significantly increased by >20% in three dogs.
MAMlateral was significantly increased in one dog and decreased in two dogs.
B.26.2.3. Dopplerparameters
Doppler parameters of aortic flow are shown in Table B.55.e. The peak Aov
(subcostal view) was increased by >20% in two dogs and not significantly decreased
in any, although there was a trend to decreasing velocities. One dog showed a
significant increase in aortic vti, and two dogs showed a significant decrease in vti.
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The dv/dtmax was significantly decreased in one dog, and significantly increased in
one dog. The dv/dtmean was significantly decreased by >20% in four dogs and
increased in one. The acceleration time was significantly longer in one dog. The
corrected PEP was significantly (>20%) longer in four dogs but was shorter in one
dog (NF042/P542). ET was significantly shorter in one dog (NF008/P534). The
corrected PEP:ET ratio was significantly greater in five dogs and reduced in one dog
(NF042/P542). Vcf was significantly decreased in three dogs and increased in three
dogs (but was, however, less than 1.00 circs/s in all three and therefore was
abnormal).
Doppler parameters of mitral inflow for the DCM group are shown in Table B.55.fi
Mitral Ev was different (>20%) in two dogs (increased) and two dogs (decreased)
and Av was increased in two dogs and decreased in one dog. Evti was significantly
increased in two dogs and decreased in one dog. Avti was significantly increased in
two dogs and decreased in seven dogs. E duration was significantly shorter in one
dog and was longer in one dog. E deceleration time was significantly shorter in three
dogs and longer in one dog. No differences exceeding 20% were identified for mitral
A wave duration. IVRT was greater by >20% in two dogs and was significantly
shorter in three dogs.
The PVF parameters for the DCM group are shown in Figure B.55.g. Arv was
increased (>20%) in three dogs and decreased in one dog. Sv was significantly
increased in one dog and decreased in four dogs. Dv was increased >20% in four
dogs and decreased in one dog. R2v was significantly increased in two dogs and
decreased in two dogs. Svti increase (>20%) was identified in one dog, but a
significant decrease was recorded in four dogs. Dvti was increased in two dogs and
decreased in one dog. Ar duration was significantly longer in four dogs. S duration
was significantly shorter at the second scan in one dog. D duration was significantly
longer in two dogs and shorter in two dogs. D deceleration time was significantly
longer in two dogs and shorter in three dogs.
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Doppler parameters for the right heart are shown in Table B.55.h. for the DCM
group. RPS PAv was significantly lower (>20%) in three dogs. LPS PAv was
significantly higher in one dog. Tricuspid Ev was significantly greater in three dogs
and lower in four dogs. Tricuspid Av was significantly greater (>20%) in two dogs
and lower in five dogs.
B.26.3. The depressed fractional shortening (dFS) category
There were nineteen dogs in the dFS category. General details, including
classification of each serial scan, are recorded in Table B.56.a. Six dogs moved from
Normal to dFS 18-20%. One dog moved from dFS 18-20% to "■normal", although the
presence of VPCs suggested otherwise, which warranted inclusion of this individual
in the "equivocal" category (NF107/P289). Three dogs changed from "normal" to
dFS<18%. Nine dogs remained in one or other of the dFS categories (either
dFS<l 8% or dFS 18-20%) for both scans.
B.26.3.1. 2D parameters
The 2D LV parameters are shown in Table B.56.b. and the LA parameters in Table
B.56.C. In the dFS group, the LVdv was increased by >20% in three dogs and
decreased by >20% in two dogs. LVsv was significantly increased in one dog and
was decreased in two dogs. EF was significantly (>20%) increased in four dogs and
decreased in three dogs. LAad was significantly increased in two dogs and decreased
in two dogs. LAas was significantly increased in one dog and decreased in two dogs.
LAld did not significantly change in any dog. LAls was significantly increased in two
dogs. 2D LAd was significantly greater in two dogs. No significant changes in Aod
were identified.
B.26.3.2. M-mode parameters
M-mode parameters are shown for the dFS category in Tables B.56.d.(a) and
B.56.d.(b). The M-mode criteria for the dFS group showed a number of significant
differences for RVd, with seven dogs with values >20% above baseline and six dogs
with values of 20% less than baseline. There was one individual with a difference
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smaller than 20% for the IVSd measurement, and no differences in either direction
for IVSs of >20%. LVpwd was not significantly different between scans for any
individual in the dFS category, although two individuals showed significantly greater
LVpws from the initial scan. LVIDd was only significantly different in one individual
(NF037/P48), when it was dramatically smaller (54.58 mm to 41.68 mm). LVIDs
was significantly increased in one individual (NF049/P287). FS% was decreased
(>20%) in eight individuals and increased in three dogs. Mitral EPSS was
significantly increased in five dogs but decreased in four dogs. M-mode LAs was
increased by >20% in one dog and decreased in one dog. Aod increased by >20% in
three dogs. MAMseptal was significantly greater in three dogs and was significantly
reduced in two dogs. MAMlateral showed differences >20% in one dog (decrease).
B.26.3.3. Doppler parameters
Doppler parameters of aortic flow are shown in Table B.56.e. Subcostal Aov was
significantly decreased between scans in one individual. Aortic vti was significantly
decreased in two dogs. The dv/dtmax was significantly (>20%) increased in three dogs
and decreased in two dogs, whereas dv/dtmean was significantly decreased in three
dogs (two of whom were the same individuals as the significant dv/dtmax decreases).
Acceleration time was significantly longer in one dog and was shorter in three dogs.
The corrected PEP was significantly longer in three dogs. There were no significant
differences in ET between scans for any individual. The corrected PEP:ET ratio was
significantly longer in five dogs, with a trend to this ratio increasing in most dogs in
this category. Vcf was significantly greater in four individuals and significantly
reduced by >20% in seven dogs.
Doppler parameters of mitral inflow are recorded in Table B.56.f. Mitral Ev was
significantly (>20%) increased in two dogs and decreased in three dogs. Av
%diffMeans exceeded 20% in four dogs (increased) and three dogs (decreased). Evti
was significantly greater in three dogs and less in five dogs. Avti was significantly
greater on repeat scan in eight dogs and was smaller in five dogs. E duration was
significantly (>20%) increased between scans in three dogs and decreased in two
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dogs. E deceleration time was significantly different in three dogs (increased; the
same dogs as E duration increases) and three dogs (decreased). A duration was
significantly increased in four dogs and decreased in one dog. IVRT was significantly
longer in one dog and was significantly shorter in three dogs.
Doppler parameters of PVF for the dFS group are detailed in Table B.56.g. Arv was
significantly increased by >20% in four dogs and was decreased in one dog. Sv was
significantly increased in three dogs and decreased in two dogs. Dv was significantly
increased in two dogs, and decreased in one dog. R2v was increased (>20%) in four
dogs and decreased (>20%) in five dogs. Svti was significantly greater in three dogs
and less in four dogs. Dvti was greater in one dog and less in six dogs. Ar duration
increased in three dogs and decreased in two dogs. S duration was significantly
longer in one dog and shorter in two dogs. D duration and deceleration time was
significantly longer in one dog; D duration was significantly shorter in three dogs and
D deceleration time significantly decreased in five dogs.
Doppler parameters of right sided results are detailed in Table B.56.h. RPS PAv was
decreased (>20%) in four dogs. LPS PAv was significantly different in two dogs
(greater) and seven dogs (decreased). Tricuspid Ev was significantly increased
between scans in three individuals and decreased in three. Tricuspid Av was
significantly increased (>20%) in eight dogs and decreased in two dogs.
B.26.4. Left ventricular enlargement (LVE) category
Only one individual had a repeat scan which remained in this category on both
occasions (NF021/P552). Results are shown in Table B.56.a. - B.56.h. There was no
significant difference for any of the 2D LV parameters for this individual, despite a
10.61% increase in LV systolic volume. A significant increase in LAad was
identified by the second scan. No significant differences for most of the M-mode
criteria were reported between scans. However, FS% significantly decreased from
31.67 to 23.89% and mitral EPSS was significantly increased in the second scan.
There was an apparent decrease (>20%) M-mode LAs. MAM septal was decreased
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by more than 20% in the second scan. When the Doppler parameters of aortic flow
where compared, dv/dtmax and dv/dtmean significantly decreased and the acceleration
time of aortic flow increased. Vcf decreased. Changes were consistent with
deteriorating systolic function. Mitral inflow showed a significantly greater Avti and
significantly shorter IVRT on repeat scan. PVF Ar, S, and R2 wave velocities were
significantly decreased, as were the Svti and Dvti. S duration was also significantly
reduced (without a major difference in heart rate between the two scans). Tricuspid
Ev and Av were significantly lower than the initial scan.
B.26.5. Category with subcostal aortic velocity >1.7 m/s (SAS category)
Eleven dogs with an aortic velocity exceeding 1.7 m/s on at least one occasion had a
minimum of one repeat scan, and NF005/P515 had two repeat scans. General
information is displayed in Table B.57.a. Only three of these dogs remained in the
Aov >1.7m/s group for both scans (NF055/P258, NF068/P304 & NF023/P248).
NF005/P515 had the two initial scans in this category, but not the final scan. Five
dogs changed between the normal and Aov>1.7m/s categories, and one dog was
initially in the dFS 18-20% category before the elevated aortic velocity was identified
(NF091/P47).
B.26.5.1. 2D parameters
In the SAS group, the 2D LV parameters are displayed in Table B.57.b. Significant
differences, exceeding 20%, were identified in of LVdv in three dogs (increased) and
one dog (decrease). LVsv was significantly increased on repeat scan in two dogs, and
decreased in three dogs. EF was significantly greater in five dogs on repeat scan.
Left atrial 2D parameters are displayed in Figure B.57.C. One dog had a significantly
increased LAad on the second scan. One dog showed a significant decrease in LAld.
LAas was significantly increased in three dogs LAls was significantly increased in
two dogs. 2D LAd was significantly increased compared with initial scan in two
dogs, but there were no significant differences recorded for Aod.
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B.26.5.2. M-mode parameters
The M-mode parameters for the SAS group are recorded in Table B.57.d.(a) and
B.57.d.(b). Differences exceeding 20% were identified for the RVd, with five dogs
showing a significant increase and one dog showing a decrease. One dog showed a
significant increase in IVSd, and another individual showed a significant increase in
IVSs, with IVSs significantly decreased in one dog. LVpwd and LVpws showed no
significant differences. LVIDd and LVIDs were also not significantly different
between scans. FS% significantly increased in two individuals (NF005/P515 &
NF058/P256). Mitral EPSS was significant increased in three dogs and decreased in
two dogs. M-mode LAs was significantly decreased in one dog, with no significant
differences for Aod. Septal MAM was significantly (>20%) increased in two dogs
and decreased in two dogs. Lateral MAM was increased in two dogs and decreased in
three dogs.
B.26.5.3. Dopplerparameters
The Doppler parameters of aortic flow are shown in Table B.57.e. Significant
differences (>20%) for Aov were identified in one dog (increase) and one dog
(decrease). Significant differences in aortic vti were identified in the same
individuals. The dv/dtmax was significantly increased in three dogs and decreased in
three dogs. The dv/dtmean was significantly increased in one dog and decreased in four
dogs. The acceleration time was significantly increased in one dog and decreased in
one dog. The corrected PEP was significantly longer (>20%) in three dogs. There
were no significant differences between scans for ET or PEP:ET ratio. Vcf was
significantly different, with four dogs showing an increase and one dog showing a
decrease.
The Doppler parameters for mitral flow are shown in Table B.57.f. Mitral Ev was
significantly (>20%) greater in two dogs and less in one dog. Av was significantly
increased in two dogs and decreased in two dogs. Evti was significantly increased in
three dogs. Avti was significantly increased in five dogs and decreased in one dog. E
duration was significantly (>20%) increased above baseline in one dog and E
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deceleration time was increased in one dog and decreased in one dog. A duration was
significantly longer in five dogs. IVRT was significantly longer in two dogs and
shorter in two dogs.
The PVF parameters are recorded in Table B.57.g. Arv was significantly increased in
six dogs. Sv was significantly decreased in two dogs. Dv was significantly increased
in one dog and decreased in two dogs. R2v was significantly larger in five dogs and
was decreased in one dog. Svti was significantly increased in one dog and decreased
in two dogs. Dvti vti was significantly increased in three dogs. Ar duration was
significantly longer in five dogs, S duration was significantly longer in two dogs and
D duration was significantly longer in three dogs and shorter in one dog. D wave
deceleration time was significantly shorter in the second scan in three individuals.
The results of the Doppler parameters from the right heart analysis are shown in
Table B.57.h. RPS PAv exceeded 20% difference between scans in two dogs, one
with a significant increase and one with a significant decrease. LPS PAv was
significantly decreased in three dogs. Tricuspid Ev was significantly increased in two
dogs and decreased in one dog. Tricuspid Av was significantly increased in six dogs
and decreased in three dogs.
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AN ECHOCARDIOGRAPHY / DOPPLER EVALUATION
OF A POPULATION OF NEWFOUNDLAND DOGS
DISCUSSION
B.27. Beat to beat variation and the effect of respiration
In humans, images for quantification are recorded during an end-expiratory apnoeic
phase, by instructing breath-holding in patients. Dubrey and others (1997) showed
that an average of four beats of regular sinus rhythm and thirteen beats of atrial
fibrillation were required to estimate cardiac output with variability less than two
percent. In human patients, there is usually less than 10% variation in R-R interval
through an examination, which results in 33% difference in beat to beat evaluation of
left ventricular volumetric indices (Seliem et al 1996). Breath-holding did not reduce
the amount of beat to beat variability. In younger patients, with more sinus
arrhythmia, these authors recommended that more than five beats should be
measured. Bett and Dryburgh (1981) also reported that five or more cardiac cycles
should be measured to reduce the effect of beat to beat variation for M-mode
dimensions.
In this study, six measurements of each parameter were normally made.
Newfoundlands do not normally have accentuated sinus arrhythmia but it does exist
to a greater degree than in man. It can therefore be argued that more cardiac cycles
should have been measured, and this is certainly true for dogs in atrial fibrillation,
where a maximal of ten beats were measured, but typically six or seven. Most
veterinary echocardiography studies report only three measurements of each
parameter. It is virtually impossible to control respiration in canine patients.
Respiration, by causing rapid chest wall motion, means that is difficult to maintain
transducer orientation through a consistent plane (Schiller & Foster 1996), and this
was certainly a problem during M-mode examinations. Panting made it virtually
impossible to record diagnostic sub-costal aortic spectra. Even with calm respiration,
considerable beat to beat variation was evident in the spectra, apparently associated
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with the respiratory cycle, due to altering position of the Doppler plane with blood
flow.
B.28. Normal Newfoundlands
In generating reference ranges, this study may be criticised for including younger
dogs as well as dogs over eight years old, since the younger dogs may develop DCM
in the future. However, it was decided to combine the two Normal groups as there
were so few animals present in the older group. Another compromise made in this
study was the fact that most animals in the Normal group did not have a repeat scan
to confirm normality. There were too few serially scanned dogs present in the
Normal category on two or more occasions and it was felt that the group would be
too small to generate statistically significant reference ranges for the breed.
In combining the two normal groups with animals over and younger than eight years
of age, it was found that most parameters were not statistically significantly different
between the two groups. This was true for all the M-mode parameters, although there
were significant differences for some of the two-dimensional parameters, particularly
left ventricular diastolic area and volume, which was significantly smaller in the
older age group, as was ejection fraction and stroke volume. It was speculated that
this may be an effect of age, and this was investigated further.
B.28.1. Effect of body weight or body surface area
In the Normal group, the relationship between body weight and BSA was linear,
probably due to the fact that a single breed of approximately uniform size was being
investigated. Where regression analysis identified weight or BSA as an independent
variable significantly affecting 2D echo or M-mode parameters, in general, there was
no advantage of using BSA over weight, except for IVSd where the relationship to
body weight did not achieve statistical significance despite a significant relationship
to BSA.
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The M-mode LV parameters which were influenced by weight or BSA were RVd,
IVSd, LVpwd, LVpws and LVIDd. IVSs and LVIDs were not influenced by weight
or BSA in the Normal group, and FS or EF (Teicholz) also failed to show a
significant relationship to size. Mitral EPSS showed a significant relationship to size,
which was suggested by Kirberger (1991a), who found a trend to increasing EPSS for
larger dogs although this did not achieve statistical significance in his study. In
children, if EPSS was normalised to LVIDd, no relationship was evident with BSA,
height, weight or age (Engle et al 1983). There was a significant relationship
between size and M-mode Aod and LAs, although the ratio (LAs:Aod) was not
influenced by any of the independent variables. Mitral annulus motion (MAM) was
not significantly related to weight or BSA, although the apparent gender effect on
septal MAM was lost once the parameter was indexed to BSA.
The 2D echocardiography left ventricular parameters, LVld, LVdv, LVsv and SV
were all significantly influenced by body weight or BSA. The parameters of left atrial
size measured from the four chamber long axis view also showed similar positive
relationships, and, from the short axis view, 2D Aod and LAd also showed increasing
size in larger dogs, although the ratio (2D LAd:Aod) was not determined by body
size.
Wong and others (1995) reported that in man, BSA was the strongest positive
predictor of left ventricular volumes, followed by total skin fold thickness, which
had negative associations with end-diastolic and end-systolic left ventricular
volumes, even after correcting for body surface area. This indicates that the known
association of body size and volumes may be counteracted in part by the relative
amount of body fat, indicated by total skin fold thickness. These authors suggest that
obesity is associated with lower absolute blood volume and myocardial and
peripheral perfusion than normal individuals. Newfoundlands are large dogs, and a
massive build is considered desirable. Although body condition was not semi-
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quantitatively assessed, many tended to be over-weight in the author's opinion,
particularly the older dogs. It may be that this is one reason that these
Newfoundlands had smaller left ventricular size than would be expected compared to
breeds such as Dobermanns. It would be useful to assess body condition or even skin
fold thickness in this breed during future investigation in order to ascertain this as a
possible independent variable on echocardiographic parameters.
M-mode parameters regressed to body weight or BSA have been reported in the
veterinary literature. Boon and colleagues (1983) gave linear regression equations for
M-mode parameters and BSA for dogs or various breeds weighing between 9.8 and
28.6 kg. The regression lines given by Lombard (1984b) were to body weight and so
the two studies are not directly comparable, although a slighter wider weight range
was included in the Lombard study (5 - 44 kg). Although regression lines of M-mode
parameters to weight are given by Bonagura and others (1985) for dogs up to 35 kg,
the regression equations are not supplied. Jacobs and Mahjoob (1988b) used
multiple linear regression for BSA and cardiac cycle length. Snyder and colleagues
(1995) compared these three references in illustrating the differences identified in a
group of greyhounds, showing that specific breeds may differ from reference values
generated for all breeds. Morrison and colleagues (1992) emphasised the importance
of breed specific reference ranges using regression equations showing that for some
parameters, the equations differed for breeds of differing somatotypes, and some
breeds did not show significant regression with body surface area (e.g. Afghan
hound). Heritage (1994) also indicated that absolute values of normal M-mode
echocardiographic data were more suitable for boxers, as no statistically significant
relationship between the parameters and body size was evident. In this study,
Newfoundlands do have a significant relationship between most M-mode parameters
and weight or BSA, which is not unexpected when the wide range of body weights
are considered. Although in this study, a table of means with confidence limits have
been generated for this breed, it appears that regression tables with 95% prediction
intervals should be used to compare echocardiographic results of new patients with
these reference values. If regression equations published by Boon et al (1983) or
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Lombard (1984b) were used to predict Newfoundland M-mode parameters, they
resulted in significant over-estimation of the observed values and regression data.
Borgarelli and colleagues (1996) reported that the use of published reference
regression lines in great Danes also significantly over-predicted observed data, but
unfortunately, these authors did not give great Dane specific regression equations for
comparison with this Newfoundland study. This over-estimation was also noted by
Koch and others (1995), in a group of normal giant breeds including Newfoundlands,
great Danes and Irish wolfhounds. These findings actually may not reflect
somatotypic differences of a specific or a giant breed, but may just support the
statistical advice that regression equations should not be extrapolated for independent
variable dimensions which had not been observed in generating the line. Indeed,
Pietra and others (1998) reported that the M-mode criteria for English setters, with
weights similar to those generating published regression lines, did have similar
values to those predicted.
O'Grady and colleagues (1986) also published regression equations for some 2D
echocardiographic parameters based on clinically normal dogs from 4.5 - 30 kg.
When these equations were used to predict Newfoundland measurements, again, they
significantly over-estimated those values observed in the normal Newfoundland
population.
When categorising Newfoundlands prior to data analysis in this study, M-mode
LVTDd was considered to be enlarged if it exceeded 50 millimetres in bitches or 55
millimetres in dogs. However, these data now indicate that the LV M-mode
parameters depend on weight or BSA and are independent of gender. The mean (with
confidence intervals) LVIDd of 45.35mm (44.49 - 46.21mm) do not include all
Normal Newfoundlands. The mean plus or minus two standard deviations (45.35 + (2
x 4.03)) gives limits of 37.29 - 53.41 mm, which suggests that a criterion for left
ventricular enlargement may be >2 standard deviations or >53.5 mm. The mean
LVIDs is 34.31 mm, and if normal ranges within two standard deviations are
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considered, then LVIDs should be within 28.31 and 40.31 nun. Newfoundlands with
LVIDs >40.5 mm may be suspected as being abnormal. These figures of "normality"
of <(mean + 2sd) correspond to LVEDd or LVEDs of <118% of the mean value. This
is greater than the criteria of 112% above predicted, used to define left ventricular
enlargement in human echocardiography (Baig et al 1998), although this is based on
the predicted values using patient height, weight and age. It is therefore preferable to
compare future Newfoundland values, including the individual's weight, with the
regression data generated from this study.
Doppler parameters were not usually influenced by body size. However, the mitral
Avti was shown to be predicted by weight or BSA in a multiple linear regression
model with gender. Mitral Av has been directly related with body mass index in
humans (Kangro et al 1996; Pai & Stoletniy 1997). Female dogs also tended to have
higher Avti. Since female dogs tend to be fatter than male dogs, this result may
support the fact that left ventricular compliance is reduced in obese patients (Lewis
1996). A limitation of this study was that more detailed records of body condition,
such as skin fold thickness, had not been kept, so this interesting finding could not be
investigated further. No effect of body weight or BSA was identified for any of the
PVF parameters.
B.28.2. Effect of gender
Forward stepwise regression or multiple linear regression identified gender as a
significant independent variable affecting a few of these parameters. ESVI was
influenced by gender. The LVld was identified by multiple linear regression to be
associated with both size and gender, with male dogs and larger dogs having longer
ventricles. Associated with this finding was that the ratio of LVld:LVIDd (index of
sphericity) was larger in males, although when the index was corrected for BSA, this
gender effect was no longer apparent. The index of sphericity used in this study was
simple in contrast to others proposed (St.John Sutton et al 1998).
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The same apparent interaction of gender effects and BSA was also seen for
MAMseptal; the gender effects disappeared after correcting for BSA despite the
absence of a significant relationship between BSA and MAMseptal identified by
simple linear regression. MAMmean was also apparently significantly influenced by
gender.
It was surprising that some of the Doppler parameters were influenced by sex. The
corrected PEP was weakly but significantly related to gender, with a trend to a longer
time in the male dogs although normalisation for heart rate (PEP/VR-R) suggests that
gender is not a significant predictor of this parameter. However, male dogs also
tended to have faster acceleration time of aortic outflow which was retained after
normalisation for heart rate. Mitral Avti appeared to be influenced by gender, with
larger Avti in female dogs. Female dogs had significantly lower proportion of early
LV filling (Evti/total vti) and higher proportion of late ventricular filling (atrial
systole) (Avti/total vti) than male dogs, further supporting this relationship.
Gender was shown to influence mitral inflow parameters in a group of fifty year old
human patients (Kangro et al 1996), with women having lower E:A velocity ratio
than men, which is consistent with this study. Women are reported to have increased
mitral A wave and PVF Ar wave, when expressed as a percentage of total forward
flow, and also longer durations of A and Ar, than men (Klein et al 1998). In this
study, no significant association was identified between gender and the various PVF
parameters.
B.28.3. Effect of heart rate
In this study, the mean R-R interval was calculated from the mean heart rate recorded
during the time of image acquisition for the frames which were measured. Few
parameters showed a significant relationship to the R-R interval when the 2D or M-
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mode echocardiographic results were considered. Forward stepwise and multiple
linear regression did identify the mean R-R interval to be an influencing independent
variable for EDVI, LAad and LAEI. The 2D LAd:Aod ratio was significantly
positively related to the R-R interval. The trend to increasing left atrial area and left
ventricular volumes with longer R-R intervals is not surprising, as it indicates
enhanced preload associated with longer diastole. Forward stepwise regression did
not identify the R-R interval to be a significant predictor of M-mode parameters in
most instances. This is in contrast to the studies of Jacobs & Mahjoob (1988a;b).
One reason for this may be that the mean R-R interval rather than the preceding R-R
interval was recorded. Jacobs and Mahjoob (1988b) showed that the preceding R-R
interval did have a significant effect 011 M-mode echocardiographic parameters in the
dog and improved confidence intervals and prediction intervals if they were included
in multiple regression analysis with BSA. Jacobs & Mahjoob (1988a;b) also found
that there was a non-linear relationship between R-R interval and the M-mode
parameter, and transforming the R-R interval by using its square root rendered the
data linear. Where there was a dependence 011 R-R interval shown in this study, the
relationship did appear to be linear, but this may merely reflect the relatively low
range of heart rates recorded in this population, compared with the large range in
heart rate generated by atrial pacing in the Jacobs & Mahjoob (1988a;b) study.
MAMmean was also significantly predicted by R-R interval, with gender and age
also significant independent variables in a multiple linear regression model.
As expected, many of the Doppler parameters were influenced by heart rate. Aov
tended to reduce with longer R-R interval, presumably in association with the
expected association between ET and R-R interval, since the vti was not affected by
R-R and cardiac output was maintained. An increase in peak velocities with faster
heart rates was also reported in two dog breeds by Kirberger and colleagues (1992b).
It was logical, also, that the peak and mean acceleration of the aortic flow (dv/dtmax
and dv/dtmean) tended to reduce with longer R-R interval, in the absence of any
significant heart rate prediction of the aortic acceleration time. Vcf followed the
same trend as ET under the influence of R-R interval, tending to decline at slower
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heart rates. Although stepwise regression did not indicate that the R-R interval was a
significant independent predictor for PEP, once the effect of gender had been taken
into account, simple linear regression did indicate a weak positive but significant
association. This is in contrast with most veterinary studies (Pipers et ol 1978;
Atkins & Snyder 1992). The lack of dependence of the PEP:ET ratio on other
variables is consistent with the human and veterinary literature. The fact that the R-R
interval is the most significant predictor of the various STis is supported by the fact
that once PEP, ET, the PEP:ET ratio and Vcf were indexed to VR-R interval, all
other independent variables were eliminated from the forward stepwise regression
model. The exception to this was the acceleration time/VR-R interval, which retained
its relationship with gender.
As expected, mitral E duration, E deceleration time, A duration and IVRT were all
independently predicted by R-R interval. The E:A velocity ratio increased and Av
decreased with lengthening R-R, showing that there is less requirement for active
atrial contraction in ventricular filling at slower heart rates, with more time for
passive diastolic filling.
Many of the PVF parameters were significantly influenced by heart rate. Arv, Sv
and R2v declined at longer R-R intervals, as did the S:D velocity ratio. Longer R-R
allow more passive diastolic filling of the LV, which reduces the late diastolic atrial
volume and pressure, explaining the trend to reduced mitral A and PVF Ar velocities.
With increasing R-R, passive diastolic filling of the left ventricle allows most
forward PVF to occur during the D wave, possibly explaining the lower S velocity
seen with slower heart rates. The haemodynamic events associated with R2 remain to
be confirmed, although Schober and others (1998) suggest that it may represent
pressure changes in the left atrium as a consequence of mitral annulus recoil. The S
wave is due in part to MAM, and so a reduced R2 in association with reduced S
would be logical. The systolic fraction of total forward flow also decreases as R-R
interval lengthens. PVF durations increase with longer R-R interval, especially S and
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D durations and D deceleration time. The D velocity time integral is also associated
with longer R-R interval and the S:D vti ratio therefore decreases.
PAv tended to be lower with longer R-R interval, which reflects similar findings for
aortic velocity. Longer R-R intervals were associated with lower tricuspid Av, and
increased Ev:Av ratio, mirroring the mitral inflow findings.
B.28.4. Effect of age
A major finding in this study was that age significantly negatively influenced some of
the 2D and M-mode echocardiography parameters. Multiple linear regression
showed that advancing age was associated with smaller LVIDd and lower LVdv,
EDVI, LVsv and ESVI. This is consistent with the M-mode data provided in humans
(Gardin et al 1979; Henry et al 1980), although changes in the left ventricular lumen
are not identified in all studies (Gerstenblith et al 1977). Modest inverse correlation
between age and left ventricular systolic volume is reported in man by Wong and
others (1995). Associated with the apparent trend of reducing left ventricular cavity
size with age, most marked in diastole, was the finding that the stroke volume and
stroke volume index were also affected, tending to reduce in older dogs, despite
linear regression showing no significant positive or negative relationship between
heart rate (R-R interval) and age; i.e. this trend is not due to faster heart rates in older
dogs and it must be presumed that cardiac output is therefore also reduced in the
older dogs. Age associated decline in cardiac output is reported in man (Wei 1992).
When both parameters were indexed to BSA, the ratio of LVpwd: LVIDd showed a
positive correlation with advancing age. The decrease in LVIDd associated with age
explains this, although the R value shows a stronger relationship than that expressed
between LVIDd and age, implying that wall thickness also increases with age.
Although the effect of age on wall thickness had not been a statistically significant
trend in this population of Newfoundlands, it is noted to be a common age related
finding in man (Gerstenblith et al 1977; Gardin et al 1979; Henry et al 1980;
Feigenbaum 1994d). The M-mode parameters showed a non-significant trend that
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FS% and EF reduced with age, which is consistent with the age independence of
these parameters in man (Gerstenblith et al 1977; Gardin et al 1979; Henry et al
1980). MAMlateral tended to decrease with advancing age, and this relationship
became even more pronounced once the parameter was indexed to BSA.
The finding that the M-mode LVIDd decreased with age and that chamber walls were
not influenced by age is in contrast to work in Scottish deerhounds. Bodey (1998)
reported that age resulted in thinner LV walls and larger LV lumens in Scottish
deerhounds. No attempt was made in the Bodey study to distinguish between normal
and cardiomyopathic deerhounds and a number of dogs had dilated chambers with
relatively thin walls. This finding may indicate that older deerhounds are more likely
to develop DCM.
Many human echocardiographic texts publish references for the effect of ageing in
children, but information about M-mode and two-dimensional echocardiographic
parameters in ageing adults is sparse. However, Feigenbaum (1994d) provides an
appendix showing the effect of age from infancy to old age for M-mode parameters,
with some graphs of parameter and BSA, with different levels for age groups (20, 40,
60, 80 years). These are based on the work of Henry's group (Henry et al 1978;
Gardin et al 1979; Henry et al 1980). These show that the LV diastolic and systolic
diameter decreases with advancing age and wall thicknesses increase. The aortic root
dimension and left atrial dimension also increase with age, although fractional
shortening, ejection fraction and percentage thickening of septum and free walls are
not influenced by age (Gardin et al 1979; Henry et al 1980). Benjamin and others
(1992) noted that there were age associated changes in cardiac anatomy with
increased left atrial size and left ventricular wall thickness, while reporting on the
age-related effects on diastolic function.
The formula ofHenry (Henry et al 1980) is sometimes used to predict left ventricular
end-diastolic diameter in man (e.g. Baig et al 1998). It is given as:
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LVIDd(predicted) = 45.3 x BSA°3 - (0.03 x age) - 7.2
This formula indicates that there is a positive association with the cube root of body
surface area and a negative linear association with age. This was consistent with the
data presented from this Newfoundland study, although the relationship to BSA was
linear, which may be due to the relatively uniform size of this particular dog breed.
Study of the residuals in the linear regression for age, however, showed that the
negative relationship was not perfectly linear in Newfoundlands, when the residuals
were assessed for normality, although attempts to transform the data did not improve
linearity.
B.28.4.1. Doppler parameters and age
Increasing age was associated with a decrease in the Aov, Aovti and stepwise and
multiple linear regression identified age as a negative predictor of ET. A significant
effect of age was evident on many of the mitral inflow parameters. Ev, E:A velocity
ratio, Evti and E:A vti ratio, the proportion of early LV filling and the peak filling
rate indexed to mitral stroke volume all decreased with advancing age. E duration
and deceleration time and E deceleration/VR-R showed a significant positive
relationship with advancing age. The changes associated with age identified in
Newfoundlands mirror the similar findings in the human population (Manyari et al
1985; Bowman et al 1988; Nishimura et al 1989; Stork et al 1990/91; Nishimura &
Tajik 1997) and cats (Santilli & Bussadori 1998) (although in cats, there was no age
association with E deceleration time). The E wave changes indicate reduced left
ventricular compliance with age (Yamamoto et al 1996). However, in this study, no
age predicted effect on mitral A wave was identified, a finding which is normally
reported in the human literature (Stork et al 1990/91; Mantero et al 1995) and has
been reported in a single feline study (Santilli & Bussadori 1998). The exception in
this study was that the proportion of late ventricular filling (Avti/total vti) did
increase with advancing age. Age is the most significant predictor of trans-mitral
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flow patterns in man (Lewis 1996; Mantero et al 1998) and this study suggests that
this is also true in Newfoundland dogs.
In this study, age was not identified as an independent predictor for IVRT. When
IVRT was normalised for heart rate, by dividing by the square root of the R-R
interval, there was a trend to increasing values associated with advancing age, but
the relationship was weak and not statistically significant.
Age significantly influenced many of the PVF parameters. Increasing age was
associated with an increased Arv, Sv, Svti, S:D velocity and vti ratios and increased
systolic fraction of total forward flow. These findings are consistent with the human
literature (Klein & Tajik 1991; Gentile et al 1997) and the findings in cats (Santilli
& Bussadori 1998). In cats, no age association was reported for the Ar wave, neither
was this a significant association in humans in the study by Gentile and others
(1997). The changes affecting the D wave indicate reduced LV compliance
(Yamamoto et al 1996), which decreases with age, supporting the findings from the
mitral E wave data. D wave duration also tended to be shorter with advancing age,
despite no significant association being identified for age and R-R interval. The
effects of age on the PVF pattern is thought to be due to altered left ventricular
relaxation due to ageing (Klein & Tajik 1991).
The mechanisms of the change in diastolic function with advancing age have not
been fully explained, although the human literature suggests a few hypotheses, which
were reviewed by Wei (1992). Benjamin and others (1992) queried whether other age
associated conditions such as myocardial ischaemia, hypertension or diabetes
mellitus could be responsible. They proposed that the changes may be due to a
combination of cellular hyperplasia, cell death and fibrosis, reduced calcium
sequestration and increased passive stiffness (Benjamin et al 1992). Although blood
pressure was not routinely measured in the Newfoundlands in this study, essential
hypertension and myocardial ischaemia resulting from coronary artery disease are
uncommon in dogs. It also appears unlikely that diabetes mellitus is prevalent enough
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without resulting in other clinical signs in the Newfoundland population to affect
these echocardiographic results significantly. However, blood pressure does tend to
rise with age in the canine population (Bodey & Michell 1996). It was unfortunate
that blood pressure had not been recorded in Newfoundland dogs in this study,
although this had been the initial intention, in order to determine systolic wall stress.
Because of thick hair coats and fleshy tails, it proved to be time-consuming
procedure and usually unrewarding. The lack of significant changes in left ventricular
wall thicknesses do not support an increased afterload related aetiology. In the M-
mode study of Gardin and others (1979), the age-associated echocardiographic
changes were present in a group of 136 adults aged from 20 to 97 years old, in which
the mean diastolic and systolic blood pressures varied by less than 15 minHg between
the age groups. In the study by Gerstenblith and others (1977), although systolic
blood pressure did increase with age, there was no correlation between systolic blood
pressure and wall thicknesses indexed to BSA and hypertensive individuals were
excluded from the study. It appears, therefore, that these changes occur in the absence
of associated age related increases in blood pressure. Another potential reason for
the increasing afterload in the elderly is increased aortic stiffness (Wei 1992). It
remains to be proven whether the left ventricular chamber does genuinely decrease in
size with age in an individual animal. Serial evaluation of a number of animals over
their life-times is required to confirm this.
Wei (1992) reviewed the age related changes affecting the myocardium.
Cardiomyocyte volume increases, although numbers decrease. An increased rate of
degenerative changes, with lipid, lipofuscin and amyloid deposition and an increase
in the amount of interstitial fibrosis and collagen with increased collagen cross-
linking all probably increase myocardial stiffness. These changes occur in man even
in the absence of coronary artery disease. Diastolic function is further impaired by an
age related decline in the rate of relaxation. Relaxation requires more oxygen and
energy than the process of cardiomyocyte contraction and Wei (1992) noted that in
humans, there was an age dependent decline in arterial partial pressure of oxygen
which was quantified as about 4 mmHg per decade. The author proposed that this
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mild hypoxia may play a part in the slowed relaxation process. Another factor which
may play a role in compromised diastolic function in elderly humans is that an age
associated decline in the rate and maximal capacity of calcium sequestration by the
sarcoplasmic reticulum and an increase in the net calcium trans-sarcolemmal influx
may slow the active relaxation process. It seems reasonable to propose that most of
these factors would also apply to non-human species including this Newfoundland
population.
PAv tended to decrease with age and tricuspid Ev and E:A velocity ratio also tended
to decrease with age, indicating that right ventricular compliance is affected by age in
a similar way to left ventricular compliance.
B.28.5. Assessment of Normal Newfoundlands: comparison with previous
studies
Tidholm and Jonsson (1996) reported that normal Newfoundlands should have a
FS% of over 25%, whereas the mean value in this population was only 24.47%.
However, 10% of dogs in Tidholm and Jonsson's (1996) control group had FS%
<22%, although these authors suggested using FS<22% as a diagnostic criterion for
DCM in this breed. In this study, nineteen out of 86 Normal dogs (22%) had a
FS<22%, with the minimum FS recorded as 20% (which was an initial diagnostic
criterion of normality when categorising Newfoundlands). The reference range for
the LVIDd ranged from 3.5 to 6.0 centimetres, and LVIDs from 2.2 - 4.4 centimetres
in the control group, which included juvenile dogs (Tidholm & Jonsson 1996),
whereas in this study of normal adult Newfoundlands, the maximal recorded LVIDd
and LVIDs were 5.49 and 4.12 centimetres respectively, and dogs with LVIDd of 6
cm or LVEDs of 4.4 cm were unequivocally abnormal in the author's opinion. It is
not clear whether the dogs in the Tidholm and Jonsson (1996) control group were
serially evaluated to confirm normality, although this is also a criticism of this study;
not all the dogs in this normal group received a repeat scan. Limited details about
normal echocardiographic values for giant breeds, including 27 Newfoundlands as
well as great Danes and Irish wolfhounds, were provided by Koch and others (1995).
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These workers noted that fractional shortening was lower in giant breeds than
published normal values, and suggested that systolic function in giant breeds may be
compromised.
For normal cavalier King Charles spaniels, the 2D LAd:Aod ratio was 1.0 + 0.06
(Haggstrom et al 1994). The equivalent ratio in this study was 1.10 + 0.11, which is
slightly larger, although whether comparison between dog breeds of such diverse size
and conformation is valid may be controversial. The M-mode LAs:Aod ratio is
normally 0.8 -1.2 (Bonagura et al 1985), which is consistent with the normal
Newfoundland group, even though the internal left atrium/left auricular appendage
measurement was the method used in this study, rather than a dimension including
the posterior aortic wall (Sahn et al 1978).
The PEP:ET ratio was longer in this normal Newfoundland group than reference
ranges given in the veterinary literature, which range from 0.24 to 0.34 (Pipers et al
1978; Atkins & Snyder 1992; Darke et al 1993; Amberger & Lombard 1998). It is, of
course, still a concern that the ultrasound machine used is still overestimating PEP
despite the correction to the data (Appendix B.I.). However, similar STI data is now
generated by M-mode or Doppler, and so it appears that this is genuinely a breed
specific difference.
These Normal Newfoundlands were compared with the results from normal dogs
described by Schober and our group (1998). Systolic function appeared to be lower in
the Newfoundland group than the previous study (Schober et al 1998) (EF: 41.77%
versus 58%, FS: 24.47% versus 31%, PEP:ET ratio: 0.40 versus 0.35, Vcf: 1.38
versus 1.56 circs/s). There were also differences in the transmitral patterns. Ev and
Ev:Av were lower (0.61 versus 0.73 m/s and 1.32 versus 1.63 respectively) although
Av and Avti were similar between the two studies. Evti and E:A vti ratio were
slightly higher in the Newfoundland study. Similar contrasting findings were evident
on comparison of the PVF patterns. Sv was similar in both studies, although Dv was
much lower (0.37 versus 0.56 m/s), the S:D velocity and vti ratios were higher (1.04
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versus 0.7 and 0.81 versus 0.72 respectively) and Arv was slightly higher (0.24
versus 0.2 m/s) in the Newfoundland study. The systolic fraction (Svti/total forward
vti) was similar in both studies. These two studies were performed on two different
makes of echocardiograph and measurements were made by different observers,
which may explain some of the differences. However, age differences between the
two groups may also be responsible. The mean age was not given for the Schober
study, but most of the dogs were young and the oldest dog was only eight years old.
The mean age in the Newfoundland study was 4.35 years old, but older animals were
common in the group.
hi all but three dogs in this study, mitral A duration exceeded the PVF Ar duration,
and the differences were not felt to be significant. This is consistent with the human
data, where the majority of normal subjects have longer mitral A duration, although
similar "insignificant" outliers are also reported (Abdalla et al 1998; Klein et al
1998).
The MAM data were consistent with the canine data provided by Schober and
colleagues (1997). In both studies, MAMlateral was greater than MAMseptal. The
fact that the Schober study included mainly small and medium sized breeds of dogs,
and this study included a single giant breed with no significant predictive effect of
body surface area or weight, yet both studies generated similar values is surprising.
It appears odd that dog size bears no relationship to the magnitude ofMAM, but both
studies are consistent in this finding. In the normal Newfoundland population,
although a weak relationship was demonstrated between FS% and MAMmean and
MAMlateral, no relationship was identified between any of the MAM measurements
and EF. This relationship is reported in dogs (Schober et al 1997) and man (Alam
1991, Pai et al 1991, Willenheimer et al 1997), although these studies were in
patients with heart disease.
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B.29. Comparison between Newfoundland groups
B.29.1. 2D LVparameters
DCM, almost by definition, is associated with left ventricular dilatation and it was
not therefore surprising to find that the DCM group had larger LVdv than the other
groups. Normalisation to BSA also resulted in identification of increased EDVI in the
SAS group. Although the LVE group had been defined by M-mode criteria, LVdv
showed a non-significant trend to increased volume, although this was associated
with a shorter LV systolic length, implying that the LV in the LVE group was more
spherical than groups other than the DCM group. The DCM group had a significantly
larger LVsv than the other groups (other than the LVE group). The ESVI was very
specific, in that the DCM group had significantly greater volume than all other
groups.
The low EF associated with DCM is expected. SV was not significantly lower than
the Normal or the two dFS groups. This is probably because most dogs in the DCM
category had occult disease or were relatively stable on medication. SV was therefore
relatively well maintained, utilising the Frank-Starling mechanism. It should also be
appreciated that not all the stroke volume is forward, effective flow; the DCM group
did have mitral regurgitation of varying severity also.
Both dFS groups had intermediate EF between the Normal and DCM groups. SV was
relatively preserved in these two equivocal categories, although tended to be lower in
the dF<18% group. The slightly lower EF in the two dFS groups appeared to be
mainly due to lower diastolic volume rather than increased systolic volume. It was
surprising to find that the LVE group tended to have increased EF, SV and SVI than
the other groups. This appeared to be due to a larger diastolic volume with a
relatively normal systolic volume. Numbers in the LVE group were small, so
identifying statistically significant differences was not always possible. One reason
for the difference was that this LVE group did have a trend to a lower heart rate
(although not statistically significant). However, normalising for heart rate, by
dividing by VR-R, rendered these differences statistically insignificant.
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The SAS group showed significantly increased EDVI and slightly higher ESVI than
the Normal group, with significantly increased SVI. This may reflect concurrent
mitral or aortic regurgitation volume overloading the LV. Certainly, aortic
regurgitation was commonly identified in Newfoundlands with even very minor
severity of subaortic stenosis, and was rare in Normal dogs (see later).
B.29.2. 2D LA parameters
As expected, the left atrial diastolic parameters in the DCM group were larger than
the other groups, although this was not statistically significant for the LVE group,
which showed a trend to larger LAad. The difference was less marked for the left
atrial systolic parameters, although the DCM group did show larger LAas and LAls
than the dFS<18% group. The dFS<18% group appeared to have smaller left atria
than the other groups, based on these RPS four chamber views and the short axis
view, which is interesting as this group also showed the smallest LV volumes.
LAas and LAls showed a trend to being larger than normal in the SAS group,
particularly once indexed to BSA, although this was not generally statistically
significant. This suggests that the left atrium is functioning further up the Frank-
Starling curve, due to the increased LA afterload associated with subaortic stenosis
and possibly elevated end-diastolic left ventricular pressure or a stiffer left ventricle
than normal dogs.
The LAEI was significantly lower in the DCM group, although this trend was also
shown in the LVE group. This suggests that there is probably intrinsic left atrial
dysfunction as part of the manifestation of DCM in Newfoundland dogs. This lower
index in the DCM group may also be explained by the presence of atrial fibrillation
in ten out of the 35 dogs in this group, so an absence of atrial systole will certainly
have affected this index. However, the LVE group showed a similar reduction in the
LAEI and none of these dogs had AF. If the LVE finding is a predictor of dogs
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destined to develop DCM, this suggests that intrinsic atrial dysfunction may be an
early feature of the condition.
The 2D LAd:Aod ratio supports the suggestion that the DCM and LVE groups have
larger left atria than the other groups, although the only significant difference was the
smaller ratio identified in the dFS<l 8% group.
B.29.3. Mitral regurgitation
Trivial amounts ofMR are common in Newfoundland dogs, with approximately fifty
percent of Normal dogs showing CFDE evidence of mitral valve incompetence. The
absence of any significant relationship between any of the left atrial parameters and
the severity ofMR for dogs in the Normal, dFS<18%, dFS 18-20% and SAS groups
supports a lack of haemodynamic significance. In contrast, dogs with DCM showed a
highly significant relationship between MR and LAld, LAls or LAas. This supports
the hypothesis that associated with LV and LA dilatation, mitral annulus stretch or
dilatation associated disruption of the mitral valve apparatus is responsible for MR.
This in turn, by further volume overloading of the LA and LV, results in further
dilatation (Keren et al 1988b). In DCM, the severity ofMR is also determined by the
degree of LV dilatation and reduced contractility (Mukharliamov et al 1986).
However, specific papillary muscle dysfunction may also play a role (Junker et al
1993). The mitral regurgitant fraction is reported to be typically about 20% in many
human patients with DCM, although it may exceed 40% in some (Keren et al 1988b).
Junker and colleagues (1993) reported that the presence of MR in human patients
with DCM was associated with a higher NYHA class of congestive failure and
increased LV volumes and end-diastolic pressure, reduced EF and increased right
sided pressures compared with DCM patients without MR. In addition, the one year
survival was decreased in the MR group. The limited follow up to date in this study
does not allow any conclusions to be drawn about the significance of mitral
regurgitation in the DCM group. However, one patient (NF002/P500) had moderately
severe MR with only a slowly progressive course.
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The LVE group, although not significantly different from the other groups, did have a
lower percentage of dogs with no MR, and a trend to more severe MR, which would
be consistent with the LV enlargement and associated effects on the mitral annulus. It
is probable that the small numbers in this group were responsible for the failure to
identify statistically significant differences.
The observation of the presence ofMR in a large proportion of normal and abnormal
Newfoundland dogs was made without any attempt to differentiate so-called
physiological mitral regurgitation from pathological mitral regurgitation, as a
consequence of degenerative mitral valve disease or dilatation of the atrioventricular
annulus. Wittlich and colleagues (1990) reported the presence of MR in all young
healthy adult human individuals evaluated by transoesophageal CFDE. With the less
sensitive trans-thoracic approach, Yoshida and colleagues (1988) reported MR in
between 38 and 45% of healthy subjects in different age groups, and PW Doppler
was positive for MR in 40% of normal subjects reported by Kostucki and others
(1986). Trivial or closing regurgitation, as a consequence of valve coaptation, should
not be confused with pathology (Wittlich et al 1990). Sahn and Maciel (1988)
attempted to define criteria for differentiating between innocent and pathological
MR. Regurgitant jets which remained very close to the site of valve coaptation and
colour M-mode MR duration of less than 100 milliseconds suggest innocent
regurgitation. Pathological MR jets accelerate (with colour aliasing and variance) as
they pass through a restrictive orifice in a closed valve, and this may be compared
with the reversal of the closing volume of blood pushed by the coapting valve.
MR jet area has been used as a method of semi-quantifying the severity of mitral
regurgitation in patients (Goldberg et al 1988b; Kisslo et al 1988). However, factors
other than disease severity influence the colour flow mapping of the mitral
regurgitant jet, and include pressure difference between the LA and LV, the size and
compliance of the LA, the size and configuration of the regurgitant orifice, loading
conditions, heart rate and rhythm, orientation of the jet to the ultrasound beam and
the gain settings on the ultrasound machine all influence these variables (Kisslo et al
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1988; Sahn & Maciel 1988; Keren & LeJemtel 1989). Another major factor is the
detectability of a colour flow signal. With poor 2D images, colour cannot be encoded
into pixels filled with grey scale (Yoshida et al 1988), and certainly colour flow
imaging was sub-optimal in a large number of Newfoundlands, particularly the larger
and older dogs. Despite these limitations, however, a number of authors have mapped
jet area by CFDE or PW Doppler echocardiography (Perry 1989; Keren & LeJemtel
1989). The best correlation with angiographic derived severity ofMR was the use of
the maximal jet area, assessed from three orthogonal planes (right parasternal long
axis and short axis views and the left apical four chamber view), and expressing the
jet area as a fraction of the left atrial area from the corresponding image (Helmcke et
al 1987). Day to day variability in mitral regurgitant jet areas of approximately 15%
have been reported (Grayburn et al 1989). In this study, MR was assessed from the
RPS long axis view and the L.Ap. four chamber view, and jet area as an approximate
proportion of the left atrium was subjectively assessed (Figure B.5.I.). It is probable
that a number of dogs with "trivial" or 1+ MR merely showed normal closure
regurgitation.
It was disappointing that CW spectra ofMR jets were of sufficiently high quality to
allow determination of left ventricular dP/dt in only five individual scans from four
dogs. Four of these were in the DCM group and one in the dFS<18% group. An
example of the measurement is shown in Figure B.5.2. The mean dP/dt for this
limited group of individuals was 2049.40 + 1029.57 mmHg/s. With the high
prevalence of MR jets evidenced by CFDE, it was hoped that CW spectra of these
jets would be obtainable in some normal individuals to allow comparisons between
groups of this important, relatively load-independent parameter of contractility. The
instantaneous rate of change of left ventricular pressure, peak dP/dt, is reported to
show excellent correlation between CW of mitral regurgitant jets and invasive
measurements (Bargiggia et al 1989; Chen et al 1991; Vuille & Weyman 1994). The
mean dP/dtmax in an experimental dog model with mitral regurgitation, under
anaesthesia, was reported as 1266 + 701 mmHg/s (Chen et al 1991) and Bargiggia
and colleagues (1989) gave a range of Doppler derived rate of change in pressure
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from the CW MR jet as 410 - 2601 mmHg/second for human patients with a variety
of underlying diseases. From these results, the values obtained from these
Newfoundland dogs with systolic dysfunction seem rather high. This may be due to
the difficulty in measuring very short time durations with accuracy.
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Figure 5.1.
An example of CFDE demonstration of a mitral regurgitant jet within the left atrium of a
Newfoundland with DCM and atrial fibrillation (NF002/P500). The jet area proportional to left atrial
area from this RPS view was subjectively graded 2+.
Figure 5.2.
An illustration of the determination of left ventricular dP/dt obtained from a mitral regurgitant jet
recorded by continuous wave Doppler from a left apical view. This was from a Newfoundland with
DCM and atrial fibrillation (NF002/P500).
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B.29.4. M- mode parameters
The left ventricular dimensions were predictably and significantly increased in both
diastole and systole in the DCM group. LVIDs was rather more specific at
differentiating between normal and cardiomyopathic dogs, with little overlap
between data points between the Normal and DCM groups. By definition, the LVE
group had a large LVIDd, but LVIDs was also significantly greater than the Normal,
dFS 18-20%, dFS<18% and SAS groups. The DCM and LVE groups' LVIDs was
generally larger than the mean + 2sd value generated from the Normal group (40.31
mm), whereas the values for dFS<18%, dFS 18-20% and SAS groups were within
this value, despite showing a trend to higher mean values than the Normal group. The
dogs in both dFS categories tended to have both smaller LVIDd and larger LVIDs
than Normal dogs.
IVSd was not significantly different between the groups, although indexing to BSA
showed that this measurement was significantly greater in the SAS group, showing
some hypertrophy. IVSs, however, was greater in the LVE, SAS and the Normal
groups compared with some of the other groups. Little difference was evident
between the Normal and the DCM groups for the IVSs measurement, until indexing
for BSA. Both dFS categories showed a trend to lower IVSs.
LVpwd showed no significant differences between groups, although indexing to BSA
showed thicker walls in the SAS group. LVpws was greater in the LVE, SAS and
Normal groups.
There is such a wide spread of data points obtained for %thIVS and %thLVw that it
is tempting to dismiss these values as being poorly reproducible. However,
statistically significant differences were identified. %thTVS showed a significantly
higher value for the LVE group and the Normal group than the dFS<18% group. The
DCM group was also low, but not significantly so. There is less data spread for the
%thLVpw results, probably since there is not the same difficulty in identifying
endocardial surfaces. %thLVpw was significantly low in the DCM group. There
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was a non-significant trend to the greatest value for both %thIVS and %thLVpw in
the LVE group, which is interesting as other parameters of systolic performance
appeared to be non-significantly enhanced in this group.
The LaPlace relationship describes the relationship between chamber pressure (P),
wall thickness (w), radius (r) and wall stress, (S) on the left ventricle, if it is
considered as a hollow sphere with a certain wall thickness (Levick 1995). The
relationship is given by:
Consequently, the wall stress increases with larger radius or diameter of the LV, and
with decline in wall thickness.
The LVpwd:LVlDd ratio may be considered as an indicator of the LaPlace
relationship, to indicate the degree of wall stress in the different groups. The LVE
group had the lowest value, indicating that the large diastolic diameter of the LV, the
measurement which had been selected to define this group, was not associated with
proportional LVpw hypertrophy and the wall stress can be inferred to be high in this
group. The DCM group was also similarly low, and the geometry of the DCM heart
is known to be associated with high wall stress (Levick 1995). The fact that the
dFS<18% and dFS 18-20% groups had indexes similar to Normal dogs, reflects the
smaller LV diastolic diameter identified in these groups, and wall stress may be
inferred to be less high than the other groups, although this was not statistically
significant. Although the mean value of LVpwd:LVIDd for the SAS group was not
significantly different from Normal, this was probably associated with the eccentric
left ventricular enlargement with compensatory hypertrophy in this group, there were
outlying data points corresponding to dogs with more severe stenosis that did have
LVpw concentric hypertrophy, compensating for the high wall stress associated with
increased afterload, and therefore a larger index.





The index of sphericity (LVld:LVIDd) was significantly lower in the LVE and DCM
groups, showing that the LV enlargement is predominantly along the minor axis, and
LV chambers were more spherical. It was surprising that the LVE group had the
lowest value, since subjectively, this group was assessed to have relatively normal
LV appearance. It is possible that the preserved or enhanced systolic function in this
group masked the characteristic appearance of a rounded LV which is subjectively
easy to identify in the DCM group.
By definition, the FS% was lower in the DCM, dFS<18% and dFS 18-20% groups
than the Normal, LVE and SAS groups. Since the Teicholz method of calculating EF
uses the same minor axis M-mode dimensions as used for the FS, it is not surprising
that identical differences were identified.
Significantly increased mitral EPSS in the DCM group is consistent with the
literature. Although there was also a trend to larger LVE EPSS, once EPSS had been
normalised to LVIDd, this was no longer evident, and only the DCM group showed a
disproportional increase in this parameter. This is due to both LV dilatation and
decreased mitral stroke volume as a consequence of the systolic dysfunction so
diminishing mitral leaflet opening.
Increase in M-mode LAas is expected in DCM, particularly once the dogs become
symptomatic, so this finding was not surprising. There was also a trend to higher LAs
in the LVE group. Subjectively, dogs in this group had relatively normal appearance
to the LA and LV, which suggests that the LA enlargement is in proportion with the
LV enlargement. As expected, there was no significant difference in Aod between the
various Newfoundland groups, once this measurement had been normalised to BSA.
It was surprising that the M-mode LAs:Aod ratio was not significantly increased in
the DCM group. However, M-mode measurements are difficult to obtain through
consistent regions of the left atrium or left auricular appendage once the aorta is
bisected by the M-mode cursor and the altered LV geometry of the DCM heart makes
this more difficult still. Additionally, many dogs in the DCM group were
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asymptomatic and so are presumed not to have significant elevated LA pressure, and
therefore the left atrial enlargement is less pronounced than in symptomatic DCM
cases. It was surprising to identify a trend for an increased ratio in the LVE group,
particularly as cardiac morphology had been subjectively assessed as being relatively
normal. The anterior aortic root excursions associated with systole were a good
subjective indication of systolic function (Figures B.6.1. & B.6.2.), although no
attempt was made to quantify this. Some DCM Newfoundlands also demonstrated
early systolic partial closure of the aortic valve on M-mode (Figure B.6.2.). This is a
common M-mode finding in human DCM patients (Gardin et al 1984).
MAM (septal, lateral and mean) was reduced in the DCM group (Figures B7.1. &
B.7.2), which is consistent with the findings reported by Schober and others (1997) in
dogs and Alam and colleagues (1990) in humans with DCM.
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Figure 6.1.
Example of good anterior aortic root systolic excursions subjectively interpreted as representing good
systolic function, from an aortic M-mode from a Normal Newfoundland.
Figure 6.2.
Aortic M-mode showing a "flat" aortic root with minimal systolic anterior excursion, consistent with
poor systolic function from a Newfoundland with dilated cardiomyopathy and atrial fibrillation. Early








Example of good mitral annulus motion, from M-mode of the septal annulus from a four chamber
apical view. This is consistent with good systolic function, from a Normal Newfoundland.
Figure 7.2.
Mitral annulus motion from a Newfoundland with DCM and atrial fibrillation. This is an M-mode of
the septal annulus from an apical four chamber view. It shows reduced MAM, consistent with poor
systolic function.
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B.29.5. Aortic flow parameters
There was a trend to lower Aov in the DCM Newfoundlands than the other groups,
with velocities from the dFS<18%, dFS 18-20% and LVE groups being intermediate
between the DCM and Normal Newfoundlands. There was, however, significant
overlap between all groups and this, as well as inclusion of the SAS group, with high
aortic velocities by definition, probably explains the lack of statistical significance in
these trends. Similar trends were also shown in the aortic vti, although the Normal
dogs did have significantly higher aortic vti than dFS<18% and DCM
Newfoundlands. The trend to lower Aov and Aovti in the DCM group is consistent
with the findings in man by Gardin and colleagues (1983).
Since peak and mean acceleration are parameters of systolic function, it was not
surprising that dogs with other evidence of impaired systolic function, in the DCM,
dFS<18% and dFS 18-20% groups, showed lower dv/dtmax and dv/dtmean than the
Normal dogs. There was no significant difference between the Normal and LVE
groups. This offers further evidence that the LVE group, if indeed it is a predictor of
dogs destined to develop DCM, have many aspects of systolic function well
compensated, presumably by utilisation of the Frank-Starling mechanism. Dogs with
SAS had significantly higher dv/dtmax and dv/dtmean than most of the other groups,
which is expected as they require to have enhanced systolic function to compensate
for the increased afterload due to a fixed obstruction.
DCM is known to be associated with increased PEP and slightly lower ET, with an
increased PEP:ET ratio (Darke 1994; Amberger & Lombard 1998) and this study
supports these findings. There is little overlap between the data for PEP and
PEP/VR-R interval between the Normal and DCM Newfoundlands, and dogs in the
dFS<18%, dFS 18-20% and LVE groups had intermediate data ranges, with
surprisingly little overlap between these groups and the Normal Newfoundlands.
Differences between the Newfoundland groups were less evident with respect to the
ET or ET/a/R-R, although values tended to be lower in the DCM group. The PEP:ET
ratio is significantly longer in the DCM group than the Normal Newfoundlands, with
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little overlap between the groups. The PEP:ET ratios for the dFS<18%, dFS 18-20%
and LVE lie between the DCM and Normal groups, with gradual decrease between
the groups. STIs appear to be rather sensitive and specific at distinguishing Normal
from DCM Newfoundlands. This is in marked contrast to the reports by Calvert and
Brown (1986) and Darke and colleagues (1993), who did not find any significant
difference between cardiomyopathic and normal dogs.
There was no significant difference between Normal and SAS groups for PEP or
PEP/VR-R, although the values for the SAS group tended to be slightly lower. There
is no statistically significant difference between the SAS and Normal groups for the
PEP:ET ratio. This is surprising, as left ventricular hypertrophy in the absence of
systolic dysfunction is normally associated with an increased PEP and PEP:ET ratio.
This is thought to be due to elevated end-diastolic LV pressure and possibly to
decreased preload (Matsuno et al 1988). However, SAS was not severe in this group,
and significant hypertrophy was not evident.
The aortic flow acceleration time or accel/VR-R was significantly longer in the DCM
group than Normal or SAS Newfoundlands. There was some overlap between
Normal and DCM groups apparent, which is consistent with the findings of Gardin
and others (1983). Dogs in the dFS<18%, dFS18-20% and LVE categories showed
similar medians, which were intermediate between the DCM and Normal groups.
The acceleration time tended to be shorter in the SAS group, especially after indexing
to VR-R. As acceleration time is another indicator of LV systolic function, these
findings are to be expected.
The Vcf data for the Newfoundland groups follows the expected trends of FS%.
There is little overlap between the Normal and DCM Newfoundlands, with both dFS
groups reflecting the DCM group, with little overlap ofNormal data. The Vcf for the
LVE group, however, is very similar to normal data or SAS data. There appears to be
little advantage of using Vcf over the use ofFS%.
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B.29.6. Sensitivity and Specificity and Predictive value of PEP or the
PEP. ET ratio in distinguishing between Normal and DCM
Newfoundlands
There was surprisingly little difference in whether PEP alone or the PEP:ET ratio
was used to differentiate between the Normal and DCM Newfoundlands, although
the sensitivity results for the PEP:ET were slightly greater. One limitation of this
study was that the final status of the Newfoundlands in each of the groups had not
been confirmed in most cases. Indeed, a large number of dogs had not been
rescanned. A major assumption that the inclusion of a scan in a particular category
represents the conclusive status of a dog must be a major criticism of this study.
From scrutiny of the data, the use of a cut-off of two standard deviations above the
mean is too conservative, although it does result in very high specificity for both PEP
and PEP:ET ratio (98.8% in both cases) and high positive predictive value (95.5% in
both cases). Sensitivity was improved by using a cut-off of one standard deviation
above the mean, but at the expense of specificity and positive predictive value. If the
option was made for a criterion for the diagnosis of systolic dysfunction as a PEP:ET
ratio >0.460, the sensitivity was 85.3%, specificity 82.9%, positive predictive value
67.4% and negative predictive value of 93.2%. This criterion was positive for 51.7%
of the dFS<l 8% group, 45.8% of the dFS 18-20% group and 25% of the LVE group.
The one dog in the SAS group with increased PEP:ET ratio (NF023/P248 Scan
NF7/7) also had an increased LVsv, LVdv and M-mode parameters, suggesting that
this dog was developing DCM, by the time of his second scan (SAS group; scan
NF13/8). However, his STIs had become normal. This dog certainly has a positive
family history for DCM and it is interesting to speculate whether the PEP:ET ratio
was predictive of the development of a myocardial insult, or whether it reflects a
transient insult. Only further evaluation of this individual will confirm the
progression.
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The significance of STIs in the identification of dogs with early DCM still requires
to be confirmed with serial evaluation of these dogs with abnormalities in the future.
It is likely that the cut-off criterion of one standard deviation above the normal mean
is still too conservative and this requires to be refined in the future. However, this
study shows that STIs, in particular PEP/ET, are sensitive indicators of systolic
dysfunction, which are unaffected by regional wall motion abnormalities and they do
not require any geometrical assumptions to be made. Obviously, the value of the
PEP:ET criterion in the diagnosis of DCM is enhanced if other classical and more
conventional features of the disease are also present.
Although an alternative criterion could be PEP >0.082 seconds, the dependency of
this parameter of heart rate in normal Newfoundlands makes it less suitable as a
diagnostic criterion, particularly in individuals with slow heart rates. Similar results
were evident to the PEP:ET criterion in assessing the other Newfoundland groups,
although 5/8 dogs in the LVE group (62.5%) had PEP > 0.082 seconds. However, it
has already been noted that dogs in the LVE group tended to have lower heart rates
than dogs in the other Newfoundland categories.
B.29.7. Aortic insufficiency
Aortic insufficiency was not common in Newfoundlands without any aortic valve or
left ventricular outflow tract pathology. It was absent in between 70.8% and 89.7% of
dogs in the Normal, DCM, dFS<18%, dFS 18-20% and LVE groups. In contrast,
aortic insufficiency was present to some degree in 67.5% dogs with aortic velocities
in excess of 1.7 m/s, a difference which was highly significant (x analysis: p<0.001).
In general, no significant relationship was identified between peak aortic velocity and
the grade of aortic insufficiency, although the dFS<18% group actually did show a
modest relationship which just achieved statistical significance (R=0.433; p<0.05).
However, the SAS group showed a more significant relationship between these two
parameters (R=0.422, p<0.01) with more severe aortic insufficiency with higher
aortic velocities in the aortic stenosis group. It is logical that the presence of
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congenital abnormality of the aortic valve or subvalvular region may result in
valvular insufficiency as well as stenosis. However, it should be noted that the grade
of aortic regurgitation was never more than mild, and it is unlikely that the aortic
insufficiency identified in any of the groups was haemodynamically significant. In
the SAS group, which tended to have larger left ventricular chamber dimensions
from 2D and M-mode echocardiographic methods, the degree of aortic insufficiency
was not judged to be sufficient to result in LV volume overload, although this was an
entirely subjective opinion.
The relationship between subcostal aortic velocity from all Newfoundland groups
and the CFDE record of aortic insufficiency identified by linear regression analysis
(R=0.445, p<0.001) is difficult to explain in the groups where aortic valve or
subvalvular pathology was not identified.
Aortic regurgitation has been variously reported in normal humans as never occurring
(Yoshida et al 1988), to occur in 26% of patients (Kostucki et al 1986) or to occur in
68% of normal individuals, with very short duration (Wittlich et al 1990). The
discordant results probably merely reflect the sensitivity of the detection system; the
latter study used transoesophageal CFDE. It appears to be an uncommon finding in
Normal Newfoundlands assessed by trans-thoracic echocardiography. Although the
jet area and length was used to subjectively assess the severity of any AoR identified
in this study, this was probably inaccurate. Switzer and colleagues (1987), in an in
vitro model, and Perry and co-workers (1987), in patients with CFDE, showed that
the jet width at the origin, relative to the short axis area of the left ventricular outflow
tract at the same level, was the best predictor of the severity of aortic regurgitation.
214
B.29.8. Mitral inflow parameters
Ev was significantly higher in the SAS and DCM groups. In the DCM group, there
also a trend to lower Av. The apparent differences between groups for Ev and Av
were no longer apparent after normalising for total vti. There was no significant
difference between groups for the E:A velocity ratio, although it was higher in the
DCM and LVE groups than the other groups. As the peak mean E:A velocity ratio
was 1.48 (LVE group), no group showed evidence of restrictive physiology or
abnormal relaxation based on this parameter. It was interesting to note that the SAS
group had higher Ev and Av than the other groups, although the E:A ratio was not
altered. The SAS group also had the highest total vti than the other groups, although
this was only significantly different from the dFS<l 8% group.
Although there was no significant differences between groups for Evti, some
significant differences between groups were apparent for Avti. The DCM and
dFS<18% groups showed a trend to lower Avti than the other groups. However, there
were no statistically significant differences between groups for the E:A vti ratio,
although it was greatest in the DCM group. No statistically significant difference
could be confirmed between groups for the proportion of early LV filling (Evti/total
vti) or late LV filling (Avti/total vti). Although no attempt was made to exclude dogs
with atrial fibrillation from the data (A wave data was treated as "missing"), a trend
was identified for a higher proportion of early filling and lower proportion of filling
subsequent to atrial systole in the DCM group. Since there was no other confirmation
of restrictive physiology or abnormal mitral filling pattern in the DCM, this result
may reflect the intrinsic atrial dysfunction identified in this group, determined by the
LAEI. However, a similar trend was identified by Darke and others (1993), with AF
excluded from their DCM study group.
Although there were apparent differences for E duration and E deceleration time
between the Newfoundland groups, these appeared to be related to heart rate as no
significant differences between groups was evident after normalising to VR-R
interval. From these data, since no group exhibited unequivocally restrictive
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physiology, it was not possible to define a mitral E wave deceleration value as being
consistent with a restrictive pattern, such as is commonly used in human
echocardiography (Little & Cheng 1998; Hurrell et al 1998), where values <130
milliseconds are associated with a grave prognosis and values more than 150
milliseconds are regarded as being relatively normal. In the Normal Newfoundland
population, E deceleration time was 117 milliseconds. It is apparent that definitions
of restrictive physiology cannot be merely extracted from the human literature, and
confirmed cases of restrictive physiology are required in dogs (perhaps with severe,
end-stage DCM), to attempt to define these values further, probably indexed to VR-R
interval.
No statistically significant differences were identified between the groups for 1VRT.
However, after correcting for heart rate, (IVRT/VR-R), it was apparent that this
result was much greater in the DCM group (0.095), compared with all other groups
(Normal, 0.080; dFS<18%, 0.081; dFS 18-20%, 0.084; LVE, 0.085 and SAS, 0.080).
This result was surprising when so many of the DCM group had mitral regurgitation
to some degree, which implies that an isovolumic relaxation phase cannot occur. This
may be because MR was not severe in any dog. However, Keren and others (1986)
found that the majority ofMR occurs during the ejection phase (79%) rather than the
pre-ejection period (13%) in human patients with DCM, in contrast with the
angiographic reports that 50% of regurgitant volume occurs during the pre-ejection
period in patients with valvular heart disease. This finding explains why a distinct
IVRT phase occurs in DCM, despite the presence of significant mitral regurgitation
(Keren et al 1988b). This trend, even though not statistically significant, to prolonged
IVRT in the DCM group is consistent with impaired relaxation.
It was disappointing that so few statistically significant differences between
Newfoundland groups could be identified. It had been hypothesised prior to this
study that diastolic dysfunction may precede systolic abnormalities or changes in
chamber dimensions, although this is apparently not true. It may be that the presence
of MR may have played a part in masking abnormalities of diastolic function,
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particularly as the DCM group were stable and most individuals probably did not
have elevated LV end-diastolic pressure. The confounding influence MR in the use
of trans-mitral filling patterns in DCM has been noted by a number of authors
(Takenaka et al 1986; David et al 1989; Lavine & Arends 1989).
B.29.9. Pulmonary venous flow
Arv was found to be significantly increased in the SAS group. It was striking that a
significant number of data points exceeded the 90% percentile in the Normal group.
This had been observed during the scans; a number of dogs showed high Arv
without having any other clinical or echocardiographic evidence of heart disease.
Some of these dogs were stressed during the examination, judged by observation and
from questioning the owner, although they were not tachycardic. Such a dog,
confirmed to be Normal, is shown in Figure B.8.1. (NF063/P244 scan 11/1). Her
repeat scan (scan 17/5) no longer showed this abnormality. It is difficult to explain
this finding physiologically.
No significant differences were identified between groups for the Sv although
differences were evident for the Dv, with a trend to higher velocities in the DCM
group. Although there was no statistically significant difference in the Sv:Dv ratio
between groups, it should be noted than values are similar to or greater than 1.0, even
in Normal Newfoundlands (1.04). Although an age related increase in the Sv:Dv ratio
is reported (Klein & Tajik 1991; Gentile et al 1997) and was identified in the Normal
Newfoundlands in this study, the ratios in all groups are much higher than those
reported in normal dogs by Schober and colleagues (1998). There were similar
findings for the S:D vti ratio in Normal dogs in this study. However, the S:D vti ratio
in the DCM and dFS<18% and dFS 18-20% groups were similar to the normal value
of 0.72 (Schober et al 1998).
R2v showed a trend to higher values in the SAS and DCM groups. If this parameter
does indeed reflect mitral annulus recoil (Schober et al 1998), it is surprising to find
relatively large (although not statistically significant) values in the DCM group,
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which tended to have lower MAM and probable recoil. As the R2 wave, with the
other components of pulmonary venous flow, reflect pressure changes within the left
atrium, the relatively increased R2 wave velocity in the DCM and SAS groups may
merely reflect the fact that the left atrium is less compliant than in Normal dogs.
The DCM group tended to have a lower Svti, S:D vti ratio, total vti and systolic
fraction of total forward flow than the other groups, although most of these
parameters failed to achieve statistical significance. Durations of the various wave
components of the PVF, even when indexed to heart rate, do not appear to be
informative at distinguishing between Newfoundland groups.
Some dogs with mitral regurgitation showed reverse systolic flow as a consequence
of mitral regurgitation (Figure B.8.2).
Again, it was disappointing that so few significant differences between
Newfoundland groups were identified. Although there were trends shown in the
DCM group compared with Normal dogs, few of these achieved statistical
significance. This may, in part, be due to the fact that the majority of the DCM group
had mild disease. Many were not in congestive failure, or failure was well controlled
by medication. Certainly, it is apparent that PVF evidence of diastolic dysfunction
does not appear to be a predictor of dogs destined to develop DCM. Typically, in
human patients with DCM, peak S wave velocity and the S:D velocity ratio are
significantly lower than normal individuals (Kranidis et al 1994).
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Figure 8.1.
Pulmonary venous flow pattern from a Newfoundland with an otherwise normal scan (NF063/P244),
showing very large atrial reversal (Ar) waves with velocity of >1.0 m/s. The cause of these is
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Figure 8.2.
Pulmonary venous flow pattern from a Newfoundland with occult DCM showing reversed systolic
flow (RSF) as a consequence of mitral regurgitation. The other components of PVF are labelled. PVF
S wave > D wave.
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B.29.10. Pulmonary artery parameters
PAv from RPS or LPS views were significantly higher in the SAS group, although in
no case was a velocity consistent with a diagnosis of pulmonic stenosis identified.
The pulmonic velocities were higher from Normal Newfoundlands than in the DCM,
dFS<18%, dFS 18-20% and LVE groups, from both windows, although these
differences were only statistically significant between Normal and the DCM and
dFS<18% groups. The trend to lower pulmonic velocities in the DCM group is in
contrast to the findings of Gardin and colleagues (1983), who noted no difference in
peak pulmonic velocity between normal and DCM human patients.
Increased pulmonic velocities have been reported in association with aortic stenosis
in boxers (personal communication, A.French), and this prompted the investigation
of a relationship between pulmonic artery velocity and subcostal CW peak aortic
velocity. Although a significant relationship was identified, there was also a
moderate but highly significant relationship between RPS and LPS PAv and
subcostal CW Aov when data from all Newfoundland groups were combined (R
values 0.576 (RPS) & 0.546 (LPS) and p<0.001). It is therefore probable that the
increased pulmonic velocities in association with SAS do not represent a minor
degree of contralateral semilunar valve stenosis, but merely represent the fact that
the cardiac outputs of both ventricles must be equivalent. Since right sided function
was not investigated in more detail in this study, further conclusions could not be
drawn.
Pulmonic insufficiency was identified by CFDE in between 27.6% and 50% of
Newfoundlands in this study. This was never more than mild and was subjectively
assessed as being haemodynamically insignificant in all groups. There was
significantly more pulmonic insufficiency in the SAS group and the dFS 18-20%
groups, although the significance of the relationship in the dFS 18-20% group is
difficult to explain.
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Pulmonic regurgitation has been reported in 70% of normal dogs (Yuill & O'Grady
1989), and is common in normal humans. It was reported in between 28 - 88% of
subjects reported by Yoshida and others (1988), with an apparent age related decline
in frequency, and 92% of subjects studied by Kostucki and others (1986).
B.29.11. Tricuspid valve parameters
The SAS group tended to have higher tricuspid Ev and Av than other groups,
although this was not statistically significant for all groups. The DCM group tended
to have a lower tricuspid Av, but no significant differences were identified between
the groups for the tricuspid Ev:Av. Few conclusions can be drawn from the limited
analysis of right sided function in this study.
Tricuspid regurgitation was recorded in between 0% and 36.1% ofNewfoundlands in
the various groups. TR was identified in a significantly higher proportion of DCM
dogs than dogs in other groups (x analysis: p<0.05). This finding is consistent with
the fact that some right ventricular involvement will also be evident in DCM, with
possibly stretching of the tricuspid annulus with the consequence of tricuspid
incompetence. A number ofNewfoundlands in the DCM category were noted to have
biatrial enlargement.
In normal human subjects, TR has been variously reported to occur. Yoshida and
colleagues (1988) reported that 15 - 77% of people in different age groups had TR,
with an apparent age related decline. TR was identified in 44% of patients by
Kostucki and others (1986) or 100% of patients in the trans-oesophageal echo study
by Wittlich and colleagues (1990). It is also reported in 50% of normal dogs (Yuill &
O'Grady 1989).
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B.30. Dilated cardiomyopathy category
Thirty five scans were obtained from 29 individual dogs. In this group, sixteen dogs
had only one scan. Eight dogs in this group had had a previous scan in another
category before the subsequent scan fulfilled the criteria for the diagnosis of DCM.
Four dogs in this group had repeat scans, both in this DCM category and two of these
had received a third scan. Of the 35 scans, ten dogs were reported to be symptomatic
by the owners at the time of the scan (overt DCM) and were either on therapy or
therapy was advised after the scan. No attempt was made to monitor therapy or
investigate the relationships of any of the echocardiographic parameters with therapy.
Twenty five scans were from dogs not reported to be symptomatic (occult DCM).
Atrial fibrillation (AF) was identified in seven dogs with overt DCM and three dogs
with occult DCM. Ventricular premature complexes (VPCs) were identified in two
dogs with overt DCM (one in association with AF) and seven dogs with occult DCM,
one of whom had a paroxysm of monomorphic ventricular tachycardia during
echocardiographic evaluation (NF070/P274, scan NF18/12). Two scans from the
same dog with occult DCM (NF042/P542 scans NF9/5 & NF13/5) showed frequent
supraventricular premature complexes. Only two scans with overt DCM and twelve
scans from dogs with occult DCM did not have any arrhythmia identified. One dog
with occult DCM appeared to have first degree atrioventricular block, although this
was measured from the ECG on the echocardiographic recording. The presence of
arrhythmias in association with echocardiographic abnormalities were felt to support
the decision to include dogs in this DCM category rather than other categories. It is
apparent that arrhythmias, particularly atrial fibrillation, became more prevalent
during progression of the disease course.
Systolic heart murmurs were reported in seven of the ten scan records from dogs with
overt DCM, and only six of the scan records from dogs with occult DCM. The
murmurs in all cases were consistent with mitral regurgitation.
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The echocardiographic / Doppler parameters in this study were consistent with those
expected in DCM, and those reported in human DCM (reviewed by Levine, 1994).
The DCM group had larger LV volumes and M-mode dimensions than other groups,
especially in systole. Tire LV ESVI and M-mode LVIDs appear to be more specific
and sensitive at distinguishing between DCM dogs and other Newfoundland groups.
The DCM group showed a trend to thinner walls, especially in systole, and a lower
percentage thickening of the 1VS and LVpwd. EF and FS were reduced and EPSS
was increased. The various 2D or M-mode LA parameters all tended to be increased
relative to the other Newfoundland groups, and left atrial dysfunction was identified
in DCM dogs by the LAEI, even in dogs in sinus rhythm. Twenty seven scans
(77.1%) showed MR of variable severity. The fact that MR grade correlated with
LAls and LAld as well as the LAas supports the fact that MR is a consequence of
dilatation of the mitral annulus.
During the course of this study, it was evident that dogs with a firm diagnosis of
DCM showed increased sphericity of the chamber, hi an attempt to quantify this
subjective finding, the ratio of diastolic LV length: LV minor axis dimension
(LVld:LVIDd) was used and was found to be significantly reduced in the DCM
group.
In dogs with overt DCM, there appeared to be two forms to the disease. While some
dogs developed marked LV dilatation and hypokinesis, with LA enlargement
appearing later in the course as clinical signs became evident, other dogs showed
only minor LV dilatation, although increased sphericity was evident, but marked,
disproportionate left or biatrial enlargement (usually in association with atrial
fibrillation) (Figures B.9. - B.ll.). Dogs in the former group appeared to deteriorate
more rapidly. The group without marked LV dilatation were usually older with
slower progression, or even echocardiographic improvement with appropriate
treatment. They may have significant MR (Figure B.5.1. & B.5.2.), although LA
enlargement was subjectively judged to be disproportionate to volume over-loading.
LA enlargement may result in dilatation of the mitral annulus and MR (Tanimoto &
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Pai 1996), even in the absence of LV dilatation. However, some mitral valve
degeneration was evident on gross and histopathology in the old Newfoundlands
(personal communication, Dr. R. Else). It is possible that the age of onset does
determine the course of the disease. It has already been noted that the left ventricular
cavity tends to be smaller in older, normal dogs, and it was postulated above that this
may be due to increased collagen deposition and collagen cross bridge formation.
This may have a protective effect in dogs with a later age of onset of DCM,
preventing massive left ventricular dilatation. It is also possible that this represents
the cardiomyopathy described as "mildly dilated congestive cardiomyopathy"
(MDCM) described in man (Keren et al 1988a; D'Cruz et al 1992), which also is
associated with a more favourable prognosis. Keren and colleagues (1990) gave a
detailed clinical and pathological description of MDCM, which is characterised by
minimal myofibrillar loss.
The aortic Doppler findings of decreased Aov, Aovti, dv/dtmax and dv/dtmean and
increased acceleration times are also consistent with other reports about DCM
(Gardin et al 1983). Both PEP (or PEP/VR-R) and the PEP:ET ratio data appeared to
show minimal overlap with Normal Newfoundlands. A PEP:ET ratio exceeding
0.460 appeared to be reasonably sensitive (85.3%) and specific (82.9%) at identifying
Newfoundlands with DCM.
There was no conclusive evidence of significant diastolic dysfunction in the DCM
group compared with Normal dogs or Newfoundlands in the other categories,
although trends to differences between Normal and DCM Newfoundlands were
identified for a number of the mitral inflow and PVF parameters. Criteria for a
diagnosis of impaired relaxation or restrictive physiology were not identified in the
majority of these cases. Although the DCM group did have higher IVRT or
IVRT/VR-R interval than the other groups, consistent with impaired relaxation, this
difference did not achieve statistical significance.
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Figure B. 9.
Newfoundland NF008/P534 with occult DCM showing marked left ventricular dilatation, but minimal




Newfoundland NF010/P10 with overt DCM, prior to any treatment, showing marked left ventricular
dilatation, increased sphericity of the LV and left atrial enlargement. The left ventricle is very
hypokinetic. RPS 2D long axis view (top) and LV M-mode (bottom).
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Figure B.II .
Newfoundland NF002/P500 with overt DCM receiving treatment with an ACE inhibitor prior to
diuretic or digoxin therapy. Although the LV is slightly rounded, it is not particularly dilated or
hypokinetic. Marked biatrial enlargement is apparent. This dog was in atrial fibrillation. RPS 2D long
axis view (top) and LV M-mode (bottom).
227
B.31. Left ventricular enlargement category
This was a small group, and even when differences appeared to exist in the box and
whisker plots between this group and other groups, they often did not achieve
statistical significance. These data showed that as well as the significantly increased
M-mode LV diastolic dimensions, which had been used as a defining criterion in
selecting this group, individuals had larger systolic diameters than the normal group.
This group had a trend to larger LV diastolic volumes. Although M-mode diastolic
wall thicknesses were not significantly different between groups, the fact that no
eccentric hypertrophy was evident (from the LVpwd:LVIDd ratio) indicates that the
chamber is significantly dilated and that wall stress can be inferred to be increased.
This was surprising in that the left ventricular geometry and function was
subjectively assessed as being unremarkable (Figure B.12.). The systolic wall
thicknesses were increased compared with other groups for both IVSs and LVpws. It
was striking that the conventionally used parameters of systolic function obtained by
M-mode or 2D techniques were not depressed in this group; indeed individuals
appeared to have enhanced systolic performance compared with other groups,
although this did not achieve statistical significance for most of the parameters.
Means for EF, SV or SVI, %thIVS and %thLVpw, FS and EF (Teicholz) all tended
to be higher than the other groups. The Doppler parameters of aortic flow, dv/dtmax
and dv/dtmean, were not significantly different from the Normal dogs. It is possible
that if these individuals do progress to develop DCM, at the stage of the recorded
echocardiographic examination, they have suffered some myocardial insult, but are
compensating by functioning further up the Frank-Starling curve.
The LAEI was depressed in this group in comparison with the other groups, which
may indicate some intrinsic left atrial dysfunction.
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Figure B.12.
Two dimensional RPS long axis four chamber view (top) and left ventricular M-mode (bottom) from a
Newfoundland bitch in the LVE category (NF098/P73). This bitch was rescanned after 12 months,
during writing of this thesis (data not included), and no significant changes were identified in M-mode
dimensions.
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The STIs, determined from subcostal Doppler aortic flow spectra, were more
sensitive at distinguishing abnormalities of systolic function between the LVE group
and Normal Newfoundlands. PEP or PEP/WR-R and PEP:ET ratio values were
intermediate between the Normal and DCM categories, with similar values to both
dFS. Differences were not identified as being statistically significant, probably
because of the small numbers in the group. Aortic acceleration time and accelNR-R
also tended to be higher in the LVE group than Normal or SAS Newfoundlands, with
similar values to both dFS categories.
Unfortunately, only two dogs in this group were able to be re-scanned at the time of
writing. More individuals are required in this group, with further follow up in order
to validate the tentative conclusion that these dogs do have early stages ofmyocardial
disease. If confirmed, this group is consistent with the left ventricular enlargement
category of human relatives of DCM patients described by Baig and colleagues
(1998), which did appear to have progressive disease and this echocardiographic
abnormality was concluded to be a manifestation of incipient occult DCM by these
workers.
There was no evidence of significant diastolic dysfunction in the LVE group when
this was compared with Normal dogs or Newfoundlands in other categories.
It was interesting to note that the recorded heart rate tended to be lower in the LVE
group than the other groups during recording of many of the echocardiographic
parameters, which was statistically significant in some instances. This may explain
why some of the parameters of systolic function were apparently enhanced in this
group, with greater time for diastolic filling. However, it does not support the fact
that dogs in this group are compensating for some myocardial insult, when an
increase in sympathetic drive and heart rate may be expected. However, it may be
speculated that the left ventricular remodelling changes subsequent to such an insult
have compensated sufficiently to preclude the necessity for such an increase in
sympathetic drive. Other factors explaining both the left ventricular size increase and
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relatively slow rates must, however, also be considered, such as concurrent
hypothyroidism. This condition was not excluded in this study, although it is
common in the Newfoundland breed. Fruhwald and colleagues (1997a) identified
sonographic or subclinical functional abnormalities in 59 out of 61 human patients
with DCM and they recommend that thyroid function is assessed in patients with
DCM or atrial fibrillation. Calvert and others (1998c) found no difference in the
incidence of hypothyroidism between normal or cardiomyopathic Dobermanns,
another breed predisposed to this endocrinopathy.
As there was no gender influence on M-mode LV parameters in Normal
Newfoundlands, the future criteria for the diagnosis of an LVE category should be
modified. It should be based on body weight or BSA, and possibly also age, as these
criteria all influenced the M-mode LV chamber parameters. The mean + standard
deviation for the LVIDd/m2 for Normal Newfoundlands is 29.78 + 3.4 mm/m2. The
upper limits may be defined as (mean +lsd) 33.18 mm/m or (mean + 2sd) 36.58
mm/m2. Weights or BSA were only available for six dogs in the existing LVE
category. All six dogs were positive for LVE if the first cut off (mean +lsd) was
used, but only two dogs were positive if the second cut off (mean +2sd) was used. If
these cut-offs were applied to the Normal group, 9/64 dogs had LVIDd/m > 33.18
mm/m2 (14.1%) and only one dog had LVIDd/m2 > 36.58 mm/m2 (1.6%). In
contrast, there were 13/26 dogs in the DCM group with LVIDd/m2 > 33.18 mm/m2
and 3/26 dogs in the DCM group with LVIDd/m2 > 36.58 mm/m2. It can be seen that
these criteria are not particularly sensitive or specific and it is probably preferable to
define a LVE category based on systolic dimensions indexed to BSA.
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B.32. Depressed fractional shortening categories
Dogs in the two dFS categories (dFS<18% and dFS 18-20%) tended to show this
classifying feature due both to slightly smaller LV diastolic dimensions or volumes
but also to increased LV M-mode systolic dimensions (although systolic volumes
from 2D were similar to normal dogs). As well as FS, EF, SV and SVI were also
reduced, with values intermediate between DCM and Normal groups. The LA
parameters tended to be similar to Normal or even small, and the LAEI was
intermediate between Normal and DCM groups, suggesting some degree of intrinsic
left atrial dysfunction in this group. Although IVSd and LVpwd were similar for all
groups, IVSs and LVpws for both dFS groups tended to be lower than Normal, and
the %thIVS and %thLVpw were reduced compared with Normal dogs. The
LVpwd:LVIDd index was similar to Normal dogs, suggesting that this group did not
have increased left ventricular wall stress. They showed no alteration in LV chamber
conformation, with normal or even slightly increased LVld:LVIDd measurements.
Indeed, in some dogs, there was a subjective appearance of a long, thin left ventricle
(Figure B.13.). The EPSS in these dFS groups was intermediate between Normal
and DCM groups.
In the dFS<18% group, of the 29 scans, twelve dogs had not been re-evaluated at the
time of writing. One factor identified to be responsible for the depressed FS% was
the presence of regional wall motion abnormalities (e.g. Figure B.14.). Intercurrent
disease may be responsible, such as lymphoma and hypercalcaemia in one bitch with




A young Newfoundland male from the dFS 18-20% category (mean FS = 18.2%). This dog
(NF099/P76) also had occasional VPCs during the echocardiographic / Doppler examination. A
repeat scan has not yet been performed.
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In the dFS<18% group, two dogs (litter mates) progressed to occult DCM by the
follow up scan and one dog in the dFS 18-20% category developed overt DCM with
initially life threatening pulmonary oedema with ascites indicating biventricular
failure, although he is currently stable. Dogs in the dFS<18% group included seven
dogs with evidence of deteriorating systolic function. One dog improved marginally.
The scans in the dFS 18-20% probably do not represent a homogenous group. Almost
certainly, some of these dogs are normal, but only serial evaluation will be able to
separate normal from abnormal dogs. There were 24 scans in this group, five dogs of
which have not received a repeat scan. One did develop DCM, as discussed above.
Two dogs remained similar on repeat scan and three dogs showed improvement in
the FS%, although two of these dogs had arrhythmias. Five dogs showed some
deterioration in systolic function, although this was not always judged to be
significant, although further conclusions cannot be drawn until future serial
examinations are performed. Other dogs which deteriorated sufficiently to enter the
dFS<18% group were discussed above.
Tidholm (1998) suggested that the echocardiography finding of a fractional
shortening of less that 25%, in the presence of radiographic or pathological evidence
of congestive heart failure, was reliable in the diagnosis of DCM in approximately
90% of cases. However, no comment was made on the usefulness of depressed
fractional shortening in dogs without congestive failure. In Tidholm's current
longitudinal study of Newfoundland dogs in Sweden, some dogs with initially
depressed fractional shortening are reported to normalise (Tidholm et al 1998b). In
this study, dogs undergoing serial evaluation (see later), this was also recognised,
although most dogs remained similar or progressed over the three years of this study.
In many cases, dFS appeared to be due to regional wall motion abnormalities. These
could be very bizarre (Figure B.14.), including apparent paradoxical septal motion,
but usually were due to either flat septal or posterior wall motion, or significant left
ventricular free wall lag. The presence of these abnormalities makes it preferable to
assess systolic function by methods other than M-mode. Paradoxical septal motion
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has been recognised in veterinary cardiology since 1985 (De Madron et al 1985),
although initially it was felt to merely indicate right ventricular volume or pressure
overloads. In human cardiology, regional wall motion abnormalities are common,
particularly with ischaemic heart disease but they may occur in cardiomyopathies
also (Wallis et al 1984; Sunnerhagen et al 1990; Bach et al 1995). Segmental wall
motion abnormalities are reported to be common. They tend to occur in older patients
and are associated with less severe congestive failure, less LV dilatation and
improved one year survival compared with patients with diffuse disease (Wallis et al
1984). Digitised ventriculograms have shown that diastolic regional wall motion
abnormalities occur more frequently than systolic abnormalities (Sunnerhagen et al
1990), which was postulated to be due to a loss of myocardial elasticity in dilated
ventricles. The apical segments were more commonly associated with regional wall
motion abnormalities (Wallis et al 1984; Sunnerhagen et al 1990) and the proximal
lateral wall shows relatively preserved function (Bach et al 1995). The reason for
these segmental abnormalities in association with angiographically normal coronary
arteries in DCM is unclear, although a proposed mechanism is that they are a
consequence of heterogeneity of local wall stress (Sunnerhagen et al 1990; Bach et al
1995). Bach and colleagues (1995), however, showed that the regions with better
function were associated with improved regional oxidative metabolism, assessed by
carbon-11 acetate clearance positron emission tomography in an eight segment model
of the left ventricle, suggesting that other mechanisms were also responsible for the
heterogeneity of function.
In canine cardiology, coronary artery disease is presumed to be rare and is not
excluded in the investigation of DCM, in the same way as coronary angiography is
indicated in humans to rule out an ischaemic aetiology. However, a sibling of two
DCM dogs in this study with echocardiographic features consistent with a diagnosis
of DCM was shown to have a myocardial infarct at post-mortem examination
(personal communication; Dr. P.R. Wotton).
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Figure B.14.1.
Bizarre septal motion from a Newfoundland from the dFS<18% category (NF038/P538). If the start of
the QRS complex was used to prompt diastolic measurements, this corresponded to the nadir of the




Two-dimensional RPS short axis views of the left ventricle analysed by frame by frame advancing of
the videotape recording. Bizarre septal motion was recorded on the M-mode (Fig. 14.1.) from a
Newfoundland from the dFS<18% category (NF038/P538). If the start of the QRS complex was used
to define diastole, the septum appears flat (top). After the T wave of the same cardiac cycle,
representing systole, the septum has moved anteriorly rather than towards the left ventricular posterior
wall (bottom), explaining the bizarre M-mode appearance.
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It was interesting to note that the STIs determined from subcostal CW spectral
Doppler of aortic flow did indicate a degree of systolic dysfunction between the dFS
and Normal groups. This included Aovti, dv/dtmax, dv/dtmean, PEP or PEP/VR-R,
acceleration time or accel/VR-R and the PEP:ET ratio.
Most of the dogs in the dFS categories did not progress significantly or rapidly. Only
three out of the total of 53 scans and 34 different individuals in these two groups
have developed DCM, only one of whom is currently symptomatic. These data are
consistent with the depressed fractional shortening group of relatives of DCM
patients described by Baig and colleagues (1998). At the time of publication, most of
these patients remained similar on repeat examination (within three years) and these
workers suggested that depressed fractional shortening may be a limited
manifestation of DCM in patients with familial disease. Flowever, personal
communication with one of the researchers in this group has indicated that some of
these relatives have indeed developed DCM with longer follow up. Nevertheless, it
appears that both humans and Newfoundland dogs with depressed fractional
shortening deteriorate more slowly than dogs with left ventricular enlargement or
dilatation or showing increased sphericity of the LV chamber.
In general, dogs in the two dFS categories did not show evidence of diastolic
dysfunction, assessed by mitral inflow, PVF and IVRT.
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B.33. Newfoundlands with aortic velocities over 1.7 m/s or overt
subaortic stenosis
Forty dogs had peak aortic velocities (usually from a subcostal view) exceeding 1.7
m/s and were defined as subaortic stenosis (Lehmkuhl & Bonagura 1995). Of these,
23 had lesions evident by 2D echocardiography, such as echogenic nodules, or ridges
(57.5%) (Figures B.15.1., B.16. & B.17.). Twenty six cases (65%) had turbulent
blood flow assessed by CFDE determined presence of colour variance in the left
ventricular outflow tract, often associated with the 2D lesions where these were
imaged (Figures B.15.1., B.17.). CFDE showed that 27/40 dogs (67.5%) had
concurrent aortic regurgitation (Figure B.17.). These findings support the fact that
these dogs did have mild aortic stenosis (Lehmkuhl & Bonagura 1995).
The 2D echocardiographic findings recorded are entirely consistent with the
pathology of discrete subaortic stenosis in the Newfoundland breed described by Pyle
and others (1976). Pathologically, grade 1 SAS is recognisable on gross examination
as one or more small slightly raised whitish nodules on the endocardial surface of the
interventricular septum below the aortic valve. Grade 2 SAS is associated with a
narrow ridge of whitish, thickened endocardium extending partially around the
LVOT. In grade 3 SAS, a fibrous band or ridge completely encircles the LVOT. The
fact that the subvalvular lesions are acquired after birth (Jones et cil 1982) does not
confound this study, where dogs were all over 18 months old.
In canine subaortic stenosis, the use of colour variance at the level of the obstruction
has been described (Darke 1990; 1992). Visualisation of the jet of aortic stenosis may
be difficult (Khandheria et al 1986), and cranial RPS or LPS views are more likely to
be successful than apical views, limited in adults (and therefore it is presumed in
giant breeds of dog) by far-field imaging and the problem of attenuation of signal
strength (Khandheria et al 1986). Although the use of green encoded pixels to
identify dispersion or spectral broadening of the returning spectral Doppler signal has
been traditionally considered to be evidence of turbulent flow, Perry (1989) pointed
out that high velocity laminar flow, aliasing due to the Nyquist limit being exceeded,
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may be misinterpreted by machine software as turbulent flow, and this author urged
caution in interpreting the presence of turbulence from CFDE. Sahn (1988) went into
considerable depth about the physics of displaying colour Doppler images,
illustrating how an understanding of the physics was mandatory to interpretation of
images. However, despite these possibilities of misinterpretation, the appearance of
the colour variance map at the site of two dimensional subvalvular lesions (rather
than at the "core" of LV outflow) is supportive of genuine turbulence, as illustrated
in Figures B.15.1. and B.17.
A systolic heart murmur was detected in only 14/40 dogs (35%), with ten dogs with a
grade 1 /6 murmur, two dogs with a grade 2/6 murmur and one dog each with a grade
3/6 and a grade 4/6 murmur. It is striking that 26 of these dogs did not have an
audible heart murmur at the time of auscultation, or even retrospectively, knowing
the result of the Doppler velocity. The broad chest, thick hair coat and tendency to
pant confounds the use of auscultation as a screening tool for aortic stenosis in this
breed.
The aortic velocities, determined from the subcostal window, ranged from 1.71 to
2.15 m/s in dogs with no murmur detected (mean + sd: 1.87 + 0.14 m/s) (Figure
B.15.2.). In dogs where a grade 1/6 murmur was detected, the aortic velocities ranged
from 1.73 - 2.39 m/s (mean + sd: 1.92 + 0.19 m/s), and the two dogs with a grade
2/6 murmur had velocities of 1.92 and 1.79 m/s respectively. The aortic velocity in
the old dog with the grade 3/6 murmur was 2.24 m/s and in the young dog with the
grade 4/6 murmur was 3.94 m/s (Figure B.16.). No significant differences were
identified between the groups divided by murmur grade on Kruskall-Wallis One Way
ANOVA, although obviously data was limited in the higher grade murmur groups.
An unpaired two-tailed /-test of the data in the murmur free and grade 1/6 murmur
groups also failed to identify any significant difference between these groups. It
appears that factors other than the simple velocity of peak aortic flow determine the
audibility of the murmur and murmur grade. Many of these factors are dog related,
with massive conformation, the tendency to being overweight, the very heavy coats
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and the tendency to pant incessantly all confounding the use of auscultation. Operator
determined factors may also have played a role, although this could not be
investigated for this study and this breed without another cardiologist in attendance.
These findings are a serious concern, when The Newfoundland Club utilises
auscultation as a screening tool for aortic stenosis in this breed, with a cardiologist
attending most of the major shows. It may be argued that for this particular breed,
screening breeding stock by CFDE by an experienced echocardiographer is
preferable.
The failure to demonstrate a significant relationship between any of the 2D or M-
mode echocardiographic parameters and the peak aortic velocity obtained from the
subcostal view was surprising. However, it probably just reflects the fact that the
majority of dogs in the SAS group had only mild disease, as during the course of this
study, participation of dogs with congenital heart murmurs had not been solicited.
The trend to thicker IVS or LVpw in the SAS group was predicted, as compensation
for the increased afterload due to the presence of the stenosis. It was surprising to
identify larger 2D end-diastolic volume index (EDVI) and a tendency to larger M-
mode LV diameters in both diastole and systole in this group. However, Douglas and
colleagues (1987b) described a sub-group of human patients with subaortic stenosis
and reduced ejection fraction. These individuals were shown to have a larger LV
cavity, lower relative wall thickness (i.e. LVpwd/LVIDd) and therefore higher
circumferential wall stress than patients with subaortic stenosis with normal left
ventricular function, despite a similar LV mass in both groups. The sub-group with
lower ejection fraction also had altered LV geometry, with a more rounded LV
cavity, as determined by the ratio between LV minor axis dimension and length.
These authors concluded that the decreased pump function resulted in changes in LV
shape and increased wall stress which made it impossible for LV architectural
changes to normalise for increased afterload despite adequate LV mass (Douglas et al
1987b). It is possible that the general indication of low systolic function even in
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normal Newfoundlands compared with published reference ranges for normal dogs
resulted in similar changes occurring in Newfoundlands with aortic stenosis.
This group also tended to have larger left atria, presumably due to left atrial afterload
being increased ejecting into a stiffer LV, even if LV diastolic pressure was not
elevated. A trend to higher total LV stroke volume and stroke volume index was also
identified.
Although the significantly higher Aov and Aovti was expected in an SAS group, it
was striking that these dogs, with mild disease, showed significantly greater dv/dtmax
and dv/dtmean than other groups. Although this could be inferred to be a consequence
of the higher peak velocity, the fact that the aortic flow acceleration time and
accel/VR-R was lower than other groups indicates that this is genuinely due to
enhanced left ventricular systolic performance compensating for the fixed stenosis
and increased LV afterload.
Dogs with aortic velocities exceeding 1.7 m/s showed no conclusive evidence of
diastolic dysfunction in this study, probably because the disease was mild in most
cases. However, the group showed increased mitral Ev and Av and total vti than the
other groups, in the absence of significant MR in the group. The SAS group also
tended to have higher PVF velocities (Arv, Dv and R2v), and a higher total forward
vti and Svti than the other groups, although ratios were unremarkable.
PAv and tricuspid Ev and Av were also increased compared with the other
Newfoundland groups. The reason for increased velocities across all other
anatomically normal valves as well as PVF is difficult to explain. It is interesting that
the findings are not simply related to the left side. It is possible that generalised
myocardial compensatory changes result in enhanced systolic performance as a
consequence of the aortic stenosis. Without more detailed analysis of right sided
function, or determination of cardiac output, further conclusions about these
interesting observations cannot be drawn.
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Figure B.15.1.
Two dimensional right parasternal cranial long axis view of the aorta and left ventricular outflow tract
from a Newfoundland in the SAS group (Scan NF9/6). An echogenic nodule was evident below the
aortic valve (top) and this was associated with colour variance (bottom). (Mean aortic velocity: 1.81
m/s.). This dog did not have an audible heart murmur.
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Figure B. 15.2.
CW Doppler of aortic outflow from a subcostal view from a Newfoundland in the SAS group (Scan
NF9/6), as in Fig. 15.1. The mean aortic velocity was 1.81 m/s, while very calm.
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Figure B.16.
RPS cranial long axis 2D view of the left ventricular outflow tract and aorta from a Newfoundland
with subaortic stenosis ofmoderate severity (P301) (mean aortic velocity 3.94 m/s). A circumferential




RPS cranial long axis 2D view and CFDE of the left ventricular outflow tract and aorta from a
Newfoundland with mild subaortic stenosis (NF044/P285). Colour variance at the area of a distinct
subvalvular nodule is shown (top). Mild aortic regurgitation was also apparent (bottom). The mean
aortic velocity at presentation was 1.92 m/s (scan NF9/8) although on repeat examination,
corresponding to these images, the mean aortic velocity was 1.52.m/s (scan 17/7, "Normal" category).
The dog was systemically unwell and had shown considerable weight loss at the second examination.
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B.34. Other findings recorded
There were two sudden deaths recorded during this study, both in dogs included in
the Normal category. One bitch suddenly died, while exercising and eating cow-pats,
and the owner considered that she had asphyxiated, although no post-mortem was
carried out. Another sudden death, while running in a field, was recorded for a two
year old dog. Although echocardiographic/Doppler evaluation was limited in this
case, as the dog severely resented restraint, a full post-mortem examination by the
dog's veterinary surgeon and a detailed cardiac examination by Dr. Rod Else failed to
identify any significant abnormalities or the cause of death. A number of this dog's
litter mates did show minor evidence of subaortic stenosis and the brief 2D and
CFDE examination he received suggested that he had similar changes, consistent
with the pathological grade 1 SAS described by Pyle and others (1976), although this
was not confirmed by post-mortem examination. Consequently, caution in the
interpretation of these two-dimensional echocardiography abnormalities must be
urged.
Other findings during this study included two dogs, with echocardiographic findings
consistent with a persistent left cranial vena cava (Figure B.i8.). One dog was not
related to other dogs in this study, although he had other congenital defects,
particularly affecting his urinogenital system. The other was related to other dogs in
the study and he later developed evidence of occult DCM with atrial fibrillation.
Another congenital heart defect, an atrial septal defect, was identified in a dog
included in the Normal category, as, other than mild right atrial enlargement, it did
not appear to be haemodynamically significant.
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Figure B. 18.
Right parasternal long axis view optimised to show a persistent left cranial vena cava entering the right
atrium. Although "Normal" at the time of this scan, this dog (NF036/P40) did develop occult DCM
with atrial fibrillation.
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B.35. Influence of independent variables on the echocardiographic
parameters for the Newfoundland groups: Comparison with
the Normal group
Although a number of differences between the abnormal Newfoundland groups and
Normal Newfoundlands were identified with the respect to the influences of
independent variables on the 2D or M-mode echocardiographic or the Doppler
parameters under investigation, it proved difficult to draw any conclusions about the
meaning of such differences. The effect of these independent variables on
echocardiographic parameters for the different Newfoundland groups is, however,
detailed below.
B.35.1. 2D and M-mode parameters
LVdv was positively and significantly related to BSA or weight in Nonnal dogs, the
dFS<18% and SAS groups and more weakly with the DCM group, but not in the
dFS 18-20% or the LVE groups. Male gender had most influence over LVdv and
EDVI in the dFS 18-20% group. Age had a negative predictive influence on LVdv in
Normal dogs and this was also evident in the dFS<18% group. No parameter
significantly predicted LVdv or EDVI in the LVE group, although numbers were
small.
LVsv was positively influenced by BSA or weight and negatively influenced by age
in Normal dogs. Similar relationships to size were shown by the DCM, dFS<18%,
dFS 18-20% and the SAS groups. Only the SAS group showed a similar negative
predictive relationship with advancing age as the Normal group. The LVE group
showed that longer R-R intervals were associated with larger systolic volumes, which
was surprising as one would expect improved systolic emptying of the LV with
improved diastolic filling associated with longer cardiac cycles, by the Frank -
Starling mechanism. Although the LVsv SAS group was predominantly predicted
by BSA or weight, lengthening R-R interval was positively associated with larger
volumes in a multiple linear regression model. The ESVI in Normal dogs was
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significantly larger in males than females, even after normalising for BSA. Male dogs
with DCM also had significantly larger ESVI than females.
EF was not significantly predicted by these independent variables in Normal, dFS 18-
20% or SAS groups. The major positive predictor of EF was the R-R interval in dogs
with dFS<18%. The LVE group showed decreasing EF with advancing age. SV was
positively associated with BSA or weight and negatively associated with advancing
age in Normal and dFS<18% groups. The R-R interval predicted SV in dogs in
dFS<18% and dFS 18-20% groups.
In Normal dogs, LAad was positively influenced by age or BSA and R-R interval.
BSA influenced LAad in the dFS<18% group, but age was negatively predictive of
LAad in this group. In the SAS and dFS 18-20% groups, LAad was positively
influenced by size and also R-R interval. LAld positively associated with BSA or
weight in Normal dogs, and dogs in the dFS<18% and dFS18-20% groups. LAld in
the SAS group was positively influenced by the R-R interval. LAas and LAls were
influenced by BSA or weight in Normal, SAS and dFS<18% groups and also weakly
but significantly in the DCM group. LAls appeared to be significantly influenced by
gender in the dFS 18-20% group. 2D LAd was related to BSA or weight in Normal
dogs, and the dFS<18% or dFS 18-20% groups, although age was also a negative
predictor of LAd in the dFS<18% and LVE groups and male gender a positive
predictor of LAad in the dFS 18-20% group. In the Normal and dFS 18-20% groups,
the major predictor of the 2D LAdrAod ratio was the R-R interval. In dogs with
dFS<18%, body size was predictive of the 2D LAd:Aod ratio. In association with the
age related decline of LAd in the LVE group, the 2D LAd:Aod ratio also was
significantly negatively associated with age. Rather bizarrely, the LAEI declined in
larger dogs in the dFS 18-20% group which is difficult to explain as in the other
groups, it appears to be predicted by category rather than any independent variable.
LVIDd in Normal dogs was positively related to body weight or BSA and negatively
predicted by age. These associations were also evident in the dFS<18% group.
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LVIDd in DCM dogs was weakly correlated with body size. Dogs in the dFS 18-20%
and LVE groups also demonstrated the association between body size and LVIDd. In
the dFS 18-20% group, this parameter was also positively related to the R-R interval.
In dogs with SAS, LVIDd was only weakly positively related to R-R interval
(complementary to the effect of the R-R interval on the RVd measurement). No
significant association between LVIDs and any independent variable was apparent in
the Normal group, although this parameter was associated with size in the SAS
group, the dFS<18% and the dFS 18-20% groups and weakly so in the DCM group.
The dFS 18-20% also group showed a significant association between LVIDs and R-
R interval. When LVIDd and LVIDs were indexed to BSA, both were negatively
predicted by age in the Normal dogs. This was also evident for LVIDd/BSA in the
dFS-M 8% group.
IVSd and IVSs showed no relationship with any independent variable in Normal
dogs or dogs with dFS18-20% or SAS. In the DCM group, there was a trend to
thinner IVSs/BSA in male dogs. The dFS<18% showed thinner IVSs in female dogs,
although this gender influence was not apparent after indexing to BSA. IVSd in the
LVE group was negatively predicted by R-R interval. The %thFVS increased with
longer R-R interval in the dFS 18-20% group.
LVpwd and LVpws were influenced by BSA or weight in Normal dogs. In DCM
dogs, the only variable exerting an influence was the trend to increasing LVpwd/BSA
with advancing age. No independent variable influenced the LVpw parameters in the
dFS<18% group. In the dFS 18-20% group, male Newfoundlands tended to have
larger LVpwd and LVpws although the effect of gender was negated after indexing to
BSA. In the LVE group, LVpws/BSA decreased in association with advancing age
and %thLVpw also declined in older dogs. The LVpw parameters were not predicted
by any of the independent variables tested in the SAS group. IVS and LVpw
parameters are presumably predominantly affected by afterload rather than any of the
independent variables in the SAS group.
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LVpwd:LVIDd index was not influenced by any independent variable in Normal
dogs, although in dogs with dFS<18% it appeared to be negatively influenced by
body size and in dogs with SAS, it increased, presumably due to progressive
concentric hypertrophy in association with advancing age.
The index of sphericity, LVLd:LVIDd, was not significantly influenced by any
variable in Normal Newfoundlands or in any other group. The major influence on
this parameter appeared to be category.
FS% and EF(Teicholz) were not influenced by any independent variable in the
Normal group, the DCM group, the dFS 18-20% group or the LVE group. However,
in the dFS<18% group, these parameters were positively influenced by the R-R
interval. This suggests that optimised diastolic filling will improve systolic function
in this group. Rather surprisingly, in the SAS group, both FS and EF significantly
decreased in larger dogs, negatively associated with weight or BSA.
In Normal dogs, mitral EPSS showed an association with body size, which was still
apparent after normalising to LVIDd. EPSS/LVIDd significantly decreased in the
dFS<18% group in association with longer R-R interval. R-R interval did not
influence this parameter in Normal dogs. It may be inferred that EPSS declines with
improved diastolic filling and more open mitral valve early in diastole with longer
cardiac cycles.
M-mode LAs and Aod were both influenced by weight or BSA in normal dogs. Dogs
with dFS<18% showed a predictive effect of size on LAs. Dogs with dFS 18-20%
only showed a significant positive influence of BSA or weight and age on Aod,
although the effect of age was no longer apparent after indexing Aod to BSA. In
contrast, the Aod in the LVE group appeared to significantly decline with increasing
size, but it must be remembered that numbers were small in this category. Female
dogs with SAS had larger Aod/BSA. The M-mode LAs:Aod ratio was not predicted
by any independent variable in Normal dogs, although this ratio was greater in male
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Newfoundlands with DCM than females. In dogs with DCM, LAs increased with
advancing age. Aod was influenced by body size in the DCM group.
In Normal Newfoundlands, no significant independent variable influenced
MAMseptal. This was also true in the DCM and dFS<18% groups. However, in the
dFS 18-20% group, a significant negative relationship was identified between
MAMseptal and R-R interval. In contrast, the R-R interval was a significant positive
predictor of MAMseptal in the SAS group. In the LVE group, significant positive
predictors of MAMseptal were identified as R-R interval and body weight (or BSA)
in a multiple linear regression model. MAMlateral was negatively influenced by age
in Normal dogs and the dFS<18% and dFS 18-20% groups. Body weight was the
major significant predictor of MAMlateral in the DCM group and was also a positive
predictor in the dFS 18-20% group. When MAMmean was considered for Normal
dogs, the R-R interval, age and gender all significantly influenced the parameter in a
multiple linear regression model, although significant simple linear regression
relationships were only identified for age (a negative predictor) and gender (larger
values in male dogs). In the SAS group, similar influences of R-R interval and age
were identified for MAMmean. MAMmean was not significantly influenced by any
of the independent variables under consideration in the DCM, dFS<18%, dFS 18-20%
or the LVE groups.
B.35.2. Doppler parameters ofAortic flow
In Normal dogs, Aov tended to decline with lengthening R-R interval, and this
relationship was also identified in the dFS 18-20% group. Aovti tended to decline
with advancing age in the DCM group, similar to the Normal Newfoundlands. The
dv/dtmax was only significantly influenced by R-R interval in Normal
Newfoundlands. However, in the LVE group, both age and gender appeared to be
independent predictors of this parameter in a multiple linear regression model, with
values tending to be negatively associated with age and the female gender. Aortic
dv/dtmean decreased in relation to longer R-R values in Normal Newfoundlands and
dogs in the dFS 18-20% group. Acceleration time was apparently significantly
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predicted by gender in Normal Newfoundlands and the SAS group, with longer
acceleration time in male dogs. This apparent gender influence in the SAS group was
lost after indexing to VR-R, although it was retained in the Normal group. The LVE
group showed a positive association between acceleration time and age, although this
relationship was no longer apparent after indexing to VR-R.
PEP tended to increase with lengthening R-R interval in Normal dogs, and this
relationship was also shown in the dFS 18-20% group and the SAS group. Although a
significant trend to longer PEP in male dogs in the Normal population, this
relationship was not evident after indexing to VR-R and no gender influence was
identified in the other Newfoundland groups. However, PEP did increase with
advancing age in the dFS 18-20% group and the LVE group, despite no evidence of
age prediction on this parameter in the Normal group. However, the relationship
between age and PEP was no longer apparent in the LVE group after indexing to
VR-R.
The association of ET and R-R interval identified in Normal Newfoundlands was
also evident in the dFS<18%, the dFS 18-20% and the SAS groups. However, also
influencing this parameter in the Normal group and both dFS categories was age (ET
tended to decrease with advancing age) and gender in the dFS<18% group (ET
tended to be greater in bitches). The influence of age was abolished for ET/VR-R in
the Normal and dFS 18-20% group.
The trend to increasing PEP:ET ratio in DCM dogs with advancing age was also
present in the dFS 18-20% and the LVE groups, although was not evident in the
Normal Newfoundlands, and the age influence was no longer apparent in the LVE
group after PEP:ET was indexed to VR-R. In Normal Newfoundlands, Vcf was not
significantly influenced by age, but the DCM group and the dFS 18-20% groups
showed an age related increase in Vcf, which was difficult to explain. In contrast, the
non-significant trend to a negative relationship between Vcf and advancing age
became statistically significant for VcfVR-R and age in the SAS group. VcfNR-R
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also appeared to be influenced by gender in the dFS 18-20% group in a multiple linear
regression model (with age), with a trend to higher Vcf in bitches, although this
gender influence was not apparent in a simple linear regression model.
B.35.3. Doppler parameters ofmitral inflow
In Normal Newfoundlands, mitral Ev, the E:A velocity ratio, Ev/total vti, Evti, E:A
vti ratio and Evti/total vti were all significantly negatively influenced by age. Age
was also one of the independent variables influencing the E:A velocity ratio in the
dFS 18-20% group in a multiple linear regression model with body weight and in the
SAS group in a multiple linear regression model with R-R interval. Age was also
found to be an independent predictor of Ev/total vti in the SAS group. In Normal
Newfoundlands, mitral Avti/total vti was significantly positively associated with age.
Normal Newfoundlands showed a positive relationship between age and E duration
(and Edur/VR-R) and E deceleration time (and E decel/VR-R). Dogs in the SAS
group also showed a significant relationship between E duration and deceleration
time and age, although, in contrast to the Normal group, these relationships were no
longer apparent after these parameters were indexed to VR-R interval. The SAS
group showed a positive relationship of mitral A wave duration and Adur/VR-R with
age.
In Normal Newfoundlands, body weight (or BSA) only significantly influenced Avti.
However, in the DCM group, body weight appeared to be a significant predictor of a
number ofmitral inflow parameters. Ev:Av and Ev/total vti increased in heavier dogs
and A duration (Adur/VR-R) were negatively associated with weight. Body weight
also positively influenced Ev:Av in the dFS 18-20% group. A similar relationship of
E:A velocity ratio to body weight was also evident in the LVE group, although in a
multiple linear regression model including R-R interval. In multiple linear regression
models, increasing body weight was associated with a decrease in Av/total vti and
Avti/total vti and an increase in Evti/total vti in the dFS 18-20% group. Weight was a
significant positive predictor ofEvti/total vti and a negative predictor of Avti/total vti
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in the SAS group. These relationships were in contrast to findings in the Normal
group.
Mitral E:A velocity ratio was positively associated with R-R interval in Normal
Newfoundlands and the SAS group. Evti and the E:A vti ratio were significantly
associated with R-R interval in the SAS group. Av tended to decrease with
lengthening R-R interval in Normal Newfoundlands and the SAS group, and this
parameter, normalised to total mitral vti (Av/total vti), showed a similar relationship
in the dFS 18-20% and the SAS groups. Dogs in the dFS 18-20% group also showed a
significant positive relationship between the proportion of early LV filling
(=Evti/total vti) and a significant negative relationship between the proportion of late
LV filling (=Avti/total vti) and the R-R interval.
In Normal Newfoundlands, female gender was found to positively influence Avti and
Avti/total vti. It negatively influenced the E:A vti ratio. In the dFS<18% group, a
number of other predictive effects of gender were identified. Evti was significantly
greater in male Newfoundlands and there was a non-significant trend to male dogs
showing higher mitral E:A velocity ratio than females. Female dogs showed higher
Av/total vti. E deceleration/VR-R was significantly longer in females in the DCM
group, although no gender influence had been apparent on this parameter in Normal
Newfoundlands or in the other Newfoundland groups.
In Normal Newfoundlands, E duration was significantly influenced by R-R interval
as well as age. A similar positive relationship between E duration and R-R interval
was identified in the dFS 18-20% group. E deceleration time was significantly
influenced by the R-R interval in Normal Newfoundlands. A duration was positively
associated with R-R interval in Normal Newfoundlands, and the SAS and dFS<18%
groups.
IVRT was positively related to age in the Normal group, but the other Newfoundland
groups did not show any relationship of any independent variable on this parameter.
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B.35.4. Doppler parameters of pulmonary venous flow
In Normal Newfoundlands, age significantly influenced a number of the PVF
parameters. Arv, Sv, S:D velocity ratio, Svti, S:D vti ratio and the systolic fraction of
total forward vti (=Svti/total vti) all increased with advancing age. The DCM group
showed a similar but negative association of Sv and S:D vti ratio and age although
these relationships did not achieve statistical significance. D duration (and Ddur/VR-
R) significantly decreased with advancing age in the DCM group. D deceleration
time and D decel/VR-R significantly increased with advancing age in the LVE group.
In Normal Newfoundlands, the S:D velocity and vti ratios and Svti/total vti all
decreased with lengthening R-R intervals. Sv:Dv was also negatively associated with
the R-R interval in the dFS 18-20% and the LVE groups. R2 velocity tended to
increase with longer R-R intervals in Normal dogs. S and D durations and D
deceleration time were all positively associated with R-R interval. In the DCM
group, Dv tended to decrease with lengthening R-R interval. R2 velocity increased
with R-R interval, similar to the Normal group. In the dFS<18% and dFS 18-20%
groups, both Arv and Sv declined with lengthening R-R interval. A similar
relationship was shown for Ar duration in the SAS group. The DCM group also
confirmed the expected influence of R-R interval on S and D durations and D
deceleration time, seen in Normal dogs. In the dFS 18-20% and the SAS groups, R-R
interval only significantly influenced D duration and D deceleration time. In the
dFS<18% group, R-R interval only influenced D deceleration time.
Although gender did not influence any of the parameters of PVF in the Normal
Newfoundlands, in the DCM group, sex influenced D deceleration time (and
Ddecel/VR-R); values were longer in females. In the SAS group, in a multiple linear
regression model, gender was shown to influence Dvti (with body weight), with a
trend to higher Dvti in male dogs.
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Body weight did not influence any of the PVF parameters in the Normal
Newfoundlands. However, in the LVE group, Dv velocity was significantly
positively influenced by body weight. Conversely, in the SAS group, Dv and Dvti
were negatively associated with increasing body weight. The SAS group also showed
a significant positive predictive influence of body weight on S duration and Sdur/VR-
R. In the dFS18-20% group, R2 dur/VR-R was positively influenced by weight in a
multiple linear regression model. It is difficult to explain the influence of body
weight on these parameters, particularly when in some groups, it appears to exert
opposing effects.
B.35.5. Right sided function
In Normal Newfoundlands, PAv tended to decline with lengthening R-R interval, and
increasing age. In the DCM, dFS<18%, dFS 18-20% and SAS groups, a similar
negative association was identified for age, although this was evident only in the RPS
recording of pulmonic flow in the DCM and dFS 18-20% groups and the LPS view in
the dFS<18% and SAS groups. The influence of R-R was not statistically significant
in the other groups.
Tricuspid Ev and E:A velocity ratio decreased with advancing age in Normal dogs.
The dFS<18% group also showed an age related decrease in E wave velocity,
although the E:A velocity ratio was not significantly affected. The R-R interval
negatively influenced the tricuspid Av and positively influenced the tricuspid E:A
velocity ratio in Normal dogs. The DCM and SAS groups also showed an R-R
interval determined decrease in Av although tricuspid Ev:Av was not significantly
affected in the DCM group, although age influenced this ratio in the SAS group in a
multiple linear regression model.
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B.36. Serial scans in the Newfoundland population
Serial scans were undertaken in 54 dogs. When the serial scans were compared, a
large number of differences were identified between the initial and second or final
scan recorded for each individual, when the method of comparison used was the
value of the percentage difference of the means and whether this exceeded the
maximal value of the standard deviation expressed as a percentage of the mean for
one of the scans. The Student t test also identified significant differences, and in
general, as anticipated, these tended to identify the same parameters as the initial
method. It may be argued that this technique in comparing scans is too conservative.
Although it does take into account actual changes in the echocardiographic parameter
under consideration, possibly as a consequence of evolving cardiac disease, it fails to
consider day to day variation in the dog. Some dogs showed considerable changes
between serial scans, in body weight, or heart rate between scans. If dogs became
obese, it was much more difficult to obtain diagnostic images, or Doppler parameters
with good signaknoise ratio. Even though the same operator and observer performed
and measured all the serial scans, it is probable that there will be differences in
technique and skill between the scans obtained at the beginning or towards the end of
the study. Consequently, it was decided that a more valid method of comparing the
serial scans was using the pooled coefficient of variation (c.o.v.) data from the boxer
repeatability study. The fact that these data were generated from a different breed
may be criticised. Boxers show more beat to beat variation as a result of accentuated
sinus arrhythmia not generally evident in Newfoundlands. However, the quality of
boxer echocardiographic images and the signal:noise ratio is generally better than in
Newfoundlands, and the author presumes that an equivalent repeatability study in
Newfoundland dogs would have resulted in greater coefficients of variation than
boxers. Both operators and observers were very familiar with boxer
echocardiographic images, whereas the second operator/observer in the repeatability
study was far less experienced with Newfoundland images and this may also have led
to a higher coefficient of variation in this breed. The day to day repeatability in the
boxer study was over consecutive days, whereas in the Newfoundland study, the
serial scans were many months apart. In conclusion, use of the boxer repeatability
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c.o.v. data for comparison with the Newfoundland serial scans is valid, and probably
is still fairly conservative.
B.36.1. Normal Newfoundland category
There were some marked differences between scans for the 2D echocardiographic
LV parameters. Most marked was NF063/P244, where the initial LV volume was
significantly smaller than the second scan. Since the LV length is small, it can be
concluded that this is due to differences in imaging plane between the two scans. It is
probable that the LV length and area was not maximised in the initial scan. Almost
certainly, this was the greatest reason for differences between consecutive scans, as
these parameters are exquisitely image plane dependent. Similar factors apply to the
two dimensional echocardiographic criteria of the left atrium and aorta. Again, some
marked differences between scans from the same individual are more likely to be due
to a failure of regaining identical or correct imaging positions.
In general, the greater accuracy in obtaining M-mode echocardiographic images is
reflected by the lower percentage differences between the means for these parameters
in the Normal Newfoundland category. There were some marked differences
identified, however, these could be explained by the presence of concurrent disease
in two dogs (Dogs NF015/P42 and NF053/P229). Dog NF015/P42, with multicentric
lymphoma at the time of her final scan, was nearly always a significant outlier in the
data comparing serial scans regarding parameters of systolic function.
In general, results of percentage differences between scans for the same individual
with respect to the Doppler parameters were more consistent with the c.o.v. data
from the repeatability study. Unfortunately, where results were discordant, it is much
more likely to be a consequence of image plane and angle dependence of these
parameters.
In evaluating the serial scans from individuals judged to be normal, no attempt was
made to correct for heart rate or any of the independent variables known to influence
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various echocardiographic parameters in normal individuals. It is probable that if this
had been done, less variability would have been evident.
In assessing whether differences between serial scans are genuine, further
information is required. The individuals defined as being normal have to be
confirmed to be normal with future repeat scans and preferably by post-mortem
examination at the end of their natural lives. Future analysis should include all scans
and not just the initial and final scan. Correction for changes in body condition, heart
rate and probably age, where these are significant, should be made to allow valid
serial comparisons to be made.
One general conclusion may be made, based on the serial scans from the
Newfoundland group judged to be normal and the repeatability study. For most of the
echocardiographic parameters under consideration, a difference between scans of
more than twenty percent is likely to be significant, provided that both scans are of
optimal diagnostic quality.
B.36.2. Dilated cardiomyopathy category
If this arbitrary figure of >20% was used to determine whether changes between
serial scans were significant, general trends to increasing left ventricular volumes and
left atrial size were identified in a number of the DCM Newfoundlands. The one dog
who showed considerable echocardiographic improvement associated with
optimising therapy (NF002/P500) showed a significant decrease in LV systolic
volume.
Although the trends, achieving a significant difference exceeding 20%, of increasing
M-mode left ventricular minor axis dimensions was expected with the progression of
DCM, it was not evident in all dogs, and in NF002/P500 in particular, decreases were
evident, presumed to be a consequence of successful treatment. It was surprising to
find that in many of the DCM dogs, the IVS and LVpw (diastole and systole)
increased in many of the dogs. This presumably represents an attempt at
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compensatory hypertrophy in the early stages of this disease. Although FS% varied in
either direction between sequential scans, it was unequivocally low. As expected,
there was a trend to increasing mitral EPSS between scans in the same individual
with progressive disease, although this could be reversed, presumed to be due to
successful treatment. M-mode LAs decrease was in contrast to the 2D LA
parameters, and this probably reflects the altered geometry of the LA and LV, making
it difficult to maintain M-mode cursor position through the same part of the LA
during sequential scans. No consistent change in the long axis contractility of the LV,
assessed by MAM, was identified, although values tended to be low as expected in
this DCM category.
The Doppler parameters of aortic flow in the DCM group indicate some differences,
particularly in aortic velocity, which are not dependent on the underlying disease
process, but rather reflect the importance of repeatable image acquisition and angle of
interrogation for Doppler evaluation. However, these data indicate that the use of
Doppler parameters and particularly STIs are extremely useful at indicating
progression of disease. Only one dog showed an apparent improvement in PEP:ET
ratio and shorter PEP (NF042/P542), but this individual was one with marked
differences in recorded aortic velocity between scans and such differences may
reflect variability in scan technique rather than genuine variation in this individual.
The mitral inflow parameters do not show significant trends in any particular
direction in association with disease progression with time in the DCM group. This is
not unexpected, since there were few significant differences identified in the mitral
inflow parameters when comparing Newfoundland groups. Similarly, no significant
trends were identified in general for the DCM group with regard to the parameters of
PVF. Although four dogs showed a decrease in Sv, these were not the same four dogs
with an increased Dv, so it does not appear that the Sv:Dv ratio monitors progression
ofDCM.
Fewer differences of significance were identified for PAv from the LPS view than the
RPS view, suggesting that the LPS view, as well as usually resulting in higher
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velocities, is more repeatable. No general pattern was evident with progression of
DCM over time with respect to the tricuspid inflow parameters.
B.36.3. Depressed fractional shortening categories
There were surprisingly few differences in the 2D LV or LA echocardiography
parameters between serial scans for most individuals in this final category. Again,
M-mode criteria were surprisingly similar between scans, with few differences
exceeding 20%. One peculiar exception was NF037/P48, who showed a dramatic
decrease in LVIDd. Although this dog had gained six kilograms weight between the
two scans, it is otherwise difficult to explain such a discordant result, unless it was
measurement error (for example, the M-mode cursor in the initial measurement was
obliquely positioned across the LV).
The Doppler parameters of aortic flow also showed few significant differences
between sequential scans for the individuals in the dFS categories. Again, the trend to
negative differences between the means for the corrected PEP:ET ratio in the
majority of this group, which indicates larger values for the ratio for the repeat scans,
supports the fact that this is a sensitive parameter for evolving deterioration in
systolic function.
The Doppler parameters of mitral inflow failed to demonstrate any significant trends
consistent with disease progression. In many cases, where there were significant
decreases or increases in velocity or vti of E or A waves, these affected the same
individual to a similar degree (e.g. NF006/P243), suggesting that such differences
reflected different angle of interrogation or image position rather than genuine
changes in mitral inflow. The PVF parameters for the dFS categories also showed
surprisingly few significant differences between scans, and these probably reflect the
repeatability issues rather than changes inherent in individual dogs. It is probable
that the right sided parameters reflected differences between the images acquired and
the angle of interrogation between scans, although there did appear to be a trend to
decreasing PAv from either view in the later scans.
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B.36.4. Left ventricular enlargement category
Although no significant differences greater than 20% were identified for the 2D LV
echocardiographic parameters were recorded between the two scans for this
individual, by the time of the second scan, the LV was assessed to be rounded, and
the only reason the author was reluctant to identify this dog as occult DCM was the
presence of a fractional shortening >20% and the absence of any supporting
arrhythmia. The evidence of LAad increase supported the fact that this individual
was probably developing DCM. The dramatic decrease in FS%, even though it
remained above 22%, and increase in mitral EPSS adds further supportive evidence.
The significant decreases in dv/dtmax and dv/dtmean and Vcf and increase in
acceleration time despite minimal differences in Aov or Aovti are also supportive of
deteriorating systolic function. Mitral inflow parameters were probably not of great
importance in determining disease evolution, although of note was the fact that the
IVRT was >20% shorter than the initial scan despite similar heart rates.
B.36.5. Category with aortic velocity >1.7 m/s
Although some dogs were identified with significant increases in LV or LA
parameters, it is difficult to separate genuine trends from a lack of optimal
repeatability. There were very few differences identified between scans from the
particular individuals with regard to the M-mode echocardiographic data. FS%
significantly increased in two individuals, NF005/P515 and NF058/P256, both of
which had depressed fractional shortening initially. Although significant differences
in Aov were identified in this group, with associated significant differences in Aovti
and dv/dtmax and dv/dtmean, it is much more probable that the differences were due to
inadequate alignment with aortic flow during at least one of these scans. Despite the
depressed fractional shortening identified in two individuals on at least one occasion,
the lack of progression of PEP:ET ratio suggests that these cases do not have
progressive systolic dysfunction. No significant trends were identified for the
differences between scans for the mitral inflow parameters or the pulmonary venous
flow parameters.
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In conclusion, it is apparent that it is difficult to distinguish between significant
trends due to progression of cardiac disease and variability due to differing imaging
planes and angles of interrogation. In general, differences have to exceed 20% to be
presumed to be genuine rather than artefactual, although this varies between
parameters, and the repeatability data from the boxer study (Appendix B.8.) forms a
guide for values (coefficients of variation) which need to be exceeded before a
genuine difference can be accepted.
Although serial evaluation of humans has been alluded to in evaluation of relatives of
DCM patients (e.g. Baig et al 1998) and has been advocated in Dobermann dogs
(O'Grady & Home 1992; 1998; Calvert 1995b; Calvert et al 1997b), there are no
published reports giving the details of changes identified in humans or dogs.
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SECTION C
THE GENETICS OF DILATED CARDIOMYOPATHY IN
MAN AND DOGS AND PRELIMINARY WORK TO
INVESTIGATE THE POTENTIAL FOR GENETIC
LINKAGE ANALYSIS IN NEWFOUNDLAND DCM
A REVIEW OF THE LITERATURE
C.1. Familial dilated cardiomyopathy in man
Until recently, DCM in man was considered to be a sporadic disease (Fragola et cd
1988; Valantine et al 1989; Michels et al 1992; Mestroni et al 1994a). Occasional
reports of familial DCM were published as exceptions (Ross et al 1978; Voss et al
1984).
Currently, however, familial DCM (FDCM) is recognised to account for more than
20% cases of all cases of DCM (Michels et al 1992; Keeling & McKenna 1994;
Mestroni et al 1994a;b; Goerss et al 1995; McMinn & Ross 1995; Mestroni et al
1995; Gavazzi et al 1998; Grtinig et al 1998).
C.1.1. The inheritance of human FDCM
Human FDCM is most commonly transmitted as an autosomal dominant trait,
(Gardner et al 1987; Schmidt et al 1988; Michels et al 1992; Keeling & McKenna
1994; Mestroni et al 1994a,; Durand et al, 1995; Keeling et al 1995; Krajinovic et al
1995; Mestroni et al 1995; Bowles et al 1996; Olson & Keating 1996; Messina et al
1997) although X-linked dominant (Mestroni et al 1994a), X-linked recessive
(Neustein et al 1979; Valantine et al 1989), matrilineal (mitochondrial) (Zeviani et al
1991; Suomalainen et al 1992; Mestroni et al 1994a), autosomal recessive (McMinn
& Ross 1995) and polygenic (Zachara et al 1993) modes of inheritance have been all
been proposed in various families (Keeling & McKenna 1994; Mestroni et al 1995).
It is now known that FDCM is not a homogenetic condition (Mestroni et al 1994a;b;
1995; Durand et al 1995). FDCM has proved to be a phenotypically (Grtinig et al
1998) and genetically heterogeneous (Schultz et al 1995) disease.
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Human FDCM is most commonly due to the presence of a single dominant locus
(Michels et al 1992; Mestroni et al 1994a). The gene frequency is estimated to be
10"4 in the overall population (Mestroni et al 1994a; b). Because of the variable and
histological heterogeneity of DCM in family members, incomplete penetrance is
suspected. This may merely reflect an age related penetrance, with delayed age of
onset, with penetrance increasing in older age groups (Mestroni et al 1994a). Keeling
and others (1995) estimated that penetrance in their series of 40 families was variable
and incomplete (65 - 95%) and the likelihood of an affected individual transmitting
DCM to a child was 20%.
C.1.2. Molecular genetics of human FDCM
Cardiology as a discipline was initially slow to use the resources provided by the
human genome project but recently genetic cardiology has been increasingly
important (Schwartz 1994). A genome based resource is now available for molecular
cardiovascular medicine, based on expressed sequence tags (ESTs) generated from
human heart cDNA libraries (Hwang et al 1997). In identifying a genetic defect,
traditionally, a biochemical defect leads to identification of the responsible gene,
with demonstration of the mutation in this gene (the technique is known as functional
cloning). In human FDCM, however, the underlying biochemical defect is unknown,
and reverse genetics can be applied, or a positional cloning strategy (Marian &
Roberts 1993). This technique detects linkage of the disease with an often
anonymous chromosome locus, following which an attempt to identify genes
encoded at that locus can be made. Initially these markers were restriction fragment
length polymorphisms (RFLP) (Schwartz 1994) where 200 - 300 covered the human
genome (Mestroni et al 1994a). More recently, hypervariable and highly polymorphic
markers, amplified by the polymerase chain reaction (PCR) were described leading to
accelerated identification of new loci for human diseases. These markers are short
interspersed tandem repeats of nucleotides in dinucleotide, trinucleotide or
tetranucleotide sequences which are distributed throughout the human genome, called
microsatellite markers (Marian & Roberts 1993). High density linkage maps are
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available for the human genome (Weissenbach et al 1992). Over 2000 microsatellite
markers cover the human genome (Marian & Roberts 1993; Schwartz 1994).
The molecular genetics behind the technique of linkage analysis has been described
for clinicians by Mestroni and colleagues (1994a;b; 1995). The aim is to correlate
one of the known markers with transmission of the disease. Where they are linked,
this implies that the disease gene and the marker lie in the same chromosome region.
The probability that the genetic marker and the disease gene are linked is expressed
as a LOD (logarithm (base 10) of the odds) score. A LOD score exceeding +3
supports linkage with 95% confidence (=1:1000 odds for linkage) and a LOD score
of less than -2 implies that there is no linkage (=1:100 odds against linkage). LOD
scores vary as a function of 0, the recombination fraction, the frequency with which
two loci recombine during meiosis. By calculating the frequency of the
recombination events, the genetic distance between two loci can be estimated. If
linkage exists with a recombination fraction, 0 = 0, the distance between the disease
gene and the marker gene is close; there is tight linkage and the two genes are
always inherited together. In contrast, a recombination fraction, 0 = 0.5 implies that
the two loci segregate fully independently and there is no linkage (Mestroni et al
1994a).
The mapping of a chromosomal location of the disease gene can lead to study of this
area with identification of the gene and its cloning with subsequent detection of
markers responsible for the disease. For linkage studies to be successful, a large
family is required, with members in several generations. The disease must be a
homogenous trait with a known pattern of transmission and penetrance (Mestroni et
al 1994a) and an accurate definition of the physical characteristics of the condition
(phenotype) is required (McMinn & Ross 1995). In addition, the disease must be
correctly diagnosed; an incorrect diagnosis will affect the interpretation of the linkage
analysis (Marian & Roberts 1993). Indeterminate members may (Mestroni et al
1994b) or may not be included (Goerss et al 1995). With DCM, the variable
penetrance of the disease, the absence of early clinical markers and premature
268
mortality is recognised to be a significant obstacle in collecting human families that
are adequate for linkage analysis (Mestroni et al 1995). The lack of confirmed
diagnostic criteria for the pre-clinical stages of DCM make phenotyping relatives
difficult (Keeling & McKenna 1994; Baig et al 1998). All these factors confound the
production of an informative pedigree suitable for linkage analysis.
C.1.3. Human FDCM identified to date by Linkage Analysis
Despite these difficulties, a range of chromosome loci have successfully been
identified in some human families with DCM, as indicated in Table C.l. In most of
these cases, a distinct phenotype, possible as part of a syndrome, has been identified.
TABLE C.l.
Chromosome loci linked with human dilated cardiomyopathy
Chromosome Locus Phenotype Reference
Chromosome 1 lq32 DCM Durand et al 1995
Chromosome I lpl-lql Conduction disease and DCM Kass et al 1994
Chromosome 3 3p22 - q25 Conduction disease and DCM Olson & Keating 1996.
Chromosome 6 6q23 Conduction disease, adult onset
limb-girdle muscular dystrophy
and DCM
Messina et al 1997.
Chromosome 9 9q13 - q22 DCM Krajinovic et al 1995
Chromosome 10 10q21 - q23 DCM and mitral valve prolapse Bowles et al 1996.
Chromosome X Xp21 DCM with or without Duchenne
/ Becker muscular dystrophy
Towbin et al 1993
Muntoni et al 1993
Franz et al 1995
Muntoni et al 1997.
Chromosome X Xq27-28. DCM with or without Emery-
Dreifuss muscular dystrophy
Hodgson et al 1986
Cartegni et al 1997
Chromosome X Xq28 DCM with or without Barth
syndrome, various X-linked
infantile DCMs
Bolhuis et al 1991
Bione et al 1996
D'Adamo et al 1997.
C.1.3.1. Autosomal loci
Chromosome locus lpl-lql
Graber and colleagues (1986) described a phenotypically distinct condition
characterised by arrhythmias associated with perturbed atrioventricular conduction
which progressed to four chamber dilatation and impaired systolic function, with
autosomal dominant transmission and high penetrance. Kass and colleagues (1994)
identified the locus at the centromeric region of chromosome 1, with a maximal LOD
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score of 6.28 at 9=0.1. A form of limb girdle muscular dystrophy (type IB), has also
been linked to this region (van der Kooi et al 1997) which has been proposed to be
allelic (van der Kooi et al 1997; Messina et al 1997). The proposed candidate gene,
encoding connexin 40, is also centromeric.
Chromosome locus lq32
Durand and colleagues (1995) identified autosomal dominant DCM in a family of 46
members over four generations, with ten affected individuals. Two-point linkage
analysis identified the locus at lq32 with a highly significant LOD score of 6.37 at
0=0.
Chromosome locus 9ql3 - q22
Krajinovic and colleagues (1995) detailed a large, Italian six generation kindred of
eighty members, thirteen of who were identified with autosomal dominantly
transmitted DCM. Linkage was established and multipoint linkage analysis identified
the locus at 9ql3-q22, with a peak LOD score of 4.2 at 0 = 0.
Chromosome locus 1Oq21-q23
Familial autosomal dominant cardiomyopathy with mitral valve prolapse linked to
chromosome 10 q21 - q23 was reported by Schultz and colleagues (1995) and
Bowles and others (1996). A significant LOD score of 3.91 at 0=0 was obtained.
Candidate genes in this region include muscle membrane proteins such as vinculin,
metavinculin, actin. ankyrin and laminin, i.e. cytoskeletal proteins.
Chromosome locus 3p22 - q25
Olson and Keating (1996) described a family of 26 individuals, thirteen of whom
were affected, with abnormal cardiac automaticity and conduction with progression
resulting in dilated atria and / or ventricles with systolic failure and congestive heart
failure. Transmission was autosomal dominant, with high penetrance. A LOD score
of 6.09 at 9 = 0 was achieved.
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Chromosome locus 6q23
Messina and colleagues (1997) identified the locus associated with DCM, conduction
system disease and an adult onset limb girdle muscular dystrophy in a large French
Canadian kindred with autosomal dominant inheritance. Linkage analysis resulted in
a LOD score of 4.99 at 0 = 0, linking the disease locus to chromosome 6 q23.
C.1.3.2. X-linked DCM
C.1.3.2.1. Duchenrte / Becker muscular dystrophy
Dystrophin is the product of the Duchene / Becker muscular dystrophy gene. It is a
large, sarcolemmal, cytoskeletal protein that forms an integral part of the oligomeric
membrane associated protein complex known as the dystrophin - glycoprotein
complex (Stevenson et al 1998). This complex tightly associates cytoplasmic, trans¬
membrane and extra-cellular components, and includes the four proteins of the
sarcoglycan subcomplex, linked laterally to p-dystroglycan (fomerly called 43-
DAG). P dystroglycan is bound to a-dystroglycan (a peripheral extracellular
membrane protein), which is in turn is linked to laminin-2 (formerly known as
merosin). The multiple protein interactions and the internal membrane cytoskeleton,
mechanically coupled to the extracellular matrix, are strategically placed to
strengthen the plasma membrane during muscle contraction (Stevenson et al 1998).
Lack of dystrophin in Duchenne / Becker muscular dystrophy results in reduced
capacity of the plasma membrane to withstand mechanical forces imposed by
repeated muscle contraction, leading to damage, progressive necrosis and
degeneration (Stevenson et al 1998).
Duchenne / Becker muscular dystrophy (MD) typically affecting young boys is
associated with DCM and the cardiac involvement is frequently the cause of death in
these patients (McMinn & Ross 1995). Duchenne and the milder Becker MDs are
allelic disorders, both resulting from mutations of the dystrophin gene (Muntoni et al
1997). Myocardial involvement was found to be frequent in patients with subclinical
or mild Becker's muscular dystrophy (Melacini et al 1996). It was postulated that the
absence of significant myopathy led to such patients undertaking exercise, with the
271
resulting volume or pressure overload harming the dystrophin-deficient myocardium.
Cardiomyopathy may be the only sign of dystrophinopathy in female carriers of
Duchenne / Becker MD (Mirabella et al 1993; Nigro et al 1995; Politano et al 1996).
Additionally, a dominant X-linked DCM has been shown to occur unassociated with
a skeletal myopathy, affecting males in their late teens, early 20s and females over
50. The disease is more severe and rapidly progressive in males than females (who
are heterozygous) (Berko & Swift, 1987). Linkage analysis has identified linkage for
X-linked DCM to Xp21, the dystrophin locus (Muntoni et al 1993; Towbin et al
1993). A deletion involving the first exon containing the muscle promoter of the
dystrophin gene was identified in all affected patients by Muntoni and colleagues
(1993) who speculated that dystrophin was relatively normal in skeletal muscle
because transcription could be driven by another promoter, such as the brain
promoter. Towbin and colleagues (1993) did not identify any deletion, but did
suggest that in this form of FDCM without skeletal muscle involvement, the region
of the 5' dystrophin coding sequence is affected, possibly involving a cardiac specific
promoter which could lead to altering gene expression or abnormal splicing of the
messenger RNA or to mutations in the amino terminus of the cardiac isoform of the
protein. Other dystrophin mutations resulting in FDCM have been described (Franz
et al 1995; Muntoni et al 1997; Ortiz-Lopez et al 1997; Ferlini et al 1998) showing
that there is allelic heterogeneity ofX-linked DCM (Ortiz-Lopez et al 1997).
C.1.3.2.2. Emery-Dreifuss muscular dystrophy (EDMD)
EDMD is an X-linked inherited disease characterised by early contracture of the
elbows, Achilles tendons and post-cervical muscles, with slow progressive muscle
wasting and weakness and cardiomyopathy, initially manifested as conduction
disturbances Cartegni et al 1997). Cardiac problems are also recognised in female
carriers. The disease was shown to be linked to the X chromosome, Xq28 (Hodgson
et al 1986; Bione et al 1994). Bione and colleagues (1994) identified a novel gene,
STA, with mutations associated with EDMD. The gene product is a ubiquitous
protein, called Emerin, localised at the nuclear rim of most cell types. However,
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Cartegni and colleagues (1997) found that in cardiomyocytes, emerin was specifically
and uniquely localised to fasciae adherentes of intercalated discs and desmosomes
and they proposed a role for emerin in membrane anchorage to the cytoskeleton. The
fasciae adherentes anchor bundles of sarcomere myofilaments and consist of
transmembrane adhesive glycoproteins, such as members of the cadherin family and
cytoplasmic proteins like vinculin, catenins and actin binding proteins. A lack of
cardiac emerin may alter cardiomyocyte adhesion and communication between
adjacent cells resulting in arrhythmias and conduction disturbances (Cartegni et al
1997).
C.1.3.2.3. Barth Syndrome (BTHS)
Barth syndrome was first described in 1983 and is an X-linked cardioskeletal
myopathy associated with growth retardation, neutropenia and abnormal
mitochondria (Bione et al 1996). DCM is congenital and is associated with
endocardial fibroelastosis, and is a common cause of death within the first months of
life (D'Adamo et al 1997). There is a lipid myopathy with reduced plasma free
carnitine. The locus for BTHS at Xq28 was identified (Bolhuis et al 1991). Gedeon
and others (1995) reported that X linked fatal infantile cardiomyopathy also mapped
to Xq28 and proposed that this condition was allelic with Barth syndrome.
Subsequently, mutations in a novel X-linked gene, G4.5, were identified in BTHS
patients and female carriers (Bione et al 1996). These authors proposed that the gene
products, putative novel proteins, should be called tafazzins which were postulated to
serve as a membrane anchor. It is now recognised that mutations in the G4.5 gene are
associated with BTHS, severe X-linked DCM and X-linked endocardial
fibroelastosis, and therefore these conditions are allelic (D'Adamo et al 1997).
Although most patients with X-linked DCM die within a few months of age, one
patient was described who survived and was normal at 25 years old, which led the
authors to consider that the tafazzins are important in foetal and neonatal life
(D'Adamo et al 1997).
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Another X-linked cardiac disease, isolated non-compaction of the left ventricular
myocardium (INVM), characterised by pathognomic echocardiographic findings and
post mortem changes (Chin et al 1990), has been linked to the G4.5 gene at Xq28
(Bleyl et al 1997). The absence or inconsistent presence of other findings of BTHS in
affected patients may suggest that the G4.5 mutation affects a domain particularly
important for cardiac muscle function (Bleyl et al 1997).
C.1.3.3. Other genetic causes of FDCM as part of syndromes
C.1.3.3.1. Limb Girdle muscular dystrophies (LGMD)
There are various types of LGMD which may have autosomal dominant or autosomal
recessive inheritance in certain families, or be sporadic (van der Kooi et al 1998).
The autosomal dominant LGMD 1A and IB are associated with loci at chromosome 5
and chromosome 1 respectively (van der Kooi et al 1997), but the gene products are
not identified. Another locus for adult onset LGMD and autosomal DCM has been
located by linkage analysis to chromosome 6q22-23, close to the laminin-a2 gene
(implicated in autosomal recessive congenital MD) although this gene was excluded,
implying the presence of a second locus at this site (McNally et al 1997). LGMD IB.
linked to lqll - q21, is frequently associated with cardiac involvement, initially as
atrioventricular conduction disturbances and bradyarrhythmias, which may progress
to DCM (van der Kooi et al 1997). It was speculated that this locus may be allelic to
the autosomal dominant phenotypically distinct cardiomyopathy described by Graber
and others (1986) linked to the centromeric region of chromosome 1 by Kass and
colleagues (1994) (van der Kooi et al 1997). Autosomal recessive LGMD2 has also
been linked to a number of different chromosome loci and the gene products have
been identified in a number of cases. Some of these are the sarcoglycans, proteins
which are part of the dystrophin - glycoprotein complex. Sarcoglycan is a complex
of four transmembrane glycoproteins: a 50kDa (A2 or 50 DAG or adhelin, now
called a-sarcoglycan), a 43 kDa (A3b, 43 DAG or p sarcoglycan), a 35kDa (A4,
35DAG or y-sarcoglycan) and a 35kDa (5-sarcoglycan) (Nigro et al 1997).
LGMD2C is associated with mutations affecting the gene encoding y-sarcoglycan
(13q locus), LGMD2D with a-sarcoglycan (previously called adhelin) (17q locus),
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LGMD2E with (3-sarcoglycan (4q locus) and LGMD2F with mutations affecting 5-
sarcoglycan located at 5q. There is a strong association between the absence of
sarcoglycan and the presence of DCM ( van der Kooi et al 1998). Deficiency of the
50kDa DAG, a-sarcoglycan or adhelin, was reported in the myocardium of a heart-
transplanted patient with DCM and mild muscular dystrophy (Fadic et al 1996).
The small animal model for cardiomyopathy, the Syrian hamster BIO 14.6, which has
autosomal recessive cardiomyopathy (initially hypertrophy followed by dilatation),
also has a mild skeletal muscle myopathy. Nigro and colleagues (1997) have recently
identified the cardiomyopathy gene as the gene encoding 5-sarcoglycan, known to be
located on hamster chromosome 9qa2.1-bl. In the hamster model, the 5-sarcoglycan
regulatory sequences and the first exon is deleted and it shows that sarcoglycan
mutations may result in predominantly myocardial expression and effects.
C.1.3.3.2. Other myopathies
Cardiac involvement has been described in a number of other myopathies. These
include myotonic muscular dystrophy, with unstable repetition of a trinucleotide
CGT sequence in the myotonin protein kinase gene (Phillips & Harper, 1997;
Hayashi et al 1997; Hiromasa et al 1988), congenital MD, with deficiency of the
laminin a? chain of merosin (McNally et al 1997; Spyrou et al 1998), proximal
myotonic myopathy (Von zur Miihlen et al 1998) and others (De Visser et al 1992).
It may be appreciated that the myopathies and associated DCM are similar in that the
genetic defects affect the cytoskeleton or cell to cell communication. Associated
DCM differs from non-syndromic DCM in most cases by the initial presence of
conduction disturbance or arrhythmias.
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C.1.4. Arrhythmogenic right ventricular cardiomyopathy / dysplasia (ARVD)
ARVD is usually an autosomal dominant trait with reduced penetrance due to a
degenerative process affecting right ventricular myocardium with focal necrosis
followed by adipose and connective tissue replacement. Ventricular arrhythmias are
common (Rampazzo et al 1997). The gold standard for diagnosis is the histological
demonstration of a fatty or fibrofatty substitution of the right ventricular myocardium
(Severini et al 1996). Over 30% of cases have a positive family history (Severini et
al 1996).
ARVD is genetically heterogenous. Loci have been identified by linkage analysis at
14q23-q24 (ARVD1) (Rampazzo et al 1994), lq42 -q43 (ARVD2) (Rampazzo et al
1995) and 14q 12 - q22 (ARVD3) (Severini et al 1996) and 2q32.1-q32.3 (ARVD4)
(Rampazzo et al 1997). An autosomal recessive syndrome called Naxos disease
which is associated with right ventricular cardiomyopathy, diffuse nonepidermolytic
keratoderma and woolly hair, limited to the geographical area of the Greek island of
Naxos, has also been located by linkage analysis to a locus on chromosome 17 (q21)
(Coonar et al 1998).
Rampazzo and colleagues (1994) noted that the degenerative process occurring in the
myocardium was similar to that of skeletal muscle in Duchenne's muscular
dystrophy. In the first identified locus, these authors noted that the gene encoding a-
actinin-1 was located here, and they speculated that this could be a candidate gene,
since there was strong structural homology between a-actinin and the N-terminal
domain of dytrophin. Further support to the involvement of a-actinin was given
when Rampazzo and colleagues (1995) identified the second ARVD2 locus at lq42-
q43; the location of the a-actinin-2 gene (ACTN2). Actinin genes are highly
conserved throughout evolution. Sarcomeric a-actinin is the actin binding protein
linking actin filaments from adjacent sarcomeres at the Z line (Arber et al 1997).
However, in the new loci for ARVD3 and ARVD4, a-actinin genes were not known,




Structural changes in human mitochondrial DNA have been implicated in various
diseases with dysfunctions in oxidative phosphorylation, called OX-PHOSPH
diseases (Marin-Garcia et al 1996). Mitochondria have their own extra-chromosomal
DNA which is double stranded and circular. It encodes for transfer and ribosomal
RNA as well as proteins involved in cellular energy production (McMinn & Ross
1995). The human mitochondrial genome is 16.5 kb long and contains 37 genes
encoding for 13 proteins involved in oxidative phosphorylation (Marian & Roberts
1996). Mutations in mitochondrial DNA are implicated in hypertrophic and dilated
forms of cardiomyopathy (Ozawa 1995), usually also associated with neurological,
myopathic and metabolic abnormalities. As mitochondrial DNA is inherited from the
mother, mitochondrial mutation diseases are characterised by maternal inheritance
(matrilineal). A number of mutations have been identified (Zeviani et al 1991;
Hattori et al 1991; Obayashi et al 1992; Suomalainen et al 1992; Marin-Garcia et al
1996). Paternal transmission has been reported, explained by nuclear encoded
mitochondrial proteins (Morgan et al 1996).
The heart in MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke
like episodes) has been shown to have initial hypertrophy of the left ventricular
posterior wall followed by progressive dilatation and deteriorating contractile
function (Okajima et al 1998).
C.1.6. Identification of candidate genes associated with DCM
Although gene mutations affecting the dystrophin or G4.5 genes have been identified
and implicated some of the X-linked cardiomyopathies, progress in identifying the
genetic defect underlying non-syndromic autosomal dominantly transmitted human
DCM has been slow, despite intensive research on potential candidates, some
proposed and some excluded (Kass et al 1994; Kelly & Strauss 1994; Krajinovic et
al 1995; Schultz et al 1995; Leiden 1997; Messina et al 1997; Mestroni 1997). This
was probably due to the small size of most families and confounding factors
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including premature mortality, an absence of early markers of the disease and
reduced penetrance (in part age-related) (Mestroni 1997). In addition, even when a
locus is identified, the families are still too small for positional cloning of DCM
genes (Olson et al 1998).
Recently however, cardiac actin gene (ACTC) mutations have been identified in
DCM (Olson et al 1998). A candidate gene approach was used in two small DCM
families, testing the hypothesis that actin dysfunction leads to heart failure. The
cardiac actin gene, ACTC, is located on chromosome 15 (ql4), an area not so far
identified by linkage analysis in DCM families. Cardiac actin is the main component
of the thin filament of the sarcomere. One end forms cross-bridges with myosin and
the other end is immobilised, attached to a Z band or an intercalated disc. Actin
consequently transmits force between adjacent sarcomeres and neighbouring
myocytes to effect co-ordinated contraction of the heart. Olson and colleagues
(1998) identified two missense mutations in the families, which affected amino
acid sequences that are highly conserved. These mutations both affected the
immobilised end of the actin filament, and resulted in altered rather than loss of
function of actin. They proposed that DCM resulted from an episodic defect in force
transmission, predisposing affected myocytes to mechanical injury and cumulative
cell death, secondary interstitial cell fibrosis and cardiac dilatation, a degenerative
process that may take years to develop.
This report supports the probability that DCM may result from defects in genes
encoding cytoskeletal structure. It is apparent that a variety of defects lead to a
similar phenotype.
Experimental models have also shown that DCM may result from cytoskeletal
abnormalities. Leiden (1997) commented on the fact that one major type of gene
implicated in DCM include those encoding structural proteins like dystrophin and
other proteins of the dystrophin associated glycoprotein complex. These proteins
organise the contractile apparatus of cardiac myocytes and ensure their structural
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integrity. Another similar protein is muscle LIM (Lin-11, Isl-1 and Mec-3) protein
(MLP). MLP may act as a scaffold protein to promote protein assembly along the
actin based cytoskeleton (Arber et al 1997). Mutations in the cytoskeletal gene MLP,
have been shown to cause cardiomyopathy in mice (Arber et al 1997). The human
homologue of MLP(CLP) is located at chromosome 11 p 15.1. a locus not so far
associated with human DCM (Arber et al 1997).
Juvenile transgenic mice with induced tropomodulin over-expression developed
DCM with loss of myofibril organisation (Sussman et al 1998b). Tropomodulin is a
tropomyosin binding protein that terminates the pointed end of actin filament
polymerization. It is believed that tropomodulimactin filament stoichiometry is
critical for the maintenance of actin filament length (Sussman et al 1998a). Reduced
tropomodulin content in vitro resulted in the formation of abnormally long actin
filament bundles with resulting change and disruption of myofibril structure but not
increased cell turnover. Regulated tropomodulin expression was concluded to be
necessary to maintain stabilised actin structure within cardiomyocytes (Sussman et al
1998a).
Another hypothesis about the aetiology of DCM is through the function or perturbed
function of cytokines. Cardiotrophin 1 (CT-1) belongs to a family of cytokines
known to signal through transmembrane protein gpl30 and to stimulate
cardiomyocyte hypertrophy in vitro. Erdmann and colleagues (1997) used PCR single
strand conformation polymorphism (PCR-SSCP) in 67 unrelated DCM patients and a
group of controls. Two rare mutations were identified in DCM patients, giving rise to
the hypothesis that cytokine encoding gene mutations may be important in the
pathogenesis of DCM. Another transgenic mouse model of DCM was created by a
MHC promoted over-expression of tumour necrosis factor a (TNFa) (Kubota et al
1997). It is known that increased TNFa in vivo results in a substantial decrease in
cardiac contractility.
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Another possible genetic influence over the cause or development of DCM include
genetic factors linked to immunoregulatory loci. Carlquist and colleagues (1991)
reported that HLA class II (DR and DQ) antigen associations were evident in DCM
patients in a number of different studies and from different populations. They
proposed that predisposing genetic factors may be present in DCM patients.
It can be appreciated that there is a vast range of potential candidate genes which may
be responsible for the phenotype ofDCM.
C.1.7. Human hypertrophic cardiomyopathy: an illustration of a successful
molecular genetic approach to cardiac disease
Hypertrophic cardiomyopathy (HCM) in man has an autosomal dominant mode of
transmission and is now known to be caused by a number of different chromosome
loci and the genes so far identified in association with these loci all encode
sarcomeric proteins (Marian & Roberts 1993;1995;1996; Anderson 1994;
Hengstenberg & Schwartz 1994; Watkins et al 1995). Details of the molecular
genetics of HCM are not directly pertinent to the subject of this thesis. However, it is
worth noting that similar strategies in investigating FDCM in man and dogs should
be successful.
All identified gene defects in HCM appear to result in abnormalities of the
sarcomere, whereas in DCM, currently there is no single type of abnormality
confirmed. The existence of phenocopies of DCM (e.g. ischaemic cardiomyopathy
and alcoholic cardiomyopathy) have made the elucidation of FDCM more difficult
than in HCM, as has the later age of onset and premature mortality associated with
the disease. Both conditions pose problems in differentiating between normal
relatives and relatives with early abnormalities. In HCM, the identification of
relatives with genetic mutations similar to probands or other relatives with overt
HCM has led to the realisation that echocardiographic identification of this disease is
not precise (Solomon et al 1993). Hagege and colleagues (1998) screened genetically
affected individuals with HCM with apparently normal hearts on echocardiography
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and proposed that the phenotype of the disease was a continuous spectrum from
normal structure to typical hypertrophy. Similar problems are encountered in the
evaluation of FDCM.
C.1.8. The diagnosis of DCM in asymptomatic relatives of DCM patients
A diagnosis of DCM based purely on clinical symptoms is likely to significantly
underestimate the prevalence of the disease. Echocardiography is a sensitive, non¬
invasive method of phenotyping the disease (McMinn & Ross 1995; Marian &
Roberts 1996). In screening families to ascertain a familial prevalence, it is
important to prospectively screen families of consecutive patients diagnosed with
DCM using strict diagnostic criteria (Keeling & McKenna 1994; Keeling et al 1995).
However, it is recognised that FDCM prevalence may be underestimated because
some individuals remain asymptomatic and have no echocardiographic abnormalities
for prolonged periods (McMinn & Ross, 1995). Screening relatives at one point in
time is likely to lead to underestimation of the frequency of disease within a family
(Goerss et al 1995). Csanady and colleagues (1995) reported that the time between
onset of radiographic evidence of cardiomegaly and onset of clinical signs was on
average 8-10 years and presumably this latent course will be even longer if
echocardiography is used to serially assess relatives who eventually develop DCM. It
can be seen that longitudinal screening is advisable (Lestuzzi et al 1991). The criteria
for diagnosis of FDCM include the presence of DCM in two or more relatives
(Mestroni et al 1994b) although Csanady and colleagues (1995) required that at least
two individuals in at least two generations should be identified. The finding of one
affected relative increased the probability that additional relatives in an affected
family would be found (Keeling et al 1995).
Echocardiographic abnormalities are now appreciated to be common in relatives of
DCM patients (Baig et al 1998; Gavazzi et al 1998). The problem of interpretation of
these remains to be addressed (Lestuzzi et al 1991). Patients with left ventricular
dilatation or slight hypokinesis are included in some series (Mestroni et al 1994b),
classified as indeterminate (Mestroni et al 1994b) in other series and excluded in
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others (Goerss et al 1995; Keeling et al 1995). Zachara and colleagues (1993)
referred to their indeterminate members as "carriers" and defined these as
asymptomatic relatives with echocardiographic or electrocardiographic abnormalities
or both; they fully appreciated the importance in serial evaluation of such patients in
accurately phenotyping these patients for pedigree analysis. Even where serial
evaluation has been carried out to determine the progression of equivocal
abnormalities, such studies have been short term (three years; Baig et al 1998). New
diagnostic criteria are required for the diagnosis of early DCM (Mestroni 1997).
There are recognised limitations in family screening. DCM is a multi-causal disease
and there is only very poor ability to distinguish between genetic and non-genetic
disease (phenocopies). The disease itself shows marked clinical and morphological
heterogeneity and the problem of identification of early disease all combine to
confound the evaluation of a family (Lestuzzi et al 1991; Keeling et al 1995).
However, family screening was felt to be advantageous by Keeling and McKenna
(1994) and Keeling and colleagues (1995) who felt that newly identified individuals
with DCM benefit from an early diagnosis as they benefit from early introduction of
angiotensin converting enzyme inhibition therapy even while asymptomatic, based on
data from the SOTVD trial (The SOLVD Investigators 1992). They also benefit from
close monitoring. Increased survival of human DCM patients in recent years reflects
earlier diagnosis and better treatment (Mestroni et al 1994b).
C.1.9. Other genetic factors may influence the development of
cardiovascular disease
The genetic background can influence the manifestation of a disease. The major gene
believed to influence the manifestation of a number of human cardiovascular
conditions is the Angiotensin-1 Converting Enzyme (ACE) gene. This gene is located
on human chromosome 17q23 (Mattei et al 1989). It is polymorphic based on the
presence (insertion, I) or absence (deletion, D) of a 287 base pair Alu repeat sequence
(Strachan & Read 1996a;b) within intron 16 (Rigat et al 1990; 1992), leading to three
possible genotypes, DD, II and ID. The DD genotype is associated with increased
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concentration of circulating angiotensin-1 converting enzyme (Rigat et al 1990; Tiret
et al 1992).
The DD genotype has been associated with HCM (Marian et al 1993; Marian &
Roberts 1996), myocardial infarction and artherosclerosis (Malik et al 1997)
although this is controversial and such associations have been refuted (Lindpaintner
et al 1996; Agerholm-Larsen et al 1997; Montgomery 1997). The association of
ACE genotype and DCM is even less certain. Raynolds and colleagues (1993)
reported that the DD genotype was significantly over-represented in patients with
ischaemic and idiopathic DCM, although no such association was identified in by
Montgomery and co-workers (1995) or Sanderson and others (1996). In DCM
patients, the DD genotype is associated with increased mortality and higher plasma
ACE activity than other genotypes (Skudicky et al 1998) although these authors
showed that the DD genotype patients showed a greater improvement in left
ventricular function when treated with an ACE inhibitor than other genotypes.
Zerjal and colleagues (1998) showed that certain variants of other genes involved in
the renin-angiotensin system can represent susceptibility factors for the development
of FDCM, including the angiotensinogen gene (AGT) M235T polymorphism and the
gene for receptor 1 of angiotensin II (ATiR) Al 166C polymorphism.
Proto-oncogene expression may be important in the mechanism of hypertrophy. Kai
and colleagues (1998) showed that c-H-ras, although normally expressed in
cardiomyocytes, was correlated to cardiomyocyte diameter. Expression of c-myc
mRNA is not normally evident in cardiomyocytes, but is identified in some HCM
patients, in which cardiomyocyte diameter was larger compared with c-myc negative
HCM patients. Further support for the role of proto-oncogenes in cardiac hypertrophy
come from the cardiomyopathy hamster model. Hamsters with autosomal recessive
cardiomyopathy may show cardiac hypertrophy (BIO 14.6 and UMX6.1) or non-
hypertrophy (TO-2). Although deficiency of 5-sarcoglycan results in reduced
sarcolemmal sarcoglycan and dystroglycans in both forms, it has been shown that the
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level of expression of c-myc which is upregulated only in the hypertrophic forms but
not in the TO-2 strain (Sakamoto et al 1997). Thus the disease phenotype is due not
only to the primary gene defect but also due to the expression of other genes.
C.2. Canine dilated cardiomyopathy: is it a familial or an inherited
disease ?
It has been suspected for a number of years that canine DCM may be a familial or an
inherited disease, mainly because of the specific breed predispositions (Lord, 1974;
Bond & Tilley 1980; Tilley et al 1983; Fox 1988; Calvert 1992; Calvert 1995b;
Sisson & Thomas 1995).
Boxers reported by Harpster (1983) were closely related and an inherited basis to the
disease was suspected; some family lines had greater prevalence of the disease.
Wotton (1998b) demonstrated familial disease in boxer cardiomyopathy, thought to
be an autosomal recessive trait. Further evidence supporting a genetic basis to the
disease was provided by Keene and others (1991), who documented that myocardial
L-carnitine deficiency in a family of Boxers. Goodwin (1997) and Meurs and others
(1998) thought that familial ventricular arrhythmias in three families of Boxers were
inherited as an autosomal dominant trait.
Cobb and others (1996) showed statistically that there was an inherited basis to DCM
in one line of Irish Wolfhounds, with an autosomal dominant mode of transmission.
Wood (1983) felt that Doberman DCM may be familial and this has been shown by
Meurs and colleagues (1996b). These latter authors are actively investigating familial
disease in the Dobermann. Although some families of Dobermanns appear to have an
autosomal dominant transmission of disease, with variable penetrance, not all
families are consistent with this mode of inheritance and patterns have been difficult
to determine (Meurs 1998).
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An autosomal recessive mode of inheritance has been reported for the newly
described juvenile Portuguese water dog dilated cardiomyopathy, affecting puppies
from two to 32 weeks of age (Dambach et al 1999).
C.2.1. Molecular Genetics applied to the dog and genetic diseases in the
dog.
Recently, there have been major advances in the development of a canine genome
map. A large number of anonymous microsatellites (usually di- or tetra-nucleotide
repeats) have been published (Ostrander et al 1992; Holmes et al 1993; Ostrander et
al 1993; Holmes et al 1994; Mellersh et al 1994; Holmes et al 1995; Ostrander et al
1995; Francisco et al 1996; Mellersh et al 1997; Thomas et al 1997). There has been
increased interest in developing the canine genome map, in part to obtain dog models
for human disease (Ostrander & Giniger 1997).
The frequency of microsatellites in the canine genome varies with the size of the
repeat. Dinucleotide (CA)n repeats occur approximately every 42 kilo-bases, whereas
tetranucleotide repeats are present with 340 kilo-bases between loci (Rothuizen et al
1994), although some tetranucleotides such as (GAAA)n may be more common,
estimated to occur every 100 - 200 kilobases in the canine genome (Francisco et al
1996). Although dinucleotide repeats are more frequent, there is rarely sufficient
heterogeneity in a single dog breed for these markers to be informative for a linkage
analysis study (Ostrander & Giniger 1997). Tetranucleotide repeats show greater
polymorphism although they are more likely to mutate (Francisco et al 1996).
Microsatellite markers ideally should have a large number of alleles in the general
population (i.e. they should be polymorphic), and also in a specific breed and family,
when investigating a genetic disease by linkage analysis. The polymorphic
information content (PIC) indicates the informativeness of such a marker (Ostrander,
1998).
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A number of microsatellites have been mapped separately by a predominantly
European group, called DogMap (Lingaas et al 1997) and a group centred at the Fred
Hutchinson Cancer Research Center in Seattle, US (Mellersh et al 1997). It has been
decided that this latter map with 139 markers separated by average distance of 14.03
centiMorgans (cM) will be the foundation of a comprehensive canine genome
linkage map (Mellersh et al 1997; American Kennel Club Molecular Genetics and
Canine Genetic Health conference, St. Louis, 1997). To be useful, a genetic map
should have markers placed at least every 10 cM. If the canine genome is of similar
size to the human genome, this means that at least 350 informative markers are
required (Ostrander 1998). So far. few genes have been added to the map and a
physical canine map has been slow to evolve due to the large number of small
chromosomes of similar appearance (a canine karyotype has only been agreed for 21
of the 38 pairs of canine autosomes) (Thomas et al 1997).
However, physical mapping in association with the developments in the linkage map
is under rapid development by a number of groups using different techniques. These
include: gene specific universal mammalian sequence tagged sites (Venta et al 1996);
anchor loci from comparative mammalian mapping and identification of sytenic
homology in the dog to assist in developing a functional genetic map (Meera Khan et
al 1984; Sack et al 1996; Werner et al 1997); the use of fluorescence in situ
hybridisation (FISH) techniques (Dutra et al 1996; Fischer et al 1996; Guevara-Fujita
et al 1996; Thomas et al 1997); chromosome specific paints from a high resolution
flow canine karyotype (Langford et al 1996); the use of comparative anchor tagged
sequences (CATS) (Lyons et al 1997); and construction of canine-rodent hybrid cell
lines (Langston et al 1997). The rapid evolution of a canine physical map offers
opportunities for multipoint linkage analysis and a search for candidate genes.
Interbreed variability is also under investigation (Fredholm & Wintero 1995; Ezer et
al 1996; Pihkanen et al 1996; Zajc et al 1997). Additionally, studies on the
homology between the human, mouse, canine and other mammalian genomes are in
progress and will allow identification of regions of comparative interest (Dutra et al
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1996; Venta et al 1996; Mellersh et al 1997; Werner et al 1997). The degree of
identity between canine and other mammalian index species sequences for certain
genes is between 70 -100% (Venta et al 1996).
To date, canine microsatellites have been used for dog parentage testing (Binns et al
1995), linkage analysis in Copper toxicosis in Bedlington terriers (Yuzbasiyan-
Gurkan et al 1997; Holmes et al 1998a) and progressive retinal atrophy in miniature
long-haired Dachshunds (Ryder et al 1998), and a specific allele of a microsatellite
marker has provisionally been linked to absence of von Willebrand's disease status in
Dobermanns (Holmes et al 1996).
Specific gene defects have also been identified, including the genetic basis of
fucosidosis in English springer spaniels (Occhiodoro & Anson 1996) which has
resulted in development a DNA test for this disease and for the carrier state (Holmes
etal 1998b).
An interest in the genetics of certain conditions is blossoming in veterinary
cardiology (Towbin, 1996a; 1996b; Meurs 1997). The modes of inheritance of
various canine congenital heart disease has been investigated (Patterson 1996). This
includes subaortic stenosis in Newfoundlands, which is now believed to be an
autosomal dominant condition with variable expression (Patterson 1996) after initial
doubt (Pyle et al 1976). Indeed, many conditions in man and dogs initially felt to be
polygenic or multifactorial (Robinson 1991) are now believed to have more simple
inheritance (Patterson 1996). The conotruncal defects affecting Keeshonden, initially
thought to be have a polygenetic basis, is now known to be associated with a single
gene defect in homozygous animals, with incomplete penetrance in heterozygotes
(Paterson et al 1993).
Kittleson and colleagues (1998) have reported on an autosomal dominantly
transmitted hypertrophic cardiomyopathy in Maine coon cats. The gene defect has
not yet been identified.
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C.2.2. Canine DCM: Molecular genetics
Although a number of groups are interested in this area, relatively little has been
published. Schatzberg and colleagues (1998) reported on a massive deletion of all
three dystrophin promoters (cortical, purkinje and muscle) along the entire length of
the dystrophin gene in two male German short-haired pointer littermates with severe
skeletal myopathy and DCM. Schatzberg and co-authors (1997) found no
abnormality in any of the three dystrophin promoter regions in five male Dobermanns
with DCM.
Western blot analysis was used by Spier and colleagues (1998) to assess the presence
of the protein products of the DCM candidate genes, dystrophin, alpha-sarcoglycan
and beta-dystroglycan, in the myocardial tissue from six dogs with DCM (4
Dobermanns, one Irish Wolfhound and a Boxer) and six control dogs. No
abnormalities were detected in these proteins in these samples.
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PRELIMINARY WORK TO INVESTIGATE THE
POTENTIAL FOR GENETIC LINKAGE ANALYSIS IN
NEWFOUNDLAND FAMILIAL DCM
MATERIALS AND METHODS
C.3. Aims of this study
It was evident during investigation of the Newfoundland population that DCM was a
familial disease. An aim of this part of the study was to determine the mode of
inheritance of DCM within this breed.
The extended family of Newfoundland dogs investigated as the major part of the
Newfoundland population in this study appears to be suitable for a linkage analysis
study. It is large, has individuals in several generations and serial evaluation of
family members to determine a final phenotype was possible. However, the family
was relatively inbred, the breed in the UK has a relatively small gene pool and it was
not certain whether canine microsatellites would show enough polymorphism or
sufficient heterozygosity to make this an informative investigation. Consequently,
preliminary work was required to investigate whether a linkage analysis study was
feasible within this breed.
C.4. Family studies in Newfoundlands
C.4.1. Dogs
Where there had been a family prevalence of DCM reported by breeders or owners,
as many dogs as possible related to affected dogs in several generations were
recruited into the study. Most of the dogs in the study population were actually
related in an extended family, based on scrutiny of the Kennel Club registration
document for each dog.
Each dog recruited into the study had a general history taken and received a full
clinical examination prior to a complete echocardiographic / Doppler examination as
described previously. In addition, note was made of any relatives known to the owner
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of each individual who had been diagnosed with congestive heart failure or other
cardiac problems. Such cases were usually included as suspected DCM cases, unless
they had been confirmed by echocardiography and / or post mortem examination to
have definite DCM, and other heart disease had been excluded.
C.4.2. Pedigree details
As well as pet name, owner details and status of each individual, The Kennel Club
registered name, date of birth, and names of sire and dam were recorded for each
dog. In addition, the numbers of siblings (dogs and bitches) of each dog's litter was
recorded and verified whenever possible by consulting either The Kennel Club Breed
Record Supplements (Working Group) (KCSB Breed Records Supplements;
published quarterly) or the Newfoundland Club records. Details of other
Newfoundlands with confirmed DCM which had presented to other veterinary
cardiologists were included in the analysis.
C.4.3. Pedigree analysis and phenotype
From a copy of the Kennel Club registration pedigree obtained for each dog in the
study, with knowledge of the phenotype based on echocardiography and / or post
mortem examination, data was input into a pedigree drawing programme,
PEDIGREE / DRAW (For the Apple Macintosh, version 4.4; Population Genetics
Laboratory, Southwest Foundation for Biomedical Research, San Antonio, Texas),
which displayed the extended family tree, as far back as common ancestors,
including the kinship coefficient (identical to the coefficient of inbreeding) for each
mating, calculated by the software. Males were drawn as squares and females as
circles. Dogs known to be deceased were indicated by a diagonal slash, and cause and
age of death, if known, was noted. From the family history, confirmed DCM dogs
were displayed as filled and suspected DCM (e.g. those without post-mortem or
echocardiographic confirmation of the diagnosis, or dogs suffering sudden death)
were displayed as hatched shapes. Dogs which had received an echocardiographic
examination were indicated the symbol, . In a similar manner, dogs included in this
study identified with clinical and echocardiographic or post mortem abnormalities
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conclusively identified as overt or occult DCM were included as solid black shapes
and those with equivocal abnormalities were included as shaded shapes (code details
given). Dogs who had received one or more echocardiographic examinations were
coded as the status of the latest scan. Dogs from which DNA samples had been
obtained were also indicated by code (+). The Pedigree / Draw (P) number and DNA
number specific for each individual included in the study are shown in Appendices
B.2. to B.7. from the previous section, in order to locate an individual in both
formats. P numbers were also given to common ancestors or important individuals in
the family tree as they are important in the pedigree analysis, but details about these
dogs are not included. For each dog, a record was made of the number, gender and
status of siblings where this information was known or was able to be obtained by the
owner or consulting Kennel Club or Newfoundland Club records. Dogs were not
classified as confirmed Normal dogs unless they were over eight years old with two
successive scans without any echocardiographic or clinical abnormality being
identified. Although dogs younger than this without abnormalities at the time of
preparation of this thesis were illustrated in the pedigrees as being unaffected, they
were included as being of "unknown" status in the later linkage analysis.
The coefficient of inbreeding may be defined as the probability that an individual will
have, at a given locus, two genes identical by descent from a common ancestor
(Emery 1986a; Nicholas 1987a). The Quaas-Henderson iterative method of
computing the kinship coefficient was used by the Pedigree/Draw software
(Pedigree/Draw Version 4.4 User's Guide p. 35 (1993); Boyce 1983).
For simplicity of presentation and ease of handling, smaller "nuclear family" type
pedigrees were drawn using the PowerPoint (Microsoft) and the Draw facility in
Word 7 for Windows (Microsoft), including the coefficient of inbreeding data from
Pedigree/Draw. In these family trees, individuals from whom DNA had been
obtained are indicated by digits. If no DNA sample had been obtained, then the P
number identifying this individual from Pedigree/Draw was used, preceded by P.
Dogs not studied but important in the pedigree were indicated by their P number.
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The table included in Appendix C.2. indicates the corresponding P and DNA
numbers for each individual for dogs included in the study.
Pedigree information was updated after successive echocardiographic evaluations or
when information was received from the owner, breeder or the dog's veterinary
surgeon.
Where sufficient information was available in a number of generations and siblings
in litter, these families were used for statistical analyses in order to hypotheses test
for different models of inheritance to attempt to identify the mode of inheritance in
these families.
C.4.4. Description of the Population
From the number of dogs scanned, the number of males and females in the
population were determined. The number of dogs with echocardiographically proven
DCM was determined and yp analysis was used to identify any sex predominance.
C.4.5. Determination ofmode of inheritance by observation ofpedigrees
The "nuclear" family trees were scrutinised in an attempt to identify the probable
mode of inheritance in this disease, to determine whether data were consistent with a
particular mode of simple Mendelian inheritance (Nicholas 1996), the criteria for
which are summarised below.
(i) An autosomal dominant disorder is transmitted from generation to generation
without skipping generations. Every affected animal should have at least one affected
parent. Normal offspring do not transmit the disorder to their progeny. Males and
females are affected approximately equally. Assuming most matings are
heterozygous affected (D/-) to normal (-/-), the segregation frequency between
normal and affected should be 0.5. (Mueller & Young, 1995; Nicholas 1996;
Strachan & Read 1996c).
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(ii) Autosomal recessive conditions require common ancestors on both sides of an
affected dog's family. Generations may be skipped and affected animals may arise
from two normal (but carrier) parents. Males and females are approximately equally
affected. In matings between two carriers (d/- and d/-), the segregation frequency of
disease is 0.25 (with 0.5 of progeny being carriers and 0.25 genotypically normal,
from the Hardy-Weinberg equilibrium). In autosomal recessive conditions, the
genetic relationship between parents of affected individuals is greater than parents
not producing affected progeny (Mueller & Young, 1995; Nicholas 1996; Strachan &
Read 1996c).
(iii) An X-linked recessive mode of inheritance would solely or predominantly affect
males, or females may be affected to a lesser degree or with older age of onset and
transmission of disease should be from mother to son. Generations may be skipped
and affected animals may have two normal parents. In an X-linked dominant
condition, affected males mated to normal females transmit the disorder to all
daughters but no sons. Affected females mated to normal males transmit the disorder
to approximately half of their daughters and half their sons. The incidence of the
disorder is about twice as common in females than males in the population and every
affected offspring has at least one affected parent (Mueller & Young, 1995; Nicholas
1996; Strachan & Read 1996c).
(iv) Matrilineal inheritance, from mother to both sons and daughters, would be
consistent with a mitochondrial defect resulting in the disease (McMinn & Ross
1995).
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C.4.6. Test for fit for a particularmode of inheritance
As the condition is believed to be autosomally transmitted, the frequency of the
condition in affected families compared with the frequency of the condition in the
general population could be compared to test for fit for a particular mode of
inheritance. Multifactorial inheritance, i.e. multiple gene effects or a combination of
genetic and environmental factors, was also considered. The observed relative
frequencies of the disease in siblings (sibs) versus the frequency of the disease in the
general population compared with the expected relative frequencies in sibs for
various modes of inheritance was tested according to the methodology detailed by
Emery (1986c). Expected frequencies are given as l/2q for an autosomal dominant
trait, l/4q for an autosomal recessive trait and l/(Vq) for a multifactorial trait, where
q is the frequency of the disease in the population.
The frequency of DCM in the general population is not reported in the literature, but
during the course of this study (and for the linkage analysis; see later) has been
estimated as 0.08 (=q).
A mean frequency of DCM was estimated from the nuclear families, assessing only
siblings where at least one case of confirmed DCM had occurred, but including
suspect cases and dogs with equivocal echocardiographic abnormalities as being
affected. This is the frequency of the disease in sibs (s).
The value of s/q was then compared with the expected frequencies.
C.4.7. Segregation analysis
The simplest approach to investigating a mode of inheritance is to compare the
observed number of affected individuals in families with the expected number for a
particular mode of inheritance (Emery 1986b).
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C.4.7.1. Family 7
In Family 7 (Appendix C.2.), where there was sufficient data in a litter (as the
majority of the litter had been ascertained by echocardiography), statistical analysis
was used to identify the ratio of affected to unaffected progeny (at the time of
examination) in comparison with the expected ratios for:
(a) an autosomal dominant mode of inheritance
(b) an autosomal recessive mode of inheritance
(since other modes of transmission had been excluded from scrutiny of the pedigree
data).
(i) Initially, only confirmed DCM cases were used (suspected but unconfirmed DCM
cases or equivocal echocardiographic abnormalities were excluded). Unassessed
individuals were treated as being unaffected.
Individuals are identified by their DNA number (excluding the affix NF), where
applicable, or their Pedigree/Draw (P) number. Progeny from the following matings
were included:
P263 x 43 (2 litters): DCM, 6; Normal, 12 (total 18).
P263 x 7: DCM, 8; Normal, 5 (total 13).
(ii) If suspected DCM cases and cases with equivocal echocardiographic
abnormalities were included as affected, this was repeated.
P263 x 43 (2 litters): DCM, 14; Normal, 4 (total 18).
P263 x 7: DCM, 9; Normal, 4 (total 13).
(iii) Unassessed individuals were excluded, and only confirmed DCM cases were
assessed.
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P263 x 43 (2 litters): DCM, 6; "Normal", 5 (all dFS) (total: 11).
P263 x 7: DCM, 8; "Normal", 1 (dFS) (total: 9).
(iv) If equivocal echocardiographic findings were included as affected, but
unassessed individuals ignored in the analyses:
P263 x 43 (2 litters): DCM, 11; Normal, 0 (total: 11).
P263 x 7: DCM, 9; Normal, 0 (total: 9)
These scenarios (i), (ii), (iii) and (iv) were tested against the expected ratios for this
family under the following hypotheses:
Hypothesis 1.
Dominant mode of inheritance. Bitch 43 normal (-/-). Bitch 7 affected (D/-) and P263
presumed affected (D/-).
P263 x 43 (D/- x -/-): expect segregation ratio normal: affected = 0.5
P263 x 7 (D/- x D/-): expect 0.75 affected (25% homozygously): 0.25 unaffected.
Fivpothesis 2.
Dominant mode of inheritance. Bitch 43 is normal (-/-). Bitch 7 is affected D/-. P263
is presumed homozygously affected (D/D).
P263 x 43 (D/D x -/-): expect affected: normal ratio = 1:0
P263 x 7 (D/D x D/-): expect affected: normal ratio = 1:0
Hypothesis 3.
Recessive mode of inheritance. Bitch 43 is normal but a carrier (d/-). Bitch 7 is
affected (d/d) and sire P263 is affected (d/d).
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P263 x 43 (d/d x d/-): affected: normal ratio = 0.5 (all "normals" are carriers)
P263 x 7 (d/d x d/d): affected: normal ratio = 1:0
Statistical analysis was performed in SigmaStat (v. 2.03 SPSS inc.).
The Chi squared (x2) test was employed unless there were insufficient observations
in a particular group, where Fisher's Exact test was used instead. Yates correction for
continuity was used in the Chi squared (x ) test, and the contingency table had one
degree of freedom. A significance level of p<0.05 was accepted as being statistically
significant.
C.4.7.2. All Nuclear Families.
From the nuclear families shown in Appendix C.2., the numbers of dogs with
confirmed DCM, dogs with confirmed or probable DCM, the numbers of
echocardiographically normal dogs (at the time of examination) and the numbers of
dogs which were unassessed were determined. Initial analysis concentrated on litters
where at least one confirmed case of DCM had occurred. A subsequent analysis
included all litters from the nuclear families, to avoid the error of ascertainment.
Statistical comparison used Chi-squared analysis, applying Yates correction and one
degree of freedom. Data was compared against (affected: unaffected) ratios of
0.5:0.5 expected for an autosomal dominant mode of inheritance and 0.25:0.75 for an
autosomal recessive mode of inheritance. Probable (suspected cases or cases with
equivocal echocardiographic abnormalities) and confirmed DCM cases were grouped
together, and unaffected (at the time of examination) and unexamined individuals
were also grouped.
C.4.7.2.1. The Proband Method of Segregation Analysis
This method of segregation analysis is sometimes referred to as Weinberg's
"proband" method and is detailed by Emery (1986b). It takes into account that there
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may be more than one proband in each litter, but not all affected dogs are probands.
The simplest method of determining the proportion of affected sibs to probands is to
count each sibship twice for each time it has been independently ascertained,
omitting the proband each time.
p = Affected sibs
Total sibs
This analysis was applied to the nuclear families, including litters where at least one
confirmed case of DCM was documented, although suspect cases and dogs with
equivocal echocardiographic abnormalities were included in the analysis as affected
sibs. This result was compared against the expected ratio of affected: normal
progeny under an autosomal dominant and an autosomal recessive hypotheses
models, using y2 analysis (SigmaStat (v.2.03; SPSS inc.)).
CA.1.2.2. The Singles Method of Segregation Analysis.
The Singles method is the simplest, quickest and most efficient form of segregation
analysis and is possible without the aid of computer software (Emery 1986b;
Nicholas 1987b). Normally, all members of each reported family must be included in
the data. One of two assumptions have to be made:
(i) either all families with affected offspring are included
(ii) a random sample of families with affected offspring have been included
(Nicholas 1987b).
The latter assumption may be made for hie nuclear family data presented here.
The segregation frequency may be estimated as described by Nicholas (1987b) as:
"p"= A- Ai
T-A-i
and its estimated variance ("pvar") is approximately:
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("Pvar") = (t-a) X {a - ai + 2a2 (t-a) }
(t-ao3 (t-ao
(.Abbreviations: A = total number of affected offspring in the available data, T = total number of
offspring in available data, Ai is the total number of families with just one affected offspring and A2 is
the total number of families with two affected offspring. (Nicholas 1987b)).
The "p" result and its variance ("pVar") is compared with the "null hypothesis" value
of po of 0.25 for an autosomal recessive mode of inheritance and 0.5 for an autosomal
dominant mode of inheritance (Nicholas 1987b). The test statistic is given by:
Z2 = ("P"- Po)2/("p,ar")
Values of Z2 are distributed approximately as y} and were therefore compared with
data given on a Chi squared distribution table, for one degree of freedom (Table B5.
p.523. In Practical Statistics for Medical Research. D.G. Altman (1991). Chapman &
Hall. London.)
The nuclear family data was used. The initial analysis included only dogs with
confirmed DCM, and the total analysis included probable DCM dogs. Values for "p"
and its variance ("pvar") were calculated with a scientific calculator and the null
hypothesis was tested for autosomal recessive and autosomal dominant modes of
inheritance.
C.5. Obtaining DNA samples
C.5.1 .Blood sampling
Dogs which were from the extended family had a blood sample obtained for a renal
health check and DNA storage, with owner consent. The renal health check,
assessing serum urea and creatinine, was believed to be useful, particularly in older
animals or in animals identified with cardiac disease prior to treatment intervention,
but also in all Newfoundlands as owners were increasingly concerned both about
Cysteinuria and Glomerulonephropathy in this breed (Booth, 1990; Koeman et al
1994; Casal et al 1995).
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The hair coat was clipped over the jugular furrow. Hibitane / surgical spirit mix was
sprayed onto the hair coat in attempt at asepsis. A blood sample of approximately
seven millilitres was obtained by jugular venipuncture with a 20 gauge one inch
needle (MicrolanceR) and divided into one tube without anticoagulant (Vacutainer,
plain Becton & Dickinson) (2 mis) and one tube with Potassium EDTA as the
anticoagulent (Vacutainer, EDTA K3; Becton & Dickinson) (5 mis). The tubes with
clotted blood were submitted to the Clinical Laboratory, Department of Veterinary
Clinical Studies, Royal (Dick) School of Veterinary Studies, University of Edinburgh
for assessment of renal function (serum urea and creatinine concentrations). The
EDTA anticoagulated blood was used for extraction of genomic DNA. Samples
were stored in a refrigerator until return to Edinburgh. Although samples were
submitted as soon as possible for laboratory analysis or for DNA extraction, there
was inevitably a significant time delay for some samples taken early during a
scanning trip.
C.5.2. Genomic DNA extraction
A genomic DNA extraction kit was used (NucleonR BACC2, Nucleon Biosciences,
Scotlab Bioscience, Coatbridge, Scotland), according to the manufacturers
instructions unless otherwise stated. Each five millilitre sample was decanted into 50
ml polypropylene tubes with conical bottom (Nunc) with ten millilitres of Reagent A.
Reagent A consists of 10 mM Tris-HCl, 320mM sucrose, 5mM MgCL, 1% Triton X-
100 and 40% NaOH added to adjust reagent to pH 8.0. The purpose of Reagent A
was to lyse the red blood cells (RBCs) leaving white blood cells (WBCs) (containing
genomic DNA) in tact. Reagent A and the blood were mixed by placing onto a roller
(Roller SRT1; Stuart Scientific) for four minutes at room temperature. The samples
were then centrifuged at room temperature in a Beckman GPR Centrifuge, which was
30 cm diameter, for 4 minutes. Kit instructions stated the force of centrifugation
should be 1300g (corresponding to 1800 rpm in this centrifuge), but during extraction
procedures, it was discovered that 3000 rpm more consistently resulted in a stable
WBC pellet. At lower centrifugation, sometimes the cell pellet was easily lost into
the haemolysed RBC supernattent during sample handling. Leaving the cell pellet
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undisturbed in the bottom of the conical tubes, the supernattent was aspirated and
discarded. Two millilitres of Reagent B were then added. Reagent B consists of
400mM Tris-HCl, 60mM EDTA, 150mM NaCl, 1% SDS and 40% NaOH added to
to adjust the pH to 8.0. Reagent B is used to lyse the WBCs. The pellet of WBCs and
reagent B were vortexed in a WhirliMixer (FSA Laboratory Supplies). The
instructions stated that brief vortex was sufficient but it was found that this did not
resuspend the cell pellet; vortex over a longer period was required. It was hoped that
this did not lead to fragmentation of the DNA. If the sample was not adequately
resuspended, this led to later difficulties in separation of DNA and protein containing
layers. Following resuspension of the lysed cell pellet in reagent B, the entire
contents of the tube were decanted into a 5ml polypropylene tube with maximum
internal diameter of 12 mm. 500pl Sodium Perchlorate were added for
deproteinisation of the sample and the reagents mixed by repeated gentle inversion
(seven times). Two millilitres of chloroform were added to the mixture, to aid in the
separation of the DNA and protein containing layers. This was mixed by gentle
repeated inversions to initially emulsify the phases. The contents of the tube were
centrifuged for 1 minute at 800g (corresponding to 1400 rpm of the 30 cm diameter
centrifuge). This led to separation of protein in chloroform at the bottom, a layer of
cell debris at the interface and an aqueous layer containing DNA at the top. 300pl of
NucleonR resin were added into the tube and without re-mixing, the sample was
recentrifuged at 1300g (corresponding to <1800 rpm) for 3 minutes. This resulted in
the resin sitting over the layer of cellular debris and the lower organic phase, so
separating the DNA containing upper aqueous phase. If the resuspension of the cell
pellet in reagent B had been inadequate, it was found that a mucoid cell plug tracked
across this resin layer from the debris layer into the aqueous DNA containing layer
and remained adherent to the resulting DNA plug, so contaminating it.
The upper aqueous DNA containing layer was aspirated by pipette without disturbing
the NucleonR resin layer into fresh polypropylene tubes. The sample was re¬
centrifuged briefly to ensure any resin contamination of the sample was pelleted, and
the upper layer was transferred into another clean polypropylene tube. To precipitate
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the DNA, twice the volume of absolute (100%) ethanol was added to the volume of
the sample. Gentle inversion allowed visible DNA precipitation which formed a
white cotton wool like mat in the tube. The DNA was then pelleted by centrifugation
at 4000 g (corresponding to 3400 rpm) for 5 minutes. The alcohol supernattent was
aspirated by pipette and discarded. The DNA pellet was washed, by adding 2 ml 70%
ethanol and mixing on the rotary mixer for about 5-10 minutes. The pellet was
recentrifuged and the alcohol aspirated and discarded. The tubes with the DNA pellet
were left open to allow the sample to dry at room temperature for about 15 minutes.
The DNA sample was resuspended in 1 ml Tris EDTA (made up from 100 pi 1M
Tris, 20 pi 0.5M EDTA and 9.88 mis distilled H2O) and allowed to dissolve by
rotary mixing over 2 hours or until dissolution was complete. The samples were then
transferred by pipette into 1.8 ml cryo tubes (Nunc), the tubes were labelled by
permanent marker and the samples stored at -80°C for prospective molecular genetic
analysis.
C.6. Determination of quantity and quality of Genomic DNA stored
C.6.1. Quantification
The Newfoundland DNA samples were labelled consecutively based on the order in
which they had been obtained, and ranged from NF001 to NF090 at the time this
work was done. The genomic DNA samples suspended in Tris EDTA (TE) were
transferred from the freezer to a refrigerator to allow them to thaw. Using a
spectrophotometric technique (Sambrook et al 1989), the quantity of DNA was
determined. Briefly, spectrophotometry at 260 and 280 nanometres (nm) is recorded.
The optical density (OD) at 260 nm allows determination of the amount of nucleic
acid in the sample, using specific coefficients, depending on the type of nucleic acid
present in the sample. An OD of 1.0 represents 50 pl/ml of double stranded DNA
(e.g. genomic DNA), or 40 microlitres per millilitre (pl/ml) of single stranded DNA
or RNA, or 20 pl/ml of single stranded oligonucleotides. Pure DNA should have a
ratio of 1.8:1 for the OD at 260nm:280 nm. If samples are significantly contaminated
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with protein (or phenol; not used in the Nucleon extraction kit), the ratio is
significantly less than this.
As the samples are suspended in 1 ml of TE, concentrations were determined as
micrograms/millilitre (pg/ml). Fifty pi of the sample was added to 700 pi distilled
water (dFfO), giving a dilution of fifteen fold. The concentration of DNA was then
determined:
conc. DNA = Dilution (15) x Coefficient (50 mg/ml) x OD260
The units are pg/ml. Conventionally, DNA concentrations are given as pg/ pi, so this
result was divided by 1000.
For the diluted samples, the ODs at 260 nm and 280 nm were recorded, and the ratio
of these was calculated for each sample.
C.6.2. To check structure of genomic DNA
As another check on the quality of the DNA and to ensure that the extraction
procedure had not resulted in significant fragmentation of the genomic samples, a
0.8% agarose gel was prepared, using 0.8 g agarose in lOOmls TBE (Tris-Boric acid-
Ethylenediamino-tetraceacetate at pFI 8.0), by microwaving the ingredients in a flask
until boiling to dissolve the agarose, and then allowing the contents to cool to hand-
warm, before incorporating ethidium bromide (EtBr) (one microlitre) prior to pouring
the gels. EtBr intercalates between base pairs, allowing migration of DNA to be
visualised. Agarose gels incorporating EtBr staining were visualised using ultraviolet
transillumination in a dark room and photographed by thermal printer. Five
microhtres of the size marker A, hind 111 was placed in the left hand well of each lane.
Placed in each of the other wells was one microlitre of genomic DNA mixed with
nine microlitres of Orange G. Once loaded, the gels were placed into TBE buffer in
an electrophoresis gel tank and allowed to run at 80 Volts for two hours until the
initial three bands of A hind III were separated. These three bands correspond to
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sizes in base pairs (bp) and DNA quantity (nanograms, ng) of: 23130 bp; 120 ng,
9416 bp; 48.5 ng and 6557 bp; 33.8 ng. Comparison of the migration distance and the
band intensity allowed the approximate size of the genomic DNA and the quantity of
DNA from the band intensity to be estimated from these gels.
C.7. Identification of a subgroup of the Newfoundland extended family
informative for genetic linkage analysis.
Clinical and echocardiographic data to phenotype individuals correct at the time of
this pilot study were utilised. Dogs closely related were selected, with at least two
individuals in a generation where possible, to allow determination of the phase and
where DNA had been obtained from as many individuals as possible. As it was
unfortunately rare that DNA had been obtained from both parents, in some cases a
number of progeny in each generation were selected which, if there was sufficient
polymorphism and heterozygosity of microsatellites among the dogs, may indicate
the microsatellite genotype data of the missing parent.
Dogs incorporated into this study are displayed in Figures C.l.a., C.l.b. and C.l.c.
(Volume II).
A simulated linkage program (Simlink; Ploughman & Boehnke 1989; Terwilliger &
Ott 1994a) was run to determine whether the selected dogs were in a family group
sufficiently informative for a genetic linkage analysis study. Data was input in
standard linkage format (Terwilliger & Ott 1994), with dogs with equivocal
echocardiographic abnormalities either included as "unknown" or assigned as
affected. An autosomal dominant mode of inheritance with complete penetrance was
assumed. Disease prevalence was estimated as 8%, giving a disease allele frequency
of 0.04.
Individuals from this family were selected once protocols for determining genotyping
data were resolved. These were (DNA identity, NF-): 80, 81, 9, 84, 75, 76, 89, 14,
83, 82, 43, 7, 59, 56, 70, 49, 54, 45, 53, 58, 63, 86, 69, 42, 8, 31, 33, 4, 20, 5, 26, 32,
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28, 30, 22, 41 and 6, with a negative control. As 40 lanes per ALF gel (see later) were
available and lanes 1 and 40 are left empty to prevent artefact, these individuals
comprised one ALF run.
C.8. Amplification of canine microsatellites by the polymerase
chain reaction (PCR)
Canine microsatellite primers were obtained from the Animal Health Trust,
Newmarket. As well as a reference name or number for the microsatellite, the
concentrations of the forward and reverse primers and the PCR conditions required
for each primer set (viz. annealing temperature, magnesium concentration etc.) are
displayed in Table C.2.a The expected product sizes and the polymorphism
information content (PIC) where known were also given. Some of the microsatellites
have been previously or subsequently published, and this information is also given in
Table C.2.a. (Volume II).
The forward and reverse primers were prepared if necessary to adjust them to
concentration of 50 ng/pl, by diluting with sterile dH20. A mixture of dNTPs (2'-
deoxynucleoside 5'-triphosphate) was prepared using each of the set (100 mM
concentration; Advanced Biotechnologies Ltd.). To make a 10 mM concentration of
dNTPs, 40 pi of each of dATP (deoxyadenosine triphosphate), dCTP (deoxycytidine
triphosphate), dGTP (deoxyguanosine triphospate) and dTTP (deoxythymidine
triphosphate) were added to 240 pi dH20 and retained as a stock solution.
All ingredients and samples were prepared and stored in an ice bath. Ingredients were
set up for 25 pi (or 10 pi) reactions. Incorporated into each reaction was dH20, the
amount calculated from the difference between 25 pi (10 pi) and the total volume of
the rest of the ingredients, Buffer (10 x PCR Buffer; Perkin Elmer): 2.5 pi (1 pi);
dNTPs from stock dilution; 0.5 pi (0.2 pi) and Magnesium chloride (MgCl2 solution,
25mM; Perkin Elmer), the quantity depending on the required conditions for each
primer set, so 2.0 pi (0.8 pi) for a 2mM [Mg++] or 1.0 pi (0.4 pi) for a ImM [Mg++],
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Into each reaction. 2.0 jj.1 (0.8 pi) of each primer (forward and reverse), 0.2 pi (0.08
pi) Taq DNA polymerase (Amplitaq DNA polymerase; Perkin Elmer) and 1 pi (0.4
pi) of genomic DNA was added. Separate GilsonR pipettes were used for setting up
the PCR reactions and for adding the genomic DNA.
Once the individual reactions were set up in small ependorf tubes, they were covered
with two drops (Pasteur pipette) of mineral oil to prevent evaporation, and loaded
into a thermal cycler block (Hybaid Omnigene). This was programmed depending on
the primer conditions required. For normal PCR, an initial denaturing phase was run,
for seven minutes at 94°C (to allow separation of the double stranded DNA strands).
Thirty five cycles of the following phases were then run: 94°C for 45 seconds, 55°C
(or primer specific annealing temperature) for 45 seconds and then 72°C for 45
seconds. Finally, a ten minute phase at 72°C completed the reaction. During the
cyclical phase, the 94°C temperature is required to separate DNA strands, the
annealing temperature (e.g. 55°C) is required for primers to anneal to complimentary
strands of DNA, and then 72°C is the optimal temperature for the action of Taq
(Thermits aquaticus) DNA polymerase which results in exponential increase in the
amount of product specific to the primers. The final 72°C phase allows all the DNA
to become double stranded again.
For each PCR run, a negative control was always run (with sterile dH20 instead of
genomic DNA) to check for DNA contamination of reagents.
C.8.1. Taq Gold
The Animal Health Trust routinely uses Amplitaq Gold (personal communication, M.
Binns). Amplitaq Gold (Perkin Elmer) will only function at high temperatures and so
this avoids spurious mis-priming resulting in additional non-specific bands or peaks
during preparation of samples prior to starting the thermal cycling. Indeed, it is said
to obviate the need to prepare samples on ice, although this was not carried out in this
pilot study; sample preparation was similar for both standard Taq and Taq Gold.
Routinely, standard Taq is used by the MRC Human Genetics Unit and so an
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experiment was performed to assess whether use of Taq Gold did result in significant
improvement of product specificity and reduction in mispriming events. For primer
pairs E41, A15, A29, A19 and F38, all of which had shown less than optimal results
with standard Taq, PCR reactions were set up using three DNA samples for each
primer set (NF071, NF072 and NF073). Product detection was on a Nuseive EtBr gel
using ultraviolet transillumination (see later).
C.8.2. Touchdown PCR
Some of the primer conditions reported by the Animal Health Trust as "Touchdown"
PCR or TD PCR, with the final annealing temperature given (e.g. Holmes et a!
1994). This was another solution to circumvent the problem of spurious bands or
peaks due to mis-priming. Mis-priming events may dominate the PCR reaction and
are more severe if the target DNA template is only present in small amounts.
Increasing the annealing temperature and / or adjusting the [Mg4"] concentration may
improve the specificity of the amplification provided that the spurious interactions
are significantly less stable than the specific ones (Don et al 1991). Don and co¬
workers (1991) described a method of taking advantage of the exponential nature of
PCR reactions by starting 10°C above the annealing temperature and reducing the
temperature by 1°C every second cycle to "touchdown" at the final annealing
temperature. Any difference between correct and incorrect annealings for a given
temperature will give an advantage to amplification of the correct template sequence.
When TD PCR was indicated, because there were an insufficient number of
programming steps offered by the PCR machine to absolutely follow the protocol of
Don and colleagues (1991), this was modified. The thermal cycler was programmed
with initial annealing temperature 10°C above the final temperature, with reduction
of 2°C every four cycles until 2°C above the final temperature, then the temperature
was reduced by 1°C for two cycles before finally arriving at the annealing
temperature, which was maintained for another fifteen cycles.
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To assess whether TD PCR was a necessary step or to indicate whether the use of
Taq Gold obviated the requirement for cumbersome TD procedures, primer pairs
K200, K209, K212, K39, K32, K120 and K292 each with DNA samples from
NF071, NF072, NF073, NF074 and NF090 were set up in reactions either by using
Amplitaq Gold or by using the TD PCR technique. The products were read in a
Nusieve EtBr gel using ultraviolet transillumination (see later).
C.9. Fluorescent dUTPs to label PCR products
C.9.1. Experiment to assess fluorescent dUTPs for labelling PCR products
Some of the primers were supplied unlabelled with laser fluorescent dye. When
product visualisation using the ALF was carried out (see later) a technique for
fluorescently labelling products during the PCR reaction itself had to be developed.
Normally, fluorescein is used during primer synthesis to label one primer strand for
detection by the ALF system. Unfortunately, after consultation with Pharmacia, it
was determined that labelling products during the PCR reaction would be
prohibitively expensive, had not been carried out previously to the company's
knowledge and may not result in successful ALF detection of products.
However, the use of fluorescent dUTPs has been recently described to label products
during the PCR reaction, for detection by the ABI systems (Applied Biosystems,
Perkin Elmer) (Rhodes et al 1997). Three dyes are available from Perkin Elmer:
R110 (blue), R6G (green) and TAMRA (yellow). Simple addition of the FdUTPs
rather than alteration of the optimised dNTP concentrations was reported to provide
sufficient incorporation into product to allow reliable detection by the ABIs (Rhodes
et al 1997).
As it was uncertain which FdUTP would be optimally detected by the ALF, a
decision was made in part on the basis of cost. The Animal Health Trust normally
used R110 (personal communication, M. Binns). The desired concentration of
[RllOJdUTP is reported as 0.5 pM (Rhodes et al 1997) which was calculated to
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correspond to five picomoles per ten microlitre reaction. [R110]dUTP contains three
nanomoles in 30 microlitres (concentration 100pM). One microlitre was diluted with
19 pi lxPCR buffer to enable the addition of one microlitre of this dilution into the
PCR reaction to produce the correct concentration. [R6G]dUTP is reported to be
incorporated into PCR reactions at a concentration of 1 pM (Rhodes et al 1997). It is
also available as 3 nmoles/ 30pl at concentration of lOOpM. One microlitre was
diluted in 9 pi lxPCR buffer so that the addition of one microlitre of this diluted
mixture gave optimal concentration in the PCR reaction. The final concentration of
TAMRA in a PCR reaction is reported to be 8 pM (Rhodes et al 1997) which meant
that each 10 pi PCR reaction would cost 90p and the overall cost was found to be
prohibitive.
Both [R110]dUTP and [R6G]dUTP were assessed in PCR reactions in the ALF
system. Using one primer pair (A15) and five DNA samples (NF071, NF072, NF073,
NF074 and NF090), it was found that R110 resulted in peaks of greater amplitude
and so this and the cheaper cost meant that it was subsequently used for fluorescently
labelling PCR reactions (see Results).
C.9.2. Improvement ofproduct detection: Use of T4 DNA Polymerase
The use of FdUTPs incorporated in the PCR reaction results in broader peaks, and
for dinucleotide repeat sequences where two alleles are just two base pairs apart,
accurate genotyping may not be possible. In part, this problem is due to the tendency
of Taq polymerase to add an extra base at the 3' end of the amplified fragments in
template independent manner (Ginot et al 1996). This results in a detectable peak one
base mobility unit larger than the actual allele base pair size, which, with broad,
poorly defined peaks, may be difficult to identify. One solution to this problem
reported by Ginot and colleagues (1996) was to correct for the one base overhangs by
the enzymatic removal of such bases by treating with T4 DNA Polymerase after the
PCR reaction.
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To assess whether this procedure did improve genotype results, as part of the
experiment to assess the FdUTPs R110 and R6G, using primer pair A15 and DNA
samples NF071, NF072, NF073, NF074 and NF090, for each FdUTP assessed,
products from the PCR reaction were either not treated or were treated with T4 DNA
Polymerase.
Initially, once the PCR was complete, as much mineral oil as possible was removed
by pipette from the layer covering the products. T4 DNA Polymerase (1 unit/pl) and
T4 DNA Polymerase Buffer (x5) (Boehringer Mannheim) were used and 0.1 pi (0.1
unit) of T4 DNA polymerase was added to 2 pi of 5X T4 DNA Polymerase buffer for
each sample destined to receive this treatment (although made up initially as a master
mix and then 2.1 pi of the mixture was added to each 10 pi PCR reaction after
completion of thermal cycling). The samples receiving the treatment were then
placed in a water bath for thirty minutes at 37°C.
As the results (see later) showed that for this primer set and these DNA samples,
there was no major difference detected by the T4 DNA polymerase treatment, this
step was not routinely used.
C.9.3. Phenol/Chloroform Extraction
The use of FdUTPs to label the PCR reactions inevitably resulted in non-
incorporation of some of the FdUTP. As the FdUTP size is approximately 200 bp, it
was judged to be important to "clean up" the DNA of the product to prevent co-
migration of the FdUTPs from confounding detection and genotyping of the alleles.
Methods detailed by the Animal Health Trust (personal communication, M. Binns)
were used. A master mix containing equal volumes of phenol (buffer saturated;
Gibco-BRL) and chloroform isoamyl alcohol was made up. An equal volume of
phenol / chloroform was added to each sample (12.1 pi to samples treated with T4
polymerase and 10 pi to samples not so treated). Samples were then vortexed briefly
and then stored on ice for five minutes. After this, each sample was centrifuged at
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14000 rpm for five minutes. The upper aqueous layer containing DNA was removed
by pipette (through the upper residual mineral oil) and placed in a fresh labelled
ependorf tube. The samples were then prepared and assessed by ALF (see later).
C.10. Determining PCR products
At the end of the PCR, the success of the reaction was assessed.
C.10.1. Agarose gel with Ethidium Bromide (EtBr)
In the EtBr technique, 5 pi Orange G was added below the mineral oil layer, or was
mixed with 12 pi PCR product on ParafilmR, depending if the remains of the product
was to be used in another gel. To assess whether PCR products were obtained and to
assess whether an agarose gel would be suitable for differentiating between product
sizes, some of the products were run by electrophoresis on a 4% Nusieve agarose gel
with EtBr, with band detection by ultraviolet transillumination. The size marker
4>X174 Haelll was run in the left-most wells to attempt to quantify product sizes, by
noting the distance each band migrated and plotting a size curve on log-linear graph
paper. From the migration distance from the well for each product, an estimate of its
base pair size could then be determined. Product detection using the Nusieve gel
with EtBr was assessed initially for primer set PEZ18 which had resulted in bright
product bands on the agarose gel, and all 90 DNA samples were assessed in order to
determine the ease of allele size differentiation.
C.10.2. A.L.F.
Some of the primers supplied by the Animal Health Trust had the forward strand
fluorescently labelled with HEX (green), FAM (Blue) or TAMRA (yellow) (Perkin
Elmer) for use on the ABI377 (Applied Biosystems, Perkin Elmer). Normally, the
laser fluorescence system, (Pharmacia LKB Automated Laser Fluorescence (A.L.F.)
Sequencer; Pharmacia Biotech) uses forward primer labelled with fluorescein during
primer synthesis (Mansfield et al 1994). However, the ABI dyes were shown to result
in detectable peaks on this system.
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The ALF system uses polyacrylamide gel electrophoresis (PAGE) with detection of
laser fluorescence by individual photodiodes for each lane of the gel (Mansfield et a!
1994). After thorough cleaning of the glass plates, prior to constructing the plates, to
ensure the top of the gel was secure prior to removing the comb, both plates had the
top one centimetre coated with bindsaline with acetic acid. The plates were separated
with spacers and the laser transmission glass and locked together.
Gels had been pre-prepared, aliquotted in 60 ml syringes and stored in a refrigerator.
The gel mixture consisted of 840 g urea, 240 mis Lone RangerR gel, 120 mis lOx
TBE, made up to two liters with dFfO. IOxTBE was made up using 242.28 g Tris,
102.64 g boric acid and 7.44 g EDTA, made up to two litres with dFLO.
The gel mixture was decanted into a mixing pot and 100 pi APS (Ammonium
persulphate 10% solution) and 52.5 pi Temed was added to it, mixed, and the
contents aspirated back into the syringe. The gel was then poured into the horizontal
plates, spreading by capillary attraction, ensuring no air bubbles were trapped (if
introduced, they were fished out with an acetate hook). The comb was inserted into
the top of the gel, clamped with bulldog clamps, and the gel allowed to set for a
minimum of two hours.
For some gel runs, a novel gel under assessment by the MRC Fluman Genetics Unit
(UV Gel 500, Pharmacia) using ultraviolet polymerisation was used. These gels set
quickly but ran more slowly on the ALF.
Once set, the comb was gently removed and the plate fitted onto the ALF machine,
into a bottom buffer tank and, after securing, the top and bottom buffer tanks were
filled with 0.6 TBE (1.0 TBE for the UV gel). Each gel could be routinely used for
two runs. The computer started the gel and was set at maximal voltage (2000V and
maximum current (70 mA) at a temperature of 50°C, with laser power of 3 mW.
Sampling interval was every 1.75 seconds and the running time usually about 140
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minutes. The laser beam alignment was checked and corrected if necessary, and the
water pre-heat to control plate temperature was set.
The ALF dye for assisting the loading of the wells was a mixture of dextran blue,
formaldehyde and EDTA. Size markers, one greater than and one less than the
expected product size range, were added. From a stock mixture of 2:1:1 of
dye:small:large size marker, four microlitres was pipetted into marked wells on a
labelled plate. Into each well, 0.5 pi each PCR product was added. The plate was
heated for two minutes at 94°C to denature and separate the double stranded DNA.
The gel wells were then loaded with the contents of the plate wells and a note made
of which lane each sample was loaded. The plates were marked into ten "clones"
numbered one to ten, each separated into four lanes labelled (left to right) A,C,T and,
G. The run was then initiated. The computer screen could display one clone in turn,
with each lane (A, C, T or G) colour coded as green, blue, yellow and red. Once
PAGE resulted in either a size marker or a product to pass through the laser beam,
this was displayed as a peak in the appropriate colour.
Once the run was complete, the run was saved and given a file name. The results
were printed out for each clone, by selecting the appropriate region between two size
markers. The time scale was printed at the bottom of each page.
The data was copied in Telnet to a PC. Analysis used the ALP (Automated Linkage
Preprocessor) program. Initially, the gel was checked using the Fragment Manager
conversion program (Pharmacia) to detect and tabulate the fluorescence peaks for
each lane (Mansfield et al 1994). Aligning the size markers in each lane, these peaks
were checked to ensure that they all fell within + 1 minute i.e. that the gel had run
uniformly across its width. In the ALP program, the known small and large size
marker size in base pairs was input as standard 1 and standard 3 respectively, and
lane 20 was normally used (the centre of the gel) as the standard lane. A note was
made from the fragment manager the modal time each standard peak arose and the
time intervals between which all the product peaks fell. Where there was a known
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repeat size for the microsatellite being amplified (e.g. four for a tetranucleotide repeat
or two for a dinucleotide repeat), this was included. Stutter was set at 70% (so peaks
preceding the main peak <70% of the amplitude of the main peak were ignored by
the program). The locus was recorded as the primer identity. Once all the required
data was input, the analysis was run.
From the report, the size of peaks (as base pair mobility units) was recorded with the
intensity (amplitude) of each peak. This was checked against the ALF printouts,
particularly in a noisy gel or a gel with subsidiary peaks due to mis-priming, stutter
etc. For each primer pair, the alleles as base pair sizes for individual dog were
recorded.
C.11. Microsatellite genotyping data from the Newfoundland sub-family
generated by the ALF/ALP system
Acquisition of the genotyping data may best be described as semi-automated, since it
depended on visualisation of peaks from the ALF printouts, recognition of any
stutter or other spurious bands and the genotyping data generated by ALP. In the case
where some products were re-run or PCR reactions repeated, one or more individuals
products with well defined alleles with size determined by this system were retained
(frozen at -20°C until required) and used as "gold standards". As different gels were
used and mobility may in any case vary between runs, this was important in order to
obtain comparable data. For printout of ALF data from each ALF run, the scale was
normally maintained, displaying the product peaks between the large and small size
markers, so that comparison of clones to compare product size and appearance was
possible by superimposition of the size markers.
Genotyping data was obtained for all 90 dogs for the microsatellite PEZ9 (data not
shown). Subsequently, for the other primer pairs, the sub-family of 38 individuals,
based on the pedigrees illustrated in Figures C.l.a., C.l.b. and C.l.c. used in the
simulated linkage analysis study, were used. These were dogs (NF-) 80, 81, 9, 84, 75,
76, 83, 14, 83, 82, 43, 7, 59, 56, 70, 49, 54, 45, 53, 58, 63, 86, 69, 42, 8, 38, 31, 33, 4,
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20, 5, 26, 32, 28, 30, 22, 41 and 6. The use of 38 individuals meant that each primer
pair occupied one ALF gel (40 lanes, leaving lane empty and lane 40 with the
negative control (no DNA)). These genotyping data were drawn under the
appropriate individual in the pedigrees shown as Figures C.l.a., C.l.b. and C.l.c.
This was in order to confirm normal Mendelian inheritance was followed for each
microsatellite. If Mendelian inheritance could not be identified, then the primer pair
was discarded as being not useful for a linkage study in this family of dogs.
If some data were repeated (for example, due to a failed PCR reaction or an error in
lane loading, resulting in no data in a particular well), the PCR products of at least
two individuals with different allele sizes were retained as "gold standards" in order
to compare new data with previous gels
For some of the complex genotype appearance produced by some primer pairs,
particularly where FdUTPs had been used, Dr. Nigel Holmes and Ed Ryder at the
Animal Health Trust were consulted about allele calling. A general principle was
maintained: alleles must retain the same appearance, however complex. Allele
calling based on similar appearance was therefore important. In addition, scrutiny of
all the family data should allow recognition of homozygotes and heterozygotes. For
complex genotype appearance, matching these with the pedigrees and assuming
Mendelian inheritance, sometimes assisted in allele calling.
From the pedigree, if a marker showed sufficient heterozygosity and polymorphism,
it was sometimes possible to infer a genotype for a missing parent, from the
genotypes of progeny and known parent.
C.12. Linkage Analysis
The linkage analysis software available at the Human Genome Mapping Project
Resource Centre (HGMP-RC) at Hinxton, Cambridge was used accessed via the
World Wide Web (Netscape) (address: http://www.hgmp.mrc.ac.uk). These
programmes are Unix based. The FASTLINK programs were used two-point linkage
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analysis (Lathrop & Lalouel 1984; Lathrop et al 1984; Cottingham et al 1993;
Schaffer et al 1994) particularly MLINK.
A dominant mode of inheritance was presumed. The disease prevalence was
estimated to by 8% in a population (see previously). If the D allele is responsible for
DCM, and - corresponds to "wild type", then the population may be divided into
D/D, D/- and -/-, where disease may be associated with the D/D homozygotes or the
D/- heterozygotes. This gives an allele frequency of 4% in the population, with 96%
of the population carrying the wild type allele (0.04: 0.96). The disease was initially
considered to be 100% penetrant in dogs over eight years old; in younger dogs, status
was included as "unknown" unless they had equivocal echocardiographic
abnormality suggesting that they were affected.
As microsatellite marker allele frequencies are unpublished in the Newfoundland
population, allele frequencies were calculated from the genotyping data generated by
the Newfoundland sub-family group. Rather than base pair size (Tables C.3.a. and
C.3.b.), the alleles were re-labelled from the smallest to the largest as allele one
upwards. The genotyping data for each dog could then be tabulated or imported into
the linkage programs as a simple integer. Data used in the linkage analysis are
displayed in Tables C.4. and C.5.
Input into the linkage programs was as described in Terwilleger and Ott 1994(a-d).
For linkage format, the individual identity has to be numbered from one upwards,
sequentially. Consequently, the individuals on the pedigree were renumbered
sequentially, as shown in Figures C.2.a., C.2.b. & C.2.c. The pedigree data
illustrated in Figures C.l.b. and C.l.c. were input in linkage format, together with the
common ancestry detailed at the top of Figure C.l.a. The number of extra loops in
the pedigree without adding significantly to the informativeness resulted in the rest of
the pedigree data from Figure C.l.a. from being excluded. Input into the pedigree
file included pedigree identity, individual numerical identity, the individual's father's
identity and mother's identity in the next two columns (0 0 if a founder), the sex of
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the individual was indicated as 1 (male) or 2 (female). In the next column, the
affectation status was input as 1 (unaffected), 2 (DCM) or 0 (unknown). Dogs which
were echocardiographically normal but were less than eight years old were classified
as "unknowns". In columns seven and eight, the genotype data (as allele numbers)
was input for each microsatellite.
For the pedigree input, the input was based on the file written in PICO, and was
similar to the following, and saved with extension -.pre. The input for the data for
PEZ11 is shown in Table C.6 as an example.
Because there were a number of loops present in this pedigree, these had to be broken
to allow the analysis to proceed. The maximal number of loops had to be reset to
allow 20 loops in order to allow the analysis to be run. Loop breakers were selected
which were parents with progeny and preferably genotypically informative, based on
the advice in Terwilliger and Ott (1994e). The loop breakers selected are indicated
by encircling in Figures C.2.a., C.2.b. & C.2.c. The loops.out file formed after the
command MAKEPED was run detailed the presence of loops identifying offending
individuals which helped in making this selection. After MAKEPED was run, a new
file with extension -.ped was created. The PREPLINK command was used to
generate a parameter file. Two loci (the affection and marker locus) were identified.
The dominant inheritance and complete penetrance was included, with disease allele
frequency set at 0.04 (wild-type 0.96). The number of alleles for the microsatellite
marker locus with the allele frequencies which had been calculated for each allele
(Table C.4.) were included for each marker. Data was input as indicated in
Terwilliger & Ott (1994b). Once the parameter file details were complete, it was
saved as a -.dat file. Two point linkage analysis (MLINK) was run using the linkage
control program, LCP (Terwilliger & Ott 1994d). Recombination increment was set
at 0.1, to allow LOD scores to be calculated at 0, 0.1, 0.2, 0.3, 0.4 and 0.5. The -.ped
and -.dat files with the corresponding genotype data were included and PEDIN was
run, which calculated LOD scores at given values of theta.
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PRELIMINARY WORK TO INVESTIGATE THE




The general population was considered as all dogs scanned. One hundred and sixty
five individuals were scanned, 69 males and 96 females. There were twelve male and
seventeen female cases of DCM identified in this population. Chi squared analysis
showed no significant gender difference in DCM when compared with the total
scanned population.
The prevalence of DCM in the scanned population was 17.6%, although it was
known that there was a bias in that families presented with a known prevalence for
DCM. Consequently, arbitrarily, a disease prevalence was estimated as 8% in the
linkage analysis (see later).
C.14. Determination ofmode of inheritance by observation ofpedigrees
Full pedigrees using Pedigree / Draw for three related Newfoundland families are
shown in Appendix C.l. The simplified nuclear families are presented in Appendix
C.2. and are numbered Family 1 through to Family 13 (F1 - F13).
Family 1 (Fl) with individuals 2 and 3 shows mother to daughter transmission,
although the status of the sire of female 3 is unknown. This is consistent with an
autosomal dominant or a matrilineal mode of inheritance but does not exclude
autosomal recessive or X-linked dominant modes. There were no common ancestors
in the three generation pedigree for 2 although common ancestry was evident in 3.
F2 and F3 had no common ancestry in five generation pedigrees. F2 (females 86 and
93) was related to the extended family under investigation, whereas F3 (female 87)
was completely unrelated as far as could be ascertained. F4 (male 17) shared
common ancestry. Without information in parental generations or any progeny from
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F2, F3 and F4, the mode of inheritance could not be determined. F5 shows
individuals 59 and 113 with confirmed DCM and dFS respectively. They are
included in the discussion about F7. Sire 65, out ofDCM female 59, did not fulfil M-
mode criteria for echocardiographic abnormalities, but did have a large systolic LV
volume. However, he also had an atrial septal defect (patent foramen ovale). The
inbreeding in this family makes interpretation of actual mode of inheritance
uncertain. Extension of this family, as F5b, shows that offspring with
echocardiographic abnormalities (dFS) are present in other progeny of both the sire
and the dam. Sire 6 is a Canadian import, illustrated further in F9. F6 (female 1) is
related to the extended family by grandsire P502, although the dam was an import
and no common ancestors were present. This family is not informative in
determining mode of inheritance as information is solely limited to the proband.
The most informative family is F7, including DCM individuals 7, 59, 56, 70, 33, 96,
8, 116, 31, 94 & 42. in addition, colleagues had confirmed a diagnosis of DCM in
three other individuals bom in 1989, by P263 x 43, and P519 (P263 x 7). A number
of relatives also had dFS. Most of this family is the progeny of one imported sire,
P263, although this dog is related to other imported UK dogs (son of P104, a widely
used stud dog). Unfortunately, no information could be obtained about this dog. On
the maternal side, DCM was prevalent and was confirmed by echo and PM in dam 7,
although the cause of death in this bitch was pulmonary neoplasia. Litter sister, dam
43, did not have a technically adequate scan, due to obesity, but subjectively,
myocardial function was good and no abnormalities were evident at post mortem at
the age of 12 years, after euthanasia for osteoarthritis. She was therefore determined
to be normal. In the progeny of normal bitch 43 and P263, in two litters, there were
18 individuals (8 males and 10 females). Two males and a female were confirmed to
have DCM and one dog was suspected to have DCM in the 1989 litter. One female,
59, was confirmed to have DCM in this study, and P27 had dFS. In the 1991 litter,
male 56 and female 70 were confirmed as having DCM and two males (54 & 110)
and two females (49 and 113) had dFS. One male had suspected DCM and a bitch
died under general anaesthesia for routine ovariohysterectomy. Four individuals were
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not evaluated. Affected female 7 x sire P263 resulted in 13 offspring, eight of whom
(four males and four females) had confirmed DCM. Another female, euthanased due
to osteosarcoma, had dFS and regional wall motion abnormalities which were shown
by many of the other dogs on initial scan before repeat scan confirmed the presence
of DCM. The other four progeny were not evaluated. Males and females are
approximately equally affected, excluding X-linked modes of inheritance. A
matrilineal mode of inheritance is excluded if dam 43 is definitely normal. If it is
assumed that bitch 43 is normal, even if a carrier in the recessive model, a proportion
of between 6/18 to 14/18 of her progeny being affected is not consistent with a
recessive mode of inheritance, even if sire P263 was affected (d/- x d/d). Affected
dam 7 x P263 resulted in 8/13 or 9/13 (69%) affected progeny, even if the individuals
not screened happen to be normal. All the progeny are expected to be affected if both
parents are affected (d/d x d/d). However, the ratios in this family could be achieved
if the sire P263 was homozygously dominant (P263 x 43 = D/D x -/-; P263 x 7 =
D/D x D/-). The ratios in the progeny of P263 mated to a normal and an affected
dam imply that this dog must be genotypically affected in both recessive or dominant
models.
In F8, the progeny of affected sire 56 are shown. There is one female (111) with dFS
out of a dam confirmed to be normal (56 x 63), although the co-existence of mild
subaortic stenosis confuses this picture. Depressed fractional shortening individuals
are evident in other progeny, although few animals in litters were screened, and dams
107 and P661 were from other DCM lines also. P661 died suddenly, although was
believed by the owner to have asphixiated by eating cow dung.
F9 is extended from F7. A large number of individuals were screened in this family.
Progeny of affected bitch 7, affected daughter P519 and affected half sister bitch 59
all ofwho had progeny to imported sire 6. The progeny in this family at the time of
writing were still quite young, where typically the age of onset appears to be about 8
years. If sire 6 is definitely normal, and the equivocal echocardiographic
abnormalities do indeed precede the development of overt DCM, then the presence of
320
abnormalities in some of these progeny (between 10 out of 29 or 10 out of 43,
depending if total of scans performed (29) or total number of progeny (43) are
included, representing 23 - 34%) suggest an autosomal dominant mode of inheritance
with complete (probably age related) penetrance. Unless the Canadian import was a
carrier, despite being completely unrelated, a recessive mode of inheritance is
excluded, although a number of assumptions have been made.
Families FlOa, FlOb, FlOc and FlOd show the relationship between a widely used
sire, P502, who appears in a number of these pedigrees (see Fl, F4 & F6 also), and
sire PI04, another commonly used sire who also appears in DCM pedigrees,
including siring P263 (see Fl, F7, F8 & F9). He is also related to PI00 and PI08 (see
F12). Sire P292 also appears in a number ofDCM pedigrees, but again was a widely
used stud dog, rumoured to have died at 12 years of age due to testicular cancer. Fl 1
shows a very complex inbred pedigree including a widely used sire, P692, who was
scanned as being normal by a colleague recently, although few of his progeny have
been assessed.
Another important family is illustrated in F12 and F13. Sire PI and dam P9 had a
male and female DCM case in their progeny (80 and 9 respectively); bitch 81 was
assessed to be normal. PI was from a litter where other suspected DCM cases
affected another 2 out of the 7 progeny in a related mating. P9 was reported to have
been euthanased due to oral neoplasia, although cardiac status was unknown. PlxP9
was also a related mating. Dog 80 has only sired two progeny, one of which was
normal at two years of age. Bitch 9 had several litters, two ofwhich were by the same
(related) sire P10, and has had two cases ofDCM with other siblings showing dFS or
DCM. Echocardiographic abnormalities (dFS and LVE) were shown in the two out
of ten individuals screened sired by an unrelated sire (P36), although this sire is
descended from P502. P36 also sired a bitch with LVE (P738) which, on mating with
a DCM patients produced dog 99, who, although young, had frequent ventricular
premature complexes as well as dFS). One daughter of bitch 9 (97; dFS) has also
been bred to a number of unrelated (imported) sires, and echocardiographic
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abnormalities were evident in some of the progeny, although again, these
abnormalities require to be conclusively proven to precede overt DCM.
F13 illustrates further details about this family. Bitch 81, defined to be normal, is
shown in two litters. Only one dog, with mild subaortic stenosis, was screened out of
12 progeny sired by 83. However, there were two normal progeny at the age of 4
years old (75 and 84) out of 12 screened sired by (related) P25 (status unknown).
Bitch 75 was mated to the imported, unrelated sire P33, and two of eleven progeny
were scamied, one of whom had DCM. This "skipped generation" is not consistent
with a dominant mode of inheritance, if 81 was genuinely normal, and 75 proves to
remain normal throughout her life. This, however, would not be the case if P33
proves to be affected. However, it is unlikely that he will be available for scanning.
Bitch 82 had left ventricular enlargement, and one DCM son (74) with the other
litter-mate not screened. The sire was again P36, also present in the predecessors of
DCM cases or those with echocardiographic abnormality (e.g. dam P738 in F12).
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C.15. Test for fit for a particularmode of inheritance
The frequency of dilated cardiomyopathy in the general Newfoundland population
has been estimated as 0.08 (=q).
The mean frequency in the siblings (s) was determined by averaging the frequency of
the disease in the nuclear families (Table C.7.).
Table C.7.
Family Frequency of DCM Decimal Frequency
Family 1 1/2 0.5
Family 1 1/1 1
Family 2 2/7 0.29
Family 3 1/6 0.17
Family 4 1/6 0.17
Family 5a 1/5 0.2
Family 6 1/13 0.077
Family 7 14/18 0.78
Family 7 9/13 0.7
Family 10a 1/4 0.25
Family 10a 2/8 0.25
Family 10b 1/9 0.11
Family 12 3/7 0.43
Family 12 2/7 0.29
Family 12 4/17 0.24
Family 13 1/2 0.5
Family 13 1/11 0.09
MEAN FREQUENCY 0.356
Relative frequency = s/q = 0.356 =4.45
0.08
Frequency Frequency Observed Expected Frequency
Frequency
General Sibs (mean) (Vq) Dominant Recessive Multifactorial
population (V2a) (V4a) (%„)
0.08 0.383 4.45 6.25 3.125 3.5
The relative frequency of this disease is below that expected for dominant mode of




The results are given for F7 (Appendix C.2.).
Results of x2 analysis (or Fisher's Exact Test where number of observations were <5)
are shown in Table C.8.
The ratio for P263 x 43 was not significantly different from the 0.5 segregation ratio
for scenarios (i), (ii) or (iii), but was significantly different if all probable cases of
DCM were included and unassessed individuals excluded from the data. P263 x 43
data was also not significantly different from the 0.75:0.25 ratio, except in the case of
(i). The l :0 ratio was also not significantly different from the P263 x 43 observed
data when probable DCM : unassessed, or excluded individuals, but was if confirmed
DCM cases versus others were considered.
The ratio for P263 x 7 was significantly different from the 0.5:0.5 ratio if confirmed
or probable DCM cases, excluding unassessed individuals, were considered. There




























































































































































C.16.2. All nuclear families
C.16.2.1. Only litters with at least one case ofDCMwere included
There were 32 cases of confirmed DCM, and a total of 50 cases with confirmed
DCM, suspected DCM or with equivocal echocardiographic abnormalities. Only
seven dogs were unaffected at the time of examination, but 101 siblings were
unevaluated, giving an "unaffected" total of 108 dogs. The ratio of "Affected:
Unaffected" dogs (50:108) (total 158 dogs) was compared to the expected ratio of
0.5:0.5 for an autosomal dominant mode of inheritance (79:79). j2 analysis showed a
significant difference (p=0.001). This ratio was also compared with the expected
0.25:0.75 for an autosomal recessive condition (39.5:118:5), which was not
statistically different.
C.16.2.2. All litters in the nuclear families were included.
There were 32 cases of confirmed DCM, and a total of 67 cases of confirmed or
suspected or dogs with equivocal abnormalities. Forty dogs were unaffected at the
time of the examination and 229 dogs were not evaluated. Confirmed and probable
DCM cases "affected" were compared to an "unaffected" total of normal and
unevaluated dogs (ratio: 67:269; total = 336 dogs). This ratio was compared to the
0.5:0.5 ratio expected for an autosomal dominant mode of inheritance (expected:
168:168), and was found to be statistically significant different (p<0.001). The ratio
was compared to the ratio expected for an autosomal recessive mode of inheritance
of 0.25:0.75 (expected: 84:252 dogs) and no statistical difference was identified by x2
analyses.
C. 16.3. Results of the "Proband" Method of Segregation Analysis




Family Proband identity Probands Affected Sibs Total Sibs
Family 1 2 1 0 1
3 1 0 0
Family 2 86 1 (2 in litter) 1 6
93 1 1 6
Family 3 87 1 0 5
Family 4 17 1 0 5
Family 5a 114 1 0 4
Family 6 1 1 0 12
Family 7 59 1 (3 in litter) 13 17
56 1 13 17
70 1 13 17









116 1 8 12
31 1 8 12
94 1 8 12
42 1 8 12
Family 10a P686 1 (2 in litter) 0 3
P704 1 1 7
Family 10b 29 1 0 8
Family 12 PI 1 2 6
80 1 (2 in litter) 1 6
9 1 1 6
10 1 (2 in litter) 3 17
36 1 3 17
Family 13 74 1 0 1
89 1 0 10
TOTALS 108 255
p = Affected Sibs = 108 = 0.42.
Total Sibs 255
Presuming that a ratio of affected: unaffected sibs is 0.5:0.5 for an autosomal
dominant mode of inheritance or 0.25:0.75 for an autosomal recessive mode of
inheritance, and the total number of unaffected sibs is 255 - 108 = 147, the observed
ratio of affected to unaffected sibs, 108:147, is compared with the expected numbers
of 127.5:127:5 (under an autosomal dominant hypothesis) and 63.75:191.25 under an
• 2 ••••autosomal recessive hypothesis), x analysis showed a statistically significant
difference from the autosomal dominant model (p=0.025) and a highly significant
difference from the autosomal recessive model (p<0.001).
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C.16.4. Results of the Singles Method Segregation Analysis
If only nuclear families with confirmed cases ofDCM were included, there were 32
affected individuals (A), out of a total size of 137 individuals (T). There were 11






The variance ("pvar") was calculated:
("Pvar") = (T- A) x { A - A, + 2A2 (T-A) }
(T-A,)3 (T-A,)
CWn = (137 - 32) x {32-11 +(2x4) x (137 - 32) 1
(137 - ll)3 (137-11)
("p.„r")= 105 X {21 + (8 x J05)}
2000376 126
("Pvar") = 0.00005 x 27.67 = 0.0014
If individuals with confirmed or suspected DCM and cases with equivocal
echocardiographic abnormalities were included as affected dogs, there were 72
affected animals (A) out of a total of 285 (T), where 24 families had one affected
offspring (A,) and 12 families had two affected offspring (A2).
"p"= A-A,
T-A,
"p" = 72-24 = 48 =0.18
285 -24 261
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The variance ("pvar") was calculated:
("Pvar") = (LA)_ X {a-A, + 2A? (T-A) }
(T-A,)3 (T-A,)
('W) = (285 - 72) x {72 - 24 + (2 x 12) x (285 - 72) }
(285 - 24)3 (285 - 24)
("Pvar") = 213_ x {48 + (24 x 213 )}
17779581 261
("Pvar") = 0.00001 x 67.584 = 0.00068
The null hypothesis was tested for an autosomal recessive mode of inheritance (po
0.25).
For confirmed cases ofDCM:
Z2 = (V-pn)2
("Pvar")
Z2 = (0.17 - 0.25)2 = 0.0064 = 4.57
0.0014 0.0014
From x2 distribution tables, with one degree of freedom, this test statistic is
significantly different from the null hypothesis for an autosomal recessive mode of
inheritance (0.02>p<0.05).
For confirmed and suspected cases and those with equivocal echocardiographic
abnormalities:
Z2 = ("p" - Po)2
("P")
Z2 = (0.18 - 0.25)2 = 0.0064 =7.21
0.00068 0.00068
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From x2 distribution tables, with one degree of freedom, this test statistic is
significantly different from the null hypothesis for an autosomal recessive mode of
inheritance (0.001>p<0.01).
The null hypothesis was tested for an autosomal dominant mode of inheritance (po =
0.5).
For confirmed DCM:
Z2 - (y - p0f
Oar")
Z2 = (0.17 - 0.5)2 = 0.1089 = 77.79
0.0014 0.0014
From y2 distribution tables, with one degree of freedom, this test statistic is
significantly different from the null hypothesis for an autosomal dominant mode of
inheritance (p<0.001).
For confirmed and suspected cases and those with equivocal echocardiographic
abnormalities:
Z2 = ("p" - pot
("Pvar")
Z2= f0.18 - 0.5)2 = 0.1024 = 150.59
0.00068 0.00068
From x2 distribution tables, with one degree of freedom, this test statistic is
significantly different from the null hypothesis for an autosomal dominant mode of
inheritance (p<0.001).
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C.17. Determination of quantity, quality and structure of genomic
DNA stored
The quantity of genomic DNA obtained by calculation using the optical density at
260nm and the OD ratios OD260/OD280 are given in Table C.10. (Volume II).
The mean (+ standard deviation) concentration of DNA in the TE was 0.18 + 0.08
pg/pl (or 180ng/pl), with a minimum of 0.059 and a maximum concentration of
0.449 pg/pl.
The mean (+ standard deviation) ratio of optical densities at 260nm/280nm
(OD260/OD280), as an indicator of the quality of DNA was 1.82 + 0.57, with a
minimum of 0.9 and a maximum of 5.1.
Using the EtBr 0.8% agarose gels, large structure DNA (similar to the 23130 base
pair initial band of the X hind III size marker) was identified, migrating only very
slowly in the gel. From the band intensity, usually slightly less than that of the
23130bp band (representing 120 ng DNA), the quantity of DNA in the 1 pi placed in
each lane was estimated to be between 90 and 240 ng/pl (average estimate of 100
ng/pl (data not shown). This was largely consistent with the spectrophotometric
results, apart from the later samples, where spectrophotometry appeared to give
greater DNA concentration than evident on the gel.
C.18. Simulated linkage analysis on the selected group of dogs
The dogs selected as a family subgroup were shown in Figures C.l.a., C.l.b. &
C.l.c., which included the phenotype data available at the time of this analysis.
Dr. Peter Teague of the MRC Human Genetics Unit ran the simulated linkage
analysis program, Simlink. If dogs with undetermined status were included as
"unknown", the maximal achievable LOD score was +2.696 at 9=0.01 (i.e. marker
within one centiMorgan of the disease alleles or +2.154 at 9=0.05 (within 5
centiMorgans). This is not generally accepted as being statistically significant. If
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dogs with equivocal echocardiographic abnormalities were included as Affected, then
a statistically significant LOD score was achievable with a marker within ten
centiMorgans of the disease allele (LOD scores: +5.262 at 0=0.01, +4.447 at 0=0.05
and +2.752 at 0=0.1). A marker giving a statistically significant negative LOD score
of< -2.0 had to be outwith 12 centiMorgans of the disease locus.
C.19. Fluorescent dUTPs for labelling PCR products
It was found that both R110 and R6G FdUTPs incorporated into PCR reactions could
successfully allow detection and genotyping of the products by the ALF/ALP system,
at least for the A15 microsatellite primer set and the individual five DNA samples
under investigation. R110 resulted in slightly greater amplitude peaks.
C.19.1. The value of adding T4 DNA polymerase
For primer pair A15 and the five DNA samples assessed, visual scrutiny of the ALF
gel printouts failed to identify any major difference in the samples treated after the
PCR reactions with T4 DNA polymerase, although peaks not treated with T4 DNA
polymerase were in many cases taller than peaks treated when comparing the same
FdUTP and same DNA sample, although this was not consistent and was not judged
to be significant.
C.20.1. Taq Gold
The experiment to assess whether the use of Amplitaq gold instead of standard Taq
showed that for A15, A29 and A19, the products were more clear with fewer
extraneous bands. F38 did not result in a detectable product with Taq Gold, but there
was a dramatic decrease in the multibanding effect. E41 still showed heavy
extraneous banding and Taq Gold did not result in perceptible improvement.
C.20.2. TD PCR versus Taq Gold
Comparison between the use of Taq Gold and the TD PCR technique using standard
Taq was subjective, based on visualisation ofproducts and any extraneous bands on a
Nusieve EtBr gel by transillumination. The touchdown technique resulted in better
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product detection for K200, K120 and K292 primer sets. The use of Taq Gold
appeared to improve product definition for K212, K39, K32. Detection of products
amplified using K209 appeared similar by both techniques.
C.21. Product detection by Nusieve gel with EtBr detection
Having used four DNA samples for each primer pair to determine whether successful
amplification resulted in discernible products on the agaorse gel, the Nuseive EtBr
gel was used for the primer set which had resulted in the most distinct, bright bands
and obvious polymorphism on the 1.8% agarose gel. However, it was not possible to
accurately determine allele size and between polymorphisms by this system.
Primers for the microsatellite PEZ18 did result in discernible polymorphisms,
although this was not accurate, since sometimes three products were evident in each
lane, and, without trisomy, these could not all represent the two alleles of a
microsatellite, so there was some evidence ofmis-priming (Figure C.3.).
PEZ18
Figure C.3. Newfoundland DNA samples 68 - 84 with PEZ18.
The size marker <f>X is shown and the bands corresponding to sizes of 281/271 (close) and 234 base
pairs are labelled. Although no products are evident in some lanes, there are three or more products in
other lanes, indicating mis-priming.
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This resulted in the need for a more sensitive technique in differentiation of alleles
which only had a small size difference, hence the use of the ALF.
C.22. Genotyping data from microsatellite primers assessed in the
pilot study
Results from analysis of PCR reaction products for each primer pair on EtBr gels and
the ALF/ALP system are presented in Table C.2.b. (Volume II). An example of an
ALF printout is shown in Figure C.4. (scanned image) (Volume II). Product size
determined by the ALF/ALP system was similar to the log-linear derived data from
the EtBr gels for microsatellites PEZ8, 2079, K298 and A15. Compared with the
ALF/ALP system, EtBr slightly over-estimated product size for products of PEZ5,
PEZ11, PEZ18, K336 and F17, and slightly underestimated product sizes of 2137
(although sub-family not run due to insufficient primer) and F66. The EtBr gel was
unable to distinguish product due to faint product or to presence of extra bands,
whereas alleles were clear by the ALF/ALP system for PEZ7 and PEZ22.
Comparison with the expected results (Table C.2.a.) reported in the literature or from
personal communication from Dr. Nigel Holmes showed that similar product sizes
were identified for primers PEZ5, PEZ7, PEZ8, PEZ11, PEZ22, PEZ18, 2137 (not
used on entire sub-family), 2079, K336, F17 and A15. Smaller products were
identified for K298 (122) as well as products similar to the reported size 148 bp
product (138, 142). Smaller product sizes were also identified for F66 (167 - 175bp)
than those reported (184 - 190bp).
No product could be identified for products of 2010, 2018, AHT109, AHT101,
AHT110 or 2001 despite several attempts using different DNAs and different
detection systems.
Products only assessed by EtBr gel showed similarity with expected product sizes for
K200, K32 and A19. EtBr slightly overestimated size of products compared with
reported values for K120, K207, K209, K211 and K292 and slightly underestimated
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for K39. The EtBr system for 2088, E41, K212, A29, A19, E38 and F38 showed
numerous extra bands making allele distinction and sizing difficult or impossible.
C.23. Fitting genotyping data to the sub-family
Initially, the genotype data produced by the ALF/ALP system was marked in the
pedigrees of the sub-family (as in Figure C.l.a., C.l.b. & C.l.c.). If there were
discrepancies identified in the family groups, the ALF print outs were scrutinised to
attempt to resolve any discordant data, and genotype data were revised based on
detection of presumed non-specific bands, stutter peaks, variable strand migration
where both strands were labelled with FdUTPs. In general (personal communication;
N. Flolmes and E. Ryder, Animal Health Trust) alleles should retain similar
appearance throughout a gel, and so the ALF printout appearance was also taken into
account, particularly in making a decision about a homozygote or heterozygote.
The genotype data for each primer pair are detailed for each individual from the sub¬
family in Table C.3. The data generated from using fluorescently labelled primers are
presented in Table C.3.a. and that from products labelled during the PCR reaction by
FdUTPs are shown in Table C.3.b. The individuals are numbered according to the
DNA number and their status correct at the time of the simulated linkage analysis and
the pilot study are also shown.
Genotyping was readily achieved for PEZ11, PEZ7, PEZ8, PEZ5 and 2079. The data
obtained were consistent with the pedigree data (Figures C.l.a., C.l.b. & C.l.c.) and
Mendelian inheritance, as illustrated in for PEZ11 in Figures C.5.a., C.5.b. and C.5.c.
(Volume II). PEZ22 also showed good fit to the pedigree, but the presence of
extraneous bands meant that use of the pedigree was instrumental in some of the
genotyping decisions for this microsatellite and consequently, the use of this
microsatellite would prove difficult if it was used as marker to screen the general
population. A15 genotype data could also be successfully fitted into the pedigree,
once it was decided that low amplitude 187/191 peaks should be ignored; genuine
peaks were of tall amplitude. However, only two alleles with very little
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heterozygosity was evident in this family group making its use for a linkage study
very limited.
Analysis of PEZ18 often showed a 215 bp peak. In the triplets (as shown in the gel
illustrated in Figure C.3.), this was always the associated peak, therefore it was
ignored as an extraneous band, and allele calling then depended on the residual data.
However, despite considering that genotyping had been successfully achieved and
checked, there were problems in matching the genotype data to the pedigree (Figure
C.5. (Volume II). Individuals 32 and 45 did not fit in with parent and the inferred
genotype of sire P263 based on the progeny out of dam 43 and dam 7 was
inconsistent. This incompatibility is detected by the linkage analysis as an error
rendering further analysis invalid.
K336 had a very complex genotype appearance. Progeny of the imported dog, 6, all
showed a very complex, four peaked pattern. Because of this appearance, it was
assumed that this was a heterozygote pattern, and the "double-peaked" alleles were
actually homozygotes where the double strands had slightly differing migrations
under electrophoresis.
It was also very difficult to interpret the ALF peaks for the products of F66.
Eventually, basing genotyping largely on appearance, it could be successfully fitted
to the pedigrees, with the exception of dog 45.
Initially, the ALF printouts and genotype data for K298 were also confusing. In the
first instance, this was because smaller size peaks less than the selected smallest size
marker were detected. The PCR products were rerun with a size marker less than
these peaks. The majority of individuals showed a 138 and / or a 142 peak. In some
dogs, there were peaks identified corresponding to base pair size 122 & 128, but
almost all of these individuals also had a 138 or a 142 peak. Consequently, it was
assumed that the first allele (arbitarily sized as the 122 peak, with an associated peak
corresponding to the 128 peak which was ignored as not being an allele) was
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genuine, with other potential alleles at 138 / 142. The genotype data derived from
these presumptions resulted in good pedigree correlation and could be applied to
other individuals.
The data from the sub-family using primers from F17 was confusing. Allele
appearance was bizarre, with two major peaks, one of which was assumed to be due
to non-specific priming. These were largely 152/160 or 154/162. Occasionally, a
presumed heterozygote appearance was evident, with a 146 or 148 peak occasionally
appearing, or a peak larger than 162, not sized by the ALP analysis (called 16X).
What was apparent was that the gel appeared to change without any regard to family
relationships; peaks of 152/160 suddenly in a lane changed to 154/162 for a number
of lanes and then back. This shift of two base pairs appeared to be genuine on
scrutiny of the ALF printouts, and, surprisingly, the points of the shifts were
repeatable when all the PCR products were rerun on a new gel. For this
microsatellite, no method of interpreting the genotype data would result in a fit to the
pedigree.
The success or otherwise of fit of genotype data to the pedigree (i.e. consistent with
Mendelian inheritance) is noted in Table C.4. (Volume II) for each microsatellite.
C.24. Allele frequencies
In Table C.4., the product sizes for the microsatellite primers are given, representing
the potential allele sizes. The number of alleles appearing in the family was noted for
each microsatellite, as well as the percentage of heterozygotes out of the 38 dogs in
the selected Newfoundland sub-family. The alleles for each microsatellite was
numbered from the smallest to the largest as indicated in Table C.4., and displayed
for the individual dogs in Table C.5. Using the genotype data from this
Newfoundland sub-family (or from all 90 dogs for PEZ11), the allele frequency in
this population was determined and displayed in Table C.4.
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C.25. Linkage Analysis Data
Data are presented in Table C.l 1.
Table C.ll.
LOD scores calculated byMLINK for some microsatellites
oIICD CD II © fS©IICD ©IICD •oIICD CD II O
PEZ11 -999.999 -2.0793 -0.9178 -0.3466 -0.0719 0
PEZ7 -999.999 -2.389 -1.186 -0.54284 -0.1815 0
PEZ8 -999.999 -1.298 -0.521 -0.167 -0.0174 0
PEZ5 -1.269 -0.0418 0.0812 0.0703 0.0275 0
PEZ22 -999.999 -1.2387 -0.4713 -0.1697 -0.03 0
2079 -999.999 -0.1275 0.0597 0.05678 0.0205 0
A15 -0.494 -0.066 0.0238 0.0384 0.0231 0
K336 -1.0763 -0.5633 -0.273 -0.112 -0.031 0
F66 -999.999 -0.611 -0.201 -0.062 -0.0122 0
K298 -999.999 -0.775 -0.2425 -0.0473 0.018166 0
Negative graphs inferred from the data or viewed through Viewlink final.out using
X-windows and the Viewlink capability offered by the HGMP Resource Centre
(designed by Frank Visser) for PEZ11, PEZ7, PEZ8, PEZ22, F66 were consistent
with no linkage being present. K336 was inconclusive with LOD scores between -2
and zero.
A slight positive LOD score was obtained for PEZ5 (peak LOD of +0.07 at 9 = 0.2),
2079 (peak LOD of 0.0597 at 0 = 0.2), A15 (peak LOD of+0.0384 at 0 = 0.3) and
K298 (peak LOD score of +0.0182 at 0 = 0.4) which all offered inconclusive
evidence for linkage. Values were very low.
LOD scores were not obtained for PEZ18 or F17 which had failed to match with the
pedigrees.
338
PRELIMINARY WORK TO INVESTIGATE THE




The incidence of familial DCM in the dog is probably underestimated as the
condition may exist sub-clinically in some family members and it may remain
undetected unless all family members are thoroughly evaluated (Meurs et a! 1996).
As the disease appears usually in adult dogs, owners may not report back to the
breeders informing them of the nature of illness or cause of death in their pet, or if
they do. breeders may not collate the information as they would for a litter of puppies
from each mating. Recognition of familial disease is often the first indication of a
genetic causation. However, this does not exclude the possibility of a non-genetic
factor common to a family of dogs which could be the primary cause of the disease
(Robinson, 1991). In screening families of dogs where FDCM is suspected, it
certainly will be important not to rely just on history or clinical findings, but to assess
pre-clinical disease by echocardiography, as has been illustrated by human series
(Keeling & McKenna 1994; Goerss et al 1995, Keeling et al 1995).
C.27. Familial DCM in this Newfoundland population
The disease frequency in this echocardiographic population of dogs is certainly likely
to be higher than in the general population, due to ascertainment of the families. The
disease was also of late onset and will result in possible underestimate of the
incidence at one point in time, particularly as some dogs may succumb to other
conditions and any cardiac disease is unrecognised in the occult stages.
Similar to most canine pedigrees, there was a significant amount of inbreeding
evident within this population. The kinship coefficient between two parents is
identical to the inbreeding coefficient of the offspring (Pedigree / Draw User's guide
p. 35.). The Pedigree / Draw programme used the Quaas-Henderson iterative method
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of calculating these values. This is one of several techniques used to compute
inbreeding and kinship coefficients in extended pedigrees (Boyce 1983). The
Pedigree / Draw software also allowed the calculation of the mean inbreeding
coefficient to be recorded for each of the three Newfoundland extended families
illustrated in Appendix C.l. Although for presentation purposes, these families were
divided, it should be emphasised that they are all part of the same extended family.
The mean coefficients of inbreeding ranged from 0.0206 (Newfoundland family 3) to
0.04364 (Newfoundland family 1).
C.28. Pedigree Analysis
In the results, the nuclear families were descriptively evaluated in order to infer a
mode of inheritance from scrutiny of these. Matrilineal and X-linked modes of
inheritance were excluded, due to apparent father to son and daughter transmission.
Despite the possibility of autosomal recessive transmission mentioned in the results
section, the presence of echocardiographic abnormalities which normally precede the
development of DCM in progeny of completely unrelated dogs and the presence of
DCM in dogs where no common ancestors were identified in the five generation
pedigrees was felt to be most consistent with an autosomal dominant mode of
transmission. The disease, based on the data acquired in this limited three year
period, did appear to affect ever}' generation although there was one possible instance
of a skipped generation.
The limited duration of the study at the time of writing means that the equivocal
echocardiographic abnormalities cannot be certain to predict DCM and future serial
evaluation is still required. Sire 6, a Canadian import initially believed to be Normal,
used in the major family F7, has progeny illustrated in F9. The presence of
echocardiographic abnormalities in his progeny supported a dominant mode of
inheritance. Flowever, the second scan on Dog 6 showed a FS% of 19% and an
increase in PEP:ET ratio, giving concern about his status. Fie will continue to be
evaluated in the future.
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There appear to be a number of instances of genetic anticipation. This may be defined
as the onset of disease at an earlier age in the progeny than the parents, but may also
refer to a more severe form of disease in the progeny than the parents (Mueller &
Young 1995a). In F5a, female 114 is affected at a young age, and this indicates an
example of genetic anticipation if dam 113 or sire 65 do progress to DCM in the
future. Another possible example of this phenomenon may be shown by dog 99 in
F12, the offspring of DCM dog 10, although the dam, P738 also showed equivocal
abnormalities. This presumes that the ventricular arrhythmia and dFS do indeed
precede the development of DCM in this individual. It may also be argued that this
individual is affected at an early age, because there were abnormalities in both sire
and dam and, if an autosomal dominant condition, homozygosity has resulted in
earlier onset although the severity of the phenotype cannot yet be determined without
monitoring his progression. The possibility of homozygously affected individuals
may be present in F7, but there does not appear to be distinct ages of onset separating
out in the progeny of sire P263.
In study of the nuclear families, it is also tempting to prefer the dominant mode of
inheritance as most familial DCM man is transmitted as an autosomal dominant trait
(Gardner et al 1987; Schmidt et al 1988; Michels et al 1992; Keeling & McKenna
1991; Mestroni et al 1994a; Dnrand et al 1995; Keeling et al 1995; Krajinovic et al
1995; Mestroni et al 1995; Bowles et al 1996; Olson & Keating 1996; Messina et al
1997). Cobb and colleagues (1996) reported that their investigations supported an
autosomal dominant method of transmission in a family of Irish wolfhounds with
DCM.
C.29. Test for fit for a particular mode of inheritance
Results for the test for fit of relative frequency of the disease in the affected nuclear
families versus the estimated frequency of the disease in the general Newfoundland
population of 8% did not confirm a particular mode of inheritance. However, the
frequency was above that expected for an autosomal recessive or a multifactorial
condition, and was less than that expected for an autosomal dominant condition.
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These data are therefore consistent with an autosomal dominant condition with
reduced penetrance. The frequency may be underestimated by the assumption that
unevaluated individuals were normal. Data may be inaccurate if the estimated
frequency of the disease in the population is underestimated or overestimated.
C.30. Segregation Analysis
C.30.1. Family F7
The ability to perform statistically meaningful segregation analysis was limited by the
lack of families where information was available for all or most of the progeny and
both parents. The late onset of the disease was also a confounding factor, as
phenotyping dogs was inconclusive if they were young, and even in the case of older
dogs with a normal post mortem examination, the potential for misclassification of
phenotype is enormous. Family F7 was the most informative for segregation analysis,
despite the lack of a confirmed phenotype or genotype in the father. All the dogs
evaluated sired by P263 out of litter sisters 43 (Normal) and 7 (DCM) appeared to
have confirmed DCM or echocardiographic abnormalities felt to precede the
development of DCM, and other cases had been confirmed or suspected with DCM
not evaluated by the author during this project. The fact that such a large proportion
of the progeny were affected meant that the sire had to be inferred to be affected. It is
unfortunate that no information about his cardiac status could be gleaned. In a
recessive model of inheritance, two affected parents will result in all progeny being
affected, unless penetrance is reduced. Flowever, a subjectively normal although
technically inadequate scan, due to obesity, and a normal post mortem in bitch 43 at
an advanced age means that it is virtually certain that she was phenotypically normal.
She could be a carrier in a recessive model, with 50% of her progeny being normal
but also carriers. The segregation analysis was also limited, and the statistical
package used noted that the Chi squared test was low power and that negative
findings should be interpreted cautiously. It may be argued that unevaluated
individuals should be excluded and ignored, as if they were not part of the family.
This is probably reasonable in the situation of occult disease, where it is assumed
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that owners will randomly decide whether or not to get the dog scanned regardless of
cardiac status. There may be a bias for scanning in a population, however, if owners
have slight concerns about their pet or if they are concerned about the apparent
family prevalence of the disease. It may be argued that unevaluated dogs are slightly
more likely to be normal than dogs submitted for scanning. However, if such dogs
are excluded from the analysis and only confirmed DCM dogs are regarded as
affected (situation (iii)), the Chi squared analysis is consistent with between 50 and
75% of progeny of P263 x 43 and between 75 and 100% of progeny of P263 x 7
being affected. If equivocal echocardiographic abnormalities and suspect DCM cases
were included as affected (situation iv), then between 75 - 100% of progeny of both
P263 matings are affected. Situation (iii) may be consistent with hypothesis 1 for the
P263 x 43 mating, but not for the P263 x 7 mating. Situation (iv) however fits
hypotheses 2 and 3 for both matings. In conclusion, this segregation analysis has
failed to differentiate between an autosomal dominant or an autosomal recessive
mode of inheritance and illustrates the difficulties in making firm conclusions from
inbred dog pedigrees.
It should be considered that there may be another (non-genetic) aetiology responsible
for the disease with such high proportion of the siblings being affected. However, the
two bitches were in geographically different areas of the country, were fed different
diets and had different lifestyles. It is hard to envisage any environmental, nutritional
or viral aetiology being responsible.
C.30.2. All nuclear families
When Chi squared analysis was performed on all the available data from the nuclear
families, the proportion of confirmed and probable DCM cases were not statistically
significantly different from the ratio expected for a population with an autosomal
recessive condition. However, although the bias of ascertainment was avoided as far
as possible, particularly in the second method of analysis, there was potentially a
huge source of error in that large numbers of unevaluated dogs were presumed to be
phenotypically and genotypically normal, in favour of a large proportion of
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"normals". Other sources of error include the presumption that dogs reported by the
breeders to have been affected did have DCM and not another cardiac or respirator}'
disease, and the presumption that equivocal echocardiographic abnormalities do
precede the development of DCM. These latter potential errors are in favour of
increasing the proportion of affected dogs, but this is negated by the fact that the
delayed age of onset and probable incomplete penetrance in this condition means that
some dogs included in the analysis as echocardiographically normal at the time of
examination may not remain normal. It may be argued that these results do not offer
confirmation of an autosomal recessive condition. It is still possible that this ratio
represents an autosomal dominant condition with incomplete penetrance, and over-
estimation of unaffected individuals by including all unevaluated individuals as
"normals". The results again illustrate the difficulty in confirming a mode of
inheritance where knowledge of all individuals in a pedigree is incomplete. It is well
understood that pooling family data is fraught because of incomplete data, possible
inaccurate diagnoses and the potential for genetic heterogeneity for a specific disease
(Emery 1986b).
C.30.3. The Proband method of segregation analysis
The p value obtained by this method, 0.42, was closer to the value of 0.5 expected
under an autosomal dominant hypothesis, although the result was significantly
different. However, it was very much higher than the value of 0.25 expected under
an autosomal recessive hypothesis. The result obtained by this technique would be
consistent with an autosomal dominant trait with reduced penetrance (known to
occur, at least due to age). The result may be unreliable for two reasons. It may be
overestimated by including dogs with equivocal findings or suspected cases as
"affected". It may be underestimated since dogs which had not been evaluated were
included as "unaffected".
C.30.4. The Singles Method of segregation analysis
When the Singles Method of segregation analysis was used on the nuclear families
available, the major requirement for this method to be valid was that all members of
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each reported family were included in the data (Nicholas 1987b). Although this was
done, the family members which had not been evaluated were included as unaffected,
and this results in underestimation of the proportion of affected individuals in the
families. This is probably the major reason why the test results gave a significantly
lower test result ("p") than the proportion of 0.25 expected under the null hypothesis
for an autosomal recessive mode of inheritance and a highly significantly lower "p"
result that the proportion of 0.5 required for an autosomal dominant mode of
inheritance. This technique of segregation analysis was consequently uninformative.
Over time in the future, it is hoped that serial evaluation and recruitment of further
family members will improve the informativeness of such analyses. There are a
number of more complicated methods of segregation analyses described (Emery
1986b), but the limited data available from a limited study makes these invalid at this
time.
C.30.5. The problems encountered in segregation analysis
The method of ascertainment for families is a particularly important consideration,
especially for recessive conditions. If families are only selected on the basis of one or
more affected progeny, families which by chance or due to genotype do not produce
affected progeny are ignored from any statistical analysis (Mueller & Young 1995b).
The bias of ascertainment is much less of a problem for an autosomal dominant
disease. To avoid this, all affected individuals may be assessed regardless of having
any affected relatives (complete ascertainment), which is still truncate since families
without affected offspring are not included in the analyses (Emery 1986b).
Obviously, as not all affected Newfoundlands in the UK were evaluated during this
study, the ascertainment is incomplete. Since one of the aims of the study was to
generate reference echocardiographic data for this breed, and normal dogs were
evaluated, some of which were not related to this extended family, it was hoped that
the ascertainment of the population was not too truncated. Cases were presented
individually, through the breeder, and consequently each evaluated case included
here may be regarded as a proband, rather than a secondary case (i.e. one evaluated
merely because of the presence of disease in a sib) (Emery 1986b). The mode of
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ascertainment for this Newfoundland population may be consequently regarded as
multiple incomplete ascertainment . Valid statistical analyses for such ascertainment
are reported by Emery (1986b) to include the Proband method and the Singles
Method (as used in this study) and the Maximum Likelihood Method, not assessed as
it was mathematically too cumbersome.
These data illustrate the difficulty in statistically proving a mode of inheritance when
a study is limited by (i) absence of information about all family members or all
siblings in an affected family, (ii) uncertainty of phenotype in a disease with acquired
onset, and initially equivocal echocardiographic abnormalities (iii) reduced
penetrance (iv) the possibility of phenocopies. Particular problems in interpretation
of echocardiographic abnormalities were also encountered. Elston (1992) described
the use of computer software to perform a variety of more complex segregation
analyses, allowing for reduced penetrance or multifactorial inheritance, although non-
inbred families are preferred. Even more complex methods of segregation analyses,
based on half-sibs from particular sires, mainly indicated for production
characteristics of farm animals are proposed by Knott and colleagues (1991a;b).
Some of the problems encountered in genetic epidemiology are reviewed by Morton
(1993). Lander and Schork (1994) discussed the difficulties in evaluating a complex
trait, which was defined as any phenotype that did not exhibit classical Mendelian
inheritance. Possible reasons for the absence of fit with classical models of
Mendelian inheritance include the fact that different genotypes may result in the same
phenotype, or the same phenotype may be due to different genotypes (as shown in
human HCM and DCM), or penetrance may be low or incomplete. If there was a
high frequency of disease gene within the population, even a simple trait can be
difficult to map (Lander & Schork 1994), and this may be the case in this
Newfoundland DCM family.
Recent evidence has also shown that a condition may behave in a non-Mendelian
manner in outbred populations despite being due to a single major gene defect
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(Patterson et al 1993). The effect of minor genes on the phenotype of conotruncal
defects in Keeshonden dogs was believed to be responsible for obscuring the simple
Mendelian inheritance of these defects, which were only "unmasked" after ten
generations of inbreeding. It is certainly possible that acquired heart disease such as
DCM may be masked in a similar manner. The authors did not speculate on the
nature of these minor genes.
The various approaches to attempt to determine the mode of inheritance in
Newfoundland DCM failed to confirm a particular mode of inheritance, and both
autosomal dominant and autosomal recessive modes of inheritance were possible.
Scrutiny of the nuclear families with disease apparent in families without any close
kinship coefficient appeared to be most consistent with a dominant trait, and the test
for fit for different modes of inheritance and the proband method of segregation
analysis offered limited but inconclusive support for this trait.
Future work on serial evaluation of young family members and work on the
progression of equivocal echocardiographic abnormalities, as well as recruitment of
new family members, is planned and may help resolve some of these difficulties
encountered in the simple segregation analyses attempted here.
Another major assumption made in this study is that DCM is due to a single gene
defect, and is not genetically heterogeneous. As it is known that human FDCM is a
genetically heterogeneous disease (Schultz et al 1995), this must remain a possibility.
However, in a single, recently evolved and inbred dog breed, this appears unlikely.
C.31. Determination of quantity, quality and structure ofgenomic
DNA stored
The mean concentration of DNA was somewhat variable. In general, there was a
trend to improved concentration during the course of the study (indicated by the
sequential numbers of the DNA identity code), presumably due to improving
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extraction technique by the author. It was noted that samples taken early on during
scanning trips, which had been stored for up to seven days prior to extraction, or
samples that had been posted, had a lower yield. However, the EtBr agarose gel
results suggested that these later samples were not genuinely of significantly higher
concentration. Spectrophotometry tends to overestimate concentration of DNA and
this is particularly so as the machine becomes hot, and this may be responsible in part
to the higher DNA concentrations shown for the later samples.
Although the mean ratio between the optical densities at 260nm/280nm was
consistent with pure DNA, at 1.82, there was considerable variation in this figure.
Some values were significantly lower than this, indicating protein contamination, and
this was felt to be a problem due to inexperience particularly with the earlier samples.
However, there were occasional samples with very high ratio. This was felt to be due
to contamination by the Nucleon silicon resin, which may have been retained in some
samples, although this will not interfere with any molecular biological procedure,
according to the manufacturer's details.
C.32. The simulated linkage analysis data
This subgroup of dogs was selected prior to detailed echocardiographic analysis,
based on the initial assessment of the scans. The final status of the dogs was not
determined, and in some cases, the final phenotype of the dogs may not be
determined for some years. Because there are a number of common ancestors, the
assumption of an autosomal dominant mode of transmission may not be correct. It is
also unlikely that the penetrance in this condition is actually complete, particularly
for younger dogs. This family was also not optimal because there were no equivalents
of nuclear families with phenotype and genotype data from both parents.
Consequently, there were a large number of factors confounding linkage analysis,
especially simulated linkage analysis, in this group of dogs. They were, however,
believed to be the most informative at the time of this pilot study. Although some
significant LOD scores were obtained by the simulated analysis, these were at very
small values of theta; i.e. a microsatellite would only be linked with the disease in
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this small family if very close to the disease gene (within ten centiMorgans). When it
is considered that the resolution of the canine genome map consists of markers a
mean distance of 14.03cM with thirty linkage groups and eleven unlinked markers
(Mellersh et al 1997), it can be seen that identification of a linked marker with this
data would be fortuitous indeed. Since this initial simulated linkage analysis, detailed
echocardiographic analysis has been carried out and a number of dogs have had
repeat scans allowing the pedigree data to be updated. In addition, new family
members have been recruited, and if this analysis was repeated, it is likely to be more
informative. Parallel advances in the canine genome map as well as FDCM in man
mean that prospects are continually improving for this study.
C.33. Optimisation of PCR conditions
Although the PCR conditions advised by the Animal Health Trust were used in this
study, in fact conditions rarely are completely reproducible in different laboratories
or with different thermal cyclers. Although some primers were assessed using
different Taq (Amplitaq and Amplitaq Gold) and whether Touchdown PCR was an
advantage, no attempt to optimise PCR conditions by adjusting annealing
temperatures or magnesium concentrations was made. Undoubtedly, this would be
worth doing. Some methods used in optimisation of PCR reactions are detailed by
Kidd and Ruano (1995). The use of Touchdown PCR may assist in preventing mis-
priming even if the correct discriminatory annealing temperature had been
determined by avoiding secondary problems such as inconsistency of well
temperatures in the PCR block or between thermal cycling machines (Don et al
1991). At the time of this pilot study, we were unaware that the Animal Health
Trust routinely used Amplitaq Gold. However, for the primer pairs requiring standard
PCR showing extraneous banding with standard Taq, improvement was identified in
most of these, with greatly reduced banding. Another comparison was only between
touchdown PCR with normal Taq or standard PCR with the reported annealing
temperature with Taq Gold. It was not assessed whether product definition or
detection would be improved by the use of both techniques together (Taq Gold with
TD PCR). It is probable that this will improve the results and consequently, future
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work with difficult primer sets known to produce extraneous bands will use both Taq
Gold and the TD PCR technique.
To prevent mis-priming events, adding the Taq polymerase only after the reactions
had initially been heated to 94°C was another solution (Thomas et al 1997) (called
Hot Start PCR), although this is made unnecessary if Taq Gold was used.
C.34. Fluorescent dUTPs for labelling PCR products
The experiment to assess the ALF/ALP system's ability to detect and genotype PCR
products incorporating FdUTPs was successful for both R110 and R6G. As R110 has
slightly greater amplitude peaks and it was cheaper, this was then selected for the
unlabelled primers to enable the ALF/ALP system rather than other techniques such
as autoradiography to be used to genotype products. Schwengel and coworkers
(1994) showed that both techniques were similarly successful. Although
incorporating FdUTPs increased the cost of the PCR reactions, ordering fluorescent
5'end-labelled primers would be significantly more expensive than this. However,
primers which have been labelled during synthesis have only one strand (the forward
primer) labelled, so that only one strand of the microsatellite product is labelled.
Incorporation of FdUTPs in the PCR reaction results in labelling of both
oligonucleotide strands, which may have slightly variable mobility, so that peaks may
appear broad and it may be difficult to differentiate allele sizes different in size by
less than four base pairs (Rhodes et al 1997). This was certainly evident with many
of the primers assessed in this pilot study, particularly those amplifying dinucleotide
repeats. This variable mobility may in part be due to the differing content of
nucleotides of complimentary strands. For example, in a dinucleotide repeat
microsatellite (CA)n with complimentary (TG)n strand, FdUTP is preferentially
incorporated into the (TG)n strand as U is complimentary to A. (CA)n strands move
more quickly than (TG)n strands (Litt 1991) and it can be appreciated that FdUTP
will result in a stronger signal due to greater labelling of the (TG)n strand.
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High throughput genotyping ofmicrosatellites for linkage to human disease has been
made possible by incorporation of sets of chromosome specific marker loci and use
ofmultiplexing PCR or multipooling of products onto a single gel (Reed et al 1994).
This requires reliable and uniform PCR reactions and it appears unlikely that such an
approach is suitable for a canine linkage study, due to the cumbersome PCR
conditions required by some primers for canine microsatellites and the difficulty in
accurate genotyping ofmany of these microsatellites. The canine genome map is also
not currently sufficiently defined at the stage to allow such an approach, and it was
not assessed during this pilot study.
C.34.1. The use of T4 DNA Polymerase
The conclusion was made that the addition of T4 DNA Polymerase to PCR products
labelled with FdUTPs did not have a significant effect on the alleles detected and
genotyped and the ALF/ALP system for the primer pair A15 and the five DNA
samples assessed. This suggested that Taq polymerase addition of one base to
amplified products was not a major confounding feature to allele detection or
genotyping for this primer pair (Ginot et al 1996). However, A15 resulted in peaks
that were less broad and less equivocal than some of the other primers which were
supplied unlabelled, and it may, in retrospect, have been useful to assess the
importance of single base addition and T4 DNA polymerase on some of the more
difficult primer sets.
The problem with this addition of single bases to the 3' end of PCR amplified
products is that not all strands receive the extra base (which is usually adenosine). In
part, the final ten minute 72°C extension phase of the PCR conditions is to allow
many of the strands to achieve this extra base addition (Magnuson et al 1996), but for
some primer sets, there is still a considerable mix of products, particularly depending
on the terminal 5' sequence of the reverse primer (Smith et al 1995; Magnuson et al
1996). An alternative solution to this problem is to provide reverse primers with a tail
5'sequence such as GTTTCTT which results in adenylation of the majority of the
strands (Brownstein et al 1996). Such modification means that the complex
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electrophoretic pattern is minimised. This manipulation of the primers is called
pigtailing (Brownstein et al 1996).
C.34.2. Other artefacts encountered during genotyping with FdUTPs
Other artefacts of Taq polymerase which complicate the migration profile of
microsatellites, particularly the dinucleotide repeats with only small difference in
allele sizes, include stutter. Stutter peaks are usually small peaks preceding each
actual allele, which are multiples of two base pairs smaller than the actual allele, and
a number of stutter peaks may be evident preceding each allele. Stutter peaks mean
that the smaller allele is often of greater amplitude than the larger allele in a
heterozygote due to the concommitant stutter peak of the larger allele (Genotyper
v2.0 Handbook, Perkin Elmer). This phenomenon is due to slippage of Taq
polymerase during PCR (Ginot et al 1996). In general, an awareness of the problem
allows accurate genotyping despite the stutter peaks, and in semi-automated
genotyping like the ALF/ALP system, stutter peaks are ignored by the software by
setting the amplitude of stutter peaks to be ignored (usually 70%). The use of
FdUTPs incorporated in the PCR reaction does, however, does make differentiation
between stutter peaks, heterozygote alleles with only small size difference and
addition of single bases resulting later peaks much more difficult, since both DNA
strands are labelled and may have slightly non-uniform migration. In some cases, a
large broad peak which was virtually impossible to genotype resulted.
The extra peaks or bands due to Taq slippage are reported to be more common at
higher temperatures (Litt 1991), and it can be readily appreciated that the high
annealing temperatures or touchdown PCR techniques required by some these primer
sets may exacerbate this problem. In contrast, spurious priming resulting in extra
bands is more likely to occur at lower temperatures (Kidd & Ruano 1995).
C.35. Genotyping data for microsatellites
The log-linear plot using the size standard ladder <j)X174 HaeIII and measuring
migration distance proved to be fairly successful in estimating the expected product
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size, although it tended to overestimate product size compared with reported data or
that obtained by the ALF/ALP system. However, it was certainly useful as a guide
prior to running the sub-family on the ALF/ALP system, in that internal size markers
for each lane (smaller than and larger than expected product size) had to be selected
and loaded. The EtBr detection system and Nuseive gel did not, however, prove to
be sensitive enough to distinguish between polymorphisms or even to identify
heterozygotes versus homozygotes.
It proved to be very difficult indeed to genotype the products of some primer pairs,
particularly if they were labelled during the PCR reaction by FdUTPs. Even
discussion with Dr. Nigel Holmes and Ed Ryder, very experienced in the
interpretation of FdUTP labelled products, did not always confirm a method of
genotyping that would fit to the pedigree, possibly since they were unused to the
ALF/ALP system but were very familiar with the more widely used ABI system.
Although a considerable amount of time and effort went in to genotyping the primers
used for the individuals in the pilot study, this may not be a solution for a full
linkage study. If a microsatellite is difficult to genotype, then even if it is
significantly linked to the affectation status, this marker would not prove to be useful
as a screening tool for the population at large unless the majority of individuals can
be unequivocally genotyped. In species where there are a large number of
microsatellites identified and comprehensive linkage maps published such as the
mouse and human, primers with demanding conditions or equivocal genotype data
are discarded.
The microsatellites and the appropriate primer sequences published by the Animal
Health Trust (Holmes et al 1993; 1994; 1995 ; Thomas et al 1997 were obtained by
screening clones from a canine genomic library in pWE15 (Stratagene) or M13mpl0
and sequencing the dinucleotide repeat sequence and flanking regions for the
generation of appropriate primer sequences. Consequently, clones are available for
each microsatellite. One solution for the difficulty in genotyping with FdUTPs is to
run the clones on an ALF and assessing the resulting appearance and genotype data
353
with the known characteristics of each clone; i.e. whether homozygous, heterozygous
etc.
It is possible to recognise mutation events in microsatellites, when they are followed
through the generations (Brinkman et al 1998). In the example illustrated in Figure
C.6., for the pedigree data for PEZ18 with the sire P263, one may argue that the
novel allele 127 detected in individual 54 may be a mutation. If this dog had
genotype 231/235, then he would be consistent with the other progeny and the
inferred genotype of the sire P263 would be consistent with his progeny out of the
other dam. However, when considering this particular microsatellite, genotying was
problematical and there were other discordant individuals also (dogs 32 and 45)
making it more likely that the incompatibilities identified were due to genotyping
error rather than inherent mutation events.
It was interesting to note that the sire imported from Canada (individual 6) often had
very different microsatellites from the major part of the family. In general, this
resulted in his progeny being very informative, although most of them are not
currently old enough to finally determine their phenotype with regard to DCM.
C.35.1. Allele frequencies and heterozygosity
The problematic dinucleotide repeat amplified using F17 (=AHT133) was reported to
have five potential alleles and expected product size of 154 - 162, with a PIC value of
0.6 (Holmes et at 1995). Consequently, it was very disappointing that in this family it
proved to be uninformative. A15 (reported as AHT104) had four alleles and product
size of 173 - 191 reported by Holmes and colleagues (1995) with a less than optimal
PIC of 0.45, so that it was not surprising that in this Newfoundland subfamily, very
little heterozygosity was identified. The other primer pairs assessed on the ALF had
not been reported with their number of alleles and their PIC, so comparison was not
possible. However, it is only to be expected that a relatively uncommon breed with
presumed small gene pool with a high degree of inbreeding does show a high degree
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of homozygosity; it was surprising that the genotyping data for some of the
microsatellites at least showed a reasonable percentage of heterozygous individuals.
C.35.2. Microsatellites
For a microsatellite to be informative in a linkage analysis study, a high degree of
polymorphism is required. This can be determined by an analysis of allele frequency
in a panel of unrelated mixed and pure bred dogs and it is expressed as the PIC value
(Francisco et a! 1996) which is published with the primer conditions for all the
published microsatellites (see Table C.2.a.). The PIC content is calculated from the
proportion of individuals homozygous and heterozygous for each allele of known
frequency using a formula and computation detailed by Strachan and Read (1996d).
The PIC varies between zero and one, where PIC = 1 represents a perfectly
informative marker. To be useful, markers should have PIC>0.5 with PIC>0.7 being
optimal (Ostrander 1998).
Dinucleotide repeat sequences are much less variable in pure bred dogs than in mixed
breed dogs and this may make them unsuitable for a linkage analysis study (Mellersh
et al 1997). However, the tetranucleotide repeats are generally more polymorphic, as
shown by their PIC value in Table C.2.a., although they do have higher mutation rate
than the dinucleotide repeats (Francisco et al 1996) resulting in detection of non-
parental alleles in some progeny. This mutation rate may differ for different alleles at
the same locus and is more likely to occur in the male germ line (Brinkman et al
1998). There was no conclusive evidence ofmutation identified in this study.
C.36. Linkage analysis and LOD scores
No significant LOD scores were obtained for the ten primers assessed with
informative genotyping data. The majority of the microsatellites were conclusively
not linked to the disease, assessed by maximally negative LOD scores at zero theta.
Some microsatellites were associated with inconclusive LOD scores which even
became slightly positive. However, these were PEZ5, 2079 and A15 and K298,
which had major allele only (PEZ5 and 2079 and K298) or minimal heterozygosity
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(A15) which meant that the equivocal LOD scores were a function of the
uninformativeness of the markers rather than the family.
It would have been exceptionally fortuitous to identify significant linkage in a pilot
study where only ten markers could successfully be used for two-point linkage
analysis. In the linkage studies described for DCM in humans, a significant
proportion of the genome was screened, from 30% (Kass et al 1994) up to 95%
(Krajinovic et al 1995).
In the inbred pedigree present in this Newfoundland family, with common ancestors
and high degree of consanguinity for some matings, there must remain some
uncertainty about the proposed mode of inheritance in this study (presumed to be
autosomal dominant). An autosomal dominant mode of inheritance is by far the most
common reported in the human literature for non-syndromic DCM. However, in
human families, it is probable that any autosomal recessive transmitted disease is
regarded as sporadic since single cases in a family will not be regarded as a familial
disease and ascertainment bias confounds recognition of this transmission (Strachan
& Read 1996e).
It is rarely possible to be completely certain about a mode of inheritance of a
character simply by inspecting a pedigree, particularly ifmany of the progeny are not
screened (or in small human families). In mice, test crosses would be carried out to
check for ratios of affected: unaffected to confirm a particular mode of inheritance
(Strachan & Read 1996e).
The use of two-point and multipoint linkage analysis is dependent on correct
assumptions of modes of inheritance, penetrance and genotype frequencies in the
population. In an acquired disease with delayed and variable age of onset and slow
progression from initial equivocal echocardiographic abnormalities, and in a species
where genotype frequencies for microsatellites are not widely published, let alone in
a specific breed, inevitably a linkage analysis study may be flawed. One technique
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which may be useful is affected sib pair analysis, which does not require any
assumptions and is a powerful tool in the investigation of complex disease (Kruglyak
& Lander 1995). Software for this analysis (MAPMAKER/SIBS) is available at
HGMP-RC. Another new non-parametric analysis has been proposed for complex
traits supported by the GENEHUNTER computer program which is less sensitive to
mis-specification of the linkage model (Kruglyak et al 1996). This has an advantage
over sib-pair analysis in that other pedigree information is utilised. This is available
at HGMP-RC and future work using this program may be very useful. However, an
alternative approach suggested by Greenberg and others (1998) was to use simple
LOD score analysis and a limited set of simple genetic models even for complex
diseases.
C.37. The future and the potential for further investigation of
Newfoundland familial DCM
Identification of a microsatellite marker linked to DCM in this family will allow
screening for the disease prior to the development of any echocardiographic
abnormality or other evidence of the disease being present. How accurate this is in
correctly identifying individuals who do go on and develop the disease will depend in
part on how tight the linkage is. If the marker is sufficiently distant from the putative
DCM disease gene, recombination may occur between the two allowing some
individuals who never develop the disease to be incorrectly labelled, or some "clear"
individuals may go on and develop the disease, having been used for breeding.
Recombination has been a problem in the use of a microsatellite marker for copper
toxicosis in Bedlington terriers (Yuzbasiyan-Gurkan et al 1997; Holmes et al 1998),
although it is still regarded as a useful diagnostic test, particularly in comparison to
the invasive alternative of liver biopsy.
At this stage, identification of a microsatellite by two-point linkage analysis may not
result in identification of the gene defect responsible for DCM in this Newfoundland
family. The canine genome linkage map is not densely packed with markers and
multipoint linkage analysis therefore may not be applicable. It is only once a
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relatively small distance of the genome has been localised by multipoint linkage
analysis that a positional cloning technique may be used in order to identify a known
or a novel gene associated with the disease. Few actual genes have been mapped onto
the canine genome map (Mellersh et al 1997), and it is probable that it will be by
investigation of synteny between genomes of the dog and other, well mapped species
such as the mouse and human that gene loci will be identified. So far, human
chromosome 17 loci have been reported to be syntenic with regions of dog
chromosomes 9 and 5 (Werner et al 1997). Other parallel advances required for
future work in the genetics of canine DCM include karyotyping of the canine
chromosomes, an area currently under active investigation (Fischer et al 1996;
Langford et al 1996; Thomas et al 1997).
A canine BAC library has been recently imported into the UK and is a resource held
by HGMP-RC. Bacterial artificial chromosome (BAC) vectors are used for DNA
cloning and in this case it has been applied to canine genomic DNA from a male
Dobermann, cloned in the pBACe3.6 vector. This may be of concern in investigating
DCM using this particularly canine BAC library because of the prevalence of DCM
in this breed.
C.38. General discussion about the genetics of DCM
There are a number of possible candidate genes that may be associated with DCM.
Genetic evidence available to date implicates abnormalities of genes encoding
cytoskeletal proteins in naturally occurring DCM as well as experimental models.
These include dystrophin abnormalities (Stevenson et al 1998), actin (Olson et al
1998), abnormalities of the dystrophin associated glycoprotein complex, such as
sarcoglycans (van der Kooi et al 1998), adhelin (a sarcoglycan) (Fadic et al 1996),
probably tafazzins (D'Adamo et al 1997) and possibly emerin (Cartegni et al 1997).
In a single DCM patient (of 23 screened), deficiency of the cardiac specific
cytoskeletal protein, metavinculin, was identified (Maeda et al 1997). Metavinculin
is an isoform of vinculin, and is located at the intercalated disc and the
subsarcolemmal attachment sites of non-sarcomeric actin.
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Further support of the importance of the cytoskeleton in DCM was gained when the
gene involved in autosomal recessive cardiomyopathy in the Syrian hamster, was
identified to be a fairly cardiac specific 5-sarcoglycan gene mutation, resulting in
absence of the element from the myocardium and depletion in the skeletal muscle
(Nigro et al 1997).
The dystrophin associated glycoprotein (DAG) complex spans the sarcolemma to
provide linkage between the subsarcolemmal cytoskeleton and laminin, a major
constituent of the extracellular matrix (ECM) (Fadic et al 1996). Several different
muscular dystrophies are the result of disruption of different components of the link
between the muscle cytoskeleton and the extracellular matrix. Fadic and colleagues
(1996) postulated that the structurally weakened sarcolemma may rupture under
mechanical stress, allowing calcium and other extracellular components to enter the
cell, which may eventually result in cell death. It seems reasonable to presume that a
similar mechanism may also result in DCM if the primary defect was in one of the
cytoskeletal proteins.
Rampazzo and others (1994) also noted that the dystrophinopathies are possibly
related to a stretch modulated Ca channel. The right ventricle is particularly sensitive
to stretch, as putatively manifested in the early involvement of the RV in Becker's
muscular dystrophy, and these authors thought that the ARVD gene may be an as yet
unknown component of the cytoskeleton specific to myocardial cells. In a later
publication identifying a fourth ARVD locus, Rampazzo and colleagues (1997).
observed that family members with active sport involvement had a more severe
manifestation of symptoms than those more sedentary family members. It is known
that exercise results in volume and pressure overload of the heart.
Mutations in the muscle LIM protein, encoded by the MLP gene, have been shown to
result in DCM in mice (Arber et al 1997). Muscle LIM protein is thought to serve as
a scaffold for organising the assembly of contractile proteins into sarcomeres along
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the actin cytoskeleton (Leiden 1997). MLP -/- mice show similar perturbed
cytoarchitecture as human DCM, although histological findings in the mouse model
are more dramatic. MLP immunoreactivity shows the protein to be associated with
the Z lines of the myofibrils, associated with vinculin (known to be involved in
anchorage of the actin based cytoskeleton to the cell membrane) (Arber et al 1997). Z
line associated structures are responsible for the lateral alignment of myofibres and
their lateral anchorage at N-cadherin and vinculin containing costameres along the
cell membrane. MLP deficient mice show disruption of the Z lines, and the gap
junctions, identified by connexin 43 immunofluoresence, are less well ordered (Arber
et al 1997). Similar changes in the cardiomyocyte ultrastructure was reported in
naturally occurring human DCM when comparing explanted human hearts with
normal pig hearts (Schaper et al 1991). Arber and others (1997) postulated that
increased load after birth resulted in systemically acting factors and stress sensors in
cardiomyocytes which induced and controlled a hypertrophic response. In the
absence of MLP in this mouse model, the deficits in cytoskeleton architectural
organisation resulted in impaired cell and tissue tension, so that, in the presence of
hypertrophic stimuli, the cardiomyocytes expanded but failed to generate sufficient
tension to control the hypertrophic response eventually resulting in hypertrophy
(increased heart mass) and dilatation consistent with DCM.
These cytoskeletal proteins act as a scaffold for force generation by interacting with
myosin (actin) or transmitting force to the extracellular matrix or adjacent
cardiomyocytes. Despite initial logical suggestions (Mestroni et al 1994), the defect
with DCM does not generally appear to be an abnormality of force generation or
sarcomeric proteins themselves. The hypothesis postulated by Olson and colleagues
(1998), when discussing actin mutations, that DCM results from an episodic defect in
force transmission, predisposing cardiomyocytes to mechanical injury and
cumulative cell death, secondary interstitial fibrosis and cardiac dilatation, would
appear to be logical to the other cytoskeletal abnormalities, whether naturally
occurring or experimental. Exertion, by resulting in volume or pressure overload on
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the cardiomyocytes with altered function, may accelerate this degenerative process
(Stevenson et al 1998).
Kaprielian and colleagues (1998) showed that DCM resulted in increased cell length
compared with ischaemic cardiomyopathy, where cell slippage was the mechanism
for cardiac dilatation. In DCM, maintenance of myocyte spatial relations with
increased cell length may be explained by cytoskeletal protein abnormalities, and
may explain the apparent cyclicity of echocardiographic changes in serial evaluation
of relatives with abnormalities possibly preceding occult DCM. Cardiomyocyte
slippage in ischaemic myocardial disease precludes the possibility of recovery of
function.
Unravelling the genetic defect(s) behind the cytoskeletal abnormalities associated
with DCM may result in better understanding of cardiomyocyte structure and
function, which could potentially direct novel treatments directed against the
pathogenetic mechanism resulting in cardiomyocyte damage. The Syrian hamster
model of cardiomyopathy is associated with absolute deficiency of 5-sarcoglycan and
depleted sarcoglycans and a-dystroglycan. It has been shown that adenoviral
construct containing human 5-sarcoglycan can effectively restore all the sarcoglycans
and a-dystroglycan, showing the potential for in vivo gene therapy (Holt et al 1997).
The extracellular matrix (ECM) proteins are also believed to be important in DCM.
Collagen sub-types I and III are essential components in the ECM. Characteristic
differences have been reported in the ECM in a variety of heart diseases including
DCM. In DCM, the ratio of collagen subtypes I:III is increased, which is not
correlated to the degree systolic dysfunction (Pauschinger et al 1998) but it may be
associated with diastolic dysfunction or decreased LV compliance (Marijianowski et
al 1995). Collagen is believed to be the major structural component determining the
architecture and functional integrity of the myocardium (Gilbert & Wotton 1998).
Collagen struts and tethers interconnect myocytes and prevent cell slippage. The
presence of collagenolytic enzymes, promatrix metalloproteinase-9 activity and
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neutrophil elastase actvity, suggests that increased levels in Dobermann DCM may
reflect structural remodelling (Gilbert et al 1997). The elevation of these enzymes
also supports the presence of inflammation (despite no histological evidence of an
inflammatory infiltrate) (Gilbert et al 1997) which Baig and colleagues (1998)
speculated may be the cause of left ventricular enlargement early in the course of
human occult DCM.
The cause of apparent upregulation of the genes encoding ECM proteins may be the
result of other substances, particular transforming growth factor pi (TGFPi),
angiotensin II, aldosterone, noradrenaline and endothelin. What is unclear is whether
the changes in ECM proteins cause the heart failure or whether they are the result of
some other primary process. It is apparent that neurohormonal factors are important
in the interaction between the cardiomyocyte and ECM (Boluyt & Bing 1995).
The observation by Tidholm (1998) and Tidholm and colleagues (1997; 1998a;b)
that histological evidence of attenuated wavy fibres is a diagnostic criterion for the
presence of DCM with high sensitivity and specificity is controversial and is
dismissed as fixation artefact by some pathologists (R. Else, personal
communication). However, it is conceivable that this finding is the result of altered




The limited evidence from this study suggests that the echocardiographic diagnosis of
left ventricular enlargement or depressed fractional shortening do predict the more
conventionally accepted findings of occult DCM. However, this is based on limited
serial evaluation over a relatively short time course (maximum three years). Future
evaluation of dogs in this study will confirm or refute these findings. A longer term
study is certainly indicated, in that the progression of early echocardiographic
abnormalities to DCM appears to be slow in this breed, which normally has relatively
benign disease, compared with other breeds such as the Dobermann.
Serial echocardiographic evaluation is also indicated in this family in order to
conclusively determine a phenotype for most individuals, so that the future work with
two-point genetic linkage analysis is robust. It is necessary to be certain about the
mode of inheritance and the true prevalence of the disease to enhance the prospects
for identifying a marker, significantly linked to the disease, which may be used for
future screening of this population.
Early identification of occult DCM or predictors of this condition is important. There
are general management reasons for this. The owners knowledge will result in better
observation and improved recognition of early abnormalities suggesting that the dog
is decompensating. The dog's veterinary surgeon was routinely informed about
abnormalities once the diagnosis of occult DCM was not equivocal. This resulted in
improved patient monitoring and special care taken, for example if the dog required a
general anaesthetic. The recognition of occult disease also has a bearing on the
timing of therapeutic intervention.
The results of this study are consistent with the conclusions ofMcMurray and others
(1998), that screening for asymptomatic left ventricular dysfunction to prevent heart
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failure is worthwhile, although it is arguable that echocardiographic screening is cost
effective in both canine and human cardiology.
There has been some evidence that Newfoundland with DCM in the USA may be
taurine deficient and may respond to taurine and L-carnitine supplementation
(Sisson, D., Veterinary Cardiology Email discussions). Newfoundlands may have
cysteinuria (Casal et al 1995), which may result in urinary loss of taurine or L-
carnitine, with consequences on myocardial function. This has been reported in a
Dachshund (cited by Kittleson 1998). One Newfoundland was reported in a group of
other breeds with cysteine or urate urolithiasis, where 13/15 dogs were identified to
be taurine deficient, although it was not clear whether the Newfoundland was
affected (Pion et al 1998). Seven of these dogs had or developed DCM, although
again it was unclear whether this included the Newfoundland. In the future, it will be
important to assess plasma taurine levels in cardiomyopathy Newfoundlands and this
is proposed.
The new index of combined systolic and diastolic myocardial performance proposed
by Tei and colleagues (1995) appears to be a promising method of distinguishing
between normal and abnormal myocardial function. There have been no reports of its
use in patients with very early DCM. Future studies will evaluate this index in
normal and conclusively cardiomyopathic Newfoundlands and Newfoundlands in the
other categories.
It is slightly concerning that two manifestations of DCM were recognised in
Newfoundlands. One form was associated with marked left ventricular dilatation and
hypokinesis, with proportionate left atrial enlargement. The other was associated with
minimal left ventricular dilatation, less severe hypokinesis but marked left atrial or
biatrial enlargement. Although both forms occurred in the same family, for future
genetic analysis it is important to validate that these are both different manifestations
of the same disease, presumed to be due to the same gene defect. If this is not the
case, then progress in genetic linkage analysis will be slowed. The description of
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mildly dilated congestive cardiomyopathy (MDCM) in man suggests that these cases,
which may be similar to the Newfoundlands with minimal left ventricular
enlargement, often do have a positive family history for classical DCM (Keren et al
1990) and it may be that this is variable manifestation of the same disease. There was
minimal or no myofibrillar loss in the MDCM patients, which finding the authors
believed may have been responsible for the preservation of fairly normal cardiac size
in this group, despite deteriorating haemodynamic status and eventual death due to
intractable congestive failure.
In most Newfoundlands in this study, DCM was a late onset disease. This resulted in
difficulty in younger dogs in determination of the phenotype. Serial evaluation of
such individuals through their lives will aid this final phenotyping. In a study over a
limited time period, such as the three year study reported here, it is not possible to
confirm with certainty that the dogs with equivocal echocardiographic abnormalities
such as depressed fractional shortening or left ventricular enlargement do indeed all
progress to DCM. Some of these findings may be limited manifestations of the
disease, as suggested in human relatives of DCM patients (Baig et al 1998). There
may be a continuous spectrum of phenotype from the grossly normal heart to the
overtly cardiomyopathic, as described in genetically determined human hypertrophic
cardiomyopathy (Hagege et al 1998). New, more sensitive diagnostic criteria may be
indicated. Although this had been an initial aim of this study, because of the slow
progression of equivocal echocardiographic abnormalities to overt DCM in
Newfoundlands, this was not possible over a three year time period, but it is hoped
that such guidelines can be provided for this breed with future evaluation of these
individuals.
This study has laid the foundation for a genome-wide linkage analysis study and
other molecular genetic techniques in the investigation of FDCM in the
Newfoundland breed, which may have implications for improved understanding of
the aetiopathogenesis of this condition, its diagnosis and treatment.
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In conclusion, this study has confirmed that DCM is a familial disease in the
Newfoundland breed, with probable autosomal dominant mode of inheritance.
Echocardiographic abnormalities do precede the development of DCM, but at this
stage, it is not possible to state that they are pathognomic for incipient disease. Future
work is indicated and will be carried out with serial evaluation of family members
showing equivocal echocardiographic abnormalities in order to confirm phenotype
and determine the progression of DCM through the earliest stages. New family
members will be recruited in order to attempt to define the mode of inheritance more
conclusively. The family is suitable for a linkage analysis study.
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